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ABSTRACT 
Human biomonitoring (HBM) measures the levels of substances in body fluids and tissues. Many countries have 
conducted HBM studies, yet little is known about its application towards chemical risk assessment, particularly 
in relation to food safety. Therefore a literature search was performed in several databases and conference 
proceedings for 2002 – 2014. Definitions of HBM and biomarkers, HBM techniques and requirements, and the 
possible application to the different steps of risk assessment were described. The usefulness of HBM for 
exposure assessment of chemical substances from food source, and for the implementation of a systematic Post 
Market Monitoring (PMM) approach for regulated chemical substances was evaluated. An inventory of HBM 
programmes provides detailed information about study design, analytical methods, reference values (RV) and 
biomarkers used. Environmental monitoring and associations between HBM values and food, as well as 
coverage of substances and remaining deficits are highlighted. The review of study results provides information 
on emerging chemicals, higher exposed and particularly vulnerable populations. 
Conclusions: HBM can bring added value for chemical risk assessment in food safety areas (namely exposure 
assessment), and for the implementation of a systematic PMM approach. But further work needs to be done to 
improve usability. Major deficits are the lack of HBM guidance values on a considerable number of substance 
groups, for which health based guidance values (HBGVs) have been developed, insufficient knowledge 
regarding exposure sources, and incomplete dietary intake assessment. Recommendations: We recommend to 
foster development of HBM based guidance values and validated analytical methods/BMs, stronger inclusion of 
substances of interest for EFSA in European surveys, expanded monitoring of highly exposed and vulnerable 
subgroups, uptake of EFSA guidance concerning dietary intake assessment, as well as biobanking, surveillance 
synergies and targeted research, and an EU wide collaborative approach to support the future use of HBM in 
PMM. 
©BiPRO GmbH, 2015 
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SUMMARY 
This report is based on an extensive literature search in major relevant databases such as Medline 
(Pubmed) and SCOPUS, in recent conference proceedings of 19 related scientific societies, in grey 
literature and in publicly available information from scientific research studies as well as on 
supplemental searches for specific topics from January up to October 2014.  
The search focussed on methodological studies and reviews discussing the use of human 
biomonitoring in risk assessment, on observational studies assessing the association between chemical 
body burden and food intake, on cohort studies and cross-sectional HBM surveys and on reviews or 
studies regarding reference and health-based guidance values (HBGVs), emerging chemicals and 
vulnerable population groups. From the 19,704 hits, the project team identified 1,201 eligible 
references and eventually selected 252 references (235 full text publications) for this report. 
As a first part it provides an overview on human biomonitoring (HBM) and possible application to 
human risk assessment via a critical review of literature to address advances in HBM activities and its 
application to chemical risk assessment over the last decade with a particular focus on applications to 
the food safety area. This includes the definition of HBM, a description of HBM techniques and 
requirements, the possible application of HBM to the different steps of risk assessment, an in-depth 
evaluation on the usefulness of HBM for exposure assessment of chemical substances from food 
source including strengths and limitations and the implementation of a systematic Post Market 
Monitoring (PMM) approach for regulated chemical substances (objective 1). The second part of this 
report provides an inventory of the different HBM surveillance programmes/initiatives at national, EU 
and international levels along with a comparative analysis in order to evaluate the added value for 
chemical risk assessment (objective 2). Finally, the report provides a review of results from HBM 
studies, allowed identifications of emerging chemicals or chemical classes of possibly higher exposed 
sub-groups or specific vulnerable groups of a population and of other issues relevant for EFSA’s risk 
assessment activities together with an inventory of validated biomarkers of exposure to chemicals that 
can be found in the diet identified through HBM (objective 3).  
The overview on HBM and its possible application to human risk assessment shows that there is no 
official definition of HBM. HBM is commonly understood as a method for assessing human exposures 
to natural and synthetic compounds based on analysis of biomarkers (BM). BMs of exposure are 
chemical substances or their metabolites measured in human biological matrices such as blood, urine, 
hair, adipose tissue, teeth, saliva, breast milk or nails. HBM techniques and requirements comprise the 
development of a study protocol, recruitment of study persons, informed consent, sampling and 
thorough sample processing, chemical analysis, data management, interpretation and communication. 
HBM can be applied to the different steps of risk assessment, but its obvious core role lies within 
human exposure assessment. The evaluation on the usefulness of HBM for exposure assessment of 
chemical substances from food source shows that the main strength of HBM is the fact that it is the 
only available tool that integrates exposures from all sources and provides data to epidemiology. HBM 
can demonstrate trends and changes in exposure, establish distribution of exposure among the general 
population, identify vulnerable groups and populations with higher exposures and emerging chemical 
risks. It can reduce the assumptions regarding consumption rates and is often more specific and 
sensitive than environmental monitoring in assessing the degree of recent and past exposure to 
chemicals. Major limitations for use of HBM in risk assessment are the facts that HBM alone cannot 
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provide information about the source of exposure or how long a chemical has been in the body, and 
HBM raises ethical and privacy issues because it involves human samples. HBM data need to be 
combined with other data and tools for interpretation in risk assessment. This includes environmental 
monitoring data, reverse modelling or HBM-related guidance values that translate a biomarker 
concentration into established guidance values from risk assessment (e.g. ADI/TDI, RfD). HBM is 
considered useful for the implementation of a systematic Post Market Monitoring (PMM) approach for 
regulated chemical substances because it could verify risk assessment results. It could be used to 
monitor real exposure and could detect exposure in case of unexpected complaints. The strength and 
limitations are similar to those from exposure assessment.  
The inventory of the different HBM surveillance programmes/initiatives at national, EU and 
international levels comprises a detailed evaluation of 37 programmes in the European Union and 
around the world in terms of funding, study frequency and design, study population and recruitment, 
analysed chemicals and matrices, Biomarkers, analytical methods and biobanking, results and 
interpretations, any additional measurements of exposure sources, communications of results and 
policy support. This inventory provided the basis for a comparative analysis among the HBM 
programmes. The comparative analysis of the results shows that HBM programmes in most cases are 
funded by the respective government and are mostly cross-sectional surveys with several longitudinal 
large-scale birth-cohorts established namely in Denmark, Norway, France and Japan. Long-term 
regular surveillance system currently exists in the USA, Germany, Czech Republic, Flanders, 
Slovenia, and South Korea. While retrospective analysis of time trends based on bio-banked samples 
is currently only conducted in Germany, there are systematic biobanks from the Danish birth cohort 
study and the Canadian national survey. The majority of investigated HBM programmes is performed 
with adults, but also elderly, adolescents, children and new-borns are increasingly included. Study 
populations range from less than 1000 to more than 100,000 participants. Metals (particularly 
cadmium, lead, and mercury), PCBs, and cotinine are the most studied chemicals among the 
investigated HBM programmes, whereas mycotoxins, fungus-specific IgE, a few selected fungicides, 
perchlorate, nitrosamine and alkaloids have only been measured in single programmes. The broadest 
range of chemicals has been covered in the investigated programmes of the USA, Canada, Flanders, 
France and Japan. Reference values (RV) tend to be stratified by region, age and gender or life-style 
and can be compared with HBM-related guidance values when available. Blood and urine are by far 
the most approved biological matrices. However, human milk is also used for persistent organic 
pollutants, and hair and saliva have become important specimens in more recent years. While many 
HBM programmes include investigation of exposure sources or additional environmental monitoring, 
only 7 out of 37 programmes included measurements in food and drinking water. Food-related 
questions have been used in roughly 60% of the investigated studies, but customised 24-hr food recall 
method according to EFSA recommendations were only used in France, Czech Republic, the USA and 
South Korea.  
The review of the results from the investigated HBM studies shows that HBM contributed to the 
identification of pyrethroids, herbicides, parabens, acrylamide/glycidamide, and nitrosamine and 
nitrate as smoke flavouring as well as perfluorinated compounds (PFCs) as emerging chemicals  in the 
sense of the EFSA definition of emerging risks. In the past HBM was able to raise awareness for 
unexpected risks from other substances groups such as heavy metals, dioxins and PCBs, brominated 
flame retardants, carbamates, and mycotoxins have been investigated as “emerging” chemicals. 
Pregnant women and foetuses, children, and in some cases elderly have been identified as possibly 
higher exposed sub-groups or specific vulnerable groups for specific groups of chemicals, including 
some with food as major exposure source. Higher socio-economic class can either be a protective or a 
risk factor to contamination from food source. Investigated programmes established reference values 
(RV) for roughly 70 substance groups, namely for various metals, PAH, phthalates, dioxins, 
pesticides, as well as for aromatic amines, perfluorinated chemicals, environmental tobacco smoke and 
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volatile organic compounds. Germany and the USA have developed HBM values and biological 
equivalent values, respectively, for direct comparisons between these values and values determined 
from HBM programmes.  
Validated BM of exposure shall reliably and accurately reflect target tissue concentrations, and shall 
be measurable in a robust, consistent and reproducible way. This requires a validation of the analytical 
test methods, demonstrating besides other appropriate selectivity and specificity, accuracy, precision, 
reproducibility, and analytes stability. BM used in population studies are generally covered by 
standard operating procedures as well as by internal and external quality assessment schemes, and 
follow the agreed validation criteria. BM meeting these criteria are available for roughly 20 substance 
groups. For metals, dioxins, furans, PCBs, PBDEs, parabens, mycotoxins, etc. the BM is the parent 
substance measured in the matrices. For phthalates, polyaromatic hydrocarbons, organophosphate, 
organochlorine and pyrethroid pesticides, acrylamide, and nitrosamine, validated BM of exposure are 
metabolites or haemoglobin adducts. 8-OHdG is envisaged to be analysed as BM of oxidative DNA 
damage. However, there is a considerable lack of BM, HBM related guidance values and RVs for a 
wide range of substances, for which HBGVs have been developed by the European Food Safety 
Authority, the Food and Agriculture Organization of the United Nations in conjunction with the World 
health Organisation or by the US Environmental Protection Agency. These deficits are particularly 
strong for several classes of currently used pesticides, mycotoxins, veterinary pharmaceuticals, food 
contact materials and food additives, flavouring agents, food preservatives and also include 
nitrosamine, perchlorate, 3-MCPD, or mineral oil hydrocarbons.  
BMs of effect and the "exposome" as attempts to establish high throughput tools and to close the 
causality gaps are current research priority, but further efforts are needed to allow for application in 
surveillance. In addition there are political obstacles in the European Union that hamper the use of 
HBM. These relate to a lack of legal frameworks that requests the use of HBM, and to the subsidiary 
principle, with major responsibilities allocated to the Member States, wheras European institutions 
would need comparable data on a European scale.  
Therefore, it is recommended to foster the development of HBM specific health based guidance values 
as core tools to translate HBM data to intake limits set, and to continue work on suitable data for 
environmental and food contamination and reverse modelling to facilitate interpretation of results. It is 
recommended to promote monitoring of substances of interest for EFSA and to expand substance 
coverage and ensure long-term HBM programmes throughout EU Member States in order to increase 
the number of HBM RVs. The monitoring in different age groups and of different dietary schemes 
should be expanded to get better information on particularly exposed subgroups, and longitudinal and 
cross-sectional approaches should be combined for an improved knowledge on potential health risks. 
In addition it was beneficiary to promote coherent use of customised 24-hr food recall method 
according to EFSA recommendations and reporting on food quality and quantity in order to improve 
knowledge on exposure source, and to establish a coherent documentation for HBM data in order to 
ensure better comparability of reported RVs. Wider use of biobanking and biobanked samples should 
be promoted in order to be able to trace back time trends for newly identified threats, and surveillance 
synergies should be further explored to limit costs and increase participation rates. It is recommended 
to evaluate the added value of BM of effect and OMICs technologies for food risk assessment and to 
continue targeted research, as well as efforts towards reducing the political obstacles in the European 
Union, which hamper the use of HBM by supporting development of an European wide collaborative 
approach, such as the recently started European HBM Initiative (EHBMI). These steps would support 
the future use of HBM in exposure assessment and PMM in risk assessment in the food safety area as 
relevant for EFSA. 
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Detailed information on the approaches of and results from literature search are presented in Appendix 
A. (search strategy from Tables 22-23), Appendix B. (results of the reviewed HBM programme from 
Table 24-37, summary of analytical methods used at Table 38 and an inventory of validated 
biomarkers at Table 39), Appendix C. (summary of reference values, health-based guidance values, 
HBM and BE values from Tables 40-43) and Appendix D.  (HBM-established reference values by 
substance from Table 44-Table 110). 
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 BACKGROUND AS PROVIDED BY EFSA 
Human biomonitoring (HBM), defined as systematic standardized measurement of concentration of a 
substance or its metabolites in human tissues (such as blood, urine, milk) has become an important 
tool in evaluating exposure to chemicals in the general population and specific subgroups (Angerer et 
al., 2007). The measured concentrations are commonly referred to as “body burdens” of these 
substances, and biomarkers are indicators of the chemical burden in the human body.  
HBM have been applied in exposure assessment to evaluate human exposures to chemical 
contaminants acquired through the environment, including food consumption. Over the years, many 
emerging chemicals of concern, such as brominated flame retardants (BFRs), perfluorinated 
compounds (PFCs), phthalates and phenols [including bisphenol A (BPA)] have been identified 
through HBM, measuring their increasing presence in populations (Casas et al., 2013; Llop et al., 
2011). Modern analytical methods make it possible to measure a wide range of chemicals in the 
human body even at very low levels. HBM can thus be used to monitor combined or mixed exposure, 
an issue of increasing concern in risk assessment (Silins & Hogberg, 2011).  
HBM can identify (i) new chemical exposures, trends and changes in exposure; (ii) establish 
distribution of exposure among the general population; and (iii) identify vulnerable groups and 
populations with higher exposures. It is generally recognised that HBM data have the advantage in 
providing information on: (i) the internal exposure of humans to chemicals or their metabolites; (ii) 
exposure from all sources including food; (iii) the whole body burden of a chemical taken up by 
ingestion and other routes. However, it should be noted that HBM by itself does not provide 
information on the source(s) or route(s) of exposure, and environmental exposure data are rarely 
collected at the same time as HBM. Additional research studies to identify the relative contribution of 
the numerous sources and routes by which humans are exposed to environmental chemicals are often 
needed.  
HBM can be used also to estimate a biological effect if a relationship has been established between the 
biological measurement and the health outcome. In this case, the associated effect to chemical 
exposure is quantified by measuring reaction products in human tissues or specimens. For a few 
chemicals only, such as lead, human data from occupational and other clinical studies allow the 
identification of body burdens for a chemical that may result in an adverse effect. For most chemicals, 
however, there are no adequate human data to be certain about health effects, particularly at very low 
chemical concentrations. In addition, most environmental exposures involve multiple substances, and 
attributing cause to a single hazard can often be difficult (Paustenbach & Galbraith, 2006). Thus, 
HBM studies can only provide information on correlations between health effects and internal 
exposure, but not a causal correlation.  
Measuring levels of chemicals in human body fluids and tissues has been in routine use in industry 
and parts of the wider public health community for more than 50 years. Currently, many countries like 
the United States, Canada, Germany, Denmark, Czech Republic, Belgium and France have established 
biomonitoring programmes that report representative values of selected biomonitoring values in non-
occupationally exposed populations (CDC, 2011; Cerna et al., 2012; Fréry et al., 2012; Health Canada, 
2010; Kolossa-Gehring et al., 2012; Schoeters et al., 2012a; Thomsen et al., 2008; Wojtyniak et al., 
2010). These programmes complement a range of other monitoring activities to investigate the levels 
of chemicals in the environment, including food. In other countries biomonitoring has not been 
institutionalised; however there are many biomonitoring studies that have taken place.  
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The value of HBM was recognised by its central role in the European Environmental and Health 
Action Plan 2004-2010 (COM 2004). However, its potential is not yet utilised. Limitations are mainly 
caused by lack of standardization in methodology (i.e. sample collection), validated biomarkers 
availability, and data integration and interpretation. Action 3 (Development of a coherent approach to 
HBM - European Environmental and Health Action Plan or EHAP 2004-2010) provided a background 
for the establishment of an expert network of European Union (EU) Member States (MS) as a first 
step towards a harmonised HBM study. EU MS are contributing to the harmonization of HBM 
methods in Europe through different projects (Consortium to Perform Human Biomonitoring on a 
European Scale (COPHES) http://www.eu-hbm.info/cophes; Demonstration of a study to Coordinate 
and Perform Human Biomonitoring on a European Scale (DEMOCOPHES) 
http://www.euhbm.info/democophes)  (Joas et al., 2012).  
Considering the possible major implications of HBM methodology for human exposure assessment of 
chemicals, the recent advancements and the challenges evidenced from national, EU and international 
programmes and research studies, it is not clear to which extent HBM can be reliably applied to risk 
assessment. For this reason, this procurement aims to critically review the state of the art of HBM with 
a view to discussing its application to chemical risk assessment in the area of food safety. 
TERMS OF REFERENCE AS PROVIDED BY EFSA 
The aim of this procurement project is to conclude a direct contract for the execution of specific tasks 
over a clearly defined period as defined in these tender specifications. 
The overall objective of this study is to provide an overview on HBM and possible application to 
human risk assessment via a critical review of literature (published and grey, when relevant) to address 
the last decade’s advances (i.e. from 2002 onward) in HBM activities and its application to chemical 
risk assessment, with a particular focus on applications to the food safety area. 
The assignment should cover the following specific objectives: 
Objective 1: 
To provide an overview on HBM and possible application to human risk assessment, including: 
1.1  Definition of HBM and description of HBM techniques and requirements, such as 
possible biological matrices, recruitment and sampling procedures, feasible parameters, 
suitable and reliable analytical methods, data interpretation and communication; 
1.2  The possible application of HBM to the different steps of risk assessment (exposure 
assessment, hazard identification, hazard characterisation and risk characterisation) in 
food safety areas (as relevant for EFSA) where HBM (and related biomarkers) can make 
a significant or unique contribution (e.g. assessment of chemical contaminants, or 
regulated chemical substances such as food contact materials, pesticides, etc.); 
1.3  An in-depth evaluation on the usefulness of HBM for exposure assessment of chemical 
substances from food source (chemical contaminants and regulated chemical substances), 
including strengths and limitations, and for the implementation of a systematic Post 
Market Monitoring (PMM) approach for regulated chemical substances. 
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Objective 2: 
To provide an inventory of the different HBM surveillance programmes/initiatives at national, EU and 
international level and the relevant HBM studies published in the literature, with a comparative 
analysis of the studies in order to evaluate the added value for chemical risk assessment. Associated 
monitoring studies to investigate levels of the chemical in the environment (in particular in food) 
should be reported when available. 
Objective 3: 
To provide a review of results from HBM studies, aimed at identifying: 
3.1  Emerging chemicals or chemical classes and possibly higher exposed sub-groups or 
specific vulnerable groups of a population from HBM investigations, with a particular 
focus on the exposure to foods; 
3.2  An inventory of validated biomarkers of exposure to chemicals that can be found in the 
diet identified through HBM (e.g. metals, polycyclic aromatic hydrocarbons (PAHs), 
phthalates, phenols, polychlorinated compounds, pesticides, etc.); 
3.3  Any other issue that the contractor deems relevant for EFSA’s risk assessment activities. 
Proposed methodology 
HBM information and data should be gathered through an extensive search of the literature from 
different sources in the public domain (e.g. scientific literature, reports from EU/national/international 
authorities’ and various other sources). Priority should be given to information from peer-reviewed 
sources; however, other sources of available data (grey literature) shall also be taken into 
consideration when relevant. References shall be collected in an EndNote
TM
 Library or in a format that 
is compatible with EndNote
TM
. The literature search strategy (from different bibliographic database 
platforms such as MEDLINE, EMBASE, etc.) and selection criteria (inclusion/exclusion) for the 
review shall be based on the EFSA Systematic Review Guidance (EFSA, 2010). 
Data on exposure biomarkers shall be extracted from studies reported into selected literature and 
summarised in a tabular-form inventory (e.g., Excel spreadsheet). The document shall outline for each 
selected study: the chemical substance and concentrations, marker (substance/metabolite), biological 
matrix, method, study design, study period, chemical substance source (when available, in particular 
for food), population studied (including age, sex, and number of participants), geographic area, and 
bibliographic reference (first author and year). Moreover, reference values of the background exposure 
in the (specific) population and health-based limit values derived from toxicological and 
epidemiological studies should be provided, when available. 
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1. Introduction and Objectives 
In Europe, the rising incidence rates for a number of chronic diseases of public health relevance raised 
concern and resulted in increasing public interest and awareness in environmental health. This is of 
particular importance as the majority of major chronic human diseases are likely to result from the 
combination of external “environmental” exposures and human genetics with environmental (e.g. 
chemical) determinants, yet their effects still being often poorly understood.  
Also, the importance of sources is changing. While at the end of the last century outdoor air was the 
main source of chemical pollution, food has been proven to be the major source of many toxicants 
today. Chemical substances occur as food additives, pesticides, pharmaceuticals or are contained in 
packaging. Other chemicals enter the food chain as pollutants. Further toxicants such as mycotoxins or 
acrylamide arise from natural sources or processing. Community food legislation and food risk 
assessment aims at a high protection level and at the reduction of contaminants. However, there is lack 
of primary information about the real-life exposure of European populations that could be used to 
verify the risk estimates. 
Human biomonitoring (HBM) provides the tools for exposure assessment by direct measurements. It is 
the advantage of HBM that it is a measure of internal exposure and effect integrating all sources and 
routes of uptake. HBM can identify new chemical exposures, trends and changes in exposure, 
establish distribution of exposure among the general population, and identify vulnerable groups and 
populations with higher exposures. However, there are limitations by lack of standardization, validated 
biomarker availability, data integration and interpretation. In addition HBM by itself does not provide 
information on the source(s) or route(s) of exposure, and environmental exposure data are rarely 
collected at the same time as HBM.  
Considering the possible major implications of HBM methodology for human exposure assessment of 
chemicals, the recent advancements and the challenges evidenced from national, EU and international 
programmes and research studies, it is not clear to which extent HBM can be reliably applied to risk 
assessment. For this reason, this procurement aims to critically review the state of the art of HBM with 
a view to discussing its application to chemical risk assessment in the area of food safety. 
2. Materials and Methods 
In order to achieve the overall project objective and the tasks as specified to the full satisfaction of the 
European Food Safety Authority (EFSA) we have developed a project concept including 6 work 
packages that correspond to the envisaged tasks. The work has been arranged in two preparatory work 
packages (WP1&2) and in three compiling and evaluating work packages (WP3-5). In the preparatory 
phase (WP1&2), a literature search strategy has been identified, and a review protocol has been 
prepared.  
The review protocol determined how references have been managed, how the search process has been 
documented and reported, which selection criteria are suitable for inclusion/exclusion of literature and 
studies. Based on this strategy, the literature research has been carried out.  
The work packages WP3 to 5 dealt with the actual elaboration of narrative reports on the study 
objectives and the provision of overview tables of collected data. WP 6 was an iterative work package 
dealing with the overall project management. Figure 1 provides an overview on how these tasks are 
reflected in work packages. 
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Figure 1 Overview of the work packages.  
2.1. Literature search strategy 
In WP 1, the project team identified all questions that needed to be answered within the project (WS 
1.1 Question types and key elements of questions for search) and discussed about their characteristics 
in line with the EFSA Systematic Review Guide
 
(EFSA, 2010). Subsequently, the project team 
concluded on the feasibility of pure systematic reviews or narrative reviews for the individual 
questions (WS 1.2 Identification of the areas for systematic, critical and narrative reviews). 
Considering the identified questions, it was deemed appropriate to perform a comprehensive literature 
search and a narrative review of the results identified. This approach was applied in particular for the 
application of HBM in human exposure assessment for food safety (Objective 1), whereas a 
systematic review of national HBM programmes was used for the inventory of different HBM 
surveillance programs (Objective 2). The literature search strategy included also the necessary specific 
information for Objective 3 (biomarker, reference values, and guidance values) although the clear 
focus of this task was on the evaluation of the HBM inventory. The strategy included an iterative 
process, i.e. testing and scoping of literature search results in order to fine tune the search terms. 
A major aim of the search was to identify relevant HBM studies/programmes (national, EU, and 
international level), evidencing exposure of general population to environmental chemicals. The 
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priority targets were studies with associated investigation of source (and route) of exposure, 
particularly food, but the search was not limited to these studies but included all relevant HBM studies 
even if the source of exposure to the environmental chemical is not clear. 
The final search strategy set the time frame as well as the search terms, the languages to be reviewed, 
the databases to be used, the substances to be focused on, and the distribution of work between the 
consortium partners in the project team. 
WP2 covered the preparation of the review protocol. This included the elaboration of search terms and 
substances to be covered as well as data management and documentation. All approaches were 
summarised in a review protocol that was agreed upon with EFSA Services.  
The following sections provide a descriptive overview of the literature search.  
2.1.1. Data sources investigated 
PubMed, MEDLINE and SCOPUS were chosen as the primary databases for the literature search with 
additional searches in other supplementary databases such as DIMDI, EMBASE, Toxnet, Web of 
Knowledge, Cochrane, OVID and Open Grey (database of grey literature in Europe). 
Relevant reports from national HBM programs or conferences not identified via database searches 
were reviewed. While most of the reports are published in English, additional references in German, 
Danish, Swedish, Norwegian, French, Dutch, Spanish, Korean, and Japanese were also considered in 
this report. Furthermore, the project team investigated the following conference proceedings from 
2013 and 2014.  
 International Society of Environmental Epidemiology (ISEE)  
 International Society of Exposure Sciences (ISES)  
 International Conference on Environmental Mutagens (ICEM)  
 International Symposium on Biological Monitoring (ISBM) 
 ISEE-ISES-ISIAQ 2013  
 ICDAM Conference on Dietary Assessment Methods 
 FENS Federation of European Nutrition Society 
 WMF meets IUPAC 2012  
 ISM-MycoRed 2013 
 MoniQA 2013  
 International Union of Toxicology (IUTOX)  
 European Environmental Mutagen Society (EEMS)   
 International Congress on Environmental Health (ICEH)  
 International Conference on Heavy Metals in the Environment (ICMET)  
 European Public Health Association (EUPHA)  
 International Network on Children’s Health, Environment and Safety (INCHES)  
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 Society of Toxicology (SOT) 
 Society for Environmental Geochemistry and Health (SEGH) 
 International Society of Indoor Air Quality (ISIAQ)  
Based on the experiences made in the first search run, it was possible to apply a refined search strategy 
for the conferences and conference proceedings. The strategy included searches with general terms 
such as “human biomonitoring” (level 1) with an “and” combination of “Food”, “Food Safety” and 
“Risk assessment” (level 2). For the 6 references obtained after the selection process, full texts were 
retrieved. 
2.1.2. Search terms  
A detailed list of search terms was elaborated on the basis of the targeted review questions for 
objective 1 (questions 1.1.a-1.1.i, 1.2a-d, 1.3 a, and b), for objective 2 (questions 2.1., 2.1.a, 2.2.a., and 
2.3a) and for objective 3 (questions 3.1a and b, 3.2 a). 
Multiple search terms were combined in the database search by using AND (rather than OR) to avoid 
a surplus of ineligible or inconsequent references. Search focussed on the terms “human 
biomonitoring” OR “HBM” in combination (AND) with programme/survey/cohort or definition as 
well as search terms for: 
 Study design (longitudinal, OR cross-sectional, OR recruitment, OR participation, OR 
sampling, OR reporting, OR communication); 
 Matrices (human tissue, OR sample matrix, OR blood, OR serum, OR urine, OR hair, OR 
saliva); 
 Food source (food, OR food safety, OR diet, OR nutrition, OR food contaminants, OR 
pollutants food, OR environmental chemicals AND food); 
 Different steps of risk assessment (risk assessment OR exposure assessment AND food, OR 
hazard identification AND food, OR hazard characterisation AND food, OR risk 
characterisation AND food); 
 Countries/regions of interest;  
 Vulnerable population groups (vulnerable group AND food); 
 Emerging chemicals (emerging OR new AND chemicals OR substances, AND food); 
 Biomarkers of exposure (food OR diet OR validated).   
Search terms were focussed on a search in “Title”, “Keyword”, and “Abstracts”. Search terms and 
combinations of terms were expanded, reduced and refined in a testing and scoping procedure, 
depending on the number of initial hits. In the case where there are only a few number of retrievable 
references, the search was expanded from “Title”, “Keyword”, “Abstracts” to “Any Field.”  
In addition the search included a long list of substance groups and substances in combination with 
“human biomonitoring” OR “biomonitoring”. 
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A full list of all search terms used in the literature search to answer the specific review questions for 
objectives 1 to 3 is provided in Table 22 of Appendix A. The full list of substance groups and 
substances that were covered in the literature search is provided as Table 23 of Appendix A.   
Information needed to address Objectives 2.1-2.3 (review questions 2.1 b, 2.2b, 2.3 b) as well as 
review question 3.2b were mostly extracted from the identified HBM programmes (see chapter 3.7) 
with additional supplement searches to fill in missing data gaps (c.f. chapter 2.1.5).  
 
Table 1 Review questions answered via a comprehensive analysis of HBM programmes identified 
 Review questions 
2.1.b 
2.2.b 
2.3.b 
 Who is the Initiator/Funder of the study 
 What is the duration of the study? 
 What study design is chosen? 
 Which study population (age, gender, number of participants, geographical coverage, and timing of 
study)) is chosen? 
 Which chemicals are investigated? 
 Which matrices are used? 
 Which recruitment strategy is used? 
 What analytical methods are used? 
 Which markers have been used? 
 What are the results, chemicals concentrations found? 
 How are results interpreted? 
 Are there any accompanying activities to investigate exposure sources, if yes, which? 
 Are reference values available, if yes, which? 
 How are results communicated to study participants/public/scientific world, etc.? 
 How is the policy support addressed? 
3.2.b  What are the criteria for their validation? 
 
2.1.3. Data documentation and Endnote database 
In WS 2.1 and 2.2, the project team identified a strategy for managing and documenting the 
references. All references were documented in an EndNote
TM
 Library. For a transparent 
documentation of references, groups according to the Objectives and subgroups according to the 
search terms were created within the EndNote library, and eligible references were appropriately 
sorted in the groups/subgroups. Furthermore, the following information has been documented 
separately for the data search in the different databases: 
 Database name; 
 Date and start and end time of search; 
 Search terms used / combinations used/ elimination of duplicates required 
 Number of records retrieved; 
2.1.4. Eligibility criteria for full text search 
Literature search was designed in a way that all studies with HBM and HBM plans published in peer-
reviewed journals as full articles and abstracts were included even if the language is not English. The 
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search occurred mainly from January to March 2014 and focussed on the time period between 2002 
and 2014. An additional search on PubMed was conducted in October 2014 to search for the latest 
relevant publications.  
To address Objective 1 (“An overview on HBM and possible application to risk assessment”), mostly 
reviews discussing the use of human biomonitoring in risk assessment were identified and imported 
into the EndNote library. Concerning chemical substances of interest, a focus was put on known 
chemicals from HBM studies such as BFRs, PFCs, phthalates, phenols, metals, PAHs, polychlorinated 
compounds and pesticides. However, the search was not limited to these chemicals. Other chemical 
substances identified from HBM studies that can be found in the diet, such as contaminants in the food 
chain and undesirable substances such as food contact materials, were considered as eligible for 
review.  
For Objective 2 (“An inventory of HBM programmes”), the following eligible studies were included: 
(1) observational studies assessing the association between chemical body burden and food intake, (2) 
cohort studies and (3) cross-sectional HBM surveys performed in humans that were published after 
January 2002. Reports providing information on the design of the programme as well as any observed 
concentrations and time trends (where possible) were included.  
Lastly, for Objective 3 (“A review of the HBM study results”), relevant reviews and studies regarding 
biomarkers, reference and health-based guidance values, emerging chemicals and vulnerable 
populations were considered and imported into the library. It should also be mentioned that 
information on kinetics (e.g. half-lives), dose-response relationship (e.g. NOAELs) and modelling 
(e.g. PBPK) of a chemical was taken into consideration when available in the investigated studies. 
However, these topics are not considered as key aspects in this report. 
According to the review protocol, the following studies were excluded:  
 No measurement of  human fluids or tissues (e.g. soil, air or food measurements); 
 Solely in vitro (i.e. cells) or in vivo (i.e. animals) studies; 
 Exclusively related to occupational exposure; 
 Only reported data older than 2002; 
 Analysis of chemicals related to radioactivity, nutritional biomarkers (food additives), illicit 
drugs, war agents, and pharmaceuticals. 
For HBM studies, the following additional exclusion criteria were applied:  
 Exclusively health outcome-oriented (e.g. HBM of cancer patients, determination of endocrine 
disruptive effects) 
 Not related to food-related exposure but to other exposure pathways (e.g. inhalation) 
Exclusively narrative reports about potential and options of HBM as well as narrative reviews about 
HBM and the use of biomarkers were not taken into account. Assessments of chemicals body burdens 
based on measurements in food and modelling of food intake were only included if measurements of 
biological samples were made in conjunction (c.f. Norway’s MoBa study). In addition, we excluded 
citations exclusively discussing the development of specific novel biomarkers, modelling methods or 
assessment tools. Studies which examined associations between chemical and health effects were not 
considered eligible if they did not examine exposure. 
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However, in order to complete the overall picture, some exceptions were made, e.g. studies featuring 
specific interest groups but with a smaller study population. Such studies could be important to show 
the overall picture of a country/region, or if the study was conducted by a health authority, it could be 
included in line with the agreements that have been taken with EFSA at the beginning of the project. 
Also, occupational "control" populations were considered if combined with environmental exposure 
settings or if associations regarding food intake and chemical exposures were made. Accordingly, 
studies related to nutritional biomarkers (i.e. food additives) and pharmaceuticals were generally not 
considered eligible, except for veterinary drugs or pharmaceutical residues that could be considered as 
food contaminants. 
When references pertained to the same study, only the most extensive and most recent ones were 
retained in order to avoid redundancies. 
2.1.5. Supplemental searches 
In order to close gaps in the database search for the HBM inventory (WP4), additional information on 
the European HBM programmes and projects were collected based on the expertise of the project 
team, and government-published reports from other HBM programmes (e.g. Germany’s GerES, Italy’s 
PROBE, etc.) were retrieved from the respective governmental websites. Therefore, a total of 120 
additional references (i.e. books, other governmental/regulatory reports, literature older than 2002, 
etc.) was imported into the EndNote library and sorted under “Expert literature.” 
In addition, information of the following European research projects related to HBM was evaluated by 
the project team: 
 Expert Team to Support Biomonitoring in Europe (ESBIO) 
 Consortium to Perform Human Biomonitoring on an European Scale 
(COPHES)/Demonstration of a Study to Coordinate and Perform Human Biomonitoring on an 
European Scale (DEMOCOPHES) 
 Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS) 
 EnviroGenomarkers – Genomics Biomarkers of Environmental Health 
 Integrated Assessment of Health Risks from Environmental Stressors in Europe (INTARESE) 
 Newborns and Genotoxic Exposure Risks (NewGeneris) 
 EXPOsOMICs 
 The Human Early Life Exposome (HELIX) 
 Health and Environment-wide Associations based on Large Population Surveys (HEALS) 
After consultation with EFSA Pesticide Unit on the HBM inventory, additional targeted investigations 
were performed on specific pesticide classes of interest for EFSA, namely imidacloprid (a 
neonicotinoid), and a number of pyrethroids and triazoles. First, references on specific pesticides were 
searched among the abstracts in PubMed using the following terms: imidacloprid OR pyrethroid of 
interest OR triazole of interest AND from 2002 onwards. All identified references have been stored in 
a separate Endnote library for potential future use for EFSA. Next, within this library, a targeted 
selection procedure was conducted among the abstracts of these groups using search terms “human” 
AND/OR “biomonitoring,” and using the aforementioned exclusion criteria, a visual selection 
procedure reduced the number of eligible scientific studies to 38 (4 studies for imidacloprid, 34 studies 
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for pyrethroids, and 0 study for triazoles). These were considered for the report, imported into the 
EndNote library and sorted in the group set “EFSA pesticides of interest.” 
Finally, a search in Open Grey (http://www.opengrey.eu/), a database of grey literature in Europe, was 
performed in October 2014. The combinations of terms used in this search were the following: (1) 
“Human biomonitoring” OR “HBM” AND “food”, (2) “Human biomonitoring” OR “HBM” AND 
“risk assessment” and (3) “Human biomonitoring” OR “HBM” AND “exposure.” 
2.1.6. Quality control measures 
For quality assurance purpose, the selection process was carried out by 2 experts of the project team in 
order to reduce the introduction of errors and personal biases. The results of the selection processes 
were compared. In case of differences, another key experts of the project team checked the opinions 
and took a decision based on the eligibility criteria.  
2.1.7. Quality appraisal 
Selection of the eligible studies included a quality appraisal, which was based on the following aspects 
in line with the recommendations of the Newcastle–Ottawa Scale (NOS) and the RTI item bank: 
1. Level of detail in methods and materials (design description, result documentation) 
2. Level of detail in discussion (including strength and weaknesses) 
3. Efforts undertaken to identify confounders 
In case there were several scientific articles providing conflicting information, the project team used 
the date and the author’s reputation as an additional aspect. The impact factor of the journal did not 
need to be used as a selection criterion in this report. 
2.2. Structure of this report 
This report is structured into the assessment of the possible application of HBM to human risk 
assessment (chapter 3.2), an inventory of the different HBM surveillance programmes/initiatives at 
national, EU and international level with a comparative analysis in order to evaluate the added value 
for chemical risk assessment (chapters 3.7 and 4.1) and a review of results from HBM studies (chapter 
4.2). 
The first part (WP3) includes the definition of HBM, a description of core HBM techniques and 
requirements, a discussion of the possible application of HBM to the different steps of risk assessment 
in food safety areas, and an evaluation on the usefulness of HBM for exposure assessment of chemical 
substances from food source and for the implementation of a systematic Post Market Monitoring 
(PMM) approach for regulated chemical substances including strengths and limitations. 
The inventory (WP4) is focussed on information on the following topics: chemical substance and 
concentrations, biomarker used (substance/metabolite), biological matrix, method, study design 
(longitudinal, cross-sectional), study period, chemical substance source (in particular for food), 
population studied (including age, sex, number of participants), geographic area, participation rate, 
bibliographic reference (first author and year), reference values of background exposure in the 
(specific) population, and health-based limit values derived from toxicological/epidemiological 
studies. Information on the key features of each programme was listed in a comprehensive excel 
matrix. Information on associated monitoring studies to investigate levels of the chemical in the 
environment (in particular in food) is provided where available. Blank fields in the Excel matrix were 
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subject to a second more targeted screening, and cross-checking with latest internal information was 
done to collect the relevant information. Quality check and cross check of data (WS 4.5) was 
performed for quality assurance. The quality check was done in accordance with the defined eligibility 
criteria in the review protocol and involved a four eye principle. For the appropriate assessment of 
information received and collected throughout the project and for selection of the most appropriate 
information, we used a systematic and justified weight-of-evidence approach. 
The discussion section (chapter 4) contains the comparative analysis of activities at national, EU and 
international level, and an evaluation of the added value of HBM for chemicals risk assessment on the 
basis of the inventory made. In this context, comparative analysis means that it was particularly 
searched for differences in study design (e.g. biological matrices, analysed substances etc.), 
associations and links between external and internal exposure (via associated food/HBM data or via 
other means to correlate food intake and elevated body burdens), and any casual links or associations 
between measured body burdens and health effects. This working step had a particular focus on the 
requirements of chemical risk assessment, and the regulated substances under food safety legislation 
(e.g. mycotoxins, dioxins, heavy metals, nitrates, chloropropanols) or chemicals regulated in the 
context of food contact materials (e.g. phthalates). 
The discussion also comprises a narrative review of the results of the investigated programmes. In the 
review (WP5), the project team has focussed on identifying emerging chemicals or chemical classes 
and possibly higher exposed sub-groups or specific vulnerable groups. In addition, the review of 
results has targeted on an inventory of validated biomarkers of exposure to chemicals that can be 
found in the diet identified through HBM (e.g. metals, polycyclic aromatic hydrocarbons (PAHs), 
phthalates, phenols, polychlorinated compounds, pesticides, etc.). Information on criteria for the 
validation has been included where available, and biomarkers of susceptibility and effect have been 
included in the review only when evaluated in the HBM studies selected for exposure assessment. 
Lastly, the inclusion of guidance values, the development of new biomarkers, and the use of food 
monitoring/questionnaires of intake have been elaborated.  
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3. Results 
This chapter provides an overview to the use of human biomonitoring (HBM) (chapter 3.2), 
information on the definition of HBM (chapter 3.2), the related techniques and requirements (chapter 
3.4) as well as it applicability in different steps of risk assessment and post-market monitoring (chapter 
3.5) and an assessment of its usefulness in exposure assessment including limitations and strengths 
(chapter 3.6). Furthermore, it provides a description of the core parameter of the analysed HBM 
programmes (chapter 3.7). 
3.1. Literature search 
This chapter covers the results from the literature search and provides a short discussion of the 
limitation of the selection process including a justification of the selection priorities. 
3.1.1. Selection of references  
Since the search process in PubMed, Medline, SCOPUS and DIMDI revealed a lot of redundancies 
and the EMBASE, Toxnet, Web of Knowledge Cochrane and OVID databases extract publications 
from the same sources as SCOPUS, the final search was focused on SCOPUS, PubMed, and 
MEDLINE.  
This strategy yielded 19 704 references in all searched databases (7 187 in PubMed, 39 references in 
DIMDI, 3 208 references in MEDLINE and 9 309 in SCOPUS), see Appendix A. A.   
The following Table 2 gives an overview of the obtained hits for the searched terms in combination 
with the database name and the time of search after the selection process.  
Table 2 Database search and references obtained 
Database name Start and end of search date References obtained
 
PubMed January-March 2014; October 2014 7 187  
DIMDI January-March 2014 39 
MEDLINE February 2014 3 208 
EMBASE Included in SCOPUS/Medline - 
Toxnet Included in SCOPUS/Medline - 
Web of knowledge Included in SCOPUS/Medline - 
SCOPUS February 2014 9 309 
Cochrane Included in SCOPUS/Medline - 
OVID Included in SCOPUS/Medline - 
In total  
PubMed/Medline and SCOPUS, no 
repeats 
2 316* 
The search in conference proceedings only yielded a few results that were not covered from the 
database searches (Table 3). 
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Table 3 Conference and conference proceedings searched for identified search terms 
Database name 
Start and end of 
search date 
References 
obtained
 
References in 
PubMed 
ISEE February 2014 -  
ISES February 2014 3 1 
ICEM February 2014 3 1 
ISBM February 2014 3  
ISEE-ISES-ISIAQ February 2014 6 1 
ICDAM February 2014 10  
FENS February 2014 -  
WMF meets 
IUPAC 
February 2014 
1 
 
ISM-MycoRed February 2014 -  
MoniQA February 2014 3 1 
IUTOX February 2014 3  
EEMS February 2014 1 1 
ICEH February 2014 3  
ICMET February 2014 2  
EUPHA February 2014 1  
INCHES February 2014 -  
SOT February 2014 -  
SEGH February 2014 1 1 
ISIAQ February 2014 -  
For these references, the eligibility of the full texts was assessed in order to exclude those records that 
failed to meet the inclusion criteria. The search in Open Grey, the database for Grey Literature in 
Europe, yielded 12 references. However, these references were excluded from the report as they did 
not fit into the inclusion criteria of this report. 
In several iterative steps, the selection process was accomplished according to the EFSA systematic 
review methodology guidelines (EFSA 2010). 
Of the 19 704 references resulting from the searches in PubMed, SCOPUS and MEDLINE, 5 075 
were excluded as duplicates. From the 14 629 retrieved individual references, 13 418 were excluded 
after screening of titles (12 313 excluded) and abstracts (1 115 excluded), resulting in 1 201 references 
eligible for inclusion. The full texts for these references were searched, and a rating was given for each 
reference (ranging from the lowest of 1 to the highest of 5) depending on its relevance for the report.  
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The eligible references were sorted in groups according to each objective and subsequently in 
subgroups according to the search terms. Figure 2 shows some of the key groups and subgroups 
defined within the EndNote library. 
 
Figure 2 The key groups/subgroups defined within the EndNote library with the numbers of sorted 
references. 
As aforementioned, supplemental searches (c.f. chapter 2.1.5) for HBM studies involving pesticides of 
interest (namely imidacloprid, pyrethroids, and triazoles) and by the project team (e.g. books, older 
references, presentations, websites, etc.) resulted in 38 and 126 eligible references, respectively, 
totalling to 164 additional references imported into the EndNote library. The pesticide references were 
sorted in the group “EFSA Pesticides of interest,” and the expert references were sorted in the group 
“Expert literature.” Altogether, with the 1 201 eligible references identified from the database searches 
and the 164 additional references, 1 365 references were imported into the EndNote library for this 
report, and 742 full texts were retrieved.  
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Altogether, a total of 252 references were finally selected and included in this report. Full texts for 235 
out of the 252 references were retrieved and imported into the EndNote library. The remaining 17 non-
retrievable references are mainly book chapters or websites. Figure 3 shows the flow chart of selecting 
the eligible studies from the database searches and by the project team. 
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Figure 3 The flow chart depicting the study selection process for this report 
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3.1.2. Limitations of the review  
The aims of this report are to assess the potential application of HBM to chemical risk assessment, 
particularly in the area of food safety and to provide a broad overview of the existing HBM activities 
throughout Europe and beyond. While an extensive search for HBM programmes and related studies 
was conducted in order to create a HBM inventory, it is by no means an exhaustive review, i.e. not all 
HBM programmes have been covered. 
Initially, national HBM programmes with large sampling (general) populations were selected for 
review. However, after the database search, it was observed that a number of European countries only 
has national HBM programmes with small sampling populations (<1000 participants) or cohort studies 
(i.e. mother-child cohorts). Thus, in order to gain a better picture of current and past HBM activities 
throughout Europe, these smaller HBM programmes were covered in this report.  
The USA’s NHANES and Canada’s CHMS programmes were included in the review because they are 
currently some of the most extensive existing HBM programmes, whereas the HBM programmes in 
South Korea, Japan and China (including mother-child cohorts) were covered in this report to provide 
additional understanding of the current or previous HBM activities in Asia. However, it should be 
brought to attention that there are upcoming national HBM activities throughout the world such as 
those in Australia, Brazil, etc.  
After the search process, the following national HBM programmes (i.e. not pilot studies) were 
identified but not discussed in the report: 
 SEBIOREC – Italy 
 Infancia y Medio Ambiente (INMA) Project – Spain 
 EDEN and PELAGIE cohorts – France 
 National Children’s Study – USA 
 Maternal-Infant Research on Environmental Chemicals (MIREC) – Canada 
The SEBIOREC study in Italy investigated the levels of POPs (e.g. dioxins, PCBs, PBDEs) and heavy 
metals (e.g. As, Cd, Hg, Pb) in pooled blood/serum samples (n=84) or milk samples (n=52) from 
donors living in the Campania region (De Felip et al., 2014). Due to the study design (e.g. 
measurements of pooled samples in one region and low sample size), this programme is not reviewed 
in this report but should be mentioned. Meanwhile, the other identified programmes are all cohort 
studies involving mothers and/or children. As our initial aim and search strategy focussed mostly on 
HBM programmes of the general populations, these programmes were not considered for the HBM 
inventory. Nevertheless, some mother-child cohorts and small scale HBM studies have been included 
in the HBM inventory due to lack of national HBM programmes from countries of interest (e.g. 
Denmark, Norway, and Sweden) or in order to get the overall impression of HBM activities in Asia.  
Even though not all the existing HBM programmes were reviewed for the inventory, it was observed 
that the study designs, sampling collection process, types of chemicals analysed, etc. were similar 
among the programmes. Therefore, even without inclusion of the aforementioned excluded 
programmes in the inventory, the outcome of this report should not affect the overall impression of the 
application of HBM on risk assessment and on food safety. 
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3.2. Overview on HBM and possible application to human risk assessment 
3.2.1. Introduction to the use of Human biomonitoring in the European Union  
Human biomonitoring (HBM) and biomarkers (BM) have a long tradition in health care. They are 
used in curative and preventive medicine in several domains, and may be applied in different context 
also in environmental health.  
In occupational medicine, HBM plays an important role within the measurement of the body burden of 
toxic substances and their metabolites for more than a century. HBM is also used in particular for 
detection of exposure and adverse health risk and for assessing the efficiency of preventive measures 
and for controlling working place limit values set. For certain industries and professions testing is 
mandatory. HBM as a surveillance tool in occupational medicine is regulated by legislation on health 
and safety in the workplace. Health surveillance in occupational medicine besides other is performed 
in the context of Occupational Exposure Limit Values (OELVs) for chemicals in the workplace 
established on European scale based on scientific recommendations of the Scientific Committee on 
Occupational Exposure Limit Values (SCOEL). 
In public health, HBM is used in population screening to identify people at risk for developing a 
specific disease in an early stage. Tests are administered not only to individuals who have no apparent 
symptoms but also to population groups with potentially elevated risk. Examples of routine population 
screening currently used in the health care field include the measurement of blood fats or glycosylated 
haemoglobin in the prevention of cardiovascular diseases, the prostate-specific antigen (PSA) to 
predict prostate cancer risk or a variety of other markers for malfunction or upcoming disease.  
In environmental health, HBM is used together with other methods such as environmental monitoring 
and modelling for research, surveillance and awareness raising. In research studies, biomarkers are 
used to improve the knowledge on causal links between environmental factors and health, often 
addressing or including (early) effect biomarkers and genetic factors (biomarkers of susceptibility).  
In environmental health, surveillance the focus is generally put on exposure biomarkers and 
measurements are intended to produce information on the prevalence of exposure to environmental 
agents and the related public health impact (Casteleyn et al., 2009). Environmental health surveys in 
general are designed to support, lead and assess policy and preventive actions in the field of 
environmental health and to raise awareness of the general population and of policy makers. However 
there are no EU initiatives of a comparable scope for the moment in population survey and 
environmental health whereas legal and administrative framework and decision procedures are well 
established since several decades in occupational health.   
3.2.2. Examples of the use of HBM in risk assessment 
The best known examples of HBM as a tool for exposure estimation are measurements of heavy 
metals such as lead and mercury in blood, urine or hair. Measurements of blood lead concentrations, a 
biomarker of exposure, were used for risk management in industries with high lead exposures. 
Workers with high blood lead concentrations, above the recommended safety levels, were transferred 
to less polluted work tasks, and could only return to their original tasks when the blood lead levels had 
declined.  
NHANES data documented an initially sharp decline of blood lead concentrations in children from 
1976–1980 and a further continuous decrease to 2001–2002. This decrease (from 160 µg/L in 1976 to 
<20 µg/L in 2001–2002) corresponds with the removal of lead in gasoline in the USA, starting in the 
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mid-1970s; the banning of lead solder in domestic food cans was also enacted during this time period, 
and later the lead abatement programmes in housing were initiated (Needham et al., 2005). 
Blood lead levels have been monitored in children and clear associations were reported with 
environmental exposure with increased levels in schoolchildren living in the vicinity of roads during 
the leaded fuel period and a decline after the removal of lead from petrol (Strömberg et al., 2008). 
Biomonitoring data also can be used to calculate the social and economic benefit (e.g. increase in IQ) 
of phasing out the use of leaded petrol. The relevance of biomonitoring in children exposed to lead is 
supported by the well-known association with adverse neurological effects. According to the HBM 
results, allowed exposure values for lead have steadily declined, and nowadays the recommended 
maximum exposure level for children of 100 mg/L should be lowered further, based on recent findings 
of adverse neurobehavioral effects (Grandjean, 2010; Jakubowski, 2011). 
Another well-developed case of use of HBM is mercury, occurring as metallic mercury (elemental 
mercury), inorganic and organic mercury, which are interchangeable from natural and microbiological 
processes. HBM of methylmercury in hair reflects the recent exposure, e.g. exposure during the past 
months if sampling is done with hair cut 3 cm from the root. Levels above 1 µg/g hair are considered 
high and were found in the DEMOCOPHES study (Esteban et al., 2014). Possible applications of 
HBM related to Hg are shown in Table 4.  
The World Health Organization (WHO) intends to use HBM to assess baseline mean concentrations of 
mercury in children's hair and to follow the levels over time, to determine whether reductions in 
mercury occur after implementation of the Minamata treaty to reduce mercury exposure to humans 
(WHO, 2012).  
Table 4 Example of possible applications of HBM in risk assessment of human exposure to Hg. 
Sources of 
exposure 
Methods of  
quantification 
Human exposure 
pathways 
HBM provides 
integrated measure 
Health 
outcomes 
Thermometers, 
lamps, etc. 
Questionnaires, 
sales.  
Intake, inhalation, 
skin contact 
Blood, urine, hair, 
nails for measurements 
of Hg and of 
methylmercury 
 Neurological 
effects 
 Developmental 
effects 
 Reproductive 
effects 
 Immunological 
effects 
 More to be 
discovered 
Dental amalgam Questionnaires, 
follow up on 
regulation 
Intake 
Lifestyle Questionnaires on 
use (e.g. skin care, 
shampoo) and 
sales on quantity 
and quality 
Intake, inhalation, 
skin contact 
Food Questionnaires on 
food intake (e.g. 
fish) and sales on 
quantity and 
quality 
Intake also of 
products from 
biotransformation in 
the environment 
Local industrial 
emission and waste 
Environmental 
measurements 
Including 
biotransformation of 
Hg to 
Methylmercury 
 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 30 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
HBM surveys in Flanders (2007-2011) identified regional differences in urinary cadmium and toxic 
arsenic in industrial hot-spot areas, which could be related to socio-economic factors and were used to 
trigger preventive policies (Vrijens et al., 2014).  
In Germany, cadmium levels in blood and urine declined as a consequence of a revision of the German 
Drinking Water Ordinance (Kolossa-Gehring et al., 2008). Furthermore, the reduction of exposure via 
a ban of pentachlorophenol (PCP) and other persistent biocides in wood preservatives resulted in a 
clear decrease of the median level of PCP in urine from 4.5 μg/l to < 0.6 μg/l in 1989 (Kolossa-
Gehring et al., 2008).  
In the late nineties, HBM surveys detecting highly elevated dioxins & PCB and other POP levels in 
human milk triggered the setup of strict limit values for dioxins and dioxin-like PCBs in food and feed 
and of dietary intake recommendations for populations at particular risks (e.g. pregnant women in the 
Baltic Sea area. Other examples are the ban of c-penta and c-octaBDE following the detection of 
increasing levels of polybrominated flame retardants in blood detected in Swedish samples (Darnerud 
et al., 2001; Noren & Meironyte, 1998).  
The most prominent example for a global approach is the WHO survey on POPs in human milk. It 
started after reaching international agreement to phase these substances out. The results indicated that 
mean concentrations of persistent organic pollutants in breast milk began to decline. After DDT was 
banned in Germany in 1972, the average concentration of DDT in breast milk decreased by 81%.  
According to (Salter Green, 2010), a World Wildlife Fund (WWF) HBM campaign (1999 to 2006) 
that showed a widespread human contamination with persistent bio accumulative and toxic chemicals 
(PBTs) and hormone disruptors in relation to its use in consumer products and food had a clear impact 
on development of the chemicals legislation REACH, the strategy for endocrine disruptors and other 
restrictive legislation in the field of pesticides, cosmetics and biocides.   
HBM was used in Germany for verification of policy effectiveness and identification of new risks 
related to phthalates by means of retrospective analysis of biobanked data. It showed that the reduction 
in DnBP/DiBP consumption due to stepwise restriction in cosmetics and toys at the end of the 1990s 
and early 2000 was coupled with a parallel decline in body burdens of corresponding phthalate 
metabolites, whereas the levels of the unrestricted compounds remained stable (Kolossa-Gehring et 
al., 2011). In addition, the German HBM survey (GerES IV) in 2003-2006 showed unexpected 
possible elevated exposure to organophosphate pesticides from fruit juice (Kolossa-Gehring et al., 
2008). 
As reported by (Kass, 2009), a study on mercury and pesticides exposure in New York City could 
illustrate how well-designed HBM surveys can provide the evidence base for policy recommendations 
and that they have a strong educational and awareness raising potential. The New York City study and 
several German HBM studies among which GerES IV were also able to demonstrate impacts of socio-
economic factors on environmental health in terms of elevated or reduced risks (Kolossa-Gehring et 
al., 2008). Therewith these studies influenced preventive measures, public health promotion and 
recommendations for policy.  
Due to the success of national, regional or local HBM programmes in tracing policy effects or in 
identifying policy needs HBM is increasingly obtaining a legal standing on national level, permitting 
repeated cycles of measurement. 
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3.2.3. Development of a harmonised approach to use of HBM as a policy tool in 
the European Union 
Within the European Union, significant resources are being spent on HBM in the environment and 
health field for scientific research, surveillance and awareness raising activities. However, the 
fragmentation and lack of a coherent approach and integration between countries and studies highly 
limit the use of the study results for European health impact assessments and cross-border comparison. 
To allow a better use of the data obtained and to allow evaluations at European scale, harmonisation of 
activities was considered required (Joas et al., 2012). 
Therefore in 2003, the European Commission and the European Member States started efforts to 
construct an efficient HBM framework across the European Union within the European Environment 
& Health Strategy (Science, Children, Awareness, Legal instrument, Evaluation or SCALE) and in 
particular the EU Environment and Health Action Plan (EHAP 2004-2010). As a result a preparatory 
feasibility study (ESBIO) was conducted from 2005 – 2007 (Joas et al., 2012; Viso et al., 2009) that 
discussed the pros and cons of a harmonised approach in the EU in close collaboration with the EU 
Parliament and a consultative forum (CF), that was set up in 2002 as the stakeholder consultation body 
for the development of SCALE. Based on the work of ESBIO (Reis et al., 2007), discussions within 
the CF and a number of supportive reports such as the midterm evaluation report of the EHAP  
(Commission of the European Communities, 2007), the pilot phase for harmonised HBM in Europe 
was started with the Consortium to Perform Human Biomonitoring on a European Scale (COPHES) in 
2009, that laid the basis for a first feasibility study DEMOCOPHES (DEMOnstration of a study to 
COordinate and Perform Human biomonitoring on a European Scale) starting in 2010. The main 
objective of COPHES/DEMOCOPHES was the development of a functional framework for a coherent 
approach to HBM in Europe in order to achieve comparable HBM data that support environmental, 
health and chemicals policy (Joas et al., 2012). 
Broad national HBM programmes established in that period, particularly in France but also in Austria 
and Italy, were developed in close collaboration with the work in ESBIO and COPHES. HBM 
programmes following the COPHES approach shall also be established in other European Member 
States. 
3.3. Definition of HBM  
HBM is a scientific technique for assessing human exposures to natural and synthetic compounds in 
the environment. It is based on analysis of human tissues and fluids and provides the only direct 
method of determining if people have been exposed to particular substances, what the magnitudes of 
their exposures are, and how these may be changing over time.  
The National Research Council of the United States of America in 2002 defined HBM "as a method 
for assessing human exposure to chemicals by measuring the chemicals or their metabolites in human 
tissues or specimens such as blood or urine" (CDC, 2005). 
According to (Kamrin, 2004), HBM is a growing discipline used for exposure and risk assessment in 
environmental and occupational health, and has become a more useful tool in recent years as the result 
of advancements in the capability to measure more and more minute amounts of chemicals in the 
human body. 
HBM relies on the use of biomarkers, measurable indicators of changes, or events in biological 
systems. Biomarkers are measurement of the concentrations of chemical substances, their metabolites, 
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or reaction products in human tissues or specimens, such as blood, urine, hair, adipose tissue, teeth, 
saliva, breast milk, and sperm. 
WHO defined biomarkers in 1993 in relation to risk assessment, where the term "biomarker" is used in 
a broad sense to include almost any measurement reflecting an interaction between a biological system 
and an environmental agent, which may be chemical, physical or biological. Three classes of 
biomarkers are identified: 
 Biomarker of exposure: an exogenous substance or its metabolite or the product of an 
interaction between a xenobiotic agent and some target molecule or cell that is measured in a 
compartment within an organism; 
 Biomarker of effect: a measurable biochemical, physiological, behavioural or other alteration 
within an organism that, depending upon the magnitude, can be recognized as associated with 
an established or possible health impairment or disease; 
 Biomarker of susceptibility - an indicator of an inherent or acquired ability of an organism to 
respond to the challenge of exposure to a specific xenobiotic substance. 
In this context internal exposure can be determined by means of the direct measurement of the 
chemical substances or their metabolites, whereas biochemical effects are measures by means of 
protein adducts and DNA adducts and biological effects are measured by means of ALA, cytogenetic 
parameters or changes in enzyme activities (Angerer et al., 2006).  
Since 1993, when this definition reflected discussions in environmental and occupational health, the 
biomarker concept has been introduced into a number of other fields such as forensic medicine, 
clinical surveillance and drug development. 
The main advantage of using biomarkers is intrinsic in their nature, representing an integrative 
measurement of exposure to a given agent (i.e., the internal dose), that results from complex pathways 
of human exposure and also incorporates toxicokinetic information and individual characteristics such 
as a genetically based susceptibility. 
Through the use of biomarkers, it is not only possible to monitor exposure, but it also becomes 
feasible to detect early health effects. Ideally, both the biomarker of effect and the biomarker of 
exposure should be associated closely with the overall individual exposure so that it provides an exact 
measure of the internal dose or the individual health risk. It should be sensitive, specific, biologically 
relevant, feasible, practical, and inexpensive.  
Seldom does a biomarker meet all of these criteria - most biomarkers represent a compromise of these 
criteria. Many biomarkers are currently used in population studies to estimate exposure or adverse 
health effects. The nature of these markers is very heterogeneous. Some markers are stable over time 
while others have very short half-life; some markers are easy to measure with standard laboratory 
techniques while others require specialised techniques, equipment, etc. (NRCWE, 2007). 
Examples of biomarkers of exposure and intermediate effects are given in 0. 
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Table 5 Examples of types of biomarkers in different biological matrices 
 Examples 
Specific biomarkers  
Concentration of specific 
substance in urine 
Cadmium concentration in urine, normally adjusted to 
creatinine excretion 
Concentration of specific 
metabolite of a substance in urine 
Cotinine concentration in urine which is a metabolite of 
nicotine reflecting exposure to nicotine from typically tobacco 
smoking 
Concentration of specific 
substance in blood 
Lead in blood reflecting the body burden as the half-life is 
long and lead is accumulated 
Concentration of specific 
metabolite of a substance in blood 
Cotinine concentration in blood which is a metabolite of 
nicotine reflecting exposure to nicotine from typically tobacco 
smoking 
Concentration of specific 
substances in exhaled air 
Concentration of benzene in exhaled air reflects the recent 
exposures by inhalation 
Protein adducts 
Haemoglobin adducts of ethylenoxide, propylene oxide, 
benzene, PAHs, acrylonitrile and acrylamide developed with 
the target of occupationally exposed persons and also showing 
background exposures in general population from smoking 
and from diet 
Haemoglobin adducts of nitrotoluene developed in rat studies 
and applied to occupationally exposed population enabling 
risk assessment 
Aflatoxin-albumin adducts provides a measure of intake of the 
carcinogenic mould contamination product Aflatoxin B1 
‘Proteomics is in a unique position to contribute to new 
protein discovery for the betterment of public health and in 
linking toxicology and pathology to a systems view of protein 
dysfunction in toxicity and environmental disease.’ 
DNA adducts 
DNA adducts of e.g. PAHs have been associated with 
cigarette smoking and exposure to combustion products 
Unspecific biomarkers  
Urinary mutagenic activity Handling of cytostatic drugs may confer risk to nurses and 
exposure may be demonstrated by excretion of mutagens in 
the urine 
Acetylcholinesterase activity in 
blood 
Organophosphorus pesticide exposure lowers activity of 
enzymes and interventions may be initiated from levels 
decreased by 25% 
DNA damage Comet assay provides a measure of single strand break that 
correlate well with genotoxic exposures in animal studies 
while several confounding factors need to be controlled in 
human studies including diet (antioxidants), exercise 
(oxidative stress), sunlight exposure. 
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 Examples 
DNA repair DNA repair may be induced by exposures and also confers 
protection against DNA damage of special relevance if active 
in the transcribed DNA 
SCE SCE is sensitive to exposures, however the mechanism is not 
known and no predictivity of increased cancer risk has been 
demonstrated 
CA CA is a robust biomarker with predictivity related to cancer 
risk. Susceptibility factors may be more important in the 
causal relationship exposure-cancer. The testing of CA has 
high demands on laboratory skills and very time consuming 
and few cytogeneticists are trained. 
MN MN is a very promising biomarker with predictivity of cancer, 
automatisation of scoring and smaller demands on skills. 
’Omics’ Omics technologies develop a new breed of biomarkers of 
environmental health which, in contrast to traditional ones, 
allow the use of the same generic methodology (e.g., 
microarrays) for the detection of cellular responses to different 
categories of chemicals and types of toxicity and provide 
mechanistic information at an unprecedented scale. By 
simultaneously obtaining, in human biosamples, a global 
picture of the functional state of the cell at the levels of DNA, 
RNA, proteins and metabolites, and integration into a holistic 
view of the perturbation of cellular pathways by the 
environment, provides a paradigm shift for environmental 
biomarker research and molecular epidemiology 
(EnviroGenomarkers). 
 
Ideally, HBM should provide information about health risk by linking the exposure to adverse health 
outcome. Another way of closing the gap between exposures and health outcomes lies in the use of 
effect biomarkers. Biomarkers of biologically effective dose are more closely related to adverse health 
effects however, require validation in large studies.  
Few effect biomarkers have been introduced in environmental health studies, and only very few (e.g. 
micronucleus test (Fenech & Bonassi, 2011) and markers for kidney function have been validated and 
linked to exposures and health effects. High-throughput technologies have recently revolutionised the 
field and make it possible to generate simultaneous information on thousands of gene transcript, 
proteins, metabolites, epigenetic marks and -omics (Wild, 2005). 
The challenge is to link these signatures to both exposures and health. The metabolome, is dynamic 
through life and can reflect the accumulated effects of multiple exposures or give signs of 
susceptibility to disease and underlying pathology. The human metabolomic profile can be influenced 
by genetic and epigenetic alteration leading to altered gene expression (Nicholson et al., 2011). 
Metabolites of endogenous molecules have recently been associated with environmental exposure 
(cadmium), diet and blood pressure (Ellis et al., 2012). 
Epigenetic changes can be driven by environmental factors and may, for example with Arsenic 
exposure, be a historical biomarker of that exposure. These epigenetic changes may be conserved 
through subsequent cell division, and additionally fertilisation and thus through generations (Jirtle & 
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Skinner, 2007)
.
 Changed methylation patterns in promoter regions of specific genes have been 
discovered that are associated with chemical exposures and diseases (Perera et al., 2009).  
MicroRNAs (miRNAs) are short non-protein-coding RNA species that have regulatory function in 
modulating protein translation from specific mRNAs. Certain miRNAs exhibit marked tissue 
specificity, and appear to be dysregulated in response to specific pathological conditions and exposure 
to toxic agents. miRNAs are detectable in various biological fluids, paving the way for their use as 
accessible biomarkers of exposure and effect (Weiland et al., 2012)
 
. Many miRNA species are 
regulated by epigenetic change in and miRNAs are considered to be the possible means by which 
epigenetic marks are transferred to the zygote after fertilisation. miRNAs, seen altered in response to 
either exposure or the effects of exposure, will be analysed for potential epigenetic control regions and 
these analysed for epigenetic change associated with exposure.  
A combination of independent measures of exposure and a range of biomarkers is the best tool 
available in human health risk assessment. 
3.4. HBM techniques and requirements 
HBM is performed on human tissue (feasible parameter in biological matrices) and implies 
recruitment of study persons, informed consent, sampling, sample processing, and sample analysis 
with suitable and reliable analytical methods, data reporting, interpretation and communication. These 
steps are normally described in a study protocol approved by ethics committees and sponsors 
including the following elements: 
1. Study Population where the representatively is considered, age groups, gender, habitation, 
occupation 
2. Study Design where the number of study persons are defined, the cross-sectional or cohort 
design, power of the study 
3. Selection of Participants/Samples where the actual number of study persons is specified 
and distribution into age classes, gender, exposures and the number of samples to request 
from each study person 
4. Recruitment of participants is described (via census registries, via local newspapers or 
organisations, workplaces) 
5. Field Work is often developed from a pilot study setting the optimal program for sampling 
and processing of samples. For example, urine samples are normally provided as the first 
morning void or collection of urine from a 24-hour period. The samples must be handled in 
a uniform manner (e.g. cooling procedure) securing reproducible results. 
6. Questionnaires will provide information about a number of critical issues related to the 
study person such as demographic data, socioeconomic data, lifestyle and specific 
exposures in the environment (e.g. from traffic and/or from occupation). 
7. Chemical Analysis of the samples should follow well-defined standard operation 
procedures for analyses to ensure validity of the result. 
8. Interpretation of HBM results involves the use of external monitoring data and 
pharmacokinetic modelling. It should be based on health based guidance values, which 
translate the measured dose to health risks.   
9. Communication involves study participants as well as translation of aggregate results to 
policy makers and the general public at various levels. It is based on a communication plan 
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with targeted information tools from the start of the fieldwork to the dissemination of 
individual and aggregate levels results.   
10. Harmonisation of Data Treatment and Evaluation is necessary when comparing 
measurements and for publication purposes. 
11. Quality Control is to be included in all steps of the process. 
12.  Feedback of results to participants - at an individual level if agreed and on group level to 
sponsoring institutions while respecting the data protection.  
The steps involve the following stakeholders: researchers, statisticians, participants, communities, 
participant representatives, research ethics committees (regional or national) regulators, politicians, 
industry and the media (Pedersen et al., 2007). 
According to (Angerer et al., 2007), HBM of dose and biochemical effect nowadays has tremendous 
utility providing an efficient and cost-effective means of measuring human exposure to chemical 
substances. HBM can identify new chemical exposures, trends and changes in exposure, establish 
distribution of exposure among the general population, identify vulnerable groups and populations 
with higher exposures and identify environmental risks at specific contaminated sites with relatively 
low expenditure. The sensitivity of HBM methods moreover enables the elucidation of human 
metabolism and toxic mechanisms of the pollutants.  
HBM can be done for most chemical substances which are in the focus of the worldwide discussion of 
environmental health. This especially applies for metals, PAH, phthalates, dioxins, pesticides, as well 
as for aromatic amines, perfluorinated chemicals, environmental tobacco smoke and volatile organic 
compounds. A number of sensitive analytical methods have been developed to measure low 
concentrations including trace amounts of various chemicals in biological samples such as urine and 
blood (WHO, 2012).  
Blood and urine are by far the most approved biological matrices (Angerer et al., 2007). In addition 
human milk has frequently been used particularly for persistent organic pollutants (Berlin et al., 2005; 
LaKind et al., 2005). In more recent years hair has become an important biological specimen, 
alternative to the usual blood and urine samples. Saliva has been used to evaluate a broad range of 
biomarkers, drugs, and environmental contaminants, including toxic metals and pesticides. Sometimes 
the ratio between the concentration of a metabolite product and that of the parent chemical in blood or 
urine is the biomarker not the chemical or the metabolite per se. (Manno et al., 2010a). 
Protein adducts, especially haemoglobin (Hb)-adducts, are used as surrogates of deoxyribonucleic acid 
(DNA)-adducts as they can specifically and sensitively measure exposure as well as biochemical 
effect. They are better means to estimate cancer risk than measuring genotoxic substances and their 
metabolites in human body fluids. Although the analytical procedures are intricate, Hb-adducts of 
alkylating agents, aromatic amines and nitro aromatic compounds are nevertheless determined 
routinely today. 
DNA-adducts indicate the mutagenicity of a chemical substance as well as an elevated cancer risk. 
DNA-adducts, therefore, would be ideal parameters for HBM. However, although there are very 
sensitive techniques for DNA adduct monitoring like P
32
-postlabelling and immunological methods, 
they lack specificity. For elucidating the mechanism of carcinogenesis and for a broad applicability 
and comparability in epidemiological studies, analytical methods must be elaborated, which are 
strictly specific for the chemical structure of the DNA-adduct.  
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In HBM studies with exposure to genotoxic chemicals, the measurement of DNA strand breaks in 
lymphocytes and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in white blood cells has become very 
popular. However, there is still a lack of well-established dose-response relations between 
occupational or environmental exposures and the induction of 8-OHdG or formation of strand breaks, 
which limits the applicability of these markers.  
Most of the biomarkers used in population studies are covered by standard operating procedures 
(SOPs) as well as by internal and external quality assessment schemes. Therefore, HBM results from 
the leading laboratories worldwide are analytically reliable and comparable. There are specialised 
laboratories that are able to elaborate the analytical prerequisites for chemicals that gain political or 
scientific interest in limited time. On the other hand, it is getting more difficult for the laboratories to 
keep up with a progress in instrumental analyses.  
As biomarker concentrations vary both within and between individuals, the variation in biomarker 
concentrations observed in a population biomonitoring study is not easy to interprete. In addition the 
biological media selected for sampling affects biomarker concentrations independent of other factors. 
Finally also disease states in particular renal or hepatic diseases impacts on biomarker variation 
(Aylward et al., 2014).  
In general, urinary concentrations are not necessarily directly informative about concentrations at 
target tissues of interest in the body. However, as urine collection is a non-invasive procedure that is 
easily applicable for almost all population (sub-) groups, it remains an essential matrix in all 
population HBM surveys or for studies that require repeated sampling (Smolders et al., 2009).  
Blood biomarker concentrations provide a measure of exposure that is more closely relevant to target 
tissue concentrations. However, relationship between the biomarker being measured and the 
toxicologically active compound has to be taken into account. If the biomarker is a deactivated 
metabolite, the relationship between the blood concentration of that metabolite and the active 
compound at the target site of interest may not be straightforward (Aylward et al., 2014). 
Aylward et al. (2014) states that any discussion of the application of HBM to chemical exposure 
characterisation and assessment of variability in biomarkers needs to take into consideration different 
exposure definitions, such as exposure characterised in terms of external media concentrations, 
exposure characterised in terms of intake dose or absorbed dose, or exposure defined as peak 
concentration from a sensitive time point to lifetime. Factors affecting variation in biomarker 
concentrations may influence the relationship between biomarker concentration and the various 
exposure definitions in different ways.  
Given the wide range of biomarkers, biological matrices, analytical methods and influencing factors 
the study design is a critical aspect in efficient use of HBM in risk assessment. This comprises the 
planning of which biomarker(s) should be measured, in which biological fluid or tissue, when and how 
many samples should be collected and from which study populations. The choice of matrix and 
biomarker depends on factors such as the toxicokinetics, the validity (specificity and sensitivity) and 
toxicological significance of the biomarkers available, their stability and reproducibility, the purpose 
of the HBM program, the size and characteristics of the study population, and many others. Further 
important aspects are the choice of the statistical methods to be used, and an estimate of the cost-
benefit and/or risk-benefit analysis, and an evaluation of the ethical procedures and constrains (Manno 
et al., 2010b).  
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As Biomarker studies allow processing and storage of biological samples an efficient study design 
should ideally include provisions for processing the original samples, such as cryopreservation, DNA 
isolation, preparation of specimens for future exposure assessment and other potential uses (Holland et 
al., 2005). 
3.4.1. Strength and limitation of HBM in risk (exposure) assessment  
HBM is the only available tool that integrates exposures from all sources and provides data to 
epidemiology enabling studies of strengths of associations, dose response relationships. Biomonitoring 
data reflect the internal dose at a point in time. 
However, HBM data does not differentiate the exposure by source, and HBM alone cannot provide 
information about the source of exposure or how long a chemical has been in the body.  For translation 
of HBM data into daily exposure estimates there is need of a detailed understanding of the potential 
analytical/methodological pitfalls and of the toxicokinetics of the individual chemical.  
As the human body burden and the development of potential health effects depend on many factors, 
such as fluid/tissue type, time of collection, containers used, preservatives and other additives, storage 
temperature, transport means and length of transit time, may affect the quality and stability of the 
samples and the measurement of biomarkers (Manno et al., 2010b), and the linking to specific sources 
can be very difficult, results from HBM studies needs proper and careful interpretation and 
clarification by experts in order to serve as a policy tool. Finding a chemical does not imply that it will 
cause a disease to develop.  
In particular, for non-persistent chemical with short elimination half-lives, within-day, between-day 
and between-person variabilities can be high. Toxicokinetic studies in humans are needed to show 
major metabolisation pathways, excretion routes and timing of the elimination process. First-pass 
effects, conjugation and elimination characteristics highly influence the results.  
With low tissue levels in the ng/kg body weight range, the detection of biomarkers can be an analytical 
challenge that is additionally complicated by contamination and the potential instability of conjugates. 
With urine sampling, the type of sampling (spot urine, 24h urine or morning void) is an important 
factor as is the use of volume-based or creatinine-based urinary concentrations. Changes in protein/fat 
composition and enzyme activity impact on reliability of human milk samples.  
Analytical sensitivity in terms of detection and quantification rates (LOD and LOQ) is a crucial aspect 
for a reliable determination of internal dose.  
Given the variability of the internal dose, documentation shall include a measure for the central 
tendency by means of geometric mean (GM) and the median (P50) as well as information on high 
exposures by means of the 95th percentile (P95). The P95 of the urinary concentration has different 
interpretations depending on whether spot urine samples, first morning urine samples, or 24-h samples 
are used. 
Furthermore, anti-contamination measures during sample work-up and the analytical procedure are 
important to limit the issue of potential contamination during the collection and storage of human 
samples.  
The core criteria for use of HBM data in the (risk) exposure assessment comprise the following: 
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  The recovery of the method (the percentage of the true concentration of a substance recovered 
during the analytical procedure depending on the internal dose) 
  The repeatability of the method (relative standard deviation RSD) 
  The limit of detection and/or limit of quantification [expressed as multiples of the signal-to-
noise ratio (S/N) of the (chromatographic) background signal] 
  The selectivity of the method (consideration of interferences) 
  Measures to reduce or avoid background contamination 
  Method-performance data  
In addition, HBM raises important ethical and privacy issues due to the fact that it involves taking 
samples in humans and partly even needs to be invasive (blood samples). 
To extend the spectrum of biochemical effect monitoring, further methods should be elaborated, e.g. 
cleavage and separation of the adducted protein molecules as a measure of sample preparation. This 
way, all sites of adduction as well as further proteins, like serum albumin, could be used for HBM. 
For elucidating the mechanism of carcinogenesis and for a broad applicability and comparability in 
epidemiological studies, analytical methods must be elaborated, which are strictly specific for the 
chemical structure of the DNA-adduct. For induction of 8-OHdG or formation of DNA strand breaks, 
there is still a lack of well-established dose-response relations between occupational or environmental 
exposures, which limits the applicability of these markers.  
In spite of all limitations, it is worthwhile to aim for the ultimate summit of HBM because it is the 
only way to identify and quantify human exposure and risk, to elucidate the mechanism of toxic 
effects and to ultimately decide if measures have to be taken to reduce exposure. Risk assessment and 
risk management without HBM could lead to wrong risk estimates and cause inadequate measures. In 
some countries like in the USA and in Germany, thousands of inhabitants are regularly investigated 
with respect to their internal exposure to a broad range of environmentally occurring substances. For 
the evaluation of HBM results, the German HBM Commission elaborates the use of reference- and 
HBM-values (Angerer et al., 2007).  
3.5. Possible application of HBM to the different steps of risk assessment in food safety 
areas 
A specific challenge related to risk assessments of chemicals is the assessment of the risk stemming 
from contaminants in food and feed. The presence of such chemical contaminants or other unwanted 
substances in food and feed is often unavoidable as these substances may occur ubiquitously. EFSA 
has established for this purpose the Panel on contaminants in the Food Chain (CONTAM Panel). In 
addition regulated chemical substances such as food contact materials, pesticides or veterinary 
pharmaceuticals may be present in food as unwanted substances that need to be assessed. 
The risk assessment of chemical contaminants in food is based on the integration of two aspects: 
knowledge about the human exposure to these substances via food and other routes, and their potential 
to cause adverse health effects.  
The safety of chemicals is assessed following the four steps of risk assessment, namely hazard 
identification (genotoxic, carcinogen, endocrine disruptive, etc.), hazard characterisation (dose-
response relationship, mechanisms/mode of action, kinetics, etc.), exposure assessment (external, 
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internal),  and risk characterisation. Important considerations in risk assessment include windows of 
susceptibility. Human exposure is a key element in risk assessment (Alexander et al., 2012). In 
conventional exposure assessment to contaminants from food, occurrence levels in food are linked 
with consumption patterns across European populations (available in a database due to national 
surveys etc.). Whenever possible, the CONTAM Panel sets an exposure level where there is no 
appreciable health risk. This is known as a health-based guidance value (HBGV) such as an ADI or 
TDI or Tolerable Weekly Intake (TWI) (see chapter 4.2.3.2). If human exposure to the substance from 
food and other sources is below the HBGV, the CONTAM Panel usually concludes that such exposure 
does not pose an appreciable risk to human health. However, the HBGV approach is not suitable for 
genotoxic substances. For unintentionally-occurring substances, no additional toxicological 
information is provided by the manufacturer, and databases are often incomplete and limited (e.g. for 
certain marine biotoxins and many mycotoxins). For substances that cause genotoxicity by a 
mechanism involving reaction with DNA, the EFSA Scientific Committee proposed the margin of 
exposure (MOE) approach as a harmonised approach for the risk assessment of substances that are 
both genotoxic and carcinogenic.  
However, the CONTAM Panel seeks to find ways to improve and refine its human and animal risk 
assessments. They rely on further integration of prospective data, and there is increasing evidence that 
HBM could play an important role in future exposure assessment. There are still considerable 
uncertainties to translate findings in selected experimental model systems to an understanding of 
human toxicology (e.g. various routes of exposure).  
According to the risk management paradigm as formulated by the EU, both the dose-response 
relationship and the exposure data is required to characterise the health risk of a specific chemical 
hazard to subsequently decide whether the risk is such that management is required. In the standard 
European Union risk assessment process, the risks for industrial operators, for consumers and for ‘man 
through the environment’ are assessed. The last category relates to health risks of the general public 
potentially caused by exposure from chemical substances in the environment. For a comprehensive 
risk management, more qualitative and quantitative data related to toxicokinetics, toxicological 
endpoints, and the strength of evidence are requested.  
HBM data is strengthened with the knowledge of the kinetics and toxicological effect levels of a 
substance of interest. Often information of the toxicokinetics is gained from animal studies, and 
interspecies extrapolation is necessary. The toxicokinetics together with sufficient toxicological 
knowledge (e.g. reproductive or carcinogenic effects) complement the HBM data and increases the 
weight of evidence for risk assessments and risk-based decision making.  
Based on but not limited to occupational risk assessment, Manno et al. (2010) identified potential of 
HBM in the different steps of the classic, general definition of risk assessment by the USA’s National 
Research Council. 
3.5.1. Hazard identification 
For hazard identification, all classical toxicological test results must be assessed and this is 
conventionally performed in toxicology studies in vivo or in vitro. HBM has a role in exposure 
assessment and for some toxicological studies where the actual in vivo exposure can only be found 
from biological monitoring. In addition HBM can provide the observation of an increased individual 
or group level of a potentially toxic chemical, or its metabolite(s), in blood, urine or other biological 
samples from exposed populations as compared to those of control individuals (Manno et al., 2010a). 
According to the ECHA Guidance on Derivation of DNEL/DMEL from Human Data,  human data can 
be used in hazard assessment under the obligation to derive limit or guidance values (DNEL/DMEL) 
(ECHA, 2010) and as part of the Chemical Safety Assessment. Forward or reversed dosimetry 
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comparing human and experimental animal concentrations bridge toxicology and human effects 
(Clewell et al., 2008). 
3.5.2. Hazard characterisation 
HBM can contribute to estimate either side of the dose-response equation, i.e. it may help to measure 
the dose (as the biological level of a chemical or its metabolite(s) corresponding to a given level of 
exposure) or to detect the response (the proportion of individuals showing some early adverse effect at 
a given level of exposure) or both (Manno et al., 2010b).  
According to (Angerer et al., 2012), it is possible to study with HBM human metabolism and 
toxicokinetics under conditions of background exposure. This enables the collection of information on 
mode of actions in order to select valid parameters for HBM and to calculate dose and health risks. 
In food risk assessment, the CONTAM Panel has been able to model human data and to incorporate 
information from biomarkers of exposure or of effect in the characterisation of the hazard, e.g. 
cadmium and lead (EFSA, 2009; EFSA CONTAM Panel, 2009, 2010). This allows the use of a body 
burden approach, where an estimate of systemic exposure (body burden), rather than external dose, is 
used in the risk characterisation, but the use of HBM is still limited.  
Besides this aspect, hazard characterisation relies on toxicological test. Data from different test types, 
ideally retrieved from the OECD pick list form the basis of hazard characterisation. The test types are: 
 acute oral toxicity (OECD phrase ID 1703)  
 acute toxic class method (OECD phrase ID 51)  
 avoidance (repellency) (OECD phrase ID 1745)  
 chronic (OECD phrase ID 1797)  
 combined repeated dose and carcinogenicity (OECD phrase ID 1807)  
 combined repeated dose and reproduction / developmental screening (OECD phrase ID 4842)  
 epidemiological  
 fixed dose procedure (OECD phrase ID 770)  
 other (OECD phrase ID 1243)  
 reproduction toxicity (OECD phrase ID 2316)  
 short-term dietary toxicity (OECD phrase ID 2357)  
 standard acute method (OECD phrase ID 1578)  
 subacute (OECD phrase ID 2398)  
 subchronic (OECD phrase ID 2399)  
 up and down procedure (OECD phrase ID 1653)  
Toxicological data are commonly derived from animal experiments and biomarkers of exposure are 
becoming more common in these studies to verify and quantify the actual exposures and to bridge with 
human exposure situations. Analytical methods and standards developed during the toxicological 
study however, are transferrable to human biomarkers. 
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3.5.3. Risk characterisation 
Risk characterisation combines the information from hazard identification and exposure assessment. 
Based on but not limited to occupational risk assessment (Manno et al., 2010b), HBM can be used to 
perform or validate risk assessment when environmental monitoring and health surveillance are 
unavailable or inadequate due to an intrinsically low sensitivity and/or specificity. HBM also allows 
assessing specific, otherwise inaccessible, components of risk, such as metabolic polymorphism, 
enzymatic inhibition or induction of the metabolizing enzymes and other susceptibility factors which 
may be responsible for a different response to chemicals. 
In addition, the results of HBM surveys can be used for risk management. As internal dose  
(biomarkers of exposure) are determined by lifestyle factors, environment and personal factors, 
elevated levels in certain subgroups allow to trigger policy interpretation and remediation measures, 
public information and sensibilisation and the definition of vulnerable subgroups (see also chapter 
4.2.2).  
3.5.4. Exposure Assessment  
Whereas the potential of HBM in hazard identification and hazard characterisation is limited, HBM 
has a critical role in exposure assessment as HBM will provide the ultimate data on actual exposure. 
HBM has the advantage that it integrates exposures from all sources: environmental exposure, lifestyle 
exposures and individual susceptibility (see Figure 4). HBM provides the summary impact of 
environmental pollution, lifestyle factors such as dietary habit, smoking or consumer products use and 
personal susceptibility determined by gender, age, genetic background, and body composition.   
 
 
Figure 4 Biomarkers of exposure as the sum of environmental pollution, lifestyle factors and 
personal susceptibility, adapted from (Schoeters et al., 2012b) 
Biomonitoring is a direct approach to estimate the human exposure from all sources and via all uptake 
routes (Angerer et al., 2007). It reflects the absorption following inhalation, ingestion, dermal 
absorption of all exposure sources such as water, air, soil, dust, personal care products and food. The 
approach is called direct because it can be directly related to the internal dose, which has actually 
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entered the systemic circulation (see Figure 5). If a substance is not absorbed, it will not enter the body 
circulation and the health effects may be none. 
 
 
Figure 5 The role of HBM in the causal exposure-effect relationship, adapted from (Needham, 
2005) 
According to (Aylward et al., 2014), "HBM has become a primary tool for exposure assessment in a 
wide variety of contexts, including population monitoring at national level, and individual exposure 
assessments in the context of epidemiological research into potential adverse health effects of 
chemical exposures" besides other "due to improvements in analytical chemistry, including growing 
lab capacity and reductions in cost, coupled with the increasing focus on more subtle exposure levels 
that involve more complex exposure sources and routes of exposure".  
The major advantage of HBM is the possibility to reduce the number of assumptions that have to be 
made regarding consumption rates. Another major advantage is the integration over all routes and 
sources that may elucidate exposures that have not been anticipated or have been neglected in external 
aggregate exposure assessments and/or models. For the complex health risk assessment for the general 
public, HBM surveys are the ideal tool to collect exposure data from European populations. 
Biomonitoring data may be especially valuable for combined exposure estimations (e.g. for 
consumers). 
Environmental monitoring and HBM are complementary tools. However, biological measures of 
exposure should be preferred, if available, to environmental exposure data as they are closer to the 
target organ dose and provide greater precision in risk estimates and in dose–response relationships. 
HBM is often more specific and sensitive than environmental monitoring (e.g. food monitoring) in 
assessing the degree of recent and, by all means, also past exposure to chemicals from all routes 
(Manno et al., 2010b). HBM is particularly valid to assess chemical persistence, can provide a 
measure of the past exposure, the early adverse effect, and the individual susceptibility to these 
persistent environmental chemicals and may be particularly useful to assess and control the risk of 
long-term outcomes associated with their exposure. An example for the role of HBM in exposure 
assessment and its relation to other HBM techniques and requirements (e.g. questionnaire data, 
environmental monitoring data) is provided in Figure 6. 
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Figure 6 The role of HBM and other data sources in mercury exposure, adapted from (Schoeters et 
al., 2012b) 
In combination with questionnaire information, HBM data may provide information about sources 
such as patterns of dietary habits. Higher levels of acrylamide adducts in haemoglobin, for example, 
have been observed in populations with high intake of fried food (Vikstrom et al., 2012). 
It has been emphasised that HBM data is particularly valuable for establishing baseline measures of 
human exposure, but that the evaluation of potential health risk remains a difficult and uncertain task 
(Clewell et al., 2008).  
Due to the fact that HBM data reflect internal exposure whilst the traditional risk assessment and the 
resulting estimates of safe exposure are generally based on external exposure, health HBM data need 
to be interpreted by means of forward or reverse dosimetry. PBPK models provide a useful way of 
accounting for the various factors controlling overall compound elimination and how variations in the 
various factors are translated into concentrations of compound/metabolite in blood and tissues 
(Aylward et al., 2014). 
HBM survey data can be interpreted for risk management purposes by means of HBM-related 
guidance values, which are currently developed only in the USA and in Germany. In Germany, these 
type of HBM-related guidance values are called HBM values (HBM-I and HBM-II). In the United 
States, they are called Biomonitoring Equivalents (BE; see also chapter 4.2.3.3). These values translate 
established HBGVs (e.g. TDIs, RfDs) into a biomarker concentration value (Angerer et al., 2011). The 
use of HBM surveys in combination with HBM values or BEs will allow initial screening of 
population exposure to chemicals, assisting in priority setting and ultimately leading to improved 
product stewardship and risk management, and the use of actual HBM data coupled with the 
corresponding BEs has the advantage of allowing a risk assessment under real-world conditions.  
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Population-based sampling can provide valuable information as to whether exposures are likely to 
reach or exceed the health-based reference value even for substances even with short half-life (e.g. 
BPA, toluene). HBM data can reduce uncertainties of exposures estimates, and properly designed 
targeted studies could inform the exposures of people with unusual exposure conditions (Boogaard et 
al., 2011).  
3.5.5. Possible application of HBM for the implementation of a systematic Post-
Market Monitoring (PMM)  
PMM, also known as post-launch monitoring (PLM) or post-market surveillance (PMS), is a concept 
that has not been specifically defined but has been used in the context of testing the conclusions drawn 
from the pre-market risk assessment, e.g. confirmation of the extent to which the product is being 
consumed by its target group and estimation of exposure in other population groups (Hepburn et al., 
2008). The concept has received attention recently as a potential tool in the approaches available for 
evaluating the safety of novel foods and ingredients (EFSA GMO Panel, 2011; Hepburn et al., 2008). 
In principle, however, the PMM methodology is applicable to all food groups.  
As mentioned in the EFSA guidance document of the Panel on Genetically Modified Organisms 
(EFSA GMO Panel, 2006), risk assessment studies cannot fully reproduce the diversity of the 
populations who will consume the marketed product, and risk assessment relies on an estimate of the 
intake of the food which is variable and subject to uncertainty.  
According to (Hepburn et al., 2008), PMM (e.g. for novel food) may provide the means to evaluate the 
actual intake of a food by consumers and may increase the probability of detecting adverse effects in 
small, well characterised segments of the population deemed most at risk in the pre-market 
assessment, when they are exposed to the food during long periods of time under conditions of 
everyday life. It may thus provide helpful reassurance that the potential for an adverse effect, judged a 
priori during the pre-market assessment to be of low probability, is indeed unlikely for the significant 
majority of consumers PMM is a hypothesis-driven, scientific methodology for obtaining information 
through consumer investigations. Elements of PMM focus on the description and quantification of at-
risk groups and target groups, and on the description and quantification of any health effects 
consequent on dietary behaviour. PMM has been used as a complement to safety assessment in a few 
specific cases, but has not been routinely undertaken to date, nor has it been routinely required. 
The following specific purposes of PMM as complement to risk assessment are considered to be in 
particular:  
 Reassurance that any occurrence of known risks in the general population is of low frequency 
and intensity and not exceeding the estimated daily intake and any significant adverse effects 
occur 
 The monitoring of real consumption patterns if estimated daily intake (EDI) is close to the 
acceptable daily intake (ADI) 
 Monitor the extent of use by the target population and/or by other groups in the population if a 
product was intended for use in foods for certain target populations 
 Monitor potential misuse of a product (over-consumption, or use in applications not originally 
intended) 
 Collection of any ‘signals,’ which may be suggestive of a health-related event 
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 Exploration of any health related hypotheses generated by new issues after the established risk 
assessment 
 Investigation of unexpected complaints 
Consequently, the determination of real-life exposure for verification of risk estimates if a major 
objective of PMM.  
Given the fact that HBM is a valid tool for individual and group level exposure assessment to 
environmental contaminants and chemicals (see chapter 3.5.4), HBM is generally useful for the 
implementation of a systematic PMM approach for regulated chemical substances, if appropriate 
analytical methods and validated biomarkers are available and if the up-take of the regulated substance 
is predominantly via dietary intake.  
One recent example that HBM can be a very powerful tool for PMM providing data on actual intake 
related concentrations in the human body is the high level of methylmercury in hair detected in sushi-
eating females that lowers when the amount of tuna fish intake is minimised [The Unborn. (2014) TV 
documentary. DR1 (Denmark), 3 Nov.]. 
3.6. Usefulness of HBM for exposure assessment of chemical substances from food source 
HBM is useful for exposure assessment of chemical substances from food source. HBM can 
demonstrate trends and changes in exposure, establish distribution of exposure among the general 
population, identify vulnerable groups and populations with higher exposures and emerging chemical 
risks. The sensitivity of modern analysis methods allows insight into human metabolism and 
toxicokinetics of chemicals. Depending on biomarkers used HBM does not only allow to monitor 
exposure but also to detect early health effects. 
HBM has not a major role in hazard identification, but could be used for verification of an increased 
individual or group level in an exposed/diseased subgroup compared to controls. In hazard assessment 
HBM can contribute to estimate either side of the dose-response equation as it may help to measure 
the dose or to detect the response or both. The core role of HBM in risk assessment is human exposure 
assessment. The major advantages of HBM are the possibility to reduce the assumptions regarding 
consumption rates. HBM is often more specific and sensitive than environmental monitoring in 
assessing the degree of recent and past exposure to chemicals. HBM data is particularly valuable for 
establishing baseline measures of human exposure. In risk characterisation HBM can be used to 
perform or validate risk assessment. HBM allows in addition to assess specific, otherwise inaccessible, 
components of risk, such as metabolic polymorphism, enzymatic inhibition or induction of the 
metabolizing enzymes and other susceptibility factors which may be responsible for a different 
response to chemicals.  
In PMM, HBM could be a valuable tool to verify risk assessment results. It could be used to monitor 
real exposure if estimated daily intake (EDI) is close to the acceptable daily intake (ADI), to collect 
any ‘signals’, which may be suggestive of a health-related event, to explore any health related 
hypotheses that are generated after the risk assessment has been established and to investigate 
unexpected complaints. 
But further efforts have to be taken to increase the usability. This relates to the interpretation of HBM 
results, where HBM data need to be interpreted by means of forward or reverse dosimetry, such as 
PBPK modelling or HBM Values and BE that translate established reference values into a biomarker 
concentration as well as to the availability of validated biomarkers of exposure for priority substances 
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related to food. Data storage and accessibility as well as comparable data collection and 
communication are further challenges that have to be tackled together with the issue of high costs. 
Major challenges are the integration of HBM in surveillance infrastructure (synergies), the 
prioritisation of substances of concerns (biomarkers) to be monitored, the development of appropriate 
reference values for exposures and of health based guidance values, the development of European 
wide comparable study protocols, and analytical methods, the establishment of quality 
assurance/control (QA/QC) systems and the sample and data storage for retrospective trend analyses 
and international cooperation/exchange in the light of ethical and data protection issues. In this context 
there is need for a consistent interpretation of data across Member States. 
If biomarkers and HBM are to contribute to EU environment and health policy and interventions, they 
have to be relevant and accurate, provide information that cannot be obtained otherwise and bring 
about acceptable consequences for the study subjects. This includes a strong need for external quality 
assessment schemes to ensure comparability of biomonitoring results.  
The questions that need to be answered and information that needs to be available in order to be able 
to use HBM as policy tool are as follows: 
1. Existence of valid accurate and relevant biomarkers,  
2. Reliable and scientifically robust analysis data 
3. Appropriate infrastructural framework and data accessibility 
4. Effective translation of study results into policy decisions 
a. Combination with environmental and health data and modelling work 
b. Comparison with reference ranges and guidance value,  
c. Thorough data interpretation and communication  
5. Feasible cost-benefit relations and funding systems 
6. Well accepted chemical parameters  and study design 
For most exposure biomarkers, the relationship with health effects remains currently unclear. This 
limits the interpretation of biomonitoring data in terms of health risk (Casteleyn et al., 2009). In 
addition, there is urgent need to develop suitable HBM methods for emerging chemicals in food 
safety. 
3.6.1. Strength and limitation of HBM in risk (exposure) assessment and for the 
implementation of a systematic PMM approach  
HBM is one of the existing tools to determine the causal chain between environmental or occupational 
hazards and potential health effects. HBM in this context can be used principally both for uptake 
monitoring and for effect monitoring as indicated in the figure above. Exposure monitoring identifies 
the pollutant or chemical concentration in human tissue (biomarkers of exposure). Effect monitoring 
determines the reaction to pollutants or chemical burden in human bodies including potential health 
effects (biomarkers of effect or biomarkers of susceptibility).  
Major advantages of HBM in risk assessment are the analysis of contamination levels and trends, the 
personalisation of exposure and potential risks (awareness raising effect), and the verification of 
exposure and risk estimates.  
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One strength and advantage of HBM in exposure assessment is the fact that it reveals the actual body 
burden of an individual person independent from the source and route of exposure by summing up and 
integrating the combined effect and taking into account processes like metabolism, bioaccumulation 
and excretion. Another advantage is that it is closer to health effects than environmental monitoring, 
that it getting pollution personal, and having a strong awareness raising and educational effect. Finally 
it can show geographical and socio-economic differences in exposure and body burdens. 
HBM can support monitoring/surveillance of control the efficiency of political risk reduction measures 
or substitution of regulated substances, it can provide data for identification of needs & priority setting 
in policy, and contribute to a decision basis for management measures such as the establishment of 
limit values. Findings from HBM surveys may also encourage initiation of further investigations and 
identifications of potential substances of very high concern (SVHC) or chemicals of equivalent 
concern. The major limitations of HBM in risk assessment include the inability to differentiate by 
source, the variability of results and the difficulty to trace back past exposure for short-lived 
substances. 
HBM offers the confirmation of human exposures enabling parallel assumptions by dosimetry of 
adverse human effects from effects seen in toxicological studies. In such comparisons, however, the 
toxicokinetics must be included. By comparisons of exposures in different population studies, more 
solid data on associations can be provided. HBM is limited by availability of reliable and sensitive 
analytical methods, and the biomarkers must reflect the risk. Table 6 provides specific strength and 
limitations of HBM in the four different steps of risk assessment. 
Table 6 Strength and limitations of HBM in the risk assessment process 
Step in process Benefits of HBM Limitations of HBM 
Hazard identification 
 
May contribute from epidemiological 
studies bridging exposures and adverse 
effects 
BM is not performed in all experimental 
toxicological studies, thus not enabling 
comparison to human levels 
Hazard 
characterisation 
May contribute from epidemiological 
studies bridging exposures and adverse 
effects 
If BM is a part of the experimental 
toxicological studies, the species-specific 
toxicokinetics have to be taken into 
account 
Exposure assessment 
Post-Market-
Monitoring 
HBM provides the ultimate proof of 
human exposure 
Analytical limitation (insufficient 
sensitivity) may develop false negatives 
Risk characterisation The size and power of the HBM study 
may specify the human risk if 
epidemiological data can confirm 
The biomarkers may not reflect the risk 
 
HBM data derived in a reliable and comparable way integrates the exposures from food as well and 
lifestyle taking individual characteristics of age, gender, body composition, disease in the study 
persons into account.  
Such information collected for groups can be used by regulators and politicians for standard setting 
and for communication of eventual risks to the populations, eventually identifying susceptible groups. 
Regional and national comparisons may reflect specific food habits, e.g. fish eating in the 
Mediterranean countries resulting in highest mercury levels found in Europe. 
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However, as with any method of characterising exposure, there are numerous factors that influence 
variation in biomarker concentrations in addition to exposure magnitude and have to be taken into 
account. Measured biomarker concentrations may hence not be interpreted as direct surrogates for 
exposure level, and biomarker concentrations may not be assumed to be linearly related to external 
exposure levels but factors related e.g. to timing of sample collection, biological matrixes and 
chemical toxicokinetics need to be taken into account (Aylward et al., 2014). 
Regarding hazard identification, BM of concentrations in experimental studies reflecting the uptake, 
distribution, metabolism and excretion in the animal studies have only recently been introduced and 
are currently not requested in all toxicological studies. Furthermore, the toxicokinetics may differ 
between human and experimental species, limiting the extrapolation between the results of adverse 
effects at given concentrations in experimental studies and eventual human effects during hazard 
characterisation. 
In addition, the lack of appropriate BM of exposure and effect, the complexity of method 
development, the comparability of results in the light of varying study design and the costs are further 
aspects that limit the use of HBM.   
In PMM as a specific form of exposure assessment, all strength and limitations of HBM for exposure 
assessment apply equally. 
In Table 7, strength and limitations of HBM are specified for the individual steps that are of relevance 
in PMM from the study person via the selection of the biological sample, sampling and analysis to the 
potential for identification of the relevant exposure source. 
Table 7 Strength and limitation of HBM in implementation of a PMM 
 Strength Limitation 
Element of HBM in PMM   
Study persons Provide human evidence of actual 
exposure 
May be selected from non- 
exposed and provide non 
informative results 
Biological matrix May mimic target tissue e.g. blood that 
comes into contact with vital organs 
The half-life of the substance may 
invalidate the results in a given 
matrix 
Sampling Provides real exposure data from humans 
at fixed time points 
If half-life is short false negative 
result may arise is samples are 
taken long time after exposure 
Analysis Signifies exposures if validated analytical 
techniques are used 
The detection limits may not be 
sufficiently sensitive to reflect the 
actual exposures 
Source identification Proper questionnaire and/or interview may 
identify known and unknown sources 
Instruction in proper response to 
questionnaires is often difficult 
Risk/safety evaluation If toxicology is well described with 
NOAEL risk assessment may be complete 
Proper information for risk 
assessment is often lacking with 
new compounds 
Communication Satisfies the participants and consumers May violate ethics if not 
respecting data protection 
 
One of the common criticisms is that HBM represents only a snapshot in time, but this deficit also 
apply to the conventional exposure assessments. Following (Hays & Aylward, 2012), sources of 
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variability that impact interpretation of biomonitoring data are often less than the uncertainties 
associated with conventional external dose-based exposure assessments.  
The EFSA’s Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) 
reported in its scientific opinion on BPA (EFSA CEF Panel, 2015) that “Internal exposures to total 
BPA, as estimated by forward modelling, are in good agreement with the backward-modelling 
estimates obtained from urinary biomonitoring, suggesting that it is likely that no major exposure 
sources have been missed for the forward-modelled exposure assessment. It is, however, important to 
highlight the fact that the internal exposure estimation of total BPA includes conservative assumptions 
resulting in likely overestimation of exposure that could in theory have hidden other possible sources 
of exposure. The CEF Panel noted also that there are considerable uncertainties in the forward and 
backward estimates of internal exposure.”  
3.7. Inventory of the different HBM surveillance programmes/initiatives at national, EU 
and international level  
This chapter provides a systematic review of major existing HBM programmes or studies in Europe 
(Germany, Flanders, France, Spain, Italy, Czech Republic, Slovenia, Sweden, Finland, and Norway), 
in North America (Canada and USA), and in Asia (primarily South Korea, Japan, and China). After an 
extensive literature search, only HBM studies measuring the exposure levels in the general population 
(i.e. not occupational workers or measurements in non-human samples) existing from 2002 on are 
covered in this report. For each HBM study, the funding source(s), study duration and design, the 
participants and its recruitment strategies, the analysed chemicals and the analytical methods used, the 
summary and interpretation of the study findings, the communication of results to the 
participants/scientific world/public, and its implications towards policy-making are addressed. 
Table 8 Overview of the included HBM studies at national, European and international level 
Country Title of study
 
Year(s)
 
Germany 
German Environmental Specimen Bank for Human Tissues 
(ESBHum) 
1974- present 
German Environment Surveys (GerES I – IV) 1985- present 
Flanders Flanders human biomonitoring network (FLEHS) 2002-present 
France 
The French Nutrition and Health Survey (ENNS) 
2006-2007, 2013-
2014 
Étude longitudinal française depuis l’enfance (ELFE) 2011-present 
Étude de santé sur l’environment, la biosurveillance, l’activité 
physique (ESTEBAN) 
2014-present 
Spain BIOAMBIENT.ES 2009-2010 
Italy 
Programme for biomonitoring the Italian population exposure 
(PROBE) 
2008-2010 
Czech Republic 
Human Biomonitoring (Cz-HBM) as part of the Environmental 
Health Monitoring System (EHMS) 
Since 1994 
Slovenia Slovenia’s national HBM programme 2010-2012 
Austria Schadstoffe im Menschen (“Pollutants in Humans”) 2008-2011 
Sweden First-time healthy mothers in Uppsala 1996-2006 
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Country Title of study
 
Year(s)
 
Denmark Danish HBM studies 2006-2012 
Norway 
The Tromsø cohort study 1997-2007 
The Norwegian Mother and Children Cohort Study (MoBa) 1999-present 
Finland Effects of nationwide addition of selenium to fertilizers 1985-present 
AMAP Arctic Monitoring and Assessment programme Since 1997 
Canada Canadian Health Measures Survey (CHMS) 
2007-2009 2009-
2011 
United States of 
America 
U.S. National Health and Nutrition Examination Survey 
(NHANES) 
1999-present 
South Korea 
The Korea National Health and Nutrition Examination Survey 
(KNHANES) 
1998-present 
Korea National Survey for Environmental Pollutants in the 
Human Body (KorSEP) 
2005-2008 
Korean Environmental Health Survey in Children and 
Adolescents (KorEHS-C) 
2011-2012 
The Mothers and Children’s Environmental Health (MOCEH) 
Study 
2006-present 
Japan 
The Tohoku Study of Child Development 2001-2003 
The Hokkaido Study on Environment and Children’s Health 2002-present 
Japan Environmental and Children’s Study (JECS) 2010-present 
China National Monitoring on POPs in human milk of China 2007 
EU-wide 
Consortium to Perform Human Biomonitoring on an European 
Scale (COPHES)/Demonstration of a Study to Coordinate and 
Perform Human Biomonitoring on an European Scale 
(DEMOCOPHES) 
2009-2013 
Environmental Cancer Risk, Nutrition and Individual 
Susceptibility (ECNIS) 
2005-2013 
EnviroGenomarkers – Genomics Biomarkers of Environmental 
Health 
2009-2013 
Integrated Assessment of Health Risks from Environmental 
Stressors in Europe (INTARESE) 
2005-2010 
Expert Team to Support Biomonitoring in Europe (ESBIO) 2005-2008 
Public Health Impact of Long-Term, Low-Level Mixed Element 
Exposure in Susceptible Population Strata (PHIME) 
2006-2011 
Newborns and Genotoxic Exposure Risks (NewGeneris) 2005-2010 
EXPOsOMICs 2013-2018 
The Human Early Life Exposome (HELIX) 2013-2018 
Health and Environment-wide Associations based on Large 
Population Surveys (HEALS) 
2013-2019 
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3.7.1. Germany 
3.7.1.1. German Environmental Specimen Bank for Human Tissues (ESBHum) 
Initiator/Funding source: The German Environmental Specimen Bank for Human Tissues 
(ESBHum), a part of the German Environmental Specimen Bank (ESB), is a permanent monitoring 
system and an archive for human specimens. The storage of human specimens over the last 30 years 
allows retrospective monitoring, especially of phthalates and bisphenol A. Retrospective monitoring 
also allows the identification of temporal trends as well as spatial differences of various pollutants. 
The ESB-Hum is funded by the German Federal Ministry of the Environment, Nature Conservation 
and Nuclear Safety (BMUB), and the German Federal Environment Agency (UBA) Wiesmüller et al. 
(2007). 
Duration: The ESBHum was initiated in 1974 by Professor Fritz H. Kemper. From 1974 to 1983, a 
pilot study started in Münster, Germany to examine the optimal storage conditions of human tissues, 
the recruitment process, and the sampling procedure. In 1984, the permanent collection, storage, and 
archiving of human tissue specimens had begun and is currently still ongoing. 
Study design: ESBHum is a retrospective cohort study with an annual routine sampling period, which 
the collected specimens are stored at -150°C. First, standardised self-reported questionnaires are given 
to the participants in order to collect personal meta-data (e.g. sex, age, place of birth), medical data 
(e.g. medical history, health status, use of medicine, body height, and body weight), personal 
behaviour (e.g. nutrition, use of chemicals) and other sources of exposure (e.g. home and living 
situation). Various tissues are then collected, stored, and analysed after collection period. 
Study population/Recruitment: Routine sampling occurs in 4 areas in Germany representing varying 
contamination levels (the potentially polluted area of Halle, moderately polluted areas of Münster and 
Ulm, and the relatively unpolluted area of Greifswald), and 500 students from the Universities in the 
sample areas (males and females; ages 20-29) are recruited each year (about 125 people per location 
per year). 
Investigated chemicals/Matrices/Analytical methods: ESBHum analyses the following substances: 
bisphenol A, fluorocarbons (PFOA, PFOS), metals (As, Cd, Cu, Pb, Hg, Se, Sr, Tl, Zn), 
organochlorine pesticides (HCB, PCP), PCBs (PCB 138, 153, 180), and phthalate metabolites. The 
following metabolites were used as biomarkers of exposure to phthalates: MBzP (for BBzP), MiBP 
(for DiBP), MnBP (for MnBP), MEP (for DEP), and MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-
MEHP, MECPP/5cx-MEPP (for DEHP). 
Pb, POPs (HCB, PCB 138, 153, and 180), PCP, PFASs (PFOA and PFOS) are measured in blood, 
whilst metals (As, Cd, Hg, Sr, Tl, Zn), PCP, BPA, and phthalate metabolites are measured in 24h 
urine. Blood, 24-hour urine, scalp, pubic hair, and saliva samples were collected until 2004. Since 
2005, saliva, scalp, and pubic hair were no longer routinely taken. Collection and storage of perinatal 
specimens such as placenta, umbilical cord blood, and amniotic fluid began around 2005. To ensure 
high quality of the samples over time, the samples (blood and urine) are stored at the minimum of -
150°C. The analytical methods for the tested substances are reported on the German Environmental 
Specimens Bank’s website (http://www.umweltprobenbank.de/en/documents/10027). 
Results/Interpretations: All the results are available on the German Environmental Specimen Bank’s 
website (http://www.umweltprobenbank.de/en/documents/investigations/analytes). The chemical 
levels found in student volunteers from Münster in 2008 are presented in Table 24. 
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Real-time monitoring is performed after completing sampling processes of one year. Results are 
interpreted as time trends. While concentrations of several substances (e.g. As, Cd, and Hg) are 
remained unchanged over time, other substances (e.g. Pb and PCP) show a clearly perceptible 
decrease. While over time the body burden of dioxins as well as PFOS and PFOA decreased, the 
PBDE concentrations in human blood increase. The observed decrease of blood lead and PCP levels 
over time is a consequence of legal prohibition and restriction. The time-dependent concentrations of 
the aforementioned substances agree with results of other national studies (Wiesmüller et al., 2007). 
Investigation of exposure sources: The Environmental Specimen Bank (ESB) not only includes the 
collection and analysis of human tissues but also marine specimens such as fish. Accompanying 
activities to investigate exposure sources comprise collection and measurements at regular intervals of 
limnetic, marine, and terrestrial specimens from typical ecosystems all over Germany, including 
coastal regions, urban settlements, and mountainous terrain to assess the levels of contaminants in the 
environment. In particular, specimens representing various levels of the food chain (e.g. algae, 
mussels, fish, and herring gulls) are collected at the 4 aforementioned participating locations for 
comparison. The following groups of substances have been measured in limnetic, marine, and 
terrestrial specimens: metals (Co, Ni, Cu, Cd, Hg/MeHg, Pb, As, Se), PCBs, pesticides (HCB, 
DDE/DDD, α-, β-, γ-HCH), HBCD, etc. 
Reference values: The results from the previous years would serve as basis for the comparison of the 
latest ESBHum findings. This comparison would determine temporal changes (if any) of substance 
levels in people living in the 4 participating locations. 
Communication to participants/scientific community/public: The results and list of publications 
are available online (http://www.umweltbundesamt.de/en/topics/health/assessing-environmentally-
related-health-risks/german-environmental-surveys) and to study participants. In case of exceedance of 
health based guidance values or strong exceedance of the reference value, participants are 
recommended to do a follow-up.  
Policy support: The results from ESBHum are used to provide scientific evidence for the BMUB on 
exposure trends. Because ESBHum is a retrospective study, it is possible to evaluate whether past 
legislation on chemical restrictions had a sufficiently positive effect towards human health and/or the 
environment. In addition ESBHum is used to identify new risks that would require action to protect 
human health and the environment.  
3.7.1.2 The German Environmental Survey (GerES) 
Initiator/Funding source: The German Environmental Survey is a nationwide human biomonitoring 
study that has been periodically conducted in Germany since the mid-1980s. Each study focuses on 
specific population of people living in Germany such as residents of East or West Germany and 
children. The study was conducted by the UBA, and the Robert Koch-Institute (RKI) carried out the 
field work on behalf of the UBA. It was financed by the BMUB and the Federal Ministry of Education 
and Research (BMBF). 
Duration: The GerES I for adults (aged 25-69) was carried out in 1985/1986 (West Germany), 
followed by GerES IIa (adults aged 25-69) in 1990/91 (West Germany) and GerES IIb (adults aged 
18-74) in 1991/92 (East Germany). In GerES II, the children (aged 6-14) and adolescents (aged 15-17) 
of participating parents were also included. In 1998, GerES III for adults (aged 18-69) was conducted 
in the reunified Germany. GerES IV, focused exclusively on children (aged 3-14), was carried out 
from 19 May 2003 to 6 May 2006. GerES V, focused on children and adolescents aged 3-17, started in 
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2013 and goes until 2016. (http://www.umweltbundesamt.de/en/topics/health/assessing-
environmentally-related-health-risks/german-environmental-surveys) 
Study design: All cycles of the GerES were nationwide cross-sectional studies, each focusing a 
representative sample of the general population. There are 3 key features to the GerES: (1) human 
biomonitoring, (2) ambient biomonitoring, and (3) standardised interview-based questionnaires. For 
completed GerES IV study, the participants (children) were randomly selected from the cross-
sectional sample of the “German Health Interview and Examination Survey for Children and 
Adolescents” (KiGGS consisting of 17,641 participants) (Schulz et al., 2012a). Multiple 
questionnaires (including FFQs) were administered to the subjects or their parents to retrieve 
information on exposure conditions (i.e., food selection, housing conditions, quality of the residential 
environment and exposure relevant behaviour) and food intake. Blood and urine samples were taken 
from the participants; furthermore, extended monitoring of the subjects’ environment (e.g., analyses of 
tap water, house dust, and indoor air) was conducted. Similar to GerES IV, the currently ongoing 
GerES V study aims to recruit participants (children and adolescents) who have previously 
participated in the KiGGS. Questionnaire will be administered to gain information regarding the 
child’s health. However, in this cycle, only morning urine samples (no blood samples) are collected 
from the participants. Extensive ambient monitoring (e.g. analyses of drinking water, contents of a 
vacuum cleaner bag, noise level at the child’s window, indoor air) will also be conducted 
(http://www.umweltbundesamt.de/en/topics/health/assessing-environmentally-related-health- 
risks/german-environmental-surveys/5th-german-environmental-survey-from-2013-to-2016). 
Study population/Recruitment: A total of 1,790 children (907 girls and 883 boys), aged 3 to 14, 
were randomly selected from the KiGGS and voluntarily participated in the GerES IV from 2003 to 
2006. Overall, 150 study locations were chosen from the total number of German communities, which 
are stratified according to the Federal States and the type of community (Schulz et al., 2012a). For 
GerES V, children and adolescents aged 3-17 have been recruited from more than 160 German towns 
and municipalities since 2013. The participants of the representative age and gender groups will be 
chosen randomly from the registers of residents in the areas of interest. The UBA intends to recruit as 
many participants as possible as higher number of participants will provide more meaningful results.  
The potential participants of GerES IV (children aged 3-14 who previously participated in the KiGGS) 
were first identified via local inhabitant registries of the selected sampling locations. The sample 
population was then drawn from a multistage random sampling procedure, and the selected 
participants voluntarily partook in the study. For GerES V, the parents of the participant can receive 
the results of the chemical analysis of their child’s urine and the analysis from the ambient 
biomonitoring by request. The participants will also receive 20 € as a token of gratitude. 
Investigated chemicals/Matrices: For GerES IV, metals (Pb, Cd, Hg), organochlorine pesticides 
[HCB, α-HCH, β-HCH, γ-HCH, DDE (metabolite of DDT)], and PCBs (PCB 138, 153, 180) had been 
measured in whole blood samples, whereas chlorophenols (2-MCP, 4-MCP, 2,4-DCP, 2,5-DCP, 2,6-
DCP, 2,3,4-TCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,6-TeCP, PCP), cotinine (as a biomarker of tobacco 
smoke exposure), metals (As, Cd, Ni, Hg), nicotine, organophosphate metabolites [DMP, DMTP, 
DMDTP, DEP, DETP, DEDTP (for DAP)], PAH metabolites [1-Hydroxypyrene (for pyrene), 1-
Hydroxypheanthrene, 2/9-Hydroxyphenanthrene, 3-Hydroxyphenanthrene and 4-
Hydroxyphenanthrene (for phenanthrene)], and pyrethroid metabolites [Br2CA (for deltametrin), F-
PBA (for cyfluthrin), cis-Cl2CA, trans-Cl2CA, 3-PBA (for cypermethrin, deltamethrin, and 
permethrin)] had been measured in urine samples. 
For the ongoing GerES V, the following substances are to be measured only in morning urine samples: 
cotinine, metals (As, Cd, Au, Hg, Pt, Pd, etc.), organophosphate metabolites [DMP, DMTP, 
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DMDTP, DEP, DETP, DEDTP (for DAP)], PAH metabolites [1-Hydroxypyrene (for pyrene), 1-
Hydroxypheanthrene, 2/9-Hydroxyphenanthrene, 3-Hydroxyphenanthrene and 4-
Hydroxyphenanthrene (for phenanthrene)], parabens, phthalate metabolites (metabolites of DEHP, 
DnBP, DiBP, BBzP, DEP, DiNP, DiDP, DMP, DnPeP, DnOP, DChP, and the more recent phthalates 
DPHP, and DINCH). 
In addition, the following classes of chemicals that had been analysed in the previous cycles of GerES 
(i.e. GerES I-III): bisphenol A, chlorophenols (2-MCP, 4-MCP, 2,4-DCP, 2,5-DCP, 2,6-DCP, 2,3,4-
TCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,6-TeCP, PCP), cotinine, fungus-specific IgE (Penicillium 
(notatum) chrysogenum, Aspergillus versicolor, Alternaria alternata, Wallemia sebi, Eurotium spp), 
metals (Sb, As, Ba, Cd, Cr, Cs, Cu, Ir, Pb, Hg, Ni, Pd, Pt, Sr, Tl, U, V, Zn), nicotine, organochlorine 
pesticides [4,4’-DDE (metabolite of DDT), 4,4’-DDT, HCB, α-HCH, β-HCH, γ-HCH], 
organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP (for DAP)], PAH 
metabolites [1-Hydroxypyrene (for pyrene), 1-Hydroxypheanthrene, 2/9-Hydroxyphenanthrene, 3-
Hydroxyphenanthrene and 4-Hydroxyphenanthrene (for phenanthrene)], PCBs (PCB 28, 52, 101, 138, 
153, 180), and pyrethroids and their metabolites (F-PBA, Br2CA, cis-Cl2CA, trans-Cl2CA, 3-PBA, 
cypermethrin, permethrin). 
Whole blood and morning urine samples were collected and analysed except for GerES V, which only 
will collect morning urine. Hair samples had been collected in GerES I. 
Analytical methods: Phthalate metabolites were measured via LC/LC-MS/MS after enzymatic 
hydrolysis. BPA was measured via GC-MS/MS (Becker et al., 2009). As was measured via HG-AAS, 
Hg via CV-AAS, and Pb and Cd via ET-AAS. Cotinine and nicotine were measured by HPLC (Schulz 
et al., 2007). Organophosphorus metabolites were measured by GC-MS after extraction with 
diethylether/acetonitrile and derivatisation with pentafluorobenzylbromide (Becker et al., 2006). 
Results/Interpretations: The extracted results from the published GerES IV report (Becker et al., 
2008) are presented in Table 25. 
Results were interpreted by region, age and gender, as well as socio-economic background. They have 
been related to potential exposures and were compared to guidance values such as HBM values and 
reference values from previous monitoring rounds whenever possible. The following interpretations 
are extracted from the GerES IV report (Becker et al., 2008): 
Heavy metals (Pb, Cd, Ni, Hg, As) in blood and urine: Arsenic level was significantly higher in 
boys than in girls and decreased with age. The levels detected in migrants, children from the West 
Germany and children from large communities were higher than those in children from the respective 
control group. An association with fish consumption within 48 hours prior to sampling was observed. 
For Cd in blood, the majority of levels measured was below the limit of quantification (LOQ). Being a 
migrant, increasing age, and smoking are factors that can increase Cd levels in both blood and urine. 
The mean Ni level was found to decrease with increasing age. Comparatively lower Ni levels in urine 
were found in children with a high socioeconomic status (SES) and in non-migrants. Age, SES, 
migrant status, size of the community and fish consumption were significant predictors of mercury 
levels in blood. The percentage of quantifiable mercury levels in urine increased with increasing 
number of teeth with amalgam fillings. Quantifiable levels of mercury in urine were more often 
detected in boys and migrants than in girls and non-migrants, respectively. 
Organochlorine compounds in blood: The levels of lower chlorinated PCB (PCB 28, 52, 101) were 
mostly below the LOQ. PCB levels (except PCB 138) found in boys were higher than those found in 
girls. The levels decreased with increasing age and increased for children with a high SES or living in 
West Germany and for non-migrants. The DDE levels also decreased with increasing age. Similar to 
PCBs, the levels found in children with a high SES was higher than that in children with a lower SES. 
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However, unlike PCB levels, DDE levels detected in migrants were higher than those in non-migrants. 
In East Germany and in large communities, the level was higher than in West Germany. The 
predictors for HCB were the same as for PCB, with the exception of gender, which was of no 
relevance for HCB levels. The predictors relevant for β-HCH were identical with those for DDE. For 
all substances described, significantly higher levels were found in children who had been breastfed as 
compared to children who had not been breastfed. 
Nicotine and cotinine in urine: Nicotine and cotinine could be detected by analysis in 44% and in 51 
% of the children, respectively. The levels of both substances increased significantly with increasing 
age. Significantly higher levels were found in migrants and children with a low SES. Smoking has 
shown a significant and very clear association with nicotine and cotinine levels. 
Organophosphate metabolites in urine: The highest detectable organophosphate metabolite levels 
were from the 2 dimethyl phosphates, DMP (15.8 μg/L) and DMTP (16.8 μg/L). The DEDTP levels 
detected were within a comparatively narrow range of values. DETP was not detectable in about 40 % 
of the samples, and no dependency on the descriptive variables was found. 
Chlorophenols in urine: Because PCP was only detectable in 49% of the samples, the LOQ (0.6 
μg/L) was considered as the mean level. None of the variables was seen to have had a significant 
influence on the percentage of values representing quantifiable PCP levels. 
PAH metabolites in urine: The results have shown excretion of 1-hydroxypyrene and 
hydroxyphenanthrenes being related to children's smoking habits. For all PAH metabolites except 4-
hydroxyphenanthrene, the level in the urine of children living in East Germany was higher than that in 
children living in West Germany. 
Pyrethroid metabolites in urine: F-PBA and Br2CA could be detected by analysis in 19% and 45 % 
of the examined children, respectively. In girls, the mean levels of cis- and trans-Cl2CA as well as of 
3-PBA were significantly higher than in boys. Age was seen to be a significant variable for three of 
the metabolites examined. 
The findings in relations to exposure sources have been further summarised in (Kolossa-Gehring et al., 
2008). The most important and health relevant source is tobacco smoke as children’s exposure 
increased slightly since 1992. DDT, PCBs, PCP, and DnBP in house dust show a small but significant 
contribution to children’s body burden. Levels of metals in drinking water (except uranium) not 
significantly correlated with the children’s exposure levels. Food is a major exposure source for 
organochlorines, biocides, and phthalates. Exposure to organophosphate pesticides is mainly 
influenced by age, consumption of fresh fruit and fruit juice. The organochlorine levels (such as HCB, 
HCH, DDE and PCB) in blood are higher in children with a higher SES and in breast-fed children. 
The exposure levels in children decreases with increasing age. Children with immigrant status or 
living from East Germany show higher DDE but lower PCB levels than non-immigrants or children 
from West Germany, respectively. Immigrants also show higher β-HCH levels. 
Investigation of exposure sources: The contribution of the domestic environment to chemical 
exposure was assessed by analysing domestic drinking tap water (mainly for metals such as Cd, Cu, 
Pb, Ni and U) and samples from indoor air and house dust. Information on exposure conditions was 
collected in addition via standardised interview-guided questionnaires from parents and children of 8 
years and older. The collected information included topics such as smoking habits, consumption of 
special food products, health status, housing situation, and the quality of the residential environment. 
A special FFQ gathered the consumption of fifty food groups for statements about the food selection 
of the children. In the programme “noise, hearing capability and stress hormones” for children aged 8 
years or older, the programme was extended by physical measurements (noise level measurement and 
screening audiometry) and by an additional interview. For participants of the additional programmes 
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on chemical and biogenic indoor contamination, further measurements and interviews were added 
(Kolossa-Gehring et al., 2008). 
Reference values: Reference values (RV95) were determined based on the 95% confidence interval of 
the 95
th
 population percentile of the concentration level of the respective parameter in the matrix 
obtained from the reference population. RVs determined from previous GerES surveys are up-dated 
with new incoming results. 
Communication to participants/scientific community/public: The findings from GerES IV are 
published by UBA as a report (Becker et al., 2008), which is free for the public to access 
(http://www.umweltbundesamt.de/publikationen/german-environmental-survey-for-children-200306). 
In addition, scientists and researchers, who intend to pursue further evaluations of the study, can 
retrieve data from the UBA of the pollutant concentrations and questionnaire data from all of the 
participants. Every participant was or will be informed about the concentrations of the analysed 
substances in her/his biological (e.g. blood and urine), drinking water, and indoor air samples. 
Additionally, an environmental-medical assessment of these data was or will be supplied. 
Policy support: GerES IV provides representative data on exposure of adults and children aged 3–14 
years to environmental factors in Germany, which is up-dated in regular intervals. The representative 
data serve to: (1) provide a basis for establishing reference values for the exposure of children to 
environmental contaminants in blood and urine as a basis for a consistent evaluation throughout 
Germany, (2) detect temporal trends and regional differences in exposure, (3) identify and quantify 
exposure sources and pathways that are important for risk assessment, management and 
communication, (4) determine connections between certain environmental factors and the health 
situation of children, (5) establish concepts for prevention, intervention and reduction strategies in the 
context of measures of health and environmental policies (e.g. the guideline values of the Drinking 
Water Ordinance for domestic drinking water, the new chemicals acts on REACH, etc.), and (6) 
evaluate the success of policy and exposure reduction measures. 
3.7.2. Flanders [The Flemish Environment and Health Study (FLEHS)] 
Initiator/Funding source: In 2003, the Flemish government voted the Decree on Preventive Health 
Care, which mandated a human biomonitoring programme in Flanders to study the relationships 
between environmental pollutants and human health. The FLEHS is implemented by the Flemish 
Centre of Expertise for Environment and Health, and within this Centre, researchers from all Flemish 
universities and two research institutes provide expertise in various fields: medical sciences, 
toxicology, epidemiology, food sciences, biostatistics, environmental chemistry and social sciences. It 
is funded and steered by the Flemish government (Department of Economics, Science and Innovation; 
Flemish Agency for Care and Health; and Department of Environment, Nature and Energy) (Schoeters 
et al., 2012a). 
Study design/Duration: This cross-sectional study measured selected pollutants and certain health 
effects in humans (mainly detection of biomarkers). The programme started in 2002, and since then, 
two cycles of human biomonitoring have been conducted. The first cycle (FLEHS I) ran from 2002 to 
2006. The second cycle (FLEHS II) expanded the list of analysed substances and ran from 2007 to 
2011. The third cycle (FLEHS III) started in 2012 and is expected to finish in 2016.
 
(http://www2.vlaanderen.be/weten/steunpunten/steunpuntenG3/beheersovereenkomsten/steunpuntmili
euengezondheid_meerjarenplan.pdf) 
Study population/Recruitment: In Flanders HBM programmes started in 2001 with FLEHS I (2001-
2006), which determined contamination levels for a number of chemicals in three selected regions. For 
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FLEHS I, more than 4400 participants (males and females) were recruited by a stratified clustered 
multi-stage design and were categorized into 3 age groups: [1] newborns and their mothers (n=1200), 
[2] 14-15 years old adolescents (n=1600), and [3] 50-65 year old adults (n=1600). FLEHS II (2007-
2011) was designed to establish reference values for a broad range of chemicals in the general 
population and including three hot-spot areas. 9 study areas were selected based on the differences in 
pollution levels (Schroijen et al., 2008). The Flemish Centre of Expertise for Environment and Health 
was interested in 3 specific groups of interest (both males and females): [1] newborns (n=250), [2] 14-
15 years old adolescents (n=200), and [3] 20-40-year-old adults (n=200). Eligible participants from all 
five Flemish provinces were randomly selected and recruited also by a stratified clustered multi-stage 
design (i.e., maternity care for newborns, schools for adolescents, and provincial institutes for adults) 
from May 2008-July 2009. The participants must have the following inclusion criteria: (1) residing at 
least 10 years in Flanders; (2) giving written informed consent, and (3) being able to fill in an 
extensive Dutch questionnaire. Participants (and parents if the participants were children or 
adolescents) were asked to fill out extensive questionnaires regarding personal background, lifestyle 
factors, and food intake, and blood and urine samples were collected from the participants. 
For the recruitment of newborns, mothers were contacted at the time of delivery. At the selected 
maternity wards, all mothers were given a short explanation about the study and asked to give cord 
blood by the maternity nurse. The adolescents were contacted via the schools. Prior to the invitation, 
the study nurses explained the FLEHS to the students that were selected for participation. The schools 
forwarded the invitation letters, information brochures and the letter of informed consent to the pupils. 
In the adult study, invitation letters, information brochures and letter of informed consent were sent to 
the potential participants via the administration of the provincial institutes. After completion of the 
study, participants received incentives (baby cape with logo of the study for the newborns; cinema 
tickets or book voucher for the adolescents; book voucher for adults).  
Investigated chemicals/Matrices: Cord blood, maternal blood, and hair samples were collected from 
the newborns and their mothers while urine and blood samples were collected from the adolescents 
and adults. Adolescent hair samples were also collected.  
FLEHS covered Cd, Pb, dioxins, PCBs, HCB, DDT, PAHs, benzene. FLEHS II expanded to 50 BM. 
In detail the following substances have been analysed in FLEHS: bisphenol A, BFRs (PBDE 28, 47, 
99, 100, 153, 154, 183, 209, HBCDDs, TBBPA), chlorophenols (2,5-DCP), cotinine (as a biomarker 
of tobacco smoke exposure), dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 
1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), fluorocarbons 
(PFOA, PFOS), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-
HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-
PeCDF, 2,3,7,8-TCDF), herbicide (2,4-D), metals [As (including toxic relevant As such as As(III), 
As(V), MMA and DMA), Cd, Cu, Pb, Mn, Hg/MeHg, Ni, Tl], organochlorine pesticides (DDE as 
metabolite for DDT, HCB), organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, 
DMDTP (for dialkyl phosphates/DAP)], PAH metabolites [1-Hydroxypyrene (for pyrene), 1-
Hydroxynaphthalene (1-Naphthol) and 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], PCBs 
(PCB 138, 153, 180), phenols (butyl paraben, ethyl paraben, methyl paraben, propyl paraben, 
triclosan), phthalate metabolites [MBzP (for BBzP), MnBP (for DnBP), MEHP, MEHHP/5OH-
MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP (for DEHP)], and pyrethroid metabolites [F-
PBA (for cyfluthrin), 3-PBA (for cypermethrin, deltamethrin, and permethrin)]. 
Table 26 shows the list of biomarkers of exposure tested in various samples (Schoeters et al., 2012a). 
Also, measurements of 8-hydroxydeoxyguanosine (8-OHdG; a biomarker of oxidative DNA damage) 
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and the Comet assay have been performed in FLEHS to determine the amount of DNA damage 
(http://www.milieu-en-gezondheid.be/English/results/Greet Schoeters - deel1.ppt). 
Analytical methods: Metals were measured in whole blood by high resolution ICP-MS. In spot urine 
samples, total As and Cd were measured by ICP-Dynamic Reaction Cell-MS. Total Hg and MeHg 
were measured in hair samples by combustion-AAS and by headspace injection-GC-atomic 
fluorescence spectrometry, respectively. POPs, BFRs, HBCD, and TBBPA were measured in plasma 
(cord blood) and serum (adolescents) using SPE and GC-ECNI-MS. CALUX assay was used to 
measure the dioxin-like compounds. Perfluorinated compounds in plasma/serum samples were 
measured with HPLC-MS/MS. BPA and triclosan were measured in urine samples after enzymatic 
hydrolysis with GC-MS in negative ionization mode. Urinary phthalate metabolites were measured 
with UPLC-MS after enzymatic release of the conjugated compounds. Metabolites of 
organophosphate pesticides and 2,5-DCP were measured in urine samples using derivatisation and 
GC–MS detection. Cotinine was measured in urine by quantitative solid-phase chemoluminescent 
immunoassay using the Immulite Nicotine Metabolite kit on Immulite 2000 Analyser. 1-
Hydroxypyrene was enzymatically released overnight followed by on line extraction and detection by 
HPLC and a fluorescence detector (Schoeters et al., 2012a). 
Results/Interpretations: An overview of the results from FLEHS I can be found in Table 27 
(Schoeters et al., 2012a). For FLEHS II, the comprehensive results of all substances analysed can be 
found in the Flanders Human Biomonitoring 2007-2011 Results Report (published in Dutch as 
“Vlaams Humaan Biomonitoringsprogramma 2007-2011 – Resultatenrapport: deel 
referentiebiomonitoring”). 
The main achievement of the study is the large set of reference values for a wide range of pollutants 
that was obtained in a representative and well-selected study group. Some general observations of the 
FLEHS were made (http://www.milieu-en-gezondheid.be/English/results/Elly Den Hond.ppt). (1) No 
alarming trends in exposure of pollutants were detected. (2) All FLEHS participants have blood lead 
levels lower than the WHO guideline (100 µg/L). (3) Area of residence determines exposure. (4) 
People living in rural areas have high exposure to persistent chlorinated compounds. (5) Cd and As are 
problematic in some regions. (6) Although DDT is forbidden, metabolites are still detected in the 
human body in considerable amounts. (7) Factors such as age, sex, smoking and nutritional intake are 
important determinants of exposure. 
Investigation of exposure sources: The Flemish Centre of Expertise for Environment and Health has 
intentions of comparing human biomonitoring results from suspected “hot spots” in Flanders with 
results obtained from the Flemish reference population. These “hot spots” not only include regions 
surrounding industrial plants, areas with high levels of particulate matter and traffic, dumping sites, 
etc. but also areas with elevated fish consumers or with high pollutant levels detected in home-grown 
vegetables or drinking water (Schoeters et al., 2012a). For example, significant correlations between 
fish consumption and arsenic concentrations in the urine samples of both adolescents and adults have 
been made from the FLEHS results (Baeyens et al., 2014). 
Reference values: Reference values are available from the first cycle of the FLEHS. These results 
were used as control values for two biomonitoring campaigns in hot spot areas: one in an industrial 
area around a stainless steel plant (Genk-Zuid) and one in an industrial area around a shredder 
(Menen).  
Communication to participants/scientific community/public: The results have been published 
(Vrijens et al., 2014). In addition, personal results were communicated to the participants after analysis 
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of all the samples. The personal value was reported, together with the median and the 90th percentile 
of the study group. For blood Pb, blood and urinary Cd, reference values were also given. A short 
overview of the biomarkers was given with main sources, main exposure routes and possible health 
effects of each pollutant. Participants also received a brochure with a summary of the group results. 
The end report of the study was delivered to the Flemish Government. In a next phase of the study, 
scientists of the research consortium and scientists of the administration of the government will work 
on the interpretation of the results and deduction of policy implications in the so-called “phased action 
plan”. From January 2013 on, there will be a public use file for external scientist. 
Policy support: FLEHS serves as a foundation for environment and health actions and puts forward 
some important concepts such as health in all policies, sustainable development, and the precautionary 
principles. Furthermore, it has led to concrete policy action plans tackling the most urgent and health 
relevant results. 
3.7.3. France 
3.7.3.1. The French Nutrition and Health Survey (ENNS) 
Initiator/Funding source: The French National Institute for Public Health Surveillance (InVS), along 
with the French National Programme on Health and Nutrition (PNNS), is responsible for carrying out 
the ENNS study. The main objective of ENNS is to describe food consumption, nutritional status, and 
physical activity in the general population in France (adults and children) and to study nutritional and 
environmental biomarkers in humans. The collected data will serve PNNS in their objective to 
“improve health of the population by intervening on one of its major component, nutrition.” (INVS, 
2007b) ENNS is funded by the InVS, the French National Health Insurance Fund for Salaried Workers 
(Caisse nationale d'assurance maladie des travailleurs salaries; CNAMTS), and the University of Paris 
13 (Falq et al., 2011). 
Study design/Duration: ENNS occurred between February 2006 and July 2007 in order to account 
for the seasonal changes in diet in the general French population. This cross-sectional study comprises 
3 parts: (1) a food consumption survey, (2) an interview using both face-to-face questionnaires and 
self-administered questionnaires, and (3) a clinical and biological examination. Examinations were 
conducted either in a health centre or by a nurse at the participant’s home. The data collected per 
participant would include a description of dietary intake, biological samples, socioeconomic and 
demographic information along with the participant’s occupation, personal activities, and exposure to 
pesticides (Saoudi et al., 2013).  
Study population/Recruitment: A total of 4,790 French residents (3,115 adults aged 18-74 and 1,675 
children aged 3-17; both males and females) participated in the ENNS study.
6
 A sub-sample of 400 
ENNS participants was then randomly selected to measure the exposure to organochlorine pesticides. 
The inclusion of subjects was performed with a probabilistic, stratified three-stage sample design. The 
first stratification was done by degrees of urbanization and by geographical areas (8 regions), resulting 
in 190 selected primary units representative of the general French population. For the second 
stratification, households were randomly drawn from phone listings, the phone numbers being 
randomly generated using the increment method. The number of households drawn from each of the 
32 strata was determined proportionally according to the number of residences in each stratum. An 
information letter about the ENNS study would be sent to the selected households. Finally, a physician 
working on the study would contact the selected household, and one member per household would be 
recruited using the birthday method (Saoudi et al., 2013). The participation to the ENNS study was 
voluntary. Each participant was asked to complete informed consent documents and had the possibility 
to withdraw at any time the participation in the study. 
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Investigated chemicals/Matrices/Analytical methods: Urine, blood, and hair samples were 
collected, and 42 substances (11 metals, 6 PCBs, and 3 families of pesticides: organochlorines, 
organophosphates, and pyrethroids) were measured via various methods (Table 9). Substances 
includes chlorophenols (4-MCP, 2,4-DCP, 2,5-DCP, 2,6-DCP, 2,3,4-TCP, 2,4,5-TCP, 2,4,6-TCP, 
PCP), metals [Sb, As (including inorganic As, MMA and DMA) , Cd, Cr, Co, Pb, Hg, Ni, Sn, U, V], 
organochlorine pesticides (HCB, α-HCH, β-HCH, γ-HCH, DDT, 4,4’-DDE as a metabolite for 
DDT),  organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP (for dialkyl 
phosphates/DAP)],  PCBs (PCB 28, 52, 101, 138, 153, 180),  pyrethroid metabolites [F-PBA (for 
cyfluthrin), Br2CA (for deltamethrin), cis-Cl2CA, trans-Cl2CA, 3-PBA (for cypermethrin, 
deltamethrin, and permethrin)]. 
Table 9 Analytical methods used in ENNS study (Fréry et al., 2013; Fréry et al., 2011) 
Substance Method 
Sb, As, Cd, Cr, Co, Ni, Sn, U, V ICP-MS 
Pb ET-AAS 
Hg ID-ICP-MS 
PCBs and organochlorines GC-ECD 
Pyrethroid metabolites GC-MSD 
Organophosphate metabolites GC-MS/MS with multiple reaction monitoring 
Chlorophenols GC-MS 
 
Results/Interpretations: The results of ENNS study are presented in the InVS-published reports 
(Fréry et al., 2013; Fréry et al., 2011) and summarised in Table 28. The findings from the ENNS have 
generated reference values of exposure to various metals and chemicals in the French adult population, 
and the following interpretations of the ENNS are extracted from InVS report of “Exposure of the 
French population to environmental pollutants” (Fréry et al., 2010): 
Metals: The blood Pb concentration has dropped sharply (by 60%) since 1995 due to the efforts to 
reduce exposure to lead in France. However, high levels of lead are still being found, particularly 
among people who have worked in old housing that may contain old lead-based paint. The urine Cd 
concentration is quite similar to those observed in previous French studies (in 1997, 2000, and 2005) 
and in other international studies. Urine Cd levels are higher with increasing age, in women, and in 
smokers. Hg levels in hair are relatively low (0.59 μg of Hg/g of hair among adults and 0.37 μg/g of 
hair among children) and are all lower than 10 μg/g (the WHO threshold). These levels are higher than 
those observed in Germany and the United States but lower than the levels in Spain. These results are 
most likely the effect of the differences in the consumption of fish in these countries. The urinary 
arsenic levels are low, which is similar to most international studies. Arsenic levels in urine are 
influenced by the consumption of seafood products and wine. The urinary concentrations of other 
metals (Sb, Cr, Co, Sn, Ni, U, and V) in adults are quite similar to those observed in other countries. 
Concentrations of metals found in the body are very often linked to age and gender. Some other 
specific factors may influence biomarker levels, such as the degree of urbanisation for vanadium, since 
this metal is emitted by catalytic converters on motor vehicles. 
Organochlorine pesticides: It was possible to quantify organochlorine pesticides and their 
metabolites in nearly all individuals, with the exception of lindane (γ-HCH). On average, levels of 
HCBs in France are between those observed in American and German populations and are generally 
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lower than those observed in other European countries. Concentrations of DDT and DDE in France are 
low, confirming that there has been no DDT exposure in France for a long time due to the ban of these 
products. Overall, the French data relating to chlorophenols is similar to that reported in the United 
States and in Germany, except for 2,5-DCP; its mean level in France is approximately 10 times higher 
than in Germany. This biomarker is a metabolite of para-dichlorobenzene, which is used as a moth-
killer, air-freshener and disinfectant. This observation needs further research to identify specific 
features in the exposure to this substance in France. 
Organophosphate pesticides: DAP metabolites, common in many organophosphorus insecticides, 
have been found in more than 90% of urine samples. The highest levels among the six DAP 
metabolites were observed for DMP and DMTP. Overall, the levels of urinary DAPs in French adults 
are similar to those observed in Germany and higher than those observed in the United States. 
Pyrethroid pesticides: Pyrethroid metabolites were found in more than 80% of samples except for F-
BPA (30%) and cis-Cl2CA (55%). The highest levels of pyrethroid metabolites were found for 3-
BPAs, which is a metabolite of many pyrethroid insecticides, including cypermethrin, deltamethrin 
and permethrin. These levels seem to be approximately 3 times higher than those observed in the 
United States and even higher than levels observed in Germany. 
PCBs: The substances present in the highest quantities are the NDL-PCBs (138, 153 and 180). These 
levels are similar to those observed in the study carried out by InVS in 2005 in areas surrounding 
incinerators. They are a little higher than those reported in the German population in 2002; these levels 
observed in Germany have probably decreased since then. The levels observed in France are also 4 to 
5 times higher than those observed in the American population or in the New Zealand population. 
However, they are lower than those observed in the Czech Republic. This observation needs an 
analysis of the specific features of each country to better understand the origin of the observed 
differences in exposure. As for other organochlorine chemicals measured in serum, concentrations of 
PCBs are influenced by age, sex and body mass index. 
Investigation of exposure sources: Dietary data was collected from the participants to further 
investigate exposure sources. The data comprised three 24-hour recalls randomly distributed over a 
period of 15 days. Participants were asked to describe, as precisely as possible, all foods and 
beverages which were consumed the day before the interview. Participants gave details on food 
recipients and amounts through a photography manual with typical portion sizes (INVS, 2007a). 
Communication to participants/scientific community/public: The study findings have been 
published as InVS reports (Fréry et al., 2013; Fréry et al., 2011), which are available and publicly 
accessible online. The biological results were communicated to participants within two months after 
the examination with a letter to his own usual physician if results were abnormal. A comparison of the 
food consumption with the French nutritional recommendations was conducted and sent to the 
participant, who also received a little book with advices on how to eat well. For environmental 
biomonitoring results, a letter from InVS was sent, and contact with a toxicologist was provided if 
levels were high or if the results could imply an adverse health outcome. 
Policy support: The ENNS study can be considered as a bridge head of the national strategy of HBM, 
elaborated by InVS in collaboration with ministries of Health, of Environment and the French Agency 
for Food, Environmental and Occupational Health & Safety (ANSES). The main component of this 
strategy will be a cross sectional survey (ESTEBAN, which is later discussed in this report) on a 
sample of 5000 children and adults designed to be representative for the French population aged from 
6 to 74 years. The aim of ESTEBAN is to assess the exposure to environmental chemicals (around 100 
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biomarkers) and to establish reference values. Furthermore, ENNS could also be integrated towards 
the harmonisation of HBM in Europe through projects such as COPHES and DEMOCOPHES. 
3.7.3.2. Étude longitudinal française depuis l’enfance (ELFE) 
Initiator/Funding source: The ELFE (translated as the French Longitudinal Study of Children) study 
is a multidisciplinary project born out of the questions raised by researchers and the concerns 
expressed by various public bodies over the last ten years. It was the national health and environment 
plan (Plan national Santé-environnement) of 2004 that provided the decisive impetus for the project to 
go ahead. The study took practical shape in 2006 and has been run by a joint National Institute of 
Demographic Studies (INED, Institute national d’études démographiques)/National Institute for 
Health and Medical Research (INSERM) research unit since March 2010. It is supported by its two 
host institutions along with the InVS, the National Institute for Statistics and Economic Studies 
(INSEE), the National Family Allowance Office (CNAF, Caisse nationale des allocations familiales), 
and government bodies such as the Ministry of Health, the Ministry of Education, the Ministry of 
Research, the Ministry of Environment, and the Ministry of Culture (Vandentorren et al., 2009). 
Duration: Two pilot studies were first carried out in 2007 to validate the questionnaires, sampling 
protocols, data collection, and analytical methods, to estimate the study’s participation acceptance rate, 
and to assess its field feasibility. Then the ELFE study began at the end of March 2011 and will 
continue until the children reach adulthood.  
Study design/population: The design of the longitudinal cohort study is based on an initial enrolment 
interview of mothers at the child's birth in order to obtain retrospective data about exposures during 
pregnancy followed by a prospective follow-up of the child. Biological collection will be conducted at 
maternity for 10,000 mother–child pairs. In addition, subsamples of 600–3000 mother–child pairs 
(depending on the compound) randomly selected from the cohort will be used for biomonitoring 
purposes. Other data to be collected include medical files (obstetric data), questionnaires (living 
conditions, social and demographic, housing characteristics, child’s growth, development, diet and 
health), as well as household environment measurements (dust trap). The follow-up of the children is 
based on data retrieval and record linkage from existing databases (INSEE demographic data, school 
follow-up, health insurance records, national environment database, etc.) as well as on several waves 
of cross-sectional surveys to be carried out at different ages. These surveys may include biological 
sampling and will be based on face-to-face interview surveys or telephone interviews, clinical 
examinations and psychomotor development tests, self-administered questionnaires, measures of the 
environment, etc. (Vandentorren et al., 2009). 
Recruitment: An information campaign will be conducted in all maternity units before the beginning 
of the study. A postal invitation to participate will be sent to all mothers during the 7th month of 
pregnancy via the newsletter sent by the CNAF. Fathers will also be invited to participate. A total of 
20,000 infants (males and females) born during four predefined 6-day periods in 2011 will be recruited 
in 344 public and private maternity units randomly selected in continental France. The selected 
children would be monitored from birth to adulthood. Births before 33 weeks and multiple births of 
more than two children will be excluded. Signed informed consent has been obtained from the parents. 
Investigated chemicals/Matrices: Biological samples include cord-blood, breast milk, mother’s 
urine, hair, and venous blood. The ELFE study analyses levels of bisphenol A, BFRs (PBDE 17, 28, 
47, 66, 85, 99, 100, 153, 154, 183, 209, HBCDDs, PBB 153), carbamate pesticide (2-
isopropoxyphenol), chlorophenols (4-MCP, 2,4-DCP, 2,5-DCP, 2,4,5-TCP, 2,4,6-TCP, PCP), 
cotinine (as a biomarker of tobacco smoke exposure), dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-
HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-
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TCDD), fluorocarbons (PFBuS, PFDeA/PFDA, PFDoA, PFHpA, PFHxS, PFNA, PFOA, PFOS, 
PFOSA, Et-PFOSA-AcOH, Me-PFOSA-AcOH, PFUA/PFUdA), furans (1,2,3,4,6,7,8-HpCDF, 
1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-
HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF), metals (Sb, As, 
Cd, Co, Pb, Hg, Ni), organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP 
(for dialkyl phosphates/DAP)], PAH metabolites [1-Hydroxypyrene (for pyrene), 1-
Hydroxynaphthalene (1-Naphthol), 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], PCBs 
(PCB 28, 52, 77, 81, 101, 105, 114, 118, 123, 126, 138, 153, 156, 157, 167, 169, 180, 189), phthalate 
metabolites [MBzP (for BBzP), MiBP (for DiBP), MnBP (for DnBP), MEP (for DEP), MiNP, oxo-
MiNP, OH-MiNP, cx-MiNP (for DiNP), MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, 5cx-
MEPP, 2cx-MMHP (for DEHP), MOP/MnOP, MCPP (for DOP/DnOP), MCHP (for DCHP) (Zeman 
et al., 2013)], and pyrethroid metabolites [F-PBA (for cyfluthrin), Br2CA (for deltamethrin), cis-
Cl2CA, trans-Cl2CA, 3-PBA (for cypermethrin, deltamethrin, and permethrin)]. 
Analytical methods: A total of 14 perfluoroalkylated substances were measured using LC-HRMS 
(Antignac et al., 2013). Dioxins, furans, and PCBs were analysed via GC-HRMS. The phthalates 
metabolites were analysed via LC-MS/MS after enzymatic hydrolysis with beta-glucuronidase. BPA 
was measured using GC-MS using Single Ion Monitoring mode.  
Results & interpretations: The levels of various perfluoroalkylated compounds, dioxins, furans and 
PCBs in breast milk have been published as peer-reviewed scientific articles (Antignac et al., 2013; 
Focant et al., 2013). The urinary levels of various phthalate metabolites (Zeman et al., 2013) and the 
levels of bisphenol A between pregnant women who gave birth naturally and who had Caesarean 
section (Vandentorren et al., 2011) have been published. As the study is ongoing, no reference values 
have been reported yet. 
PFOS, PFOA, and PFHxS were detected and quantified in most of the analysed samples (90%, 98% 
and 100%, respectively) and appeared as major contributors to the total PFAS exposure (38%, 37%, 
25%, respectively), whereas the other targeted PFAS were mostly below the limit of detection (LOD). 
Due to a limited data set, no statistically significant relation was observed between these exposure 
levels and developmental outcomes. Similarly, no relation was observed between the measured PFAS 
levels and various socio-demographical parameters such as the consumption of seafood, alcohol, 
smoking, or SES level. These results suggest a need for further research (Antignac et al., 2013). 
Based on the data from the WHO exposure study, the French PCDD/F and DL-PCB levels are located 
in the high end of the European range. However, a significant decrease is observed in terms of 
exposure of French pregnant women to PCDD/Fs compared with an earlier study in France in 2000. 
The decrease likely reflects the gradual reduction of dioxin levels in the environment and subsequent 
decline in food, resulting in reduction of human exposure (Focant et al., 2013). 
A significant exposure of French pregnant women to phthalates was observed, especially high 
concentrations of DEHP metabolites characterised by a very high variability. This finding suggested 
exposure to DEHP probably in the hospital. The study also indicated that the exposure is significant 
not only to DEHP, but also to DiNP, DnOP and BBzP (Zeman et al., 2013).  
The median concentrations of total and free BPA in urine were similar to those in other studies, and 
differences between types of delivery (caesarean vs. natural) might explain the high exposure of BPA 
(Vandentorren et al., 2011). 
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Investigation of exposure sources: The children’s immediate environment (water, air) will be 
monitored along with their exposure to certain pollutants measured by means of dust traps installed 
inside their homes. With the availability of the geographical coding of the children’s addresses, the 
results obtained can then be compared with local and national pollution indicators and matched against 
the structural characteristics of the neighbourhood (e.g. proximity of certain industrial sites).  
Communication to participants/scientific community/public: The ELFE study results will be 
published, producing invaluable information, not only to the proposing scientists, but also to countless 
researchers who will be able to interrogate the resulting data with a wide variety of research questions 
reflecting a range of hypotheses. From an international perspective, the comparative analyses that 
would ensue would be of immense public health interest. 
3.7.3.3. Étude de santé sur l’environment, la biosurveillance, l’activité physique (ESTEBAN) 
Initiator/Funding source: ESTEBAN is a health study on the environment, biomonitoring, physical 
activity, and nutrition. It will follow up on the ENNS results on diabetes, hypertension, and 
dyslipidaemias. A steering committee consisting of the InVS, the Ministry of Health, the Ministry of 
Environment, and other public health agencies decided to implement a general population, cross-
sectional biomonitoring survey coupled with health examinations and involving a nutritional 
component. (Fillol et al., 2013) 
Study design/Duration: ESTEBAN is a cross-sectional biomonitoring survey that began in March 
2014 and will continue until the 3
rd
 trimester of 2015. The study consists of visits to the participants’ 
home, where the interviewer would administer questionnaires as well as the participant would 
complete self-administered questionnaires to collect data regarding occupational and environmental 
exposures, physical activity, medical history, socio demographics, etc. Furthermore, 24-hour food 
recall data and dietary records would be collected from participants aged 11-74 and children under 11, 
respectively. Afterwards, health examination and collection of biological samples would be performed 
for subsequent chemical exposure analyses. 
Study population/Recruitment: Three degrees of stratified sampling (e.g., 1
st
 degree: area of 
residence) were used, and after stratification, phone calls were made to randomly selected residents. A 
brief presentation of the study was given to the residents, and the participants would voluntarily decide 
whether to partake or not partake in the study. About 5,000 participants (over 4,000 adults aged 18-74 
and 1,000 children aged 6-17; both males and females) are expected to be recruited over a year. 
Participants would be residents living in the continental France. 
Investigated chemicals/Matrices: Blood (whole blood and serum), urine, and hair samples were 
collected and analysed. The various groups of measured substances include the following: bisphenol 
A, BFRs (PBDE 17, 28, 47, 66, 85, 99, 100, 153, 154, 183, 209, HBCDDs, PBB 153), chlorophenols 
(4-MCP, 2,4-DCP, 2,5-DCP, 2,6-DCP, 2,3,4-TCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,6-TeCP, PCP), 
cotinine (as a biomarker of tobacco smoke exposure), dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-
HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-
TCDD), fluorocarbons (PFOA, PFOS), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 
1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-
OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF), metals (Sb, As including As species, Cd, 
Co, Pb, Hg, Ni), mycotoxins (ochratoxin A and aflatoxins), PAH metabolites [1-Hydroxypyrene (for 
pyrene), 3-hydroxybenzo[a]pyrene (for benzo[a]pyrene), 1-Hydroxynaphthalene (1-Naphthol), 2-
Hydroxynaphthalene (2-Naphthol) (for naphthalene), etc.)], organochlorine pesticides (aldrin, 
dieldrin, endrin, heptachlor, heptachlor epoxide, 4,4'-DDT, 2,4′-DDT, 2,4'-DDE and 4,4'-DDE as 
metabolites for DDT, oxychlordane, trans-Nonachlor, HCB, α-HCH, β-HCH, γ-HCH, mirex), 
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organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP (for DAP)], PCBs 
(PCB 28, 52, 77, 81, 101, 105, 114, 118, 123, 126, 138, 153, 156, 157, 167, 169, 180, 189), pesticides 
(e.g. linuron, fipronil, etc.), phthalate metabolites [MBzP (for BBzP), MEP (for DEP), MiNP (for 
DiNP), MMP (for DMP), MOP, MCPP (for DOP), MCHP (for DCHP), metabolites of DEHP and 
DBP], and pyrethroid metabolites [F-PBA (for cyfluthrin), Br2CA (for deltamethrin), cis-Cl2CA, 
trans-Cl2CA, 3-PBA (for cypermethrin, deltamethrin, and permethrin)]. 
Analytical methods/reference values/results/policy support: The analysis of the chemicals has not 
been conducted yet, so the methods or reference values have not been reported. Results are to be 
published after the completion of analysis in late 2015. ESTEBAN will offer an opportunity to assess 
the exposure levels of many chemicals within the French population. This study is meant to be 
complementary to other national biomonitoring studies such as the ELFE cohort, and the results will 
be compared with other biomonitoring surveys conducted throughout Europe. 
3.7.4 Spain (BIOAMBIENT.ES) 
Initiator/Funding source: In 2007, the Spanish Ministry of Agriculture, Food and Environment 
provided finance for a surveillance system to increase the current knowledge regarding the distribution 
of environmental pollutants in Spain. The Environmental Toxicology Area (TA) of the National 
Centre on Environmental Health of the Carlos III Institute of Health (ISCIII) was responsible for 
running the BIOAMBIENT.ES study, and the study was supported by TA, the Environmental and 
Cancer Epidemiology Unit of the National Centre of Epidemiology (also from ISCIII) and the 
coordinators of the Prevention Societies of the Mutual Insurance Companies that make up Corporation 
Mutua, the biggest Spanish Consort of Mutual Insurance Companies (Pérez-Gómez et al., 2013). 
Study design/Duration: BIOAMBIENT.ES is a nationwide cross-sectional study with a stratified 
cluster sampling designed to cover all geographical areas, gender, and occupational sectors and aimed 
to obtain a representative sample of the Spanish workforce. Recruitment and sampling periods were 
between March 2009 and July 2010. The latest finding to the study was published in early 2014 
(Cañas et al., 2014). A short self-administered epidemiological questionnaire was given to selected 
participants to collect basic individual information on socio-demographic data and environmental- and 
lifestyle-related exposure. A health exam was provided for each participant, who agreed to provide the 
results for the BIOAMBIENT.ES study, and biological samples were collected for analyses of 
pollutants. 
Study population/Recruitment: In order to guarantee the nationwide coverage of this study, the 
country was stratified into 12 geographical regions: Galicia, Asturias and Cantabria, Basque Country, 
Navarre, La Rioja, and Aragon, Catalonia, Castile and León, Madrid, Castile-La Mancha and 
Extremadura, Valencian Community and Balearic Islands, Andalusia and Ceuta, Murcia, and Canary 
Islands. A total of 38 prevention centres from these regions were randomly selected as sampling units. 
A total of 1,892 volunteers aged 16 or older (969 males and 923 females) were recruited for and 
successfully participated in the study between March 2009 and July 2010. The volunteers must have 
lived in Spain for 5 years or more in order to be eligible for the study. The selected regions covered in 
2009 a 63% of the Spanish adult population (Pérez-Gómez et al., 2013). The recruitment of the 
participants took place through the annual occupational medical check-ups in various health facilities 
within the aforementioned geographical regions. In order to improve the participation response of the 
questionnaires, communication materials was designed by the study group. Participation was 
voluntary and altruistic; only a small token USB drive was given to the participants. 
Investigated chemicals/Matrices/Analytical methods: BIOAMBIENT.ES analysed the levels of the 
following substances: BFRs (PBDE 28, 47, 85, 99, 100, 119, 126, 153, 154, 183, 196, 197, 209), 
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cotinine (as a biomarker of tobacco smoke exposure), metals (Cd, Pb, Hg/MeHg), organochlorine 
pesticides (aldrin, dieldrin, endrin, heptachlor, heptachlor epoxide, p,p’-DDT, o,p’-DDT, DDE as a 
metabolite of DDT, HCB, α-HCH, β-HCH, γ-HCH), PAH metabolites [(3-Hydroxybenzo(a)pyrene 
(for benzo[a]pyrene), 1-Hydroxyphenanthrene, 2-Hydroxyphenanthrene, 3-Hydroxyphenanthrene, 4-
Hydroxyphenanthrene, 9-Hydroxyphenanthrene (for phenanthrene), 1-Hydroxypyrene (for pyrene)], 
and PCBs (PCB 28, 52, 101, 138, 153, 180). 
Cd, Hg, Pb, cotinine, and PAH metabolites were measured in first-morning urine. Cd, Hg, and Pb 
were also measured in whole blood. PCBs, PBDEs, and organochlorine pesticides were measured in 
serum. Hg was further measured in hair (Pérez-Gómez et al., 2013). Metal levels in blood and urine 
were carried out with ICP-MS. Hg determination in hair was determined with a direct mercury 
analyser DMA-80. PCB and PBDE levels in serum were performed with a SPE followed by 
quantification via GC-MS-NCI. PAH metabolites in urine were quantified by enzymatic hydrolysis 
followed by a SPE and analysed by HPLC-fluorescence detection. 
Results & interpretations: Blood Pb (Cañas et al., 2014), hair Hg (Hg) (Esteban, 2010), and serum 
PCB levels (Huetos Hidalgo et al., 2013) have been reported and presented in Table 29. The geometric 
mean of blood Pb levels in the study population was 24.0 μg/L, with women having significantly 
lower levels than men. Mean blood Pb levels were higher in elder groups in both genders. Women of a 
childbearing age had a geometric mean (GM) blood level of 18.0 μg/L. Workers from the service 
sector had lower blood lead levels than those from the construction, agricultural and industry sectors. 
Small, although significant, geographical differences had been found. The Spanish population studied 
herein had Pb levels similar to populations in France and in Belgium but slightly lower levels than the 
Italian, Czech, German, or UK populations (Cañas et al., 2014). 
The main PCBs detected in this study were PCB 138, 153, and 180. Women had significantly lower 
levels than males, while the levels increased approximately 56% for every 10-year increase in age. 
Service workers had higher levels than those of other sectors although the differences were not 
significant in the multivariate analysis. PCB levels were lower during October-December and higher 
during April-June when compared to the average for the year. Certain geographical areas had higher 
concentrations (e.g. 88% higher than the average) as well as lower concentrations (e.g. 2.5 times 
below the average). The BMI was inversely proportional to the serum PCB concentrations but without 
significant association from the multivariate analysis. Finally, there was a significant association 
between fish consumption and serum PCB concentrations. The values reported here are similar to 
those reported in other Spanish concentration studies (Huetos Hidalgo et al., 2013).  
Communication to participants/scientific community/public: Findings from the BIOAMBIENT.ES 
study have been or will be published as scientific articles, and preliminary results of the chemical 
analyses have been presented at multiple conferences. This study was conducted to generate reference 
values, and some of the values (PCBs, Pb, and Hg) have been reported in various publications as well. 
An information leaflet including individual levels of the results for each participant as well as general 
information on each toxicant has been designed to provide the volunteers feedback about the research 
(Pérez-Gómez et al., 2013).  
Policy support: The BIOAMBIENT.ES study provides the first overview of the body burden of 
certain pollutants in the general Spanish population and can be useful for evaluating temporal trends 
and the effectiveness of environmental and health policies. 
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3.7.5 Italy [Programme for biomonitoring the Italian population exposure 
(PROBE)] 
Initiator/Funding source: The PROgramme for Biomonitoring of the Exposure (Programma per il 
Biomonitoraggio dell’Esposizione della popolazione generale; PROBE) was commissioned and 
funded by the Italian National Institute for Health (Istituto Superiore di Sanità; ISS). The study was in 
cooperation with the Italian Blood Volunteer Association (Associazione Volontari Italiani Sungue; 
AVIS) and the National Italian Association against Microcythemia (Associazione Nazionale Per La 
Lotta Contro Le Microcitemie; ANMI). The PROBE was managed by the National Center for 
Diseases Control and Prevention of the Italian Ministry of Health (Alimonti et al., 2011; Bocca et al., 
2010). 
Study design/Duration: PROBE is a cross-sectional population study to determine the exposure to 
metals of the healthy general population in Italy. The study started in 2008 and lasted until 2010. After 
the participants gave informed consent for the study, a questionnaire was given to the participants to 
collect information regarding participant’s general characteristics (i.e., gender, age, height, weight, 
etc.), medical history, lifestyle, food intake, and environmental exposure, and morning blood samples 
were collected from the participants who had fasted overnight. 
Study population/Recruitment: The PROBE population consisted of 1423 adults (953 men and 470 
women), aged between 18 and 65 years (41% between 36 and 50 years). The selected subjects were 
informed about the study and voluntarily participated. The participants were residents of one of the 
five urban regions (Calabria, Latium, Umbria, Emilia Romagna, Piedmont), which were selected to 
establish representative data for South, Central, and North Italy. The exclusion criteria adopted in 
PROBE were the following: cardiological, respiratory, kidney or liver disorders; intestinal absorption 
abnormalities; active infections; assumption of thyroid hormones or lithium; psychoactive drug intake; 
assumption of vitamins or mineral integrators; iatrogenic exposure from metallic implants such 
prostheses, surgical screws or intrauterine inserts. Subjects resulting out of the physiological ranges 
about chemical-clinical parameters were also excluded (Alimonti et al., 2011; Bocca et al., 2010). 
Investigated chemicals/Matrices/Analytical methods/Reference values: A total of 20 metals (Sb, 
As, Be, Cd, Cr, Co, Ir, Pb, Mn, Hg, Mo, Ni, Pd, Pt, Rh, Tl, Sn, W, U, V) were analysed directly in the 
blood and serum samples via SF-ICP-MS. The results are reported in Table 30 (Alimonti et al., 2011). 
The P95 from this study is considered as the reference value that can be used for comparisons with 
higher exposure scenarios in Italy. Metal concentrations higher than P95 do not necessarily mean that 
the metals trigger adverse health effect. 
Results/Interpretations: International agencies have developed other limit values to compare and 
interpret other human biomonitoring data. For example, US Environmental Protection Agency (EPA) 
has identified biological equivalents (BEs), which help identify cases that might require further 
investigations rather than to imply an effect on human health. The American Conference of 
Governmental Industrial Hygienists has also identified the biological exposure indices (BEIs) for 
exposed workers that indicate the extent of exposure but are not directly related to effects on health. 
Different from those cited limits, German Commission for Human Biomonitoring provide the human 
biomonitoring values known as HBM-II, which an adverse effect on human health is associated for 
levels above these values. Table 10 shows the aforementioned limit values set by the US and Germany 
and the number of PROBE cases (n) that exceed these values. 
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Table 10 Limit values and the number of PROBE cases that exceed these values 
 USA Germany 
Metals BE [µg/L] n >BE BEI [µg/L] n >BEI HBM-II [µg/L] n > HBM-II 
Cd 1.7 37 5 0   
Co   1 9   
Hg   15 1 15 1 
Pb   300 0 150 3 
About 2.6% of the Italian population had Cd levels higher than the BE, and 0.6% showed values above 
the BEI for Co, but these values are not conclusive for a risk characterisation. One subject and three 
subjects out of 1420 show levels of Hg and Pb, respectively, higher than the HBM-II values, and for 
such subjects, it can be assumed an exposure is associated with a health effect. Table 11 shows the risk 
factors that can influence metal concentrations in the Italian population (Bocca et al., 2013). 
Table 11 Factors that affect the metal concentrations in the Italian population  
Metals Factor 
Cd, Pb Higher in smokers 
Co, Rh, V Higher in women 
Hg, Pb, Pd, W Higher in men 
Pb, Pd Increases with age 
Ir, U, W Decreases with age 
Mn, Pb Increases with alcohol 
 
Communication to participants/scientific community/public: The findings from PROBE study 
have been published as a report (Alimonti et al., 2011), which is publicly accessible on the ISS’s 
website (http://www.iss.it/binary/publ/cont/11_9_web.pdf ). The PROBE study intends to further 
analyse the data with the stratification of sub-groups of multiple variables (such as gender, age, place 
of residence, etc.) to find and launch new environment and health measures to reduce the exposure to 
environmental metals of the Italian population (Bocca et al., 2010). 
Policy support: The results from the PROBE study can be used to support REACH regulations such 
as encouraging further investigations (Commission Regulation No. 1907/2006, art. 45, paragraph 5), 
identifying substances of very high concern, persistent, bioaccumulating and toxic or chemicals of 
equivalent concern (Commission Regulation No. 1907/2006, Annex XIV), and assessing the 
efficiency of risk reduction measures or of substitutional choice in authorised substances underlying 
the minimization requirements (Commission Regulation No. 1907/2006, art. 60, paragraph 10) 
(Alimonti et al., 2011). 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 70 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
3.7.6. Czech Republic [Human Biomonitoring (Cz-HBM) as part of the 
Environmental Health Monitoring System (EHMS)] 
Initiator/Funding source: HBM is part of the nationwide environmental health monitoring system 
EHMS funded by the Ministry of Health based on Act No. 258/2000 on Health Protection.  It has the 
purpose (1) to document the extent, distribution, and determinants of population exposure to 
environmental pollutants, (2) to follow up long-term time trends and their possible changes as a result 
of preventive measures, (3) to establish a database from which to derive the reference values important 
for the characterisation of the exposure of the general population, and (4) to use the available data for 
health risk assessment and management. (Cerna et al., 2012). 
Study design/Duration: First human biomonitoring of trace elements in the blood, serum, and urine 
of the Czech and Slovak populations in the 1980s and early 1990s (Kucera et al., 1995). Full 
integration of HBM into the nationwide environmental health monitoring system EHMS started in 
1994 (Cerna et al., 2007; 1997). The CZ-HBM has been carried out as a limited representative cross-
sectional study of the urban/suburban population and has covered two time periods: (1) between 1994 
and 2003 and (2) between 2005 and 2009. The selection of sampling areas was based on the 
categorisation of the (former) districts into four categories (A–B–C–D) according to the level of 
environmental pollution. For the implementation of the HBM, two urban/suburban areas from the least 
polluted category A and two others from the most polluted category D were selected. In the first 
period, Benesov and Zdar and Sazavou as limited representatives of category A and Plzeed and Usti 
nad Labem as limited representatives of category D were chosen (Cerna et al., 1997). For the second 
period, the areas Prague (the capital), Ostrava (an industrial city), Liberec and Kromeriz as 2 relatively 
clean urban areas were selected, and the urban area of Uherské Hradiště was also included for 
measurements of PCB exposure. Information of each participant as well as biological samples were 
collected. For food intake, data was collected via two 24-hour recall processes (Puklova et al., 2010). 
Study population/Recruitment: Three population groups were included in the HBM: adults (blood 
donors) aged 18–58, children aged 8–10, and breastfeeding primiparas. The main inclusion criteria 
were the following: (1) living in the selected area for at least 2 years, (2) good health status, and (3) 
absence of occupational exposure to chemicals for adults. Recruitment of blood donors was carried out 
through the transfusion department in the respective urban area. Children were recruited through 
schools in the first period and by paediatricians in the second period. Breastfeeding primiparas were 
contacted in the maternity clinics, and following the WHO protocol, breast milk was sampled in the 
period of 2–8 weeks after delivery. 
Investigated chemicals/Matrices: Blood, urine, breast milk, hair, and teeth samples were collected, 
and 3 groups of biomarkers were analysed: (1) selected heavy metals (Pb, Cd, Hg) and essential 
elements (Cu, Se, Zn) in blood and urine of adults and children, (2) indicator PCBs (PCB 28, 52, 101, 
118, 138, 153, 180) and organochlorine pesticides (o,p’-DDT, p,p’-DDT, o,p’-DDE and p,p’-DDE as 
a metabolite of DDT, HCB, and α-, β-, and γ-HCH) in human milk and blood serum of adults, and (3) 
cytogenetic changes in peripheral lymphocytes in blood of adults and children (Cerna et al., 2012). 
Analytical methods: Individual metal elements were determined by ET-AAS or F-AAS. Hg was 
determined directly without mineralization using a single purpose instrument, an advanced mercury 
analyser AMA 254. Certified reference materials were used throughout the study. A GC-MS/MS 
method was used for the determination of the following compounds: PCBs (PCB 28, 52, 101, 118, 
138, 153, and 180), HCB, α- to δ-HCHs, and o,p’- and p,p’-isomers of DDT, DDE, and DDD. Isotope 
dilution or internal standard methods were used for the quantification of the target compounds. 
Cytogenetic analysis was performed using the conventional Hungerford method on short-term (50 h) 
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cultures with all cells being in the first division. Peripheral blood was collected by venepuncture into 
heparinized tubes. For each subject, 100 well-spread metaphases containing 46 ± 1 centromeres were 
examined. Metaphases were analysed in coded slides. The four categories of chromosome aberrations 
were evaluated: chromatid and chromosome breaks and chromatid and chromosome exchanges. Cells 
bearing breaks or exchanges were classified as aberrant cells (AB.C.). Gaps were recorded but not 
scored as aberrations (Merlo et al., 2007; Rossner et al., 2002; 2005). 
Results/Interpretations: The summary of results has been published as a peer-reviewed article (Cerna 
et al., 2012) in the International Journal of Hygiene and Environmental Health, which is accessible 
for scientific researchers in universities and research institutes. The statistical data concerning the 
general characteristics of women who took part in the CZ-HBM and their overall concentrations in 
breast milk has been summarised (Mikeš et al., 2012), and the RVs for Cd, Hg, and Pb levels (Cerna et 
al., 2012) and for POPs (mainly PCBs and organochlorine pesticides) in breast milk samples have 
been published (Mikeš et al., 2012). If an obtained result substantially exceeded the existing RV for 
the population, the analysis would be repeated; if confirmed, the subject would be asked to undergo 
body fluid re-sampling and re-analysis, and the possible exposure sources were investigated. The 
study manager team communicated the results to the respective participants. Furthermore, 
environmental monitoring is part of the EHMS, and yearly reports 
(http://www.szu.cz/topics/environmental-health/environmental-health-monitoring?lang=2) are 
published showing trends in exposures, biomarkers and health. 
The blood Cd (B-Cd) levels in adults were about 3 times higher in smokers than in non-smokers. A 
slight but significant descending trend was observed with the median value decreasing from 0.6 μg/L 
in 1996 to 0.3 μg/L in 2003 (Puklova et al., 2005). Similarly, the median B-Cd levels in non-smokers 
measured in different areas of the country showed a similar decrease from 0.59 µg/L to 0.3 μg/L in 
2009. Increased urinary cadmium levels were observed in Czech children compared to German 
children. A significant downward time trend was observed for the blood Pb levels in adults and 
children. The blood and urinary Hg levels were higher in women than in men. The HBM results did 
not indicate any substantial sub-saturation of the Czech population with Cu and Zn. The continuous 
monitoring of the blood Se levels conducted since 1996 revealed an upward trend starting in 2000 
(Batariova et al., 2005; Cerna et al., 2007). However, no further increase in blood Se levels has been 
observed in the last few years. 
Indicator PCBs (PCB 28, 52, 101, 118, 138, 153, and 180) and selected chlorinated pesticides have 
been monitored in human milk since 1994. Since 2005, these compounds have also been analysed in 
blood serum of adults. The PCB congeners 138, 153, and 180 accounted for more than 95% of the sum 
of the indicator PCBs. To simplify the presentation of results, PCB 153 was selected as a 
representative of the NDL-PCBs. A significant long-term downward trend in human milk was 
observed in the period of 1994–1997. A slight downward trend was also recorded in the second period 
of 2005–2009 even with an addition of measuring a PCB hot-spot area of Uherské Hradiště (Cerna et 
al., 2012). However, the levels of indicator PCB congeners in the Czech human milk samples were 
still higher than in most other European countries because such existing PCB hot spots. The levels of 
organochlorine pesticides showed a substantial continuous downward trend. 
The cytogenetic analysis of human peripheral lymphocytes is a method used in the Czech Republic 
since the late 1970s as a group-based biological exposure test to assess occupational exposure to 
clastogenic carcinogens (Rossner et al., 1995; Sram et al., 2004). Therefore, this biomarker of both 
exposure and effect was included from the beginning among the spectrum of analytes followed up in 
the CZ-HBM (Cerna et al., 1997). The main purposes were to establish the spontaneous (baseline, 
reference) data for different population groups, to find potential association with the environmental 
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toxicants monitored and potential time trends (Rossner et al., 2002; 1998). The percentages of aberrant 
cells in non-exposed adults and children followers showed a U-shaped curve during the monitored 
period 1994-2008, with an initial downward trend followed by an upward trend since the early 2000s, 
with no clear causal explanation. Because the conventional method of chromosomal aberration 
analysis seemed inadequate to differentiate the impact of environmental stressors (Sram et al., 2007), 
it was excluded as a biomarker in 2008 (Cerna et al., 2012). 
Investigation of exposure sources: In the case of mercury, different food groups (e.g. meats, fish, 
vegetables, rice, etc.) as well as drinking water samples were analysed to determine the potential 
sources of mercury body burden. There, it was confirmed that fish consumption and mercury burden 
were correlated, but otherwise, there was not a substantial mercury burden in the Czech population. In 
addition, the EHMS supports CZ-HBM with regular data collection on environmental pollution 
(Puklova et al., 2010). 
Policy support: The EHMS was set up by the Government of the Czech Republic (Govt. Resolution 
No. 369/1991). Later on, it was incorporated in Act No. 258/2000 on Health Protection with the 
purpose to document the extent, distribution and determinants of population exposure to 
environmental pollutants, to follow up long-term time trends and their possible changes as a result of 
preventive measures, to establish a database from which to derive the reference values important for 
the characterisation of the exposure of the general population, and to use the available data for health 
risk assessment and management (Cerna et al., 2012). 
3.7.7. Slovenia (National HBM programme) 
Initiator/Funding source: The Ministry of Health funded Slovenia’s national HBM programme, 
which is a part of the EU-project PHIME (Public Health Impact of long-term, low-level Mixed 
Element exposure in susceptible population strata). The Minister authorises the performers and 
appoints the collaborating experts/group. The programme is coordinated by the Jožef Stefan Institute 
with the cooperation with external experts from regional institutes.(Horvat et al., 2011) 
Study design/Duration/Population/Recruitment: This national HBM programme is a cross-sectional 
study that began as a pilot study from 2007 and 2009.  The follow-up HBM study started in 2011 and 
is currently ongoing. Women of childbearing age (aged 20-35) and their partners were recruited from 
three geographically different areas in Slovenia: urban (the capital, Ljubljana), rural (Kočevje), and 
contaminated (Bela krajina for its past industrial activities). Children (aged 6-11) were recruited from 
urban, rural, and industrial area (Idrija known for former mercury mines). Older women (aged 50-60) 
were also recruited but only in Ljubljana. Approximately, 50 women (aged 20-35), 50 men, and 50 
children were recruited from each of the selected area and 50 women (aged 50-60) from Ljubljana. In 
total, 127 women (aged 20-35), 147 men, 174 children, and 66 women (aged 50-60) were sampled for 
hair, blood, and urine, and 117 lactating mothers collected breast milk samples as well (Tratnik et al., 
2013). The study participants must have permanent residence of at least 5 years in the selected 
geographic study areas, which are determined by postcode (Perharic and Vracko, 2012). Participation 
was voluntary. All participants were administered a short questionnaire on lifestyle, work, medical 
status and food consumption, and biological samples were collected from the participants (Perharic & 
Vracko, 2012). 
Investigated chemicals/Matrices: Hair, blood, urine, and breast milk samples were collected, and the 
following substances were measured directly in the samples: BFRs (No PBDE congeners were 
specified), dioxins (No PCDD congeners were specified), furans (No PCDF congeners were 
specified), metals (As, Cd, Cu, Pb, Hg, Se, Zn), and PCBs (PCB 28, 52, 101, 138, 153, 180, etc.). 
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Analytical methods: Hg in hair and blood was determined by the Direct Mercury Analyser (DMA-
80), integrating sample thermal combustion, amalgamation and detection by AAS. Hg in urine and 
milk was determined by semi-automated CV-AAS. Other elements were determined by ICP-MS. 
Results in urine were corrected for creatinine levels, and creatinine was determined by Jaffé reaction 
on biochemical analyser Dimension (Siemens). 
Results/Interpretation/Reference values: No results have been published in peer-reviewed journals 
as of July 2014, but preliminary results of biomonitoring of selected trace elements in women, men 
and children from Slovenia are available and will supplement further analyses for reference values 
(Tratnik et al., 2013). Also, multiple presentations of the study have been given at conferences.  
Most of the subjects had the levels for non-essential toxic metals below the reference levels and the 
levels for essential elements Zn, Cu and Se within the reference intervals. Concentrations of metals 
and As did not differ between genders, while significantly higher levels of Se were observed in men 
and significantly higher levels of Cu in women. Comparing women of different ages, higher Hg levels 
and lower Cd and Pb levels were found in blood of younger women (aged 20–35) than in older women 
(aged 50–60). Se levels were higher in older women while Cu and Zn levels were higher in younger 
women. In comparison to children, women (both age groups) and men showed higher Cd, Pb, Se, and 
Zn concentration in blood. Hg concentration was higher in women (aged 20–35) and men than in 
children. Looking at the difference between different geographical areas where subjects were 
recruited, they found higher Cd and Pb levels in blood of rural children than in children from urban 
area. Hg in blood and urine was in contrary, higher in children from urban area than in children from 
rural area. In adults, As was observed to be the highest in urban area. Levels of essential elements 
differed between different areas in Slovenia as well. The study provides the basis to establish 
preliminary reference values for the selected population, depending on different parameters assessed 
by questionnaires. (Tratnik et al., 2013). 
Investigation of exposure sources: The Slovenian government has also been performing 
environmental biomonitoring in scientific weighted grid-sampling/observations in aquatic and 
terrestrial ecosystems harmonized with examined areas in the HBM programme.(Kononenko & 
Horvat, 2008) 
Policy support: The HBM study was coordinated by the competent authority for chemicals and 
carried out by health and other public institutes authorised by the Minister. Conditions regarding the 
professional and technical competence of public institutes for performing the biomonitoring shall be 
set out by the Minister. The Slovenian HBM study is developed on the legislative basis of Slovenian 
Chemicals Act (O.J. RS No. 16/2008), in particular “Chapter IX: Protection of Human Health and the 
Environment; Article 51.a: Biomonitoring of Chemicals” with the following provisions: (1) for the 
purpose of preparing and monitoring of measures to limit the risk of chemicals to people and the 
environment, monitoring of presence of chemicals and their breakdown products in people and 
organisms (hereinafter: biomonitoring) shall be conducted in professionally justified intervals of time, 
(2) biomonitoring is coordinated by the competent authority for chemicals and carried out by health 
and other public institutes authorised by the Minister, for people and organisms together or separately, 
(3) biomonitoring performers shall cooperate with the competent authority for chemicals and among 
themselves on: preparing a short- and long-term biomonitoring programme, its intersectoral 
coordination, monitoring of its implementation, performing expert evaluation and proposals for 
measures, (4) conditions regarding the professional and technical competence of public institutes for 
performing the biomonitoring from the preceding paragraph shall be set out by the Minister, and (5) 
provisions for biomonitoring from this article do not infringe upon provisions for biological 
monitoring at the workplace which are governed by regulations on occupational safety and health. 
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3.7.8. Austria [Schadstoffe im Menschen (“Pollutants in Humans”)] 
Initiator/Funding source/Duration: This is the first Austrian population-based human biomonitoring 
study, which aimed to determine the exposure of the Austrian general population and to prove the 
feasibility of a representative HBM study. It was managed by the Environmental Agency Austria and 
funded by the Austrian Ministry for Agriculture, Forestry, Environment and Water Management 
(Hohenblum et al., 2012). It started in 2008 and finished at the end of May 2011. 
Study design: This cross sectional study aims at documenting the extent, the distribution and the 
determinants of human exposure to industrial chemicals. The study consisted of two parts: (1) a 
questionnaire which information pertaining to socio-demographic characteristics, medical history of 
the family, food frequency, and the living conditions were collected and (2) morning urine (mother, 
children), blood (parents), and hair (everyone) samples were taken for chemical analysis. 
Study population/Recruitment: A stratified random sampling method was used to select the study 
participants taking into account the factors such as gender age, size of community, and location. A 
total of 150 participants from 50 families (males and females; aged 6-49) were involved in this study, 
and 50 of them were children aged 6-11. Five different communities (Vienna, Linz, St. Pölten, 
Tamsweg, Ried im Traunkreis) were selected for the study. Except for Vienna, the other 4 
communities were randomly selected. The study team called randomly-selected households, and after 
describing the study, the household members voluntarily participated. 
Investigated chemicals/Matrices: Urine, blood and hair samples were collected, and the following 
substances were measured: bisphenol A, BFRs (PBDE 28, 47, 66, 85, 99, 100, 126, 153, 154, 183, 
196, 197), metals (MeHg), phenols (nonyl-phenol and octyl-phenol), and phthalate metabolites 
[MEP (for DEP), MBzP (for BBzP), MCHP (for DCHP), MiBP (for DiBP), MnBP (for DnBP), 
MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, 5cx-MEPP (for DEHP), MOP/MnOP (for 
DOP/DnOP), MiNP (for DiNP)]. The analysed substances were chosen in this study based on the 
known exposure sources of these substances in Austria. PBDEs can be absorbed by particles in 
household dust and other environmental media even in remote alpine areas, can accumulate in spruce 
needles and in humus in the soil, and can be detected in sewage sludge and sediments. Triphosphates 
have been replacing PBDEs as flame retardants or plasticisers, and subsequently, large amounts of 
triphosphates have been found in house dust samples. BPA is found in many plastic bottles, and 
humans are primarily exposed to methyl mercury via fish consumption. 
Analytical methods: Phthalate metabolites and phenols in urine were measured via HPLC-MS/MS in 
the negative mode, and triphosphates in urine were measured via HPLC-MS/MS in the positive mode. 
PBDEs in blood were measured via GC-MS with isotope dilution. MeHg in hair was measured via 
HPLC coupled to ICP-MS. 
Results/Interpretations/Communication to public: The findings have been published as a report 
(Hohenblum & Hutter, 2011), publicly accessible on the Austrian Environmental Agency’s website, 
and as a short communication (Hohenblum et al., 2012). 
BPA in urine was only detected in 4 out of 25 subjects, who were already pre-selected for analysis as 
these subjects might have high phenol exposure. The LOQ was 0.6 µg/L, and the range of detected 
concentrations was from <LOQ to 11 µg/L. Nonylphenol and octylphenol in urine were detected in 1 
and 2 out of 25 samples, respectively. MeHg in hair was detected in 51 out of 104 samples (arithmetic 
mean = 46 µg/kg Hg; P95 = 196 µg/kg Hg). Only 3 out of 100 samples had levels above the LOQ for 
any of the 8 triphosphate compounds (Hohenblum & Hutter, 2011). Sixteen of the 18 PBDE congeners 
in blood could be detected in at least one sample. PBDEs 153 (81% of all samples; mean=8 ng/L; P95 
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= 9.1) and 197 (52% of all samples; mean = 6 ng/L; P95 = 8.3) were the most abundant species in the 
Austrian population. (Hohenblum et al., 2012). The findings of phthalate metabolites from this study 
can be found in Table 31 (Hohenblum & Hutter, 2011). 
The LOQ for BPA was set at 0.6 µg/L, which is higher than the German LOQ (0.15 µg/L). This 
difference might explain why there was a low number of detectable BPA urine samples. The total 
mean MeHg level (46 µg Hg/kg) is much lower than the results from Denmark (800 µg/kg) or 
Germany (250 µg/kg). Only 11% of the sample population consume fish regularly (at least two times a 
week), which might explain for the lower Hg level compared with other regions. Triphosphates are 
metabolised very quickly and excreted via urine. Although only 3 out of 100 samples had detectable 
triphosphate levels, the authors hypothesised that the inappropriate triphosphate markers were 
analysed. After the completion of the study, an improved method of detecting triphosphate metabolites 
had been developed at the University of Erlangen-Nuremberg. The authors emphasised the importance 
of analysing this substance group given its neurotoxic properties and its effects on cognitive ability, 
especially in children. The levels of PBDEs were lower than expected given the high concentrations of 
PBDE in house dust samples and people primarily exposed to PBDEs via air and ingestion of house 
dust. However, these findings indicate that the background body burden detected is not negligible 
(Hohenblum et al., 2012). The measured levels of phthalates in Austria are below the levels detected 
in the USA and in Germany. Children have higher levels of phthalate metabolites than adults, inferring 
the role of food as an exposure source of phthalates (Hohenblum & Hutter, 2011). Overall, the first 
analytical results suggest that the body burden of the Austrian volunteers is comparable or even lower 
than in other European populations although the methods of sampling were different.  
Policy support: The design of this study guaranteed full compatibility with the available EU protocols 
and contributed to the harmonisation efforts by EU-wide projects such as ESBIO, COPHES, and 
DEMOCOPHES. 
3.7.9.  Denmark 
3.7.9.1. Danish HBM studies 
Initiator: The Department of Growth and Reproduction at the University Hospital in Copenhagen 
have analysed urine samples from four Danish cohort during the past 6 years, compiling a 
considerable amount of data that may be comparable to ongoing surveys, e.g., NHANES and GerES. 
Thus, the department presents data on more than 3600 Danish children (Frederiksen et al., 2014). 
Study design/Duration/Population/Recruitment: A collective overview of 4 different cohort studies 
from the period 2006-2012 of various Danish study populations (a total of 3,625 subjects) on human 
urinary excretion of non-persistent environmental chemicals has been published as a review 
(Frederiksen et al., 2014). Different recruitment strategies for the different studies are also discussed in 
this review (Frederiksen et al., 2014). 
Investigated chemicals/Matrices: Urine samples were collected as spot samples except for an adult 
cohort with 24 h urines, and the list of substances measured in the urine samples from the four Danish 
populations have been published (Frederiksen et al., 2014). Briefly, the following substances were 
analysed: bisphenol A, phenols (Benzophenone-3, Butyl paraben, Ethyl paraben, Methyl paraben, 
Propyl paraben, 4-tert-octylphenol, Triclosan), and phthalate metabolites (MBzP, MiBP, MnBP, 
MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP, MNP/MINP, MCPP, 
MEP, MOP). 
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Analytical methods: All urine samples were deconjugated by enzymatic hydrolysis and then the total 
(free and deconjugated) content of 13–16 phthalate metabolites, 9 phenols, and 7 parabens were 
measured by different isotope dilution-LC–MS/MS methods. 
Results/Interpretations/Investigation to exposure sources: The urinary levels of phthalate 
metabolites, phenols, and parabens in Danish mother-child pairs (Frederiksen et al., 2013) as well as 
the summary of results from various cohorts (Frederiksen et al., 2014) have been published. Briefly, 
nearly everyone in the Danish population were exposed to the six most common phthalates (DEP, 
DiBP, DnBP, BBzP, DEHP and DiNP), bisphenol A, triclosan, benzophenone-3, and at least two of 
the parabens (methyl parabens and n-propyl parabens). The exposure to other non-persistent chemicals 
was also widespread. The excretion of DnBP and DEHP has decreased over time, which perhaps 
reflects a more restrictive use of these chemicals in ordinary consumer products. Despite the 
decreasing time trend observed for excretion of DnBP and DEHP metabolites, the daily exposure 
estimated on subgroups from the presented cohorts showed that the highest exposed section of the 
Danish population was still highly exposed to DnBP and DEHP with values near or above the 
tolerable daily intake. 
Only a few European and American studies have reported biomonitoring data on other phenols and 
parabens. In general, low levels of triclosan, chlorophenols, phenylphenols, and the parabens were 
measured in the Danish cohorts compared with Spanish children and pregnant women, French 
pregnant women, and Americans from the general populations. Benzophenone-3 was measured in 
comparable levels in Denmark to levels in French and Spanish children and pregnant women while it 
was about 5-fold higher among Americans (Frederiksen et al., 2014). Questionnaires provide some 
information regarding exposure sources. 
Policy support: The phthalates measurements observed from the various studies are currently used for 
negotiations by the Danish EPA to ban four phthalates in EU. 
3.7.9.2. The Danish National Birth Cohort Study (DNBC) 
Initiator/Funding source: The Danish National Research Foundation has established the Danish 
Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort 
is furthermore a result of a major grant from this Foundation. Additional support for the DNBC is 
obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects 
Foundation, the Augustinus Foundation, and the Health Foundation (Andersen & Olsen, 2011; Olsen 
et al., 2001). 
Study design/Duration: The DNBC is a conception-to-death-cohort, characterised by repetitive 
prospective data collections, a broad subject coverage, and active linkage to routinely collected health 
data in registers, of which the most important are the Danish National Patient Register and the 
Register of Causes of Death. Pregnant women were enrolled in the study between 1995 and 2002, 
preferably in the first trimester of pregnancy, but recruitment was allowed until week 24 of gestation. 
At the first visit at the GP, a blood sample was taken to the study biobank after oral consent. The 
sample was stored with personal identification if written consent was received by mail. A second 
blood sample was taken by the GP in the second trimester, and a blood sample from the child 
(umbilical cord) was taken by midwives shortly after delivery. Data on lifestyle factors (including a 
FFQ) and environmental exposures were collected by medical questionnaires, computer-assisted 
interviews (CATI), and, more recently, web-based questionnaires. DNBC used two mailed 
questionnaires and 2 CATIs during pregnancy. After the delivery, CATIs at 6 and 18 months and 
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mailed or web-based questionnaires in the 7 years of follow-up were conducted. In the 11th year of 
follow-up, only web-based questionnaires are used (Andersen & Olsen, 2011). 
Study population/Recruitment: A total of 100,418 pregnancies (women living in Denmark; aged 15-
44) were enrolled in the study, and of these 92,670 resulted in the birth of a single live-born child and 
2,080 women gave birth to twins or triplets. Written information about the cohort was provided to the 
women by general practitioners (GP) at the first antenatal visit, and the women enrolled in the cohort 
gave consent to participate in four telephone interviews, to have blood samples taken and stored in a 
biobank, and to have her and her offspring’s data linked to routinely collected health data. Overall, the 
women gave consent that the data could be used for research purposes “with the aim of improving 
health for future children and mothers” and that they accepted to be contacted for further data 
collection rounds in the future (Andersen & Olsen, 2011; Olsen et al., 2001).  
Investigated chemicals/Matrices: Maternal blood and umbilical blood samples were collected in the 
DNBC study, and, so far, measurement analyses of fluorocarbons (namely, PFOS and PFOA) have 
been conducted in maternal blood samples. 
Results/Interpretations: Using blood samples stored in the DNBC’s biobank, it was possible to 
measure levels of PFOS and PFOA in 1,400 maternal blood samples taken early in pregnancy. The 
analyses showed that maternal PFOA levels in early pregnancy were associated with smaller 
abdominal circumference and birth length, and higher levels of PFOA were associated with lower 
placental weight and head circumference. Maternal PFOS levels were not significantly associated with 
any of the fetal growth indicators (Fei et al., 2008). 
Investigation of exposure sources: Completed FFQs allowed further studies of determining chemical 
exposure to food consumption and occupational exposures (e.g. those of laboratory technicians, green 
house workers, shift work). 
Communication to scientific community/public: Multiple scientific articles have been published 
using DNBC cohort. Data from DNBC is only available to scientific researchers in Denmark or to 
those who are collaborating with a Danish researcher, and access to data could be acquired via a 
request to the board of DNBC.  
Policy support: An advantage of using the DNBC cohort is that extensive health information is 
already available. This opens for a number of studies on possible health effects of both nutrients and 
environmental contaminants which is currently ongoing at the ages of 11 years and planned for the 
ages of 14 years of the enrolled children. 
3.7.10.  Sweden (First-time healthy mothers in Uppsala) 
Sweden has a long history of environmental monitoring, with a health related environmental 
monitoring programme coordinated by the environmental protection agency since 1993. HBM data are 
used as indicators for environmental quality. A number of times series have been performed on lead in 
children, methylmercury from fish intake in pregnant women, Cadmium for smokers and POPs (PCB, 
dioxins/furans, pesticides and phthalates) in human milk. In this study we evaluate a cross-sectional 
survey that was performed in the city of Uppsala. 
Initiator/Funding source: The study was performed by the Institute of Environmental Medicine at 
the Karolinska Institute and funded by the Swedish Environmental Protection Agency and 
VINNOVA, which is the Swedish Governmental Agency for Innovation Systems (Bjorklund et al., 
2012). 
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Study design/Duration/Population/Recruitment: A cross-sectional design was chosen to recruit 
pregnant primiparous women, living in the Uppsala County. Recruitment took place from 1996-2006 
as sub-projects in smaller periods, which are published as separate papers (Bjorklund et al., 2012; 
Darnerud et al., 2010; Glynn et al., 2007; Karrman et al., 2007; Lignell et al., 2009). First-time 
mothers giving birth at Uppsala University Hospital during the first week of the month and on 
different days according to a randomisation protocol were asked to voluntarily participate. From fall 
1996 to spring 1999, pregnant and primiparous women (n = 405) living in Uppsala County, who were 
in late pregnancy (week 32–34), were asked to participate in the study (Glynn et al., 2007). Of these 
women, 211 (52%) agreed to donate maternal milk for chemical analysis. During 4 different sampling 
periods (April 2000-March 2001, March 2002-February 2003, January-December 2004, and 2006), 
primiparous mothers were randomly recruited among women who delivered at Uppsala University 
Hospital. At each sampling period, 30–32 women (46–63% of all women who were asked) 
participated in the study. At the end, a total of 335 women were recruited from 1996 to 2006.  
Investigated chemicals/Matrices/Analytical methods: Breast milk samples were collected, and the 
following substances were measured directly in the samples: BFRs (PBDE 47, 99, 100, 153), dioxins 
(2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 
1,2,3,4,6,7,8-HpCDD, OctaCDD), furans (2,3,7,8-TCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 
1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8-HpCDF, OctaCDF), metals 
(Ag, Al, As, B, Ba, Be, Ca, Cd, Co, Cr, Cs, Cu, Fe, Hg, K, Li, Mg, Mn, Mo, Na, Ni, P, Pb, Rb, S, Sb, 
Se, Sn, Sr, Tl, W, U, V, Zn), and PCBs (PCB 28, 105, 118, 126, 138, 153, 156, 157, 167, 169, 180). 
GC/ECNI-MS was used for measuring POPs, and ICP-MS was used for measuring metals. 
Results/Interpretations: The results have been published as scientific articles (Bjorklund et al., 2012; 
Darnerud et al., 2010; Glynn et al., 2007; Karrman et al., 2007; Lignell et al., 2009). A detailed table 
with concentrations of POPs in maternal milk is available in (Lignell et al., 2009). Declining rates of 
POPs over time has been reported, and a detailed table with concentrations of elements has been 
provided in (Bjorklund et al., 2012). Briefly, concentrations of 3 PCB congeners (PCB 52, 77, 101), 2 
furans (1,2,3,7,8,9-HxCDF, 1,2,3,4,7,8,9-HpCDF), BDE-154, and HBCD were below the LOQ in 
most milk samples. PCB 153 showed the highest mean concentration in maternal milk lipids of all of 
the compounds studied. Among the PCDD/Fs, 1,2,3,4,6,7,8-HpCDD and OctaCDD showed the 
highest mean concentrations (16 and 79 pg/g lipid, respectively). However, the congeners that 
contributed most to the PCDD/FTEQ concentrations were 2,3,7,8-TCDD; 1,2,3,7,8-PeCDD; 
1,2,3,6,7,8-HxCDD and 2,3,4,7,8-PeCDF in total of 87% (range 75–93%). The mean concentrations of 
the remaining PCDD/Fs (1,2,3,4,7,8-HxCDD; 1,2,3,7,8,9-HxCDD; 2,3,7,8-TCDF; 1,2,3,7,8-PeCDF; 
1,2,3,4,7,8-HxCDF; 1,2,3,6,7,8-HxCDF; 2,3,4,6,7,8-HxCDF; 1,2,3,4,6,7,8-HpCDF and Octa CDF) 
varied between 0.21 and 2.1 pg/g lipids. Among the PBDEs, BDE-47 showed the highest mean 
concentration. The mean levels of the PBDE-congeners were lower than most mono-and di-ortho 
PCBs. For metals, the major findings were related to macronutrients (Ca, K, Mg, P, and Na) and micro 
nutrients (Cu, Al, Fe, and Se). 
The levels of PCBs and PCDD/Fs in maternal milk samples from Uppsala County in Sweden have 
decreased during the last 10 years while the levels of PBDEs do not show any consistent trend. The 
different trends among the PBDEs point to the importance of analysing trends of individual congeners. 
It is also important to consider age of the mothers when temporal trends of POPs are examined since 
there is a trend among Swedish women of having the first child at older ages. 
Investigation of exposure sources/Reference values: The study participants answered a 
questionnaire with information regarding some dietary habits, e.g. fish intake, to determine possible 
exposure sources, and reference values for some analysed substances have been established. 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 79 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
3.7.11. Finland (Effects of nationwide addition of selenium to fertilizers) 
Initiator/Funding source: The supplementation of fertilizers with sodium selenate in Finland is a 
nationwide experiment aimed at increasing the Se status of both animals and humans. The window for 
optimal intake of Se is narrow with the risk of deficiency at very low and of toxicity at excessive 
levels. Systematic monitoring of the Se status of the population is necessary for safety reasons and 
also for research purposes (Alfthan et al., 2011). In this monitoring programme, sampling of cereals, 
basic foodstuffs, feeds, fertilizers, soils, and human tissues has been carried out annually since 1985 
by 4 governmental research organizations and is still ongoing. 
Study design/Duration: A small longitudinal cohort study was performed where the plasma Se 
concentration of the same healthy adults has been monitored systematically since 1985 in urban 
Helsinki and rural Leppävirta. Subjects using Se supplements were excluded, and the intake was solely 
from foods. All subjects filled in a questionnaire regarding their health status and use of dietary 
supplements (Se) on each blood sampling occasion. An annual blood sample was drawn into a vacuum 
tube and plasma, and whole blood samples were stored at –20°C before analysis (within 6 months). 
Study population/Recruitment: Plasma samples have been obtained annually from healthy subjects 
in urban Helsinki (n = 30–35) since 1984, and both plasma and whole blood samples from rural 
Leppävirta (n = 35–45) since 1985. Their ages in the year 2000 ranged from 26 to 62 years in Helsinki 
and from 25 to 77 years in Leppävirta. The inclusion criteria for the study are good health status and 
exclusion of the use of Se-containing supplements. Participation is voluntary. The participants in 
Helsinki were members of staff of the National Public Health Institute, while those residing in 
Leppävirta were mostly the same subjects recruited in 1985 for the purposes of following their Se 
status. 
Investigated chemicals/Matrices/Analytical methods/Investigation of exposure sources: Plasma 
and toenail samples were collected to directly measure the levels of selenium via ET-AAS. The 
precision between series was 4.4%, and the accuracy was on average within 5% of external quality-
assurance plasma standards. In addition, sampling of foods has been done four times per year, and the 
measurements are complementary to the feed measurements of grains, meat, milk and soil. 
Results/Interpretations: A number of publications and findings have been mentioned in the latest 
review (Alfthan et al., 2014). The mean plasma Se concentration ranged between 0.75 µmol/L and 
1.23 µmol/L in the first half of the 1980s. Before Se supplementation of fertilizers started, the mean 
plasma Se concentration was 0.89 µmol/L, and it reached its highest mean level four years later at 1.5 
µmol/L. After the decrease in the amount of fertilizer Se in 1990, plasma Se decreased to a low mean 
level of 1.10 µmol/L in 1999. This level was still above the general plasma Se value in Europe but 
lower than that found in Canada or the USA. In the 2010s, the mean plasma Se level has reached a 
level of 1.4 µmol/L. Toenail Se concentration reflects the integrated intake of Se over a period of 6 to 
12 months. The mean toenail Se concentration of adults from 2 separate studies increased from the 
pre-supplementation level of 0.45 mg/kg to 0.72 mg/kg in 1995. Liver Se is mobile and reflects dietary 
Se intake over a time period of several weeks (Alfthan et al., 2014). 
The mean human plasma Se concentration increased from 0.89 μmol/L to a general level of 1.40 
μmol/L that can be considered to be an optimal status. The absence of Se-deficiency diseases and a 
reference population have made conclusions on the impact on human health difficult. However, the 
rates of cardiovascular diseases and cancers have remained similar during the pre- and post-
supplementation, indicating medical and life-style factors to be much stronger determinants than Se. 
The nationwide supplementation of fertilizers with sodium selenate is shown to be effective and safe 
in increasing the Se intake of the whole population as supplementation of fertilizers with selenate has 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 80 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
increased the Se concentration of all major food groups. Plasma Se concentrations of people has 
increased by 70%. The Se intake surpasses current dietary recommendations. Also, the health of 
animals has improved. 
Reference values/Policy support: Follow-up studies regarding beneficial (lower cardiovascular risk) 
and eventual adverse effects of selenium supplementation are still ongoing. Thus, it is risky to set the 
measured concentrations of plasma Se above 1.0 µmol/L as the reference value. The selenium 
supplementation is governmental. 
3.7.12. Norway 
3.7.12.1. The Tromsø cohort study 
Initiator/Funding source: The Tromsø cohort study was supported by the Northern Norway Regional 
Health Authority, the Fram Centre, the Research Council of Norway, and the EU project ArcRisk 
(http://www.arcrisk.eu) (Nøst et al., 2014). 
Study design/Duration: The objectives of this longitudinal study were to determine the following: (1) 
serum PFAS time trends on an individual level, (2) relative compositions and correlations between 
different PFASs, and (3) assess selected PFAS concentrations with respect to time (calendar year), 
age, and birth cohort (age-period-cohort) effects. Birth year and body mass index information was 
extracted from questionnaires, and blood samples (repeated measurements from the same subjects) 
were collected. The study started in 1979 and went until 2007. 
Study population/Recruitment: Five repeated population surveys took place in the municipality of 
Tromsø in Northern Norway, in 1979, 1986–1987, 1994–1995, 2001, and 2007–2008. Of 60 randomly 
selected men, 53 had sufficient sample volumes in ≥ 3 sampling years (11 missing samples were 
randomly distributed across sampling years). In total, the study comprised 254 serum samples from 53 
men. The median ages of the first (1979) and last (2007-2008) sampling periods were 43 and 71, 
respectively. Participation was voluntary, and all participants provided informed consent. 
Investigated chemicals/Matrices: Blood samples were collected, and the following substances were 
measured: fluorocarbons (PFDA, PFNA, PFUdA, PFHpA, PFHxS, PFNA, PFOA, PFOS, PFOSA), 
organochlorine pesticides (o,p’-DDT, p,p’-DDT, p,p’-DDE and o,p’-DDE as metabolite of DDT, 
oxychlordane, trans-Nonachlor, HCB, α-HCH, β-HCH, γ-HCH, Mirex), and PCBs (PCB 28, 47/49, 
52, 99, 101, 105, 118, 123, 128, 138, 141, 149, 153, 156, 157, 167, 170, 180, 183, 187, 189, 194). 
Analytical methods: HCHs, chlordanes, and mirex were measured via GC-MS in selected ion 
monitoring and negative chemical ionisation modes. DDTs and PCBs were measured via GC-MS/MS 
with electron ionisation. PFASs were measured via UPLC-triple quadrupole mass spectrometry. 
Results/Interpretations: The findings of the levels of POPs and PFASs over 5 sampling periods have 
been published (Nøst et al., 2013; 2014). The median decreases in summed serum POP concentrations 
(lipid-adjusted) in 1986, 1994, 2001, and 2007 relative to 1979 were -22%, -52%, -54%, and -68%, 
respectively. There were observable substantial declines in all POP groups with the exception of 
chlordanes. The results suggest substantial intra-individual declines in serum concentrations of legacy 
POPs from 1979 to 2007 in men from Northern Norway. These changes are consistent with reduced 
environmental exposure during these 30 years and highlight the relation between historic emissions 
and POP concentrations measured in humans. A longitudinal decrease in concentrations with age was 
evident for all birth cohorts (Nøst et al., 2013). 
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The median concentrations of PFOS and PFOA increased 5-fold from 1979 to 2001 and decreased by 
26% and 23%, respectively, from 2001 to 2007. The concentrations of PFOS and PFOA peaked during 
1994-2001 and 2001, respectively, whereas PFHxS increased to 2001 but did not demonstrate a 
decrease between 2001 and 2007. PFNA, PFDA, and PFUnDA displayed increasing trends throughout 
the entire study period (1979-2007). Although PFOS comprised dominating proportions of PFAS 
burdens during these years, the contributions from PFOA and PFHxS were also considerable. The 
concentration changes of 10 PFASs in the repeated measurements from 1979 to 2007 demonstrated 
divergent time trends between the different PFASs. The temporal trends of PFASs in human serum 
during these 30 years reflect the overall trends in historic production and use, although global transport 
mechanisms and bioaccumulation potential of the different PFASs together with a varying extent of 
consumer exposure influenced the observed trends. Sampling year was the strongest descriptor of 
PFOA, PFUnDA and PFOS concentrations, and the calendar-year trends were apparent for all birth 
year quartiles. Discrepancies between the trends in this current longitudinal study and previous cross-
sectional studies were observed and presumably reflect the different study designs and population 
characteristics (Nøst et al., 2014). 
Investigation of exposure sources/Reference values: Estimates of average and high fish 
consumption in the Norwegian population were used to model the POPs concentrations as a result of 
fish consumption (Nøst et al., 2013), and the findings of this longitudinal cohort study serve as 
reference values for comparing findings from previous sampling periods. 
3.7.12.2. The Norwegian Mother and Child Cohort Study (MoBa) 
Initiator/Funding source: The Norwegian Mother and Child Cohort Study (MoBa) is a study of the 
aetiology of diseases among mothers and their children. It was initiated by researchers at the Medical 
Birth Registry of Norway (MBRN) and at the National Institute of Public Health, which later merged 
with other institutions and renamed themselves as the Norwegian Institute of Public Health (NIPH), 
and the study was supported by the Norwegian Ministry of Health and the Ministry of Education and 
Research, USA’s NIH/NIEHS and NINDS, and the Norwegian Research Council/FUGE. Sub-projects 
involving additional data collection and analysis must have separate funding. (Magnus et al., 2006). 
(www.fhi.no/moba-en) 
Study design/Duration: The MoBa cohort is a longitudinal prospective population-based pregnancy 
cohort study. Recruitment of participants went from 1999 – 2008, and data acquisition and analysis are 
still ongoing as of 2014. Prior to the delivery of the child, participants were given a series of self-
administered questionnaires to acquire information on their medical histories, mental health, lifestyle 
habits, exposures in the workplace and at home, and health status or lifestyle changes during 
pregnancy. The paternal questionnaire focussed on the medical history, lifestyle habits, and exposures 
at work. Then when the child was 6-months-old, a questionnaire was then given to the participants to 
acquire data on the child’s health and nutrition as well as the mother’s health and well-being. The last 
follow-up of the child has been planned when the child reaches 7 years of age (Magnus et al., 2006). 
Regarding dietary intake, both FFQs and food diaries (e.g. 4-day weighed food diary) were utilised 
(Brantsaeter et al., 2008). 
Study population/Recruitment: A total of 108,000 children, 90,700 mothers, and 71,500 fathers 
were recruited from all over Norway. Pregnant women beginning at the 17th week of pregnancy, who 
attended routine examination, along with the fathers were recruited by postal invitations. All 
participants gave informed consent and voluntarily took part in the study (Magnus et al., 2006). 
Investigated chemicals/Matrices: Blood and urine samples were collected from the mothers during 
pregnancy (and blood samples from the father) and from the mothers and children (umbilical cord 
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blood) at birth. From 2008 to 2016, the MoBa study intends to collect teeth samples from the 
participating children (Tvinnereim et al., 2012). The following substances were measured in biological 
samples in this study: mercapturic acid derivatives (in urine) and haemoglobin adducts (in blood) of 
acrylamide/glycidamide, bisphenol A, cotinine (as a biomarker of tobacco smoke exposure), 
fluorocarbons (PFDeA/PFDA, PFOA, PFNA, PFOS, PFUA/PFUdA, PFHxS, PFHpS), 
organophosphate pesticide (3,5,6-trichloropyridinol (metabolite of chlorpyrifos), organophosphate 
metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP (for DAP)], and phthalate metabolites 
[MBzP (for BBzP), MiBP (for DiBP), MnBP (for DnBP), MEP (for DEP), 7oxo-MMeOP, 7OH-
MMeOP (for DiNP), MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP, 
MCMHP (for DEHP), MMP (for DMP), MOP, MCPP (for DOP)]. 
Analytical methods: All fluorocarbons were measured via either LC coupled to a triple quadrupole 
mass spectrometer (Starling et al., 2014) or HPLC-MS/MS for PFOS and PFOA (Whitworth et al., 
2012). Urinary acrylamide/glycidamide metabolites were measured using LC-triple quadruple MS 
with positive electrospray ionization mode using multiple reaction monitoring (Brantsaeter et al., 
2008), and haemoglobin adducts of acrylamide/glycidamide were measured by applying the ‘adduct 
FIRE’ procedure then analysed via LC-MS (Duarte-Salles et al., 2013b). Phthalate metabolites, 3,5,6-
trichloropyridinol, organophosphate metabolites, and BPA were all measured either by GC-MS/MS or 
reversed-phase HPLC-MS/MS (Ye et al., 2009). Plasma cotinine was measured via LC-MS/MS 
(Kvalvik et al., 2012). 
Results/Interpretations: Several studies reported negative associations between maternal exposures 
to Hg, dioxins and PCBs, or benzo(a)pyrene (all determined via reported dietary intake during 
pregnancy) and birth weight (Duarte-Salles et al., 2013a; Papadopoulou et al., 2013; Vejrup et al., 
2014). 
Maternal exposure to acrylamide: A relationship between the dietary intake of crisp bread and 
potato crisps with increased urinary acrylamide metabolites was reported (Brantsaeter et al., 2008). 
Furthermore, acrylamide intake during pregnancy was negatively associated with foetal growth 
(Duarte-Salles et al., 2013b). 
Maternal exposure to PFCs: The maternal levels (via blood samples from mothers) and foetal levels 
(via cord blood) of PFCs are significantly correlated (Gutzkow et al., 2012). The adjusted birth weight 
z scores were slightly lower among infants born to mothers in the highest quartiles of PFCs compared 
with infants born to mothers in the lowest quartiles. PFOS and PFOA were each associated with 
decreased adjusted odds of preterm birth although the sample sizes were small (Whitworth et al., 
2012). 
Maternal exposure of pesticides, phthalates, and BPA: Daily intakes were estimated from urinary 
data and compared with reference doses (RfDs) and daily tolerable intakes (TDIs). The MoBa women 
had a higher mean BPA concentration (4.50 μg/L) than the pregnant women in the Generation R Study 
in the Netherlands and in the USA’s NHANES. The mean concentration of total DAP metabolites 
(24.20 μg/L) in MoBa women was higher than that in NHANES women but lower than that in 
Generation R women. MEP was the dominant phthalate metabolite in all three studies with the mean 
concentrations of greater than 300 μg/L. The MoBa and Generation R women had higher mean 
concentrations of MnBP and MiBP than the NHANES women. The estimated average daily intakes of 
BPA, chlorpyrifos/chlorpyrfosmethyl and phthalates in MoBa (and the other two studies) were below 
the RfDs and TDIs. The higher levels of metabolites in the MoBa participants may have been from 
intake via pesticide residues in food (organophosphates), consumption of canned food, especially 
fish/seafood (BPA), and use of personal care products (selected phthalates) (Ye et al., 2009). 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 83 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Communication to scientific community/public: Multiple scientific articles have been published 
using MoBa cohort. Data from MoBa is only available to scientific researchers in Norway or to those 
who are collaborating with a Norwegian researcher, and access to data could be acquired via a request 
to NIPH.  
Investigation of exposure sources: Completed FFQs allowed further studies of determining chemical 
exposure to food consumption. In addition, a few external sub-studies had correlated maternal 
chemical exposure to the estimated levels of Hg, dioxins, and PCBs, or acrylamide in food 
(Brantsaeter et al., 2008; Papadopoulou et al., 2013; Vejrup et al., 2014), and a positive association 
was reported between smoking and plasma cotinine levels (Kvalvik et al., 2012). 
Policy support: One of the duties of the NIPH is to have an overview of the health status of the 
Norwegian population and factors influencing public health. Therefore, a human environmental 
biomonitoring program has recently been established and will use the MoBa as a basis for recruitment. 
An advantage of using the MoBa cohort is that extensive health information is already available. This 
opens for a number of studies on possible health effects of both nutrients and environmental 
contaminants. 
3.7.13. Arctic Monitoring and Assessment Programme (AMAP) 
Initiator/Funding source/Duration: Since 1997, the AMAP has produced integrated assessment 
reports on the status of and trends in environmental POPs in the Arctic ecosystem (Bonefeld-
Jorgensen, 2010). Three reports on biomonitoring of POPs and their health risks for Arctic populations 
were published in 1998, 2002, and 2009, and the programme is ongoing. 
Study design: AMAP's current objective is "providing reliable and sufficient information on the status 
of, and threats to, the Arctic environment, and providing scientific advice on actions to be taken in 
order to support Arctic governments in their efforts to take remedial and preventive actions relating to 
contaminants." Long-term monitoring and trend analysis of contaminant levels in Arctic populations is 
a crucial component of this objective. Blood is the medium of choice for biological monitoring of 
contaminants as it accurately reflects the body burden of metals as well as organic contaminants, and 
is universally available from all members of a population. For lipophilic compounds (which include 
most POPs), blood levels (expressed on a lipid basis) are well-correlated with levels in other 
compartments such as stored fat and breast milk. To ensure the comparability of data obtained from 
different countries, it is required to obtain an adequate number of preserved blood specimens and other 
samples. (www.amap.no) 
Study population: A reported study focused on adult Inuits (aged 18-50, randomly selected from the 
national register) has been published (Bonefeld-Jorgensen, 2004). There are other AMAP studies that 
have selected pregnant women. 
Investigated chemicals/Matrices: Serum samples were collected, and the following POPs were 
directly measured in the samples: BFRs (PBDE 47, 99, 100, 153), fluorocarbons (PFHxS, PFOA, 
PFOS), metals (Pb, Hg, Se), and PCBs (PCB 28, 52, 99, 101, 105, 114, 118, 123, 128, 138, 153, 156, 
157, 167, 170, 180, 183, 187, 189). 
Analytical methods: POPs were measured in serum by HPLC along with fatty acids and the 
xenobiotic hormone disrupting potential as determined by the hormone receptor transactivation of the 
luciferase reporter gene expression. 
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Results/Interpretations: The median values of PCBs, POPs, and metals (Hg, Pb, Se) found in human 
sera from Greenland have been published (Bonefeld-Jorgensen, 2010), and several studies linking to 
health effects have been published e.g. semen quality and breast cancer. For mercury, a specific 
conclusion has been issued: 
“What is the impact of mercury contamination on human health in the Arctic? (AMAP 
Assessment 2011: Mercury in the Arctic) 
Some Arctic human populations, especially some indigenous communities that consume large 
quantities of certain species of freshwater fish or marine mammal tissues for their traditional/local 
food, receive high dietary exposure to mercury. This raises concerns about human health effects, such 
as effects on brain development, and effects on the reproductive, immune and cardiovascular systems. 
Exposure at current levels in the Arctic can have adverse impacts on human health, particularly for the 
developing fetus and children. Pregnant women, mothers and children are critical groups for 
monitoring and measures to reduce dietary exposure.  
There has been an overall decline in the proportion of Arctic people that exceed (USA and Canadian) 
blood mercury guidelines, but a significant proportion of people including women of child-bearing age 
from communities in the eastern Canadian Arctic and Greenland still exceed these guidelines. Dietary 
advice has been effective in reducing mercury exposure in some critical groups, but such advice needs 
to be carefully formulated to balance risks and benefits of traditional/local food consumption.  
The general dietary transition from traditional/local to more ‘western’ diets is also reducing mercury 
exposure, but at the same time is raising risks of other conditions or diseases associated with a western 
diet and lifestyle (such as obesity, diabetes, and heart disease). Since traditional/local foods low in 
mercury are not always available to Arctic indigenous people, the achievement of declining mercury 
levels in the environment is imperative to allow for the safe promotion of traditional/local food 
consumption.” 
Investigation of exposure sources: For Greenland, the AMAP collected food intake via a semi 
quantitative food questionnaire featuring of 60 food items, namely 35 local Greenland food products 
(e.g. meats, fish, birds, berries) and 25 Danish imported foods (e.g. breads, fruits, vegetables). 
Frequency categories range from once a year to several times a day. Standard (i.e. not individually 
reported) portion sizes were used to estimate dietary intake of food (Deutch et al., 2004). 
The AMAP also has extensive focus on environmental exposures including wildlife and climate 
issuing reports frequently on these issues, available from the AMAP website. The latest reports are the 
following: 
 AMAP, 2013. AMAP Assessment 2013: Arctic Ocean Acidification. Arctic Monitoring and 
Assessment Programme (AMAP), Oslo, Norway. viii + 99 pp. 
 AMAP, 2011. Snow, Water, Ice and Permafrost in the Arctic (SWIPA): Climate Change and 
the Cryosphere. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway. xii + 
538 pp. 
 AMAP, 2011. AMAP Assessment 2011: Mercury in the Arctic. Arctic Monitoring and 
Assessment Programme (AMAP), Oslo, Norway. xiv + 193 pp. 
 AMAP, 2010. AMAP Assessment 2009: Radioactivity in the Arctic. Arctic Monitoring and 
Assessment Programme (AMAP), Oslo, Norway. xii + 92 pp.pp. 
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 AMAP, 2010. AMAP Assessment 2009 - Persistent Organic Pollutants (POPs) in the Arctic. 
Science of the Total Environment Special Issue. 408:2851-3051. Elsevier, 2010. 
 The AMAP study has been mentioned in all reports to link environmental exposures, wildlife 
and human health. 
3.7.14. Canada [Canadian Health Measures Survey (CHMS)] 
Initiator/Funding source: Statistics Canada, in partnership with Health Canada and the Public Health 
Agency of Canada, launched CHMS to collect health and wellness data and biological specimens on a 
nationally representative sample of Canadians. 
Study design/Duration: CHMS is a cross-sectional survey that started in 2007 and is carried out in 2-
year cycles. The first Report on Human Biomonitoring of Environmental Chemicals in Canada (Cycle 
1) was published in August 2010, reporting collected data from March 2007 to February 2009. The 
second Report on Human Biomonitoring of Environmental Chemicals in Canada (Cycle 2) was 
published in April 2013, reporting collected data from August 2009 to November 2011. CHMS 
intends to continue further with Cycle 3 of the survey. Home interviews would be conducted, and 
health questionnaires as well as a semi-quantitative FFQ would be administered at that point. The FFQ 
would collect data on frequency consumption (i.e. number of times per day/week/month/year) of food 
groups such as meat and fish, grains, fruits and vegetables, dairy products, dietary fats, water and soft 
drinks. After the initial data collection, the participants would report to one of the 18 collection sites 
for direct health measures and sample collection. Furthermore, indoor air (measured in Cycle 2) and 
tap water (to be measured in Cycle 3) would be measured for exposure of contaminants, namely 
fluoride and VOCs.  
Study population/Recruitment: The 2006 Canadian Census was used as the frame to select 
dwellings. Dwellings with known household composition at the time of the 2006 Census were 
stratified by age of household residents into the six age-group strata corresponding to the CHMS cycle 
2. Within each collection site, a simple random sample of dwellings was selected in each stratum. 
Statistics Canada mailed an advance letter and brochure to households that were selected. Each 
selected dwelling was then contacted and asked to provide a list of current household members; this 
list was used to select the survey participants. One or two people were selected, depending on the 
household composition. To meet the objective of producing reliable estimates at the national level by 
age group and sex, the study required a minimum sample of at least 5,700 participants. People aged 3 
to 79 residing in the 10 provinces and 3 territories were targeted. People living on reserves or in other 
Aboriginal settlements in the provinces, residents of institutions, full-time members of the Canadian 
Forces, persons living in certain remote areas, and persons living in areas with a low population 
density were excluded. All participants gave informed consent, and the participation is voluntary. 
Investigated chemicals/Matrices/Analytical methods: Urine and blood (whole blood and plasma) 
were used for substance measurements. For cycle 1 of the CHMS, the following groups of substances 
were measured: metals, chlorophenols, bisphenol A, cotinine, PFAS, pesticides, and phthalate 
metabolites. For cycle 2, the same substances as cycle 1 along with additional substances (e.g. PCP, 
triclosan, etc.) and substance groups (benzene and PAH metabolites) were measured. To summarise, 
the following substances were measured in CHMS: bisphenol A, BFRs (PBDE 17, 28, 47, 99, 100, 
153, PBB 153), carbamate pesticides (carbofuranphenol, 2-isopropoxyphenol), chlorophenols (2,4-
DCP, 2,5-DCP, 2,4,5-DCP, 2,4,6-DCP, PCP), cotinine (as a biomarker of tobacco smoke exposure), 
fluorocarbons (PFBuS, PFDeA/PFDA, PFDoA, PFOA, PFOS, PFUA/PFUdA),  metals [Sb, As 
(including total, inorganic As such as As(III)/As(V)/MMA/DMA, and organic As such as 
arsenobetaine and arsenocholine), Cd, Cs, Co, Cu, Fl, Pb, Mn, Hg (total & inorganic), Mo, Ni, Se, Ag, 
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Tl, W, U, V, Zn], organochlorine pesticides (Aldrin, p,p’-DDT, p,p’-DDE as a metabolite of DDT, 
Oxychlordane, trans-Nonachlor, HCB, β-HCH, γ-HCH, Mirex), organophosphate metabolites [DEP, 
DMP, DETP, DMTP, DEDTP, DMDTP (for DAP)], PAH metabolites [(3-Hydroxybenzo(a)pyrene 
(for benzo[a]pyrene), 2-Hydroxyfluorene, 3-Hydroxyfluorene, 9-Hydroxyfluorene (for fluorene), 1-
Hydroxyphenanthrene, 2-Hydroxyphenanthrene, 3-Hydroxyphenanthrene, 4-Hydroxyphenanthrene, 9-
Hydroxyphenanthrene (for phenanthrene), 1-Hydroxypyrene (for pyrene), 1-Hydroxynaphthalene (1-
Naphthol), 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], PCBs (PCB 28, 52, 101, 138, 153, 
180), phenols (Triclosan), phthalate metabolites [MBzP (for BBzP), MiBP (for DiBP), MnBP (for 
DnBP), MEP (for DEP), MiNP (for DiNP), MEHP, MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP (for 
DEHP), MMP (for DMP), MOP, MCPP (for DOP), MCHP (for DCHP)], and pyrethroid metabolites 
[F-PBA (for cyfluthrin), Br2CA (for deltamethrin), cis-Cl2CA, trans-Cl2CA, 3-PBA (for cypermethrin, 
deltamethrin, and permethrin)]. 
Please refer to the second Report on Human Biomonitoring of Environmental Chemicals in Canada 
for the complete list of measured substances and their analytical methods (Health Canada, 2013). 
Also, small amounts of blood and urine from consenting participants are frozen and stored 
anonymously in a biobank at the National Microbiology Laboratory in Winnipeg for use in future 
health studies (http://www.statcan.gc.ca/eng/survey/household/5071g). 
Results/Interpretations/Reference values: Table 32 shows the matrices and the geometric mean 
levels of the tested substances in CHMS. A detailed summary of the analyses of the tested substances 
in CHMS could be found in the first or the second Report on Human Biomonitoring of Environmental 
Chemicals in Canada. This report includes temporal data for substances measured in both cycle 1 
(2007–2009) and cycle 2 (2009–2011) and baseline data for substances introduced to the survey in 
cycle 2. The concentrations found for the tested substances from CHMS Cycle 1 are subsequently used 
as reference values for future CHMS cycle surveys. In addition, the data from newly-added chemicals 
in CHMS Cycle 2 would also be used as reference values. The values are published in the first and the 
second Report on Human Biomonitoring of Environmental Chemicals in Canada. Results from future 
cycles of CHMS can then be compared with the baseline data from cycle 1 and cycle 2 in order to 
begin to examine trends in Canadians’ exposures to selected environmental chemicals.  
Results/Interpretations/Communication to public: The second Report on Human Biomonitoring of 
Environmental Chemicals in Canada is accessible online. A strategy was developed to communicate 
results to survey participants with the expert opinion of CHMS Laboratory Advisory Committee, the 
Physician Advisory Committee, l’Institut national de santé publique du Québec, and Health Canada’s 
Research Ethics Board. Environmental metals (e.g. Pb, Hg, and Cd) were actively reported to 
participants. Participants could receive all other test results upon request to Statistics Canada. CHMS 
provides data access to analysts and researchers using Research Data Centres, where they are located 
in universities across the country and staffed by Statistics Canada employees. Furthermore, the CHMS 
data could also be made available to scientists upon request by contacting Statistics Canada at 
info@statcan.gc.ca for additional scientific analysis. 
Investigation of exposure sources/Policy support: CHMS cycle 2 included indoor air measurements 
of VOCs, and in the upcoming Cycle 3, household tap water samples are to be analysed for fluoride 
and VOCs. 
The CHMS is a major component of the monitoring initiatives developed under the Chemicals 
Management Plan (CMP), launched by the Government of Canada in 2006. The goal of CMP is to 
further enhance its role in protecting Canadians and their environment from exposure to chemicals. 
The CMP supports a number of additional research, monitoring and assessment activities to help 
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Canadians better understand their exposure and the potential effects on human health. These activities 
include biomonitoring studies targeting vulnerable populations (such as the MIREC study), 
environmental monitoring studies, and research to support biomonitoring. Health Canada also partners 
with Aboriginal Affairs and Northern Development Canada’s Northern Contaminants Programme to 
undertake health research and biomonitoring in Canada's northern populations. Furthermore, the 
CHMS data could help the development and implementations of health policies such as the need of 
public health actions towards substances of concern and raising public awareness about exposures and 
possible health effects relating substances of concern. 
3.7.15. United States of America (USA) [National Health and Nutrition Examination 
Survey (NHANES)] 
Initiator/Funding sources: NHANES is a programme of studies designed to assess the health and 
nutritional status of adults and children in the USA. It is a major programme of the National Center for 
Health Statistics (NCHS) and is a part of the Centers for Disease Control and Prevention (CDC), who 
has the responsibility for producing vital and health statistics. 
Study design/Duration: NHANES is a cross-sectional study that began in the early 1960s and started 
with measurements of environmental chemicals in 1976. The survey has been conducted as a series of 
surveys focusing on different population groups or health topics. The historical surveys are referred to 
as NHANES I, NHANES II (1976–1980), Hispanic HANES (1982–1984) and NHANES III (1988–
1994). In 1999, the survey became a continuous yearly programme that has adaptable components on 
a variety of health and nutrition measurements to meet emerging needs. NHANES is currently 
ongoing. 
There are two main parts to the survey: (1) health interviews conducted in the participants’ homes and 
(2) health measurements performed in specially-designed and equipped mobile centres. All 
participants visit the physician. Dietary interviews and body measurements are included for everyone. 
For dietary interviews, food intake data collection is thoroughly conducted with the “Automated 
Multiple-Pass Method,” which is a 5-step dietary interview involving 24-hr recalls (Moshfegh et al., 
2008). For the body measurements, all but the very young will have a blood sample taken and a dental 
screening. Depending upon the age of the participant, the rest of the examination includes tests and 
procedures to assess the various aspects of health. In general, the older the individual, the more 
extensive the examination. 
Study population: The sample for the survey is selected to represent the American population (non-
institutionalised civilians) of all ages, and NHANES examines a nationally representative sample of at 
least 10,000 persons from 30 localities over a 2-year period. Participants are selected through a 
complex statistical process using the most current Census information. Briefly, NHANES divides the 
USA into communities. The communities are divided into neighbourhoods, which are selected at 
random for each survey. From each neighbourhood, housing units are further selected at random. 
Selected households are approached by the study interviewers, who screen the residents to determine 
their eligibility for the survey. Participants are selected based on age, gender, and ethnic background. 
Oversampling of minority populations (e.g. Hispanics, low income residents, etc.) occur in NHANES 
to better understand the possible risk factors and exposures to specific chemicals. The study 
population includes pregnant women. The minimum age for participation is 2 months, but urine 
samples are not collected from participants less than 6 years of age. Blood samples for most 
environmental chemical measurements are collected from participants 12 years and older; however, 
because of the small amount of blood required, lead, cadmium and mercury are measured in all 
participants providing a 9-ml blood sample (most of the blood is used for nutritional and clinical 
testing) and who are at least 1 year of age. For a similar reason, cotinine is measured in everyone 3 
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years of age and older; they are asked to provide 22 ml of blood. The participants, or their parents, also 
complete an extensive questionnaire on demographics and health behaviours and undergo a complete 
physical and medical examination. The participants represent a national probability sample; thus, the 
results can be extrapolated to include the entire US population.  
Recruitment: Participants receive free measurements of various health status parameters (e.g. bone 
density) that would normally not be covered during routine physical exams. A report of medical 
findings is given to each participant. Also, all participants receive cash remuneration, and NHANES 
reimburse participants for transportation and baby/elder care. 
Investigated chemicals/Matrices: The chemical measurements are conducted on a random one-third 
subset of the NHANES participants.  
Blood (serum and plasma) and urine samples were used for analysis, and the following substances had 
been analysed at least once in NHANES: acrylamide and its metabolite glycidamide, BFRs (PBDE 
17, 28, 47, 66, 85, 99, 100, 153, 154, 183, BDE 209, PBB 153), bisphenol A, carbamate pesticides 
(Carbofuranphenol, 2-isopropoxyphenol), chlorophenols (2,4-DCP, 2,5-DCP, 2,4,5-DCP, 2,4,6-DCP, 
PCP), cotinine (as a biomarker of tobacco smoke exposure), dioxins (1,2,3,4,6,7,8-HpBDD, 
1,2,3,4,7,8-HxBDD, 1,2,3,6,7,8-HxBDD, 1,2,3,7,8,9-HxBDD, 1,2,3,7,8-PeBDD, 2,3,7,8-TBDD, 
1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-
OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), fluorocarbons (PFBuS, PFDeA/PFDA, PFDoA, PFHpA, 
PFHxS, PFNA, PFOA, PFOS, PFOSA, Et-PFOSA-AcOH, Me-PFOSA-AcOH, PFUA/PFUdA), 
furans (1,2,3,4,6,7,8-HpBDF, 1,2,3,4,7,8-HxBDF,  1,2,3,7,8-PeBDF, 2,3,4,7,8-PeBDF, 2,3,7,8-
TBDF, 1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 
1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 
2,3,7,8-TCDF), herbicides (2,4-D, 2,4,5-T), metals [Sb, As including inorganic As such as 
As(III)/As(V)/MMA and DMA and organic As such as arsenobetaine, arsenocholine and 
trimethylarsine oxide, Ba, Cd, Cs, Co, Cu, Pb, Mn, Hg (total/ethyl and methyl species/inorganic), Mo, 
Se, Sr, Tl, Sn, W, U, Zn), mycotoxins (Aflatoxin B1), NNAL (metabolite of NNK), organochlorine 
pesticides (aldrin, dieldrin, endrin, heptachlor epoxide, o,p’-DDT, p,p’-DDT, p,p’-DDE as a 
metabolite of DDT, oxychlordane, trans-nonachlor, HCB, β-HCH, γ-HCH, mirex), organophosphate 
pesticides [3,5,6-trichloropyridinol (metabolite of chlorpyrifos), Acephate, Dimethoate, Malathion 
diacid (metabolite for malathion), Methamidophos, Omethoate, Oxypyrimidine (metabolite for 
diazinon), Paranitrophenol (metabolite for methyl parathion)], organophosphate metabolites [DEP, 
DMP, DETP, DMTP, DEDTP, DMDTP (for DAP)], PAH metabolites [2-Hydroxyfluorene, 3-
Hydroxyfluorene, 9-Hydroxyfluorene (for fluorene), 1-Hydroxyphenanthrene, 2-
Hydroxyphenanthrene, 3-Hydroxyphenanthrene, 4-Hydroxyphenanthrene (for phenanthrene), 1-
Hydroxypyrene (for pyrene), 1-Hydroxynaphthalene (1-Naphthol), 2-Hydroxynaphthalene (2-
Naphthol) (for naphthalene)], PCBs (PCB 28, 44, 49, 52, 66, 74, 81, 87, 99, 101, 105, 110, 114, 118, 
123, 126, 128, 138, 146, 149, 151, 153, 156, 157, 167, 169, 170, 172, 177, 178, 180, 183, 187, 189, 
194, 195, 196, 199, 203, 206, 209), perchlorate, phenols (Benzophenone-3, Butyl paraben, Ethyl 
paraben, Methyl paraben, Propyl paraben, 4-tert-octylphenol, Triclosan), phthalate metabolites 
[MBzP (for BBzP), MiBP (for DiBP), MnBP (for DnBP), MiNP, MCOP (for DiNP), MEHP, 
MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP (for DEHP), MMP (for DMP), 
MCPP (for DOP), MCHP (for DCHP), MCNP (for DiDP)], pyrethroids and their metabolites 
[permethrin, F-PBA (for cyfluthrin), Br2CA (for deltamethrin), trans-Cl2CA, 3-PBA (for cypermethrin, 
deltamethrin, and permethrin)]. 
The complete list of chemicals and their results could be found on the CDC’s website 
(http://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory). As of July 2014, 
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the latest published NHANES data is from the sample collection during 2011-2012. The following 
chemicals were analysed in previous NHANES surveys: 
 Aflatoxin B1 from NHANES 1999-2000 
 2003-2004:  
o Acrylamide & glycidamide 
o Aldrin, dieldrin, endrin, heptachlor epoxide (Organochlorine Pesticides) 
o Carbofuranphenol, 2-Isopropoxyphenol (Urinary Current Use Pesticides) 
o Dioxins & furans (Dioxins, Furans, and coplanar PCBs) 
 2005-2006 
o 2,4,5-trichlorophenol, 2,4,6-trichlorophenol (Environmental Pesticides) 
o Acephate, Dimethoate, Methamidophos, Omethoate (Urinary Carbamates and 
Organophosphorus Pesticides) 
 2007-2008 
o Urinary Organophosphate Insecticides: Dialkyl Phosphate Metabolites 
o Urinary Pyrethroids, Herbicides, and Organophosphate (OP) Metabolites 
o NHANES pesticides from 2007-2008 
o PCBs (Non-dioxin-like Polychlorinated Biphenyls and mono-ortho-substituted PCBs) 
o Brominated flame retardants 
Analytical methods: The analytical methods of the tested substances could be found in detail in the 
data files presented under “Laboratory Data” of the NHANES website. 
Results/Interpretations/Reference values: Table 33 shows the matrices and the geometric mean 
levels of the tested substances in NHANES.  
According to CDC, NHANES’ data has stimulated important policy changes and further research such 
as the following: 
 Blood lead data were instrumental in developing policy to eliminate lead from gasoline and in 
food and soft drink cans. Recent survey data indicate the policy has been even more effective 
than originally envisioned, with a decline in elevated blood lead levels of more than 70% since 
the 1970s. 
 Overweight prevalence figures have led to the proliferation of programmes emphasizing diet 
and exercise, stimulated additional research, and provided a means to track trends in obesity. 
 Information collected in this survey will help the Food and Drug Administration decide if 
there is a need to change vitamin and mineral fortification regulations for the Nation’s food 
supply. 
NHANES partners with the EPA and the US Department of Agriculture to study the influence of 
pollutants in human health and to cooperate in planning and reporting dietary and nutrition 
information from the survey, respectively. 
Communications to participants/scientific community/public: Analyses using NHANES data have 
been published as an extensive series of articles in scientific and technical journals. For data users and 
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researchers throughout the world, survey data are also available on the internet 
(http://www.cdc.gov/nchs/nhanes.htm) and on easy-to-use CD-ROMs. NHANES participants receive 
a report of their health examination. 
Policy support: Primary data users are federal agencies that collaborated in the design and 
development of the survey. The National Institutes of Health, the Food and Drug Administration, and 
CDC are among the agencies that rely upon NHANES to provide data essential for the implementation 
and evaluation of programme activities. The US Department of Agriculture and NCHS cooperate in 
planning and reporting dietary and nutrition information from the survey.  
3.7.16. South Korea 
3.7.16.1. The Korea National Health and Nutrition Examination Survey (KNHANES) 
Initiator/Funding source/Duration: KNHANES was first established in 1998 based on the Article 16 
of the National Health Promotion Act proclaimed in 1995 and is still an ongoing surveillance 
programme. This surveillance system has been conducted by the Korea Centers for Disease Control 
and Prevention (KCDC). KNHANES has been financially supported by the Health Promotion Fund of 
Korea with administrative support from the Ministry of Health and Welfare. Furthermore, this 
surveillance system is technically supported by major academic societies in Korea based on the 
memoranda of understanding between KCDC and those academic societies (Kweon et al., 2014). 
Study design: KNHANES is a nationwide cross-sectional survey conducted every year and features 
three components: a health interview, health examination, and nutrition survey. The survey collects 
detailed information on socioeconomic status, health behaviours, quality of life, healthcare utilisation, 
anthropometric measures, health measures such as dental, vision, hearing, and bone density, X-ray test 
results, biochemical profiles using fasting blood serum and urine, food intake, and dietary behaviours. 
The nutrition survey addresses dietary behaviours, food frequency and food intake and is conducted 
using the face-to-face interview method, see (Kweon et al., 2014) for more details. 
Study population/Recruitment: Since 2008, about 10,000 individuals were surveyed every year. The 
target population comprises non-institutionalised Korean citizens (males and females) aged 1 year and 
over residing in Korea. The participants were recruited based on a multi-stage clustered probability 
design. For example, in the 2011 survey, 192 primary sampling units (PSUs) were drawn from 
approximately 200 000 geographically defined PSUs for the whole country. A PSU consisted of an 
average of 60 households, and 20 final target households were sampled for each PSU using systematic 
sampling. 
Investigated chemicals/Matrices: Urine and blood samples were collected from participants aged 10 
years and over. Aside from testing for various markers of organ functions, cotinine (as a biomarker of 
tobacco smoke exposure) and heavy metals (Hg, Pb, Cd, Mn, As, and Zn) were measured. 
Analytical methods: All metals except for mercury were measured using AAS. Mercury was 
measured using a Direct Mercury Analyser (DMA-80), and urinary cotinine was measured by GC-MS. 
Results/Interpretations: The levels of urinary As and cotinine as well as blood Mn, Hg, Cd, and Pb 
have been reported in several scientific articles (Jung et al., 2012; Koh et al., 2014; Park & Lee, 2013; 
Shin et al., 2012). The results are summarised in Table 34. 
Blood Hg levels in the high consumption groups compared to the low consumption groups were 
elevated by about 20% with seafood and alcohol and by about 9-14% with seaweeds, green 
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vegetables, fruits and tea, whereas rice had no effect on Hg levels. Urinary As levels were markedly 
increased with consumption of rice, seafood and seaweed, whereas they were moderately increased 
with consumption of grains, green and white vegetables, fruits, coffee, and alcohol. The remaining 
food categories tended to minimally lower these levels. Thus, the typical Asian diet (high in rice, 
seafood, vegetables, alcoholic beverages, and tea) may be associated with greater blood Hg and 
urinary As levels (Park & Lee, 2013). 
Blood Mn levels were significantly lower in the diabetes group compared with the non-diabetes group 
and the renal dysfunction group compared with those with normal renal function. There was no 
significant association between blood manganese levels and the presence of ischemic heart disease or 
stroke. (Koh et al., 2014). 
The increase of serum Cd in blood was associated with the increase in the prevalence of hypertension 
after adjusting for age, education, income, alcohol, smoking, and BMI. The increase in blood Cd 
concentration was also associated with the increase of both systolic and diastolic blood pressure. 
Although higher fish intakes were significantly associated with higher blood Hg concentration, fish 
intakes did not affect either blood Cd or Pb concentration, and there was no evidence of a clear 
relationship between cardiovascular disease and frequency of fish consumption (Shin et al., 2012). 
Urinary cotinine levels according to KNHANES 2007-2010 were highest for male active smokers. The 
difference between urinary cotinine levels for males and females was statistically significant. Urinary 
cotinine concentration is a useful biomarker for discriminating non-smokers from current smokers but 
is not useful in distinguishing between passive smoke exposure groups and non-exposure groups (Jung 
et al., 2012). 
Investigation of exposure sources/Reference values: One study demonstrated associations between 
blood mercury levels and the consumption of seafood, vegetables, fruits, and alcohol. Furthermore, 
urinary arsenic levels were also increased with the consumption of rice and seafood (Park & Lee, 
2013). Also, the levels of cotinine as a biomarker of tobacco smoke exposure between Korean 
smokers and non-smokers was analysed (Jung et al., 2012). Reference values for blood lead, cadmium, 
and mercury have been reported (Son et al., 2009). 
Communication to participants/scientific community/public: KNHANES reports are released 
annually and are available to the public at the end of the year free of charge. KCDC is in the process of 
preparing an English version of their homepage to be finished by the end of 2014. A growing number 
of scientific publications has used KHANES data. The data were also used in international comparison 
studies. Recent publications on inequalities in non-communicable diseases and the global burden of 
metabolic risk factors used several rounds of KNHANES data and provided comparable health 
statistics. KCDC has provided annual workshops for data users to promote the more proficient use of 
the data. For example, between 2011 and 2012, the workshops were held three times with 400-800 
researchers attending each workshop.  
Policy support: KNHANES data are widely used by governmental organizations and researchers. The 
Korean Government has periodically revised national health plans and recently established the 
National Health Plan 2020 (HP 2020). KNHANES has supported health statistics on more than half of 
target indicators for HP 2020 goals. KNHANES has been used for the development of Korean 
standards regarding health and nutrition, such as the Dietary Reference Intakes for Koreans and will be 
used for the 2017 Growth Charts for Korean infants, children and adolescents. 
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3.7.16.2. Korea National Survey for Environmental Pollutants in the Human Body (KorSEP) 
Initiator/Funding source/Duration: In order to address the concern regarding environmental 
pollution, the Ministry of the Environment in Korea has made efforts to measure the levels of 
environmental pollutants in the human body across the population and conducted regular surveillance 
to identify human exposure to toxic substances from the environment. The first survey (KorSEP I) was 
initiated as part of the KNHANES in 2005, and KorSEP II was conducted from April 2007 to 
December 2007. KorSEP III was designed in 2008 by the National Institute of Environmental 
Research (NIER) in Korea to assess the general population exposure to environmental pollutants (Lee 
et al., 2012). 
Study design: KorSEP is a national cross-sectional study surveying Korean adults throughout the 
country. The study consists of questionnaire-based interviews [for data collection regarding 
sociodemographic information, socioeconomic data, family history, indoor and outdoor environments, 
life-style (i.e., exposure to smoking, alcohol and drug consumption, and physical activity), 
occupational history and dietary information] and sample collection. 
Study population/Recruitment: KorSEP III in 2008 comprised 5087 Korean adults (males and 
females; non-institutionalised civilians) aged 20 or older from 193 areas in South Korea. Similar to 
KNHANES, the participants were recruited using a stratified multistage probability sampling design. 
In KorSEP III, 193 sampling units were randomly selected from the 264,183 primary sampling units in 
order to represent the overall Korean population (Lee et al., 2012). The participants voluntarily chose 
to partake in the survey. No financial rewards were offered, but the social impact of the study was 
explained. 
Investigated chemicals/Matrices: Blood and urine samples were collected, and the following 
substances were measured: bisphenol A, cotinine (as a biomarker of tobacco smoke exposure), 
metals [As (namely inorganic As, MMA and DMA combined), Cd, Pb, Mn, Hg], PAH metabolites 
[(1-Hydroxypyrene (for pyrene), 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], phthalate 
metabolites [MBzP (for BBzP), MiBP (for DiBP), MnBP (for DnBP), MiNP(for DiNP), MEHP, 
MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP (for DEHP), MOP (for DOP), MCHP (for DCHP)], and 
pyrethroid metabolite [3-PBA (for cypermethrin, deltamethrin, and permethrin)]. 
Analytical methods: Pb, Mn, and Cd were measured by GF-AAS. As levels were determined by HG-
AAS with a muffle furnace atomiser. Hg is measured directly using Direct Mercury Analyser 80 
(DMA-80) equipped with a cold vapour generator. Phthalate metabolites were measured using HPLC. 
1-hydroxypyrene and 2-naphthol were measured by HPLC-fluorescence after enzymatic hydrolysis. 
Cotinine was measured by GC-MS. 
Results/Interpretations: Findings from the KorSEP III study have been published as scientific 
articles. Table 35, Table 36 and Table 37 report the findings of KorSEP III (Lee et al., 2012; Lee et al., 
2011; Sul et al., 2012).  
The levels of 1-hydroxypyrene, 2-naphthol, and cotinine were very similar between Korea and 
Germany; however, these levels were slightly higher than the levels in the USA (Sul et al., 2012). The 
levels of phthalate metabolites tended to be higher than the levels found in the USA NHANES survey 
but lower than the levels found in the Germany GerES IV survey. Urinary levels of phthalates were 
observed to be higher among subjects with older age, females, subjects with higher body mass index, 
and subjects with lower income (Lee et al., 2011). The levels of arsenic (particularly inorganic As, 
MMA, and DMA) from this study had been reported to be higher than those from NHANES, GerES, 
and Eastern Europe (Lee et al., 2012).  
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Investigation of exposure sources: Statistical analyses had been performed comparing the levels of 
heavy metals and several lifestyle factors such as fish consumption and smoking, and the higher levels 
of blood Hg and urinary As could be linked by the greater seafood consumption among the Korean 
population. (Lee et al., 2012). In addition, reference values for heavy metals, PAH metabolites, and 
cotinine have been determined and reported (Lee et al., 2012; Sul et al., 2012). 
Policy support: Based on the KorSEP I-III findings, the Ministry of the Environment in Korea 
continued with the survey of Korean residents and conducted the Korea National Environmental 
Health Survey such as the KorEHS-C study (described next in detail). Analysis of the biomonitoring 
data from the Korean population provides useful information regarding one Asian population for use 
in international comparisons in environmental health research and other scientific areas. 
3.7.16.3. Korean Environmental Health Survey in Children and Adolescents (KorEHS-C) 
Initiator/Funding sources/Duration: KorEHS-C is a pilot HBM study initiated at the Dankook 
University in Cheonan, Korea and is financially supported by the Korean NIER. The recruitment 
phase of this study was conducted between December 2011 and May 2012. The exposure analysis was 
reported in June 2013 (Ha et al., 2013). 
Study design: KorEHS-C is a cross-sectional study, which the parents/guardians and children were 
given multiple questionnaires for assessment of environmental exposure, food contamination 
exposure, and health status. Blood and urine samples were collected from the participants for 
measurement of various biomarkers of exposure. 
Study population/Recruitment: From December 2011 to May 2012, a total of 351 children and 
adolescents (199 males and 152 females; age: 6-19) were recruited from Asan (rural) and Incheon 
(industrial) areas for this pilot survey. The schools were selected with the support of the Office of 
Education of each region. Students were asked to participate in the survey, and the teachers distributed 
consent forms and information brochures to the parents/guardians of the students. Those who 
participate would receive a gift voucher of 5,000 KRW (approximately 3.58 €) as an incentive. 
Investigated chemicals/Matrices/Analytical methods: Blood and urine samples were collected from 
each participant. Metals (Pb, Hg, and Cd) were measured in blood. Bisphenol A, cotinine (as a 
biomarker of tobacco smoke exposure), and phthalate metabolites [MnBP (for DnBP), 
MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP (for DEHP)] were measured in urine. Pb and Cd were 
analysed via AAS, and Hg was analysed via CV-AAS. Phthalate metabolites and BPA were measured 
using HPLC-MS/MS. Cotinine levels were determined via ELISA. 
Results/Interpretations/Communication: The levels of metals (Pb, Hg, and Cd) in blood and of 
BPA, phthalate metabolites, and cotinine in urine found in the KorEHS-C study have been reported 
(Ha et al., 2013). The results of this study would be reported to the individual participants and their 
schools after the survey is finished. 
The blood Pb level was significantly higher in male children, children in urban areas, and children 
with less educated parents compared to those of subjects who were female, lived in rural areas, and 
had higher educated parents, respectively. The level of blood lead showed a decreasing (but not 
statistically significant) trend according to increase in age. The geometric mean level of Pb in blood 
was lower than that measured in Korean children (average age=6 years) in 2005 (1.8 µg/dL) or in 
German children (aged 3 to 14) years in 2003-2006 (3.5 µg/dL) but was similar to that of US children 
(aged 6-11) in 2003-2004 (1.25 µg/dL). The decrease in blood lead level with age and the higher 
levels in boys than in girls amongst children are well-known findings. The finding of a higher level of 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 94 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
blood lead in children with lower SES is also consistent with the findings in German children, US 
children, and Korean adults. 
The blood Cd and Hg levels were not different between gender and area of residence after adjustment 
for covariates. In the higher cotinine group, the levels of Cd and Hg were higher than in the lower 
cotinine group. The Cd and Hg levels also increased with age. The median levels of Cd and Hg in 
blood were much higher than those of subjects in Germany and US. The main source of exposure to 
Cd and Hg is dietary intake in Korea. Rice accounts for about 23% of the total daily Cd intake, and the 
rest comes from seafood and vegetables. The main source of organic Hg is fish consumption, and most 
people in the Korean peninsula eat fish frequently. 
Urinary median levels of BPA were lower than those in Germany and the US while those of phthalate 
metabolites were generally similar to levels in those countries. The level of BPA was the highest in the 
youngest children and the second highest in the oldest group, which is a similar finding in other 
countries. The BPA level was higher in groups with higher cotinine level than in groups with lower 
cotinine level in the current subjects, although there was no statistical significance. 
All three kinds of phthalate metabolites showed significant decreasing trends with age even after 
adjustment for covariates. Significant decreasing trends in metabolites of phthalates by increasing age 
are consistent findings in Germany and in the US. In urban areas, the level of MEHHP was 
significantly higher than in rural areas. 
The level of urinary cotinine was the lowest in middle school students while the highest levels were 
found in high school students. Thirty-nine students (17%) were reported to be active smokers, which 
29 of them (74%) are high school students. The level of cotinine was significantly higher in children 
and adolescents whose parental educational level was lower. Parental educational level was reported 
as a good index of the socioeconomic position of Korean children as there was a relationship between 
parental education level and unequal environmental exposure to tobacco smoking and health 
inequality (Ha et al., 2013). 
Investigation of exposure sources: The KorEHS-C research group intends to use this observed data 
(Phase 1) and proceed to Phase 2 of the study, which is to conduct an in-depth investigation to indicate 
the major exposure routes and to study the relationship between certain hazardous environmental 
factors and health outcomes, particularly in the high-risk target groups. 
Policy support: The Environmental Health Act (EHA), implemented on March 22, 2009, requires 
special regulations and countermeasures in order to reduce and prevent environmental exposure in the 
“Susceptible Population,” namely pregnant women and children, including infants and toddlers and 
calls for the generation of scientific evidence (Articles 14 and 15 of the EHA). The prevention and 
eradication of environment-related diseases is the main goal of the environmental sector among 
various government-designated policy goals of the current administration (Ha et al., 2013). KorEHS-C 
could help support the EHA and supply scientific data of environmental exposure among children in 
Korea. 
3.7.16.4 . The Mothers and Children’s Environmental Health (MOCEH) Study 
Initiator/Funding sources/Duration: The MOCEH study started as an initiative of the National 
Environmental Health Action Plan (NEHAP), developed by the Korea Ministry of Environment, and it 
is funded by the Ministry of Environment (Kim et al., 2009). The recruitment for the MOCEH study 
began in 2006 and continued until 2010. The researchers intend to perform follow-up studies on the 
children up to 5 years of age. 
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Study design: The MOCEH study is a prospective hospital- and community-based cohort study 
designed to investigate the effects of pre- and postnatal environmental exposures on growth, 
development, and health from early foetal life into young adulthood. A questionnaire is administered 
to collect socio-demographic information, relevant data about the subject’s biological, medical, and 
obstetric history, information regarding drug usage, vaccinations, or complications during pregnancy, 
breastfeeding, nutrition, and environmental exposure. The air quality inside and outside of each 
participant’s home is assessed. Maternal blood is collected at 20 weeks of gestation. At birth, cord 
blood and a piece of umbilical cord are collected. Blood samples are not taken from the children until 
they are 3 years of age. Urine samples are collected from the mother at less than 20 weeks of gestation 
and from the child at 6, 12, 24, 36 months, and 5 years of age. Breast milk sample is taken at the end 
of the first feeding on the third day of delivery. Also, dietary information is collected from the mother 
prior and during pregnancy. Every 6 months after birth, mothers are asked about their child’s diet 
during a 48h recall interview. A FFQ will be administered when the children are 3 and 5 years of age. 
Assessment of outcome (i.e. birth outcomes, growth and development, neurocognitive development, 
and allergies/asthma in children) would be conducted (Kim et al., 2009). 
Study population/Recruitment: A total of 1,209 mothers (and 1,169 fathers) were recruited between 
2006 and 2010 from the following different communities: (1) metropolitan Seoul, (2) industrial Ulsan, 
and (3) medium-sized urban Cheonan. Mothers who plan to move out of the residential areas of 
interest within 1 year from the date of screening and who are cognitively impaired are excluded from 
the study (Kim et al., 2009). Pregnant women in their first trimester were approached for recruitment 
at obstetric clinics in Seoul, Cheonan, and Ulsan. Eligible women were invited to participate through 
posters on the walls of the clinics and by examining obstetric doctors. 
Investigated chemicals/Matrices/Analytical methods: Maternal and cord blood, urine, and breast 
milk samples from mothers as well as blood and urine samples from children were collected. 
Bisphenol A, cotinine (as a biomarker of tobacco smoke exposure), PAH metabolites [1-
Hydroxypyrene (for pyrene), 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], and phthalate 
metabolites [MnBP (for DnBP), MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP (for DEHP)] were 
measured in the urine. Metals (Pb, Hg, and Cd) were measured in the blood. Pb and Cd were analysed 
via AAS, and Hg was analysed via CV-AAS. Phthalate metabolites were measured using HPLC-
MS/MS. PAH metabolites were analysed by HPLC-fluorescence detection. BPA was measured by 
HPLC-isotope dilution-MS/MS. 
Results/Interpretations: A number of findings from the MOCEH Study has been published as peer-
reviewed scientific articles and summarised below. 
Phthalates metabolites: The association between prenatal phthalate exposure and the Mental and 
Psychomotor Developmental Indices (MDI and PDI, respectively) of the Bayley Scales of Infant 
Development was explored. MDI was inversely associated with the natural log concentrations of 
MEHHP and MEOHP, and PDI was inversely associated with MEHHP. In males, MDI was inversely 
associated with MEHHP, MEOHP, and MBP; PDI was inversely associated with MEHHP, MEOHP, 
and MBP. No significant linear associations were observed for females. The results suggest that 
prenatal exposure to phthalates may be inversely associated with the MDI and PDI of infants, 
particularly males, at 6 months.” (Kim et al., 2011b) 
PAH metabolites: Urinary levels of 2-naphthol, 1-hydroxypyrene, and malondialdehyde (MDA; a 
biomarker of oxidative stress) were analysed in 715 pregnant women at 12–28 weeks of gestation. The 
dietary antioxidant intake during pregnancy was estimated using the 24-h recall method. Urinary 
MDA level was positively correlated with the 2-naphthol and 1-hydroxypyrene levels. Urinary 1-
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hydroxypyrene level was positively associated with the MDA level, which only existed in pregnant 
women with either low fruit and vegetable or vitamin C intake. These results suggest that an adequate 
maternal intake of fruit, vegetables and vitamin C is beneficial to the defence against the oxidative 
stress associated with exposure to PAHs in pregnant women.” (Kim et al., 2011a) 
BPA: Urinary BPA concentrations were shown to be higher in women with a higher income level. 
Univariate regression analysis revealed a significant association between BPA levels and birth weight. 
This relationship was more pronounced in male neonates. Also, prenatal exposure to BPA was 
associated with an increase of ponderal index in total, especially in female neonates (Lee et al., 2014). 
Metals (Cd, Pb, and Hg): The blood Pb and Cd levels were measured in 884 mothers during their 
early and late pregnancy. The geometric mean of the maternal blood concentration was 1.36 mg/dL 
[90
th
 percentile (P90) = 2.13; range = 0.26–9.10] for Pb and 1.42 mg/L (P90 = 2.16; range = 0.03–
9.87) for Cd during the early pregnancy period and 1.27 mg/dL (P90 = 2.10; range = 0.12–4.28) for Pb 
and 1.52 mg/L for Cd (P90 = 2.10; range = 0.43–3.73) during the late pregnancy period. The prenatal 
Pb and Cd concentrations during the early pregnancy period showed no association with the adjusted 
MDI or PDI scores. The Pb levels during the late pregnancy period were inversely associated with the 
MDI score but not with the PDI score. The prenatal Cd levels during the late pregnancy period showed 
no association with the MDI or PDI score. These results suggest that there is a synergistic effect 
modification between Pb and Cd during the late pregnancy period. These findings suggest that there is 
dose-dependent interaction between prenatal exposure to Pb and prenatal exposure to Cd (Kim et al., 
2013b). 
Blood Hg data was analysed based on serum folate status at two gestational time points (mid and late 
pregnancy, n = 1105 and 841, respectively), and a negative association between serum folate and 
blood Hg concentrations in pregnant Korean women was found (Kim et al., 2013a). 
Policy support: The MOCEH Study Group established a database of longitudinal measures and a 
repository of both environmental and biological specimens that would allow future assessments to 
address important issues concerning clinical and public health outcomes.  
3.7.17. Japan 
3.7.17.1. The Tohoku Study of Child Development 
Initiator/Funding source: This study began at the Tohoku University in Sendai, Japan and was 
supported by several grants from the Japan Ministry of Health, Labour and Welfare, from the Ministry 
of Education, Culture, Sports, Science and Technology, from the Japan Public Health Association, and 
from the Ministry of the Environment (Nakai et al., 2009). 
Study design/Duration: The Tohoku Study was a perspective cohort study investigating the effects of 
perinatal exposures to methyl mercury and POPs on neurobehavioral development among Japanese 
children. The recruitment period occurred between January 2001 and September 2003. The latest 
findings of this study were reported in 2010. 
Study population/Recruitment: A total of 687 healthy pregnant women were recruited in Sendai, 
Japan between January 2001 to September 2003, and after recruitment, 599 eligible mother-neonate 
pairs (e.g. no in vitro fertilisation, no severe diseases or abnormalities from both the mother and infant, 
etc.) were registered in the cohort study (Nakai et al., 2004). Healthy pregnant women were recruited 
at the obstetrical wards of two hospitals in Sendai with their informed consent. 
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The participants were given several types of questionnaires to acquire the following information: 
educational background, occupation, income, smoking habit, alcohol consumption, hair treatments, 
dental treatment, and importantly, fish/seafood intake and nutrition status. For food intake, a detailed 
FFQ (e.g. amounts of consumption of 13 seafood types) was given to the participants, see (Suzuki et 
al., 2010) for a more detailed description. 
Blood samples were collected from the mothers at 28 weeks of pregnancy. Blood samples from the 
umbilical cord, placenta, and the cord tissue were collected after the delivery. Hair samples were also 
collected from the mothers after delivery, and breast milk samples were collected one month after 
delivery. Neurodevelopment assessment (e.g. Bayley Scale of Infant Development, the Kyoto Scale of 
Psychological Development, and the Fagan Test of Infant Intelligence) on children was performed.  
Investigated chemicals/Matrices: Maternal blood, cord blood, placenta, breast milk, and maternal 
hair samples were collected, and the following substances were measured: bisphenol A, dioxins 
(1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-
OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 
1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-
OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF), metals (Cd, Pb, Hg/MeHg, Se), 
organochlorine pesticides (Dieldrin, Heptachlor epoxide, p,p’-DDT, p,p’-DDE as a metabolite of 
DDT, trans-Nonachlor, HCB, β-HCH, Mirex), and PCBs (all 209 PCB congeners). 
Analytical methods: Cd and Pb were determined by GF-AAS and ICP-MS, respectively. Total Hg 
was measured via CV-AAS followed by GC-ECD. Level of Se was measured fluorometrically. PCBs 
were analysed by HRGC/HRMS using the isotope dilution method. Dioxins were assessed using the 
Chemically Activated LUciferase gene eXpression (CALUX) assay, which uses a patented 
recombinant mouse cell line that contains luciferase reporter gene under the control of dioxin-
responsive elements. The amount of light generated by the luciferase is directly related to dioxin TEQ 
value. 
Results/Interpretations: Several findings from the Tohoku Study have been published as peer-
reviewed scientific articles (Nakamura et al., 2008; Suzuki et al., 2010). Total Hg reported in maternal 
hair and detectable levels of dioxins, furans, and PCBs in breast milk, maternal blood, and cord blood 
have been reported in several scientific articles (Suzuki et al., 2010). A negative relationship between 
the maternal hair mercury level (median, 1.96 μg/g) and the motor cluster of Neonatal Behavioural 
Assessment Scale was observed. The ∑PCB level in cord blood (45.5 ng/g-lipid) was negatively 
correlated with the motor cluster, but this association was attenuated after adjusting for mercury and 
the confounders. Briefly, prenatal exposure to MeHg adversely affects neonatal neurobehavioral 
function, but the neurobehavioral effect of prenatal exposure to PCBs remains unclear (Suzuki et al., 
2010). 
The concentrations of PCDD/DFs, DL-PCBs, and PCBs in breast milk, maternal blood and cord 
blood, obtained from the participants registered in a birth cohort study in Tohoku, Japan, were 
measured. The PCBs concentrations were in the order of breast milk > maternal blood > cord blood. 
TEQ concentrations and PCBs were negatively associated with parity, and maternal age was positively 
associated with PCBs. However, the associations with BMI and fish intake during pregnancy were not 
significant. The results suggest that parity is an important factor affecting the concentrations of dioxins 
and PCBs in these specimens (Nakamura et al., 2008). 
Investigation of exposure sources/Reference values: Several studies have associated the exposure of 
methyl mercury and PCBs to fish consumption (Iwasaki et al., 2003; Mato et al., 2007). According to 
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the 2002 Annual Report on Health and Welfare from the Japan Ministry of Health, Labour and 
Welfare, more than 80% of dioxin exposure comes from consumption of fish and shellfish. No 
reference value has been reported in this study. 
Investigation of exposure sources/Policy support: The Tohoku Study offers some of the first reports 
on the neurobehavioral effects of prenatal exposure to methyl mercury and PCBs in Japanese 
neonates. These findings could address some of the questions policy makers might have regarding 
health effects from exposure to methyl mercury and other substances. 
3.7.17.2. The Hokkaido Study on Environment and Children’s Health 
Initiator/Funding sources/Duration: The Hokkaido Study began at the Hokkaido University in 
Sapporo, Japan and was supported by several grants from the Japan Ministry of Health, Labour and 
Welfare, from the Ministry of Education, Culture, Sports, Science and Technology, and from the 
Japan Society for the Promotion of Science (Kishi et al., 2011). It began in 2002 and is currently 
ongoing. 
Study design: Two perspective cohort studies are conducted: the Toho hospital cohort with one 
obstetric hospital in Sapporo and the Hokkaido large-scale cohort with 37 hospitals and clinics in 
Hokkaido prefecture. In the Toho cohort, a baseline questionnaire was given to obtain information 
regarding demographics, dietary habits, and chemical exposure in the daily life, as well as alcohol 
consumption, caffeine intake, and income. Medical records regarding pregnancy and birth were 
obtained. Maternal blood samples were collected during late pregnancy stage, and cord blood and 
placenta were taken immediately after birth. Maternal hair samples were collected within 5 days after 
delivery, and breast milk from mothers was collected within 4 weeks after birth. Chemical exposure 
analysis was conducted, and the neurodevelopment in the children was assessed. A follow-up 
questionnaire was used at 18, 42, and 84 months of age to obtain information regarding allergy 
prevalence, dietary habits, and smoking history of mother and father. In the Hokkaido large-scale 
cohort, a baseline questionnaire was given to obtain information regarding demographics, medical 
history, and dietary supplement intake during pregnancy, as well as chemical exposure at work. Birth 
records were obtained from the responsible obstetricians. Maternal blood samples were collected three 
times: between 6-14 weeks of gestation, during the third trimester, and at delivery. Maternal serum 
samples were tested for folic acid level and plasma cotinine concentration. Cord blood was taken 
immediately after birth. Follow-up questionnaires were given at 4, 12, 24, and 48 months to obtain 
information vaccination history, dietary habits, parental smoking history, and allergy prevalence 
(Kishi et al., 2011). 
Study population/Recruitment: The recruitment for the Toho hospital cohort was conducted from 
July 2002 to October 2005. The Toho cohort recruited participating pregnant women who intended to 
deliver at the Toho hospital. Of 1796 potentially eligible women, 514 agreed to participate. The 
subjects were women who enrolled at 23–35 weeks of gestation and delivered at the Toho hospital. All 
the subjects were resident in Sapporo City or surrounding areas. The Hokkaido large-scale cohort 
recruited participating women in early pregnancy (<13 weeks of gestational age) that visited one of 
associated hospitals or clinics in the study area for prenatal health care at the maternity unit. From 
February 2003 to the end of 2009, 16,306 mothers were registered in this cohort. These two cohorts 
did not show significant differences in the characteristics of mothers and infants, and both cohorts will 
follow its participants up to school age. 
Investigated chemicals/Matrices: Maternal blood, cord blood, breast milk, and maternal hair samples 
were collected for analysis, and the following substances were measured: bisphenol A, cotinine (as a 
biomarker of tobacco smoke exposure), dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 
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1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), 
fluorocarbons (PFOA, PFOS), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-
HxCDF, 1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-OCDF, 
1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF), metals (Cd, Pb, MeHg), PCBs (PCB 77, 81, 126, 
169, 105, 114, 118, 123, 156, 157, 167, 189), and phthalate metabolites (MEHP, MEHHP/5OH-
MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP for DEHP). Additional biochemical measurements 
were also analysed (Kishi et al., 2011). 
Analytical methods: The levels of PCDDs/PCDFs and PCBs in maternal blood and breast milk were 
measured using HRGC/HRMS. PFOS and PFOA levels in maternal blood, cord blood and breast milk 
were analysed by LC-MS/MS. Total Hg levels in maternal hair samples were measured by oxygen 
combustion-gold amalgamation using atomic absorption detection. Maternal serum cotinine 
concentration in maternal blood was measured using an ELISA. 
Results/Interpretations/Communication: PFOS & PFOA concentrations in maternal serum, cotinine 
concentrations in plasma, and PCDD, PCDF, and PCB concentrations in maternal blood from the 
Hokkaido Study have been published as peer-reviewed scientific articles. All collected source data are 
maintained and stored at the Department of Public Health Sciences at Hokkaido University. Inquiries 
could be made by contacting the primary investigator, Dr. Reiko Kishi.  
Among male infants, significant adverse associations with birth weight were found for total PCDDs 
TEQ level, total PCDDs/PCDFs TEQ level, and total TEQ level. However, among female infants, 
these significant adverse associations were not found. With regard to individual congeners of 
PCDDs/PCDFs and DL-PCBs, we found significantly negative association with the levels of 2,3,4,7,8-
PeCDF. This suggests that prenatal low-level exposure to PCDDs and PCDFs, especially 2,3,4,7,8-
PeCDF, may result in lower birth weight (Konishi et al., 2009). 
The associations between the total or individual PCB levels and dioxins in 134 Japanese pregnant 
women's peripheral blood and the mental or motor development of their 6-month-old infants were 
evaluated using the second edition of the Bayley Scales of Infant Development. The mean level of 
total TEQ was 18.8 (4.0-51.2) pg/g lipid in the blood. After adjustment for potential confounding 
variables, the total TEQ value was shown not to be significantly associated with MDI or PDI. 
However, the levels of 1 PCDD isomer, total PCDDs, and total PCDDs/ PCDFs were significantly 
negatively associated with MDI, and the levels of 2 PCDDs and 3 PCDFs were significantly 
negatively associated with the PDI. The background exposure of several dioxin isomers during the 
prenatal period might affect the motor development of 6-month-old infants (Nakajima et al., 2006). 
Higher levels of PCDFs were associated with a significantly increased risk of otitis media, especially 
among male infants. Higher levels of 2,3,4,7,8-PeCDF were also associated with a significantly 
increased risk of otitis media. However, there was a weak association between dioxin-like compound 
levels and allergic symptoms in infancy. At environmental levels, prenatal exposure to dioxin-like 
compounds may alter immune function and increase the risk of infections in infancy, especially among 
males (Miyashita et al., 2011). 
PFOS levels were negatively correlated with birth weight. In addition, analyses stratified by sex 
revealed that PFOS levels negatively correlated with birth weight only in female infants. However, no 
correlation between PFOA levels and birth weight was observed. This indicates that in utero exposure 
to relatively low levels of PFOS was negatively correlated with birth weight (Washino et al., 2009). 
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The exposure source of serum cotinine was investigated among smokers, smoke-exposed non-
smokers, and unexposed non-smokers. Based on self-reports, the 5,128 pregnant women were 
classified into three groups: 650 smokers, 728 ex-smokers and 3750 non-smokers, and cotinine levels 
in maternal blood samples were analysed. Using the receiver operating characteristic curve, plasma 
cotinine cut-off value of 11.48 ng/mL was established for separating smokers from non-smokers, 
resulting in a smoking prevalence of 14%. A cotinine cut-off value of 0.21 ng/mL for discriminating 
exposed and unexposed non-smokers resulted in a 63% prevalence of exposure to tobacco smoke 
among non-smokers. Cotinine biomarker analysis proved accurate in validating self-reported smoking 
information in the subjects. Lower validity of SHS exposure suggests a need to confirm questionnaire 
information with biochemical analysis (Sasaki et al., 2011). 
Policy support: The Hokkaido Study provides findings that could address some of the questions 
policy makers might have regarding health effects from exposure to POPs in mothers and children. 
3.7.17.3. Japan Environmental and Children’s Study (JECS) 
Initiator/Funding source: The Japan Advisory Board on Children’s Environmental Health, 
established by the Ministry of the Environment (MOE), proposed a large-scale birth cohort study in 
order to evaluate the effects of environmental chemicals on children’s health and development. In 
April 2008, the Working Group of the Epidemiological Research for Children’s Environmental Health 
(later JECS Working Group) was organized and started systematic reviews on existing 
epidemiological findings regarding health impact of chemical exposures and the roles of potential 
confounders and effect modifiers, such as other environmental factors, genetic factors, socioeconomic 
status and lifestyle, in order to develop JECS study design and hypotheses. In March 2010, JECS 
Working Group published a draft conceptual plan for a large-scale birth cohort study covering all of 
Japan. The budget for conducting JECS was approved in 2010, and JECS was launched in April 2010 
(Kawamoto et al., 2014). 
Study design/Duration: JECS is a nation-wide large-scale perspective cohort study. Recruitment 
period started in January 2011 and ended in March 2014. Environmental exposure analysis began after 
recruitment period and is currently an ongoing process. Participating children will be followed until 
they reach 13 years of age. The JECS is expected to continue until 2032, five years after all the 
participating children reach 13 years of age, allowing through data analysis. Self-administered 
questionnaires were given to recruited expecting mothers to obtain information regarding 
socioeconomic status, lifestyle factors, and physical environment. Medical records from the expecting 
mothers are to be obtained. Maternal blood and urine samples are to be collected during the first and 
second trimesters while the partners’ blood samples are to be collected only once. At birth, maternal 
hair and blood samples as well as the cord blood and child’s dried blood spot are to be collected. One 
month after birth, a follow-up questionnaire will be answered, and samples of breast milk from the 
mothers are to be collected. Thereafter, questionnaires are sent out every 6 months. Pending on 
approval from the Ethics committee, blood and urine samples of selected children will begin when 
they reach 2 years of age (Kawamoto et al., 2014). 
Study population/Recruitment: The Center for JECS makes contact with as many expecting mothers 
who reside in the study areas as possible. Either or both of the recruitment protocols are applied: 1) 
recruitment at the time of first prenatal examination at cooperating health care providers and/or 2) 
recruitment at local government offices issuing pregnancy journals, namely Mother-Child Health 
Handbooks. Due to the nature of recruitment at health care providers or local government facilities, 
the recruitment process is not completely random. Therefore, the Center for JECS attempts to recruit 
as many eligible expecting mothers in the study areas as possible. The eligibility criteria for 
participants (expecting mothers) are as follows: 1) They should reside in the study areas at the time of 
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the recruitment and are expected to reside continually in Japan for the foreseeable future, 2) expected 
delivery date should be between 1 August 2011 and mid-2014, and 3) they should be capable to 
participate in the study without difficulty. A total of 100,000 pregnant women is the targeted number 
of enrolment for the study. Partners are also recruited, but their participation is not mandatory. 
Recruitment period was between January 2011 and March 2014. To ensure generalizability and ability 
to extrapolate the results to the Japanese population, 15 Regional Centers are selected to cover diverse 
geographical areas within Japan (Kawamoto et al., 2014). 
Investigated chemicals/Matrices: Blood (maternal, cord, and possibly children) and urine (maternal 
and possibly children) samples will be tested for various substances. JECS intends to analyse the 
following substances: acrylamide, BFRs (PBDE 17, 28, 47, 66, 85, 99, 100, 119, 126, 153, 154, 183, 
196, 197, BDE 209, HBCDDs, TBBPA, 2,4,6-TBP, HBB, PBB153), bisphenol A, chlorophenols 
(2,4-DCP, 2,5-DCP, 2,4,5-DCP, 2,4,6-DCP, PCP), cotinine (as a biomarker of tobacco smoke 
exposure), dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-
HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), fluorocarbons (PFNA, PFOA, 
PFOS), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 
1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 
2,3,7,8-TCDF), herbicides (2,4-D, 2,4,5-T), metals (As, Cd, Pb, Hg), organochlorine pesticides 
(Aldrin, Dieldrin, Endrin, Heptachlor, o,p’-DDT, p,p’-DDT, DDE as a metabolite of DDT, 
Oxychlordane, HCB, α-HCH, β-HCH, γ-HCH, Mirex), organophosphate pesticides (Acephate, 
Methamidophos), organophosphate metabolites [DEP, DMP, DETP, DMTP, DEDTP, DMDTP (for 
DAP)], PAH metabolites [3-Hydroxybenzo[a]pyrene (for benzo[a]pyrene), 2-Hydroxyfluorene, 3-
Hydroxyfluorene, 9-Hydroxyfluorene (for fluorene), 1-Hydroxyphenanthrene, 2-
Hydroxyphenanthrene, 3-Hydroxyphenanthrene, 4-Hydroxyphenanthrene, 9-Hydroxyphenanthrene, 4-
Phenanthrene (for phenanthrene), 1-Hydroxypyrene (for pyrene), 1-Hydroxynaphthalene (1-
Naphthol), 2-Hydroxynaphthalene (2-Naphthol) (for naphthalene)], PCBs (PCB 28, 44, 49, 52, 66, 74, 
77, 81, 87, 99, 101, 105, 110, 114, 118, 123, 126, 128, 138, 146, 149, 151, 153, 156, 157, 167, 169, 
170, 172, 177, 178, 180, 183, 187, 189, 194, 195, 196, 199, 203, 206, 209), phenols (Butyl paraben, 
Ethyl paraben, Methyl paraben, Propyl paraben, Triclosan), phthalate metabolites [MBzP (for 
BBzP), MiBP (for DiBP), MnBP (for DnBP), MEP (for DEP), MiNP, MCOP (for DiNP), MEHP, 
MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP (for DEHP), MMP (for DMP), 
MOP, MCPP (for DOP), MCHP (for DCHP), MCNP (for DiDP), MHCNH (for DINCH)], and 
pyrethroid metabolites [F-PBA (for cyfluthrin), Br2CA (for deltamethrin), cis-Cl2CA, trans-Cl2CA, 
3-PBA (for cypermethrin, deltamethrin, and permethrin)]. In addition, 8-OHdG is to be measured as a 
biomarker of oxidative DNA damage. The complete list of compounds to be analysed has been 
published (Kawamoto et al., 2014). 
Results/Interpretations/Reference values: As the analysis of the listed chemicals is currently 
ongoing, no results, analytical methods, or reference values has been reported yet. 
Investigation of exposure sources: The JECS intends to conduct some environmental measurements 
(mainly indoor air monitoring) during home visits. Indoor air pollutants, including volatile organic 
compounds, aldehydes, nitrogen oxides, and fine particulate matters will be measured. Other 
parameters such as noise levels, temperature, and humidity will also be recorded. Furthermore, there 
are about 1,500 ambient air quality monitoring stations and about 500 roadside air quality monitoring 
stations throughout Japan, where levels of five classical air pollutants, carbon monoxide, suspended 
particulate matter, sulphur dioxide, nitrogen dioxide, and photochemical oxidants are monitored 
continuously. Twenty other hazardous air pollutants are also monitored at over 300 sights. Exposure to 
classical and hazardous air pollutants will be estimated from the monitoring station data using 
atmospheric simulation models. 
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Communication to participants/scientific community/public: JECS provides information that could 
allow additional adjunct studies from the Japan National Center, Medical Support Center, or Regional 
Centers to be conducted. The Center for JECS expects chemical analysis of bio-specimens to start 
after the completion of the recruitment in early 2014. Reports associating environmental factors and 
birth abnormalities are to be published within the next few years. 
Policy support: JECS aims to provide the foundation for policy making to safeguard the environment 
for the next generations (i.e. children). The ultimate goal of JECS is “to identify environmental factors 
that affect children’s health and development in order to help decision makers design better chemical 
risk management strategies.” 
3.7.18. China (National Monitoring on POPs in human milk of China) 
Initiator/Funding source: This monitoring programme was initiated by the National Institute of 
Nutrition and Food Safety of the Chinese Center for Disease Control and Prevention (China CDC). 
The study was based on the WHO-coordinated Fourth Survey of Breast Milk for Persistent Organic 
Pollutants in cooperation with the UNEP. The study was carried out in conjunction with the 2007 
Chinese Total Diet Study and was financially supported by the National Science and Technology 
Support Programme of China, the National Nature Science Foundation of China, and the Chinese 
Ministry of Health (Li et al., 2009). 
Study design/Duration: This cross-sectional study was developed based on the ‘Guidelines for 
Developing a National Protocol’ of the Fourth WHO-coordinated survey of Human Milk for Persistent 
Organic Pollutants in Cooperation with UNEP with some modifications. The collection period was 
held from July to November 2007, and the latest publication regarding this study was published at the 
beginning of 2012. A written questionnaire was completed to record the content of the face-to-face 
interview for each mother. The information included date of birth, place of birth, residence record, 
dietary habits, consumption of animal-origin food including aquatic food, meat, egg and milk, 
occupation before pregnancy, and the indoor using of DDT at home. According to the questionnaires, 
none of the mothers smoked, and none used DDT in their home. The participating mothers provided 
the samples at the local contact places, where collection was supervised. At least 50 mL of milk was 
collected from each mother. The samples were collected directly to the pre-washed collecting jars and 
were stored at -20°C until analysis. 
Study population/Recruitment: A total of 1,237 primiparous mothers (age range: 18-35; mean: 25.6) 
voluntarily participated in the study, which the collection period occurred during the second half of 
2007. The participants came from 12 provinces (Fujian, Guangxi, Hebei, Heilongjiang, Henan, Hubei, 
Jiangxi, Liaoning, Ningxia, Shanghai, Shanxi, and Sichuan), which accounts for about 50% of the total 
population of China. In each province, one urban site and two rural sites were selected for sampling. In 
each urban area, 50 donors were selected, and in each rural area, 30 donors were selected (Li et al., 
2009). 
Investigated chemicals/Matrices: Breast milk samples were collected and analysed for levels of the 
following substances: BFRs (PBDE 47, 99, 100, 153, 154, 183, HBCDDs, TBBPA), dioxins 
(1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-
OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD), fluorocarbons (PFDeA/PFDA, PFHxS, PFNA, PFOS, 
PFOA, PFUA/PFUdA), furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 
1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 
2,3,4,7,8-PeCDF, 2,3,7,8-TCDF), organochlorine pesticides (Aldrin, Dieldrin, Endrin, Heptachlor, 
Heptachlor epoxide, o,p’-DDT, p,p’-DDT, DDE as a metabolite for DDT, Oxychlordane, trans-
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Nonachlor, HCB, α-HCH, β-HCH, γ-HCH, Mirex), and PCBs (PCB 77, 81, 105, 114, 118, 123, 126, 
156, 157, 167, 169, 189). 
Analytical methods: The pesticide POPs were measured via GC-ECD & GC-LRMS with isotope 
dilution. The marker PCBs were measured by GC-HRMS or GC-LRMS with isotope dilution. The 
PCDDs, PCDFs, and DL-PCBs are analysed by GC-HRMS with isotope dilution. The PBDEs were 
measured by GC-HRMS or GC-LRMS with isotope dilution. PFCs were measured by UPLC-triple 
quadruple mass spectrometry, and HBCD (α, β, γ) were measured by LC-MS/MS with isotope 
dilution. 
Results/Interpretations/Communication: Some of the results have been already published as peer-
reviewed articles and have been presented to the United Nations Environment Programme (Wu). 
The TEQs concentrations (for PCBs and dioxins/furans) of pooled samples in 12 provinces has been 
first published in 2009 (Li et al., 2009). Subsequently, the levels of PFCs (Liu et al., 2010) and of 
various organochlorine pesticides (Zhou et al., 2011) in breast milk samples from China have been 
reported. Positive correlations were found between total-TEQ level in human milk and the 
consumption of aquatic food and meat. However, both the TEQ body burden of the sample population 
and estimated daily TEQ intake of breast-feeding infants were lower than those of developed 
countries. Continuous surveillance on PCDD/Fs and DL-PCBs levels in human milk is needed to 
correctly evaluate both the environmental impact and human health risk in China (Li et al., 2009). 
PFOS and PFOA were the predominant PFCs found in all the samples tested. A large variation in 
geographical distribution was observed for PFCs in human milk. High concentrations of PFOA were 
found in human milk from Shanghai. The estimated dietary intake (EDI) for PFOA (88.4 ng/kg/d) for 
Shanghai was close to the tolerable daily intake (100 ng/kg/d) proposed by the German Federal 
Institute for Risk Assessment and the Drinking Water Commission. The results suggest both mothers 
and infants have a high exposure to PFCs in the Shanghai region. The potential health impact of 
postnatal exposure through breastfeeding to infants should therefore be comprehensively evaluated 
(Liu et al., 2010). 
DDTs were the most prevalent agent of the organochlorine pesticides, followed by HCHs and HCB, 
whereas levels of chlordane compounds, drins and mirex were lower. The relatively lower DDE/DDT 
ratio in the Fujian rural area suggested more recent exposure to DDT than in other areas. The mean 
level of DDTs in breast milk from the southern China was higher than those from northern China (p < 
0.05). A positive correlation was observed between DDT levels in human milk and consumption of 
animal-origin food, suggesting that this parameter could play an important part in influencing 
organochlorine pesticide (OCP) burdens in lactating women. The mean estimated daily intakes of 
different OCPs for breastfed infants were lower than the tolerable daily intake (Zhou et al., 2011). 
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Investigation of exposure sources/Policy support: The China CDC intends to measure the levels of 
pollutants in the food in order to correlate to the HBM results and to evaluate their findings in order to 
set up the national maximum levels of pollutants in food. Therefore, the national food safety standards 
for pollutants could be improved. 
3.7.19. European research programmes including HBM 
Using the European Commission’s Community Research and Development Information Service 
(CORDIS) portal, several European research programs including HBM analyses and information 
about food intake are identified and described below. 
3.7.19.1. Consortium to Perform Human Biomonitoring on an European Scale 
(COPHES)/Demonstration of a Study to Coordinate and Perform Human Biomonitoring on 
an European Scale (DEMOCOPHES) 
Initiator/Funding source: Project no 244237 under FP7 
Duration: 2009-2013 
Study design: In 2009, European scientists and stakeholders from 35 institutions in 27 European 
countries began work towards setting up a European-wide human biomonitoring framework. Funded 
by the EU's Seventh Framework Programme, COPHES developed harmonised protocols allowing the 
collection of comparable HBM data throughout Europe. Its twin project, the feasibility study 
DEMOCOPHES, was launched one year later to test this hypothesis and to gain information on levels 
and major determinants of exposure in Europe as well as to establish protocols for the translation of 
HBM results into concrete policy recommendations. 
Study population/Recruitment: Participants in this study were children aged 6-11 years and their 
mothers aged 45 years and under. Fieldworkers in the participating countries collected hair and urine 
samples from a total of 3688 volunteers, half from urban areas and half from rural areas. Mothers 
provided details via a questionnaire on their living environment, nutrition (mainly exposure-related 
food intake), smoking behaviour, and other information that could help to explain the levels of the 
biomarkers measured in hair and urine. 
Investigated chemicals/Matrices: Using biomarkers and questionnaire data, research teams in 
Belgium, Cyprus, Czech Republic, Denmark, Germany, Hungary, Ireland, Luxembourg, Poland, 
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom studied 
exposure to mercury, cadmium, tobacco smoke, and some phthalates and their possible associations to 
lifestyle. Bisphenol A was added as an additional substance for a group of 6 countries. The national 
teams translated the European common protocol, which describes in detail how to implement the 
study. Without compromising the comparability of the results, small adaptations were allowed to suit 
cultural differences and sometimes specific national needs. Before starting the study, ethics authorities 
in each country approved the necessary documents (Becker et al., 2014; Casteleyn et al., in press; 
Fiddicke et al., 2014). The study measured biomarkers in human hair and urine from around 120 
mother-child pairs in the 17 participating countries, in total almost 4000 samples.  
Analytical methods: The laboratories analysing the samples were selected through a strict quality 
assurance process, comprising Interlaboratory Comparison Investigations (ICI) and External Quality 
Assessment Schemes (EQUAS) which is described by (Esteban et al., 2014; Schindler et al., 2014). 
Some countries such as Denmark extended the basic scenario with supplementary measurements 
(Mørck et al., 2014). 
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Results/Interpretations: COPHES/DEMOCOPHES results demonstrate that harmonisation is 
possible, but further capacity building is needed to establish the networks and infrastructure in EU 
countries. These results are the first step towards EU-wide databases on the distribution of the 
chemical burden in the population, which will allow to follow levels in the population and evaluate the 
effectiveness of regulatory measures such as a ban on certain chemicals or smoking regulations. At the 
same time, improved comparability of European HBM data in the future will allow cross boundary 
evaluation of gradients in human exposure throughout Europe and it will facilitate the elaboration of 
guidance values and the identification of potential high exposure populations or subpopulations and 
may help to target measures. 
Investigation of exposure sources: From the questionnaire filled in by the mothers, sources such as 
food intake, lifestyle and habitation have been identified. External sources have also been surveyed 
(Smolders et al., 2014). 
Reference values: Values found in participating countries could be considered as reference values 
when the limitations of a non-representative sample are taken account. 
Communication to participants/scientific community/public: This is the first time that we have 
information on the distribution of chemicals in 17 EU countries, which are comparable between the 
countries and with international data. Protocol considerations, national and common results are 
published, some in a special volume of Environmental Research. Special emphasis related to policy 
implications of COPHES/DEMOCOPHES has been published (Joas et al., 2014). 
Policy support: DEMOCOPHES was supported by the Life+ program financing 50% of the national 
expenses and the other 50% financed by national authorities. 
3.7.19.2. Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS) 
Initiator/Funding source: Project no 266198 under FP6 and FP7 
Duration: 2005-2013 
Study design: A major approach employed in ECNIS research is the use of biomarkers of 
carcinogenesis. Biomarkers of carcinogenesis are usually substances which can be measured in body 
fluids or tissues and provide information about a person's exposure to carcinogens or about cellular 
damage caused by carcinogens far earlier than the appearance of clinical disease. Furthermore, genetic 
polymorphisms can serve as biomarkers of individual susceptibility to carcinogenesis. ECNIS research 
also addresses the mechanisms by which chemicals alter cellular processes to cause cancer and the 
way in which food components intervene in these mechanisms. It also aims to improve cancer risk 
assessment, and to address important socio-ethical issues arising from the use of biomarker 
technology. 
Study population/Recruitment: The ECNIS Network consisted of 24 partners, which represent a 
multi-disciplinary team of nearly 200 scientists, including toxicologists, epidemiologists, food and 
nutrition scientists, chemists and molecular biologists. Coming from 13 European countries, the 
ECNIS partner institutions represent regions and populations with diverse climates, pollution levels 
and dietary habits, thus providing unique opportunities for the assessment of the impact on cancer risk 
of environmental exposures and dietary patterns over a wide range of variation, and enabling 
population studies on a pan-European scale. This diverse and wide membership also provides 
opportunities for the optimal utilization of the large number of cohorts and human tissue sample banks 
that exists throughout Europe. 
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Investigated chemicals/Matrices: The vision of ECNIS was the creation of a dynamic research 
network which will work to decrease cancer incidence by  
• identifying chemicals or other factors in the environment and food which cause cancer, 
• elucidating the mechanisms by which dietary and lifestyle patterns increase or decrease 
cancer risk,  
• facilitating the development of new foods with cancer-preventive properties,  
• discovering genetic (hereditary) factors which make individuals more or less susceptible to 
cancer, and 
• formulating improved approaches to the risk assessment of carcinogens.  
Analytical methods: ECNIS fostered collaboration between research groups with data on biomarkers 
of exposures to carcinogens and cancer risk. 
Results/Interpretations: The biomarkers have been further validated. 
Investigation of exposure sources: Environmental and occupational exposures as well as lifestyle 
including food intake have been recorded for the study subjects included in the ECNIS database. 
However, the information is at different levels of detail since only the data from the original studies is 
taken into account. 
Reference values: No reference value has been established as the ECNIS overall project is analytical 
and descriptive. 
Communication to participants/scientific community/public: The ECNIS website 
(http://www.ecnis.org/) offers background information to the public. ECNIS hosted a number of 
workshops and issued 7 special reports as well as a high number of scientific publications. Also, help 
desk facilities for ethics approval has been issued. 
Policy support: The ECNIS study has been promoting European HBM as later materialized in the 
COPHES/DEMOCOPHES project. 
3.7.19.3. EnviroGenomarkers – Genomics Biomarkers of Environmental Health 
Initiator/Funding source: Project no 226756 under FP7 
Duration:  2009-2013 
Study design: Small/medium-scale collaborative research project 
Study population/Recruitment: Existing biobanks in Europe and beyond, containing stored 
biosamples from millions subjects, represent an enormous investment and a precious resource for 
environmental health studies. However, the experience with their potential to benefit from –omics 
technologies is very limited to date. By utilising some of Europe’s major existing biobanks and 
including systematic technical validation of the application of –omics on their samples, the 
EnviroGenomarkers project helps open the way to the exploitation of this important resource.  
Investigated chemicals/Matrices: Currently, human biomonitoring is based on the measurement of 
chemicals or their metabolites in human tissues and provides information only on the level of 
population exposure to environmental chemicals. The combination of such data on chemical-specific 
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biomarkers of exposure with –omics data provides the opportunity to link exposure information with 
biological data measured on the same human biosample.  
Analytical methods: The EnviroGenomarkers project, by combining the analysis of human blood 
samples for a number of high-priority chemicals of great interest for population biomonitoring 
programmes with the –omics-based assessment of the same biosamples, is taking a step into the future 
and represents the next day in human biomonitoring activities. 
Results/Interpretations: Omics technologies provide exciting opportunities to develop a new breed 
of biomarkers of environmental health which, in contrast to traditional ones, allow the use of the same 
generic methodology (e.g., microarrays) for the detection of cellular responses to different categories 
of chemicals and types of toxicity and provide mechanistic information at an unprecedented scale. In 
fact the prospect of simultaneously obtaining, in human biosamples, a global picture of the functional 
state of the cell at the levels of DNA, RNA, proteins and metabolites, which can be integrated into a 
holistic view of the perturbation of cellular pathways by the environment, provides a paradigm shift 
for environmental biomarker research and molecular epidemiology.  
Investigation of exposure sources: Environmental and occupational exposures as well as lifestyle 
including food intake have been recorded for the study subjects included in the cohorts. However, the 
information is at different levels of detail since only the data from the original studies is taken into 
account. 
Reference values: EnviroGenomarkers project constitutes an effort in establishing this new paradigm 
of omics and since it is still under development no reference values have been obtained.  
Communication to participants/scientific community/public: Results are being published in 
scientific journals (Chadeau-Hyam et al., 2014) and are displayed on the project’s website 
(http://www.envirogenomarkers.net/). 
Policy support: Omics is considered in a number of EU projects as a tool of holistic exposure 
assessment. 
3.7.19.4. Integrated Assessment of Health Risks from Environmental Stressors in Europe 
(INTARESE) 
Initiator/Funding source: Project under FP6 
Duration:  2005-2010 
Study design: A five-year integrated project 
Study population/Recruitment: The project brought together a team of internationally renowned 
scientists in the areas of epidemiology, environmental science and biosciences to collaborate on 
developing and applying new, integrated approaches to the assessment of environmental health risks 
and consequences, in support of European policy on environmental health. The INTARESE approach 
was based on the principle that environmental health issues are not stand-alone issues but the result of 
interdependent decisions and events and can affect human health in many different interacting ways. 
Investigated chemicals/Matrices: The project describes a number of models taking exposure and 
uptake into account. 
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Analytical methods: Mathematical modelling 
Results/Interpretations: INTARESE achieved its objectives and developed the concept and 
methodology of integrated environmental health impact assessment, produced an extensive series of 
case studies and combined these findings in an on-line Integrated Environmental Health Impact 
Assessment System (IEHIAS), which provides guidance on integrated assessment, gives access to key 
data sources, models and methodologies, a large number of worked examples, and gateways to open 
platforms. 
Investigation of exposure sources: Included in the models 
Reference values: Not applicable as the project has only developed models. 
Communication to participants/scientific community/public: More information about the project 
can be found on the INTARESE’s website (http://www.intarese.org/). A series of Technical Briefs was 
published to provide more specific information on the different aspects and approaches taken as well 
as the achievements of the project. 
3.7.19.5. Expert Team to Support Biomonitoring in Europe (ESBIO) 
Initiator/Funding source: Project no 22580 under FP6 
Duration:  2005-2008 
Study design: The research team created an extended inventory of European HBM activities, past and 
present, incorporating self-registration and including information relevant to researchers and 
stakeholders alike. In addition, the investigators focused on rules and practices related to ethical 
conduct, providing recommendations regarding protocols, biobanking issues, special concerns with 
respect to the participation of children and harmonisation of overall procedures on a European level. 
 
Finally, the team provided an Excel tool for socioeconomic optimisation of future HBM projects 
providing the total necessary project budget based on user inputs. 
Study population/Recruitment: Data included people and laboratories involved in certain projects 
and entities with expertise in specific analytical areas. 
Investigated chemicals/Matrices/Reference values: A number of chemicals and matrices were 
represented with reference to the included studies, investigating different exposures and in different 
setups, primarily focused on children. No reference values could be stated. 
Communication to participants/scientific community/public: A number of reports and publications 
were issued. 
Policy support: In summary, the ESBIO project made significant progress in developing protocols 
and tools for coordinating HBM research efforts on a European level, in particular as related to 
children. Better coordination among EU countries has the potential to elucidate important findings that 
might otherwise be buried without shared data and shared methods, resulting in better health for EU 
citizens via more effective policies and regulations. 
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3.7.19.6. Public Health Impact of Long-Term, Low-Level Mixed Element Exposure in Susceptible 
Population Strata (PHIME) 
Initiator/Funding source: Project no 244237 under FP6 
Duration:  2006-2011 
Study design: PHIME had 39 partners in 22 countries, mainly in Europe but also in Morocco, 
Ecuador, China, the Seychelles, and Bangladesh. 
The background was a renewed interest in toxic metals, due to a growing awareness that the exposure 
in the general population in Europe and elsewhere is at levels with potential to cause toxic effects in 
susceptible individuals. Such exposures may have a role in the aetiology of common clinical diseases, 
as well as sub-clinical effects, which may be serious for the society. The impact of toxic metal 
(particularly cadmium, mercury, lead and manganese) exposure through foods on diseases of public 
health concern (nervous and cardiovascular systems, osteoporosis/fractures, kidneys, diabetes) was 
studied. Benefits of exposures to essential elements (selenium, zinc)/other dietary components (fatty 
acids, fibre), and some aspects of risk/benefit relationships have been described. 
Study population/Recruitment: Some studies utilize unique biobank material. Occupational 
exposures were studied as models. Mother-child cohorts were also included. 
Investigated chemicals/Matrices: From mother-new-born pairs, maternal hair, cord blood, maternal 
and child’s urine, or meconium was collected at birth. Rarely, breast milk samples at 3-6 months post-
delivery were collected.   
Analytical methods: Analyses were only performed centrally to assure comparability. 
Results/Interpretations: A wealth of important, novel information was produced. For example, the 
exposure to lead and cadmium seems to be fairly similar in many European countries, with the 
exception of particularly polluted areas. The exposure to mercury differs, according to varying fish 
intake and dental practice. The exposure to lead and mercury is decreasing, while cadmium does not 
show such a favourable time trend. The tissue concentrations of "catalytic converter elements" 
platinum, palladium and rhodium are much lower than previously thought. 
The toxic effects of methylmercury in fish on the central nervous system of foetuses and on the 
myocardium of adults are markedly modified by nutrition, notably intake of long-chain n-3 
polyunsaturated fatty acids, which also occurs mainly through fish. Arsenic and manganese, ingested 
mainly through drinking water and food, affect development and health of foetuses, infants and 
children. Lead exposure is toxic to children’s central nervous system at very low exposures. 
Data cast doubt on the urinary excretion of low-molecular weight proteins as a biomarker of cadmium 
risk to the kidney at low exposure, but, at the same time, there is now evidence of low-level cadmium 
exposure causing toxic bone effects, with decrease of bone mineral density, increase of osteoporosis 
and fractures. Preventive actions against cadmium urgently are needed, in light of the continuous 
exposure world-wide. 
Gene-environment interaction is important in metal toxicity. Thus, the metabolism (toxicokinetics) of 
mercury, arsenic, lead and cadmium was shown to be modified by genetics, as is toxicodynamics of 
arsenic, lead, cadmium and manganese. This should be considered in risk assessment, as the risk may 
vary between individuals, and between populations with different gene frequencies. 
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Investigation of exposure sources: The exposure sources were identified through questionnaires. 
Reference values: Background levels of the analysed metals from different study populations have 
been established. 
Communication to participants/scientific community/public: Information about PHIME can be 
found online (http://www.med.lu.se/labmedlund/amm/forskning/haelsorisker_av_metaller/phime). A 
number of workshops have been arranged, and the project has a large publication record. 
Policy support: Taken together, the scientific results contributed by PHIME have brought new, 
important insights to the health impact from metals, as a basis for risk assessment and prevention. 
3.7.19.7. Newborns and Genotoxic Exposure Risks (NewGeneris) 
Initiator/Funding source: Project under FP6 
Duration:  2005-2010 
Study design: Integrated project 
Study population/Recruitment: NewGeneris, with more than a hundred researchers from 25 
European Institutions, studied approximately 2,000 pregnant women located in five European cohorts 
- UK (BiB), Spain (INMA), Denmark (DKbiobank), Norway (BraMijlo/BraMat), Greece (Rhea), 
collecting information on their diet and associated intake of toxic chemicals of interest, measuring 
changes (“biomarkers”) which reflect exposure to such chemicals or their early biological effects, in 
both the blood of the mothers and of the foetus (umbilical cord blood collected at delivery). The 
project also collected information on birth outcomes (e.g. length of gestation, weight, head 
circumference and other physical characteristics of the baby at birth). A genome-wide association 
study (GWAS) on genetic variation was conducted to look for associations between specific mutations 
and the biomarkers or birth effects being measured. 
Investigated chemicals/Matrices: Blood samples from newborns (cord blood) and their mothers were 
collected at birth and processed for further analysis. Following classes of chemicals have been 
investigated: acrylamide, alcohol, dioxins, DNA reactive aldehydes, heterocyclic amines, 
mycotoxins (aflatoxin and deoxynivalenol), nitrosamines, PAHs such as benzo[a]pyrene, and PCBs. 
Analytical methods: Red blood cells were analyses for haemoglobin adducts of acrylamide, 
glycidamide and ethylene oxide. Micronuclei was analysed in lymphocytes. DNA was extracted from 
white blood cells and analysed for PAH adducts and plasma was analysed for compounds with dioxin-
like activity. 
Results/Interpretations: Main achievements of NewGeneris include the following: 
1. Establishment of new mother-child cohorts and subcohorts 
2. Construction of a database on dietary intakes, biomarkers of exposure and effect, and birth 
outcomes with data of more than 2000 mother-child pairs 
3. Development of methodology for assessment of dietary exposure of pregnant women to 
chemicals from FFQs, characterisation of geographic variation of intakes and main dietary 
sources of exposure in European regions 
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4. Measurement of biomarkers of exposure and/or early effects (DNA adducts and oxidative 
damage, gene expression profiles, micronuclei, proteomics) in approx. 1200 mother-child 
pairs 
5. Genome-wide SNP analysis on approx. 780 cord blood samples 
6. In vitro studies of a) placental perfusion and b) effects on sperm 
7. Integrative evaluation of the above data for exposure-biomarker-effect relationships 
Investigation of exposure sources: Questionnaires including FFQ gave estimates of exposures to 
compounds such as acrylamide, dioxins, and nitrose compounds. 
Reference values: Background levels in the five countries involved have been reported. 
Communication to participants/scientific community/public: Information about NewGeneris can 
be found online (http://www.newgeneris.org/). A number of workshops were hosted with reports, and 
scientific publications are still being issued. The first overall analysis has been published as a scientific 
article (Pedersen et al., 2012). 
Policy support: NewGeneris developed ethical practices to handle personal data and samples with 
strict rules (ethical permits, information sheets, informed consent) according to European standards. 
3.7.19.8. EXPOsOMICs 
Initiator/Funding source: EU-funded Project under FP 7 
Duration:  2013-2018 
Study design: This integrated project will provide better understanding by developing a personal 
exposure monitoring (PEM) system (including sensors, smartphones, geo-referencing, 
satellites) and collect data on individual external exposome as well as analysing biological 
samples (internal markers of external exposures) using multiple “omics” technologies. The 
search for relationships between external exposures (as measured by PEM, which has not 
previously been used in large scale studies) and global profiles of molecular features (as 
measured by omics) in the same individuals constitutes a novel advance towards the 
development of "next generation exposure assessment" for environmental chemicals and their 
mixtures. The linkage with disease risks opens the way to what are defined here as ‘exposome -
wide association studies’ (EWAS). 
DBPs in air and water and/or in biological samples such as exhaled breath (e.g. 
trihalomethanes) and urine (haloacetic acids) from study subjects have been examined. In 
addition to exposure measurements that include toxicity tests in water samples, bio -samples 
will be collected from subsets of subjects for the measurement of omics and  other intermediate 
markers (e.g. blood micronuclei, urine mutagenicity).  
Study population/Recruitment: The EXPOsOMICS project aims to develop a new approach to 
assess environmental exposures, primarily focusing on air pollution and water contaminants. 
Using ‘omics’ techniques, the collected exposure data can be linked to biochemical and 
molecular changes in our body. The results will help to improve our understanding on how 
these pollutants influence the risk of developing chronic diseases.  
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Investigated chemicals/Matrices: Air and water pollution in selected blood samples 
Analytical methods: Metabolomics (molecules involved in cellular metabolism), adductomics 
(in EXPOsOMICS: set of compounds that bind to human serum albumin), transcriptomics 
(the set of all RNA molecules, including mRNA, rRNA, tRNA, and other non-coding RNA), 
proteomics (the entire set of proteins produced or modified by an organism or system), and 
epigenomics (the complete set of epigenetic modifications on the genetic material of a cell) 
are to be investigated. Disinfection by-products (DBP) (trihalomethanes, haloacetic acids, 
mutagen X, chloramines, and haloacetonitriles) constitute ubiquitous pollutants in drinking 
water. Traditionally, only trihalomethanes are measured in drinking water.  
Results/Interpretations: Not available as the study is currently ongoing, but the ultimate goal is to 
use the new tools in risk assessment and in the estimation of the burden of environmental 
disease.  
Investigation of exposure sources: Focus is on air pollution and water quality. 
Reference values: May be obtained from the project 
Communication to participants/scientific community/public: Information on the EXPOsOMICS 
project can be found online (http://www.exposomicsproject.eu), and the use of omics-based 
biomarkers has been reviewed (Vineis et al., 2013). 
Policy support: The omics tool is considered most promising. 
3.7.19.9. The Human Early Life Exposome (HELIX) 
Initiator/Funding source: Project under FP7 
Duration:  2013-2018 
Study design: Integrated project HELIX, a project of 13 partner institutions, will measure 
environmental exposures of up to 32,000 mother–child pairs and their consequent impact on the 
growth, development, and health of the children. 
Study population/Recruitment: HELIX will use data from six ongoing, prospective European birth 
cohorts of mothers and children living in Spain, France, the United Kingdom, Norway, Greece, and 
Lithuania. Large amounts of health data already have been collected, which HELIX investigators will 
pool. They also plan to collect extensive biomarker data for a subset of 1,200 mother–child pairs. 
Investigated chemicals/Matrices: External exposure measures for food, water, air pollution, 
pesticides, noise, and ultraviolet (UV) radiation will be integrated with molecular markers from 
metabolomic, proteomic, transcriptomic, and other “omics” studies. Then the investigators will 
estimate the burden of childhood disease from multiple environmental exposures.  
Analytical methods: In six existing prospective birth cohort studies in Europe, HELIX will estimate 
prenatal and postnatal exposure to a broad range of chemical and physical exposures: persistent and 
non-persistent organic chemicals, metals, pesticides, environmental tobacco smoke, water 
contaminants, air pollutants, noise, UV radiation, and contact with green spaces. Exposure models will 
be developed for the full cohorts totalling 32,000 mother-child pairs and biomarkers will be measured 
in a subset of 1,200. Nested repeat-sampling panel studies (N=150) will collect data on biomarker 
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variability and use smartphone-linked sensors to assess individual mobility, physical activity, and 
personal exposure to air pollutants and UV radiation. 
Results/Interpretations: The HELIX project will run for 4.5 years and has not produced results yet as 
of 2014. 
Investigation of exposure sources: Among the innovative tools created specifically for HELIX is 
ExpoApp, a mobile application for tracking participants’ activity levels. ExpoApp uses GPS and a 
smartphone’s built-in accelerometer to track a person’s location and measure physical activity every 
10 seconds. Participants will wear ExpoApp-enabled smartphones for a week, along with air pollution 
and UV monitors. The data will be used to calculate the amount of air inhaled and an individual’s 
exposure to air pollutants. 
Reference values: To be determined 
Communication to participants/scientific community/public: Background information about 
HELIX is available online (http://www.projecthelix.eu) and has also been scientifically published 
(Vrijheid et al., 2014). 
Policy support: The project will qualify the use of omics in exposure characterisation. 
3.7.19.10. Health and Environment-wide Associations based on Large Population Surveys 
(HEALS) 
Initiator/Funding source: EU project funds 
Duration:  2013-2019 
Study design: Integrated project of 29 partners form a truly multi-disciplinary consortium and cover 
the wide range of expertise necessary for developing the integrated approach to the exposome, 
including environmental exposure monitoring and modelling, biological monitoring, -omics genetics 
and epigenetics, bioinformatics and data-mining, epidemiology, toxicology, and software 
programming as well as its impact on health. Geographically, the participants cover all main regions 
of Europe. 
Study population/Recruitment: HEALS aims at integrating, in an innovative approach, a 
comprehensive array of novel technologies, data analysis, and modelling tools that support efficiently 
exposome studies. 
Investigated chemicals/Matrices: Assessing individual exposure to environmental stressors and 
predicting health outcomes imply that both environmental exposures and epigenetic variations can be 
measured simultaneously and reliably. For the first time, HEALS will try to reverse the paradigm of 
“nature versus nurture” and adopt one defined by complex and dynamic interactions between DNA 
sequence, epigenetic DNA modifications, gene expression and environmental factors that all com-bine 
to influence disease phenotypes. 
Analytical methods: To be determined 
Results/Interpretations: Ongoing 
Investigation of exposure sources: Various methods to be determined 
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Reference values: RVs are to be expected from the end of this study. 
Communication to participants/scientific community/public: Brief description about the HEALS 
project can be found online (http://www.imp.lodz.pl/upload/projekty/heals.pdf). 
Policy support: HEALS introduces the integrated approach to health risk assessment. The external 
exposome will be derived by data and model fusion using algorithms for mining existing 
environmental monitoring datasets and ubiquitous sensing using geo-localized sensors and mobile 
phones and the coupling of these data with agent-based models. 
4. Discussion 
This chapter covers the evaluation of the study results in terms of a comparative analysis of the 
reviewed HBM programmes with an emphasis on similarities and differences which may impact on 
the added value that HBM can provide to risk assessment in food safety areas, a review of results from 
HBM studies, in terms of an identification of potential emerging chemicals or chemical classes and 
possibly higher exposed sub-groups or specific vulnerable groups of a population from HBM 
investigations, with a particular focus on the exposure to foods, an inventory of validated biomarkers 
of exposure to chemicals that can be found in the diet identified through HBM, and other issues 
considered relevant for EFSA’s risk assessment activities, such as emerging biomarker and method 
developments or a short discussion about political challenges and obstacles in the European Union. 
4.1. Comparative analysis of the reviewed national HBM programmes 
This chapter provides a comparative analysis of the similarities and differences among the 37 previous 
or currently existing national HBM programmes, which are described in detail in chapter 3.7. 
1. Funding: All national studies and programmes were funded by the respective government. 
Population representative studies were in general (Germany, Flanders, France, Spain, Italy, Canada, 
the USA, Korea Japan, China, Czech Republic, Slovenia, Austria, Finland, and Norway) coordinated 
and managed by their respective governmental centres (e.g. German Environmental Agency, Flemish 
Centre of Expertise for Environment and Health, etc.).  
Other more local studies and cohort studies (Korea’s Kor-EHS C, Japan’s Tohoku and Hokkaido 
University cohort study, Sweden’s Uppsala study, and Denmark’s HBM review study) were 
coordinated and managed by renowned Universities such as Dankook University (Cheonan, Korea), 
Tohoku University (Sendai, Japan), Hokkaido University (Sapporo, Japan), Karolinska Institute 
(Stockholm, Sweden), and University Hospital in Copenhagen (Denmark), respectively.  
The different EU-wide HBM research projects were funded by European Commission’s Research 
Programmes (FP6 and FP7), whereas the feasibility study DEMOCOPHES, which tested the European 
wide COPHES protocol received co-funding from Life+. 
2. Duration of the programmes: NHANES programme started with first measurements of 
environmental chemicals in 1971 and since 1999 is performed continuously with chemicals being 
monitored in one third of the study population at 2 year intervals. HBM programmes for Germany 
(ESBHum and GerES), Finland (selenium surveillance), and Norway (The Tromsø cohort) have 
existed for more than 28 years. However, except of NHANES these aforementioned HBM 
programmes do not occur yearly but have multiple sampling periods spanned over the years. Eleven 
out of the 37 reviewed HBM programmes are relatively new, with a study duration period of less than 
5 years. The duration of the EU funded research projects ranged from 3 to 8 years.  
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3. Study design: 21 out of the 37 reviewed HBM programmes are cross-sectional studies (Germany’s 
GerES, Flanders’ FLEHS, France’s ENNS and ESTEBAN, Spain’s BIOAMBIENT.ES, Italy’s 
PROBE, Czech Republic’s CZ-HBM, Slovenia’s HBM programme, Austria’s Pollutants in Humans, 
Sweden’s Mothers in Uppsala, Denmark’s HBM Review, AMAP, Canada’s CHMS, USA’s 
NHANES, Korea’s KNHANES, KorSEP, and Kor-EHS-C, China’s POPs in Human Milk, EU’s 
DEMOCOPHES, NewGeneris, and EXPOsOMICS). 
10 of the investigated studies are based on longitudinal cohort studies (France’s ELFE, Denmark’s 
DNBC, Finland’s Selenium Study, Norway’s Tromsø cohort and MoBa study, Korea’s MOCEH, 
Japan’s Tohoku Study, Hokkaido Study, and JECS, and EU’s HELIX). ESBHum in Germany is a 
biobank that is used for retrospective trend analyses for chemical levels when needed. Most of the EU-
wide HBM research projects (e.g. ECNIS, EnviroGenomarkers, and PHIME) utilised existing 
databanks, tissue sample banks, and cohort studies to further develop new biomarkers or assessment 
methods of environmental exposures.  
Table 12 and Figure 7 indicate the frequency (i.e. recurring vs. one-time) of the reviewed HBM 
programmes, showing that majority of the HBM programmes (27 out of 37 or 73% of the reviewed 
programmes) has only occurred once. However, it should be mentioned that 6 of these one-time 
programmes are longitudinal and are currently ongoing as of 2014. 
Table 12 Reviewed HBM programmes sorted by frequency 
Frequency HBM 
Recurring 
(n = 10) 
ESBHum/GerES (Germany), FLEHS (Flanders), ENNS (France), CZ-HBM (Czech Republic), 
Slovenia HBM, AMAP, CHMS (Canada), NHANES (USA), KNHANES (South Korea) 
One-time 
(n = 27) 
ELFE
(a)
/ESTEBAN
(a)
 (France), BIOAMBIENT.ES (Spain), PROBE (Italy), Pollutants in humans 
(Austria), Danish HBM/DNBC
(a)
 (Denmark), Mothers in Uppsala (Sweden), Selenium 
supplement monitoring
(a)
 (Finland), Tromsø cohort (Norway), KorSEP/Kor-EHS C/MOCEH
(a)
 
(South Korea), Tohoku/Hokkaido/JECS
(a)
 (Japan), POPs in human milk (China), 
(DEMO)COPHES/ECNIS/EnviroGenomarkers/INTARESE/ESBIO/PHIME/NewGeneris/EXPO
sOMICs/HELIX/HEALS (EU) 
(a): Longitudinal study that is currently ongoing as of 2014. 
 
Figure 7 The frequency pattern of the reviewed HBM programmes  
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4. Size and type of the study population: Norway’s MoBa cohort study and Denmark’s DNBC study 
have the biggest study population with over 100,000 participants (mothers, fathers, and children). 
12 of the investigated programmes (Flanders’ FLEHS, France’s ENNS, ELFE, and ESTEBAN 
programmes, Denmark’s DNBC, Norway’s MoBa, Canada’s CHMS, the USA’s NHANES, South 
Korea’s KNHANES and KorSEP programmes, Japan’s JECS, and EU’s HELIX) have study 
populations of more than 4,000 participants per recruitment period.  
8 programmes (Germany’s GerES, Spain’s BIOAMBIENT.ES, Italy’s PROBE, Denmark’s HBM 
programme, Korea’s MOCEH, China’s POPs in Human Milk Study, and EU’s DEMOCOPHES and 
NewGeneris) have study populations between 1000 to 4000 participants per recruitment period.  
9 programmes (Germany’s ESBHum, Slovenia’s HBM programme, Austria’s Pollutants in Humans 
Study, Sweden’s Mothers in Uppsala Study, Norway’s Tromsø cohort, Finland’s Selenium Study, 
Korea’s Kor-EHS-C, and Japan’s Tohoku Study and Hokkaido Study) have study populations of less 
than 1000 participants per recruitment period.  
Concerning different age groups in the study population most but not all of the investigated HBM 
programmes cover one than one age group. In particular the European cross sectional surveys aim at a 
full coverage of all age groups similar to NHANES, but except Germany and France did not yet arrive 
at such a broad coverage. Overall, slightly more than half of the investigated programmes focus on the 
adult population, and another 40% address mothers and new-born. Whereas roughly one quarter each 
are cover (also) other age groups such as children (age 3-13), adolescents (age 14-17) or the elder 
generation (age >50). 
Figure 8 and Table 13 show the targeted study populations of the reviewed HBM studies. 
 
Figure 8 The overview of the population groups targeted in the reviewed HBM programmes 
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Table 13 An overview of the targeted study populations in the reviewed HBM studies 
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Adults 
(age 18-49) 
x x x x  x x x x x x x   x x x x x x x x  x   x     21 
Children 
(age 3-13) 
 x  x  x   x x x        x x x  x      x   11 
Adolescents 
(age 14-17) 
 x x x  x x    x        x x x  x         10 
Older adults 
(age ≥50) 
 x x x  x  x x x         x x x           10 
Mothers-Newborns   x  x    x x  x x x   x       x x x x x x x x 16 
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5. Recruitment strategy: The participants for all of the HBM studies were volunteers and gave 
informed consent. For 9 programmes (Germany’s GerES, Flanders’ FLEHS, France’s ENNS and 
ESTEBAN programmes, Canada’s CHMS, the USA’s NHANES, South Korea’s KNHANES, 
Austria’s Pollutants in Humans, and Sweden’s Mothers in Uppsala), participants were randomly 
chosen.  
12 programmes (Germany’s ESBHum, France’s ELFE, Spain’s BIOAMBIENT.ES, Italy’s PROBE, 
Czech Republic’s CZ-HBM, Norway’s MoBa, Finland’s Selenium Study, Korea’s Kor-EHS-C and 
MOCEH programmes, and Japan’s Tohoku Study, Hokkaido Study, and JECS) recruited their 
participants mainly with information sessions or flyers.  
For mother-child cohorts recruitment was generally done via maternity wards or by obstetricians.  
The EU-wide HBM research projects mainly used existing cohort studies and databases. 
DEMOCOPHES however, did full recruitment according to the COPHES study protocol mostly via 
schools. 
Only for a number of the investigated studies there was information about small incentives for 
participation. For Germany’s ongoing GerES V, a 20 € allowance is given as a token of gratitude. For 
Flanders’ FLEHS, participants receive incentives (baby cape with logo of the study for the newborns; 
cinema tickets or book voucher for the adolescents; book voucher for adults) after study completion. 
For Spain’s BIOAMBIENT.ES, a small token USB drive was given to the participants. For the USA’s 
NHANES, the participants receive cash remuneration, compensation for transportation, baby/elder 
care, and a free medical report. For Korea’s Kor-EHS-C, participants received a gift voucher of 5,000 
KRW (approximately 3.58 €). In DEMOCOPHES study participants received small gifts but no 
money was paid. 
6. Analysed substances and substance groups: With the majority of the longer-existing 
programmes, the number of chemical analyses increased considerably over time. With the USA’s 
NHANES, for example, the number of measured analytes has increased from 27 (in 1999) to almost 
300 today.  
More than 65% of the investigated HBM programmes analysed various congeners and totals for 
dioxins/furans and PCBs, as well as selected heavy metals (namely As and Hg).  
For dioxins, furans and PCBs, the levels of multiple congeners were mainly measured and summed up 
as totals depending on the analytical method. For example, the Flanders’ FLEHS and Japan’s Tohoku 
Study measured total dioxin and furan levels only using the CALUX assay, and levels of indicator 
PCBs (e.g. PCB 138, 153 and 180) were measured together and reported as sums. One observed 
exception is the Japanese Hokkaido Study, where mainly 2,3,4,7,8-PeCDF (furan) was found to have a 
negative association with birth weight (Konishi et al., 2009). 
For most metals, no differentiation between different species was made. However, Flanders’ FLEHS, 
France’s ENNS, Canada’s CHMS and USA’s NHANES have measured different species of arsenic 
such as inorganic As(III), As(V), MMA, DMA as well as organic arsenobetaine, arsenocholine, and 
trimethylarsine oxide. In the FLEHS study, it was observed that levels of inorganic arsenic (more toxic 
form) were higher in participants living near an industrial plant than control participants (Vrijens et al., 
2014).  
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For mercury measurement, MeHg in hair is the primary species used in the investigated HBM 
programmes, such as Flanders’ FLEHS, Spain’s BIOAMBIENT.ES, Austria’s Pollutants in Humans 
study, USA’s NHANES and Japan’s Tohoku and Hokkaido studies. For NHANES, additional Hg 
species such as inorganic Hg and ethylmercury have also been measured. 
Cotinine (as biomarker for environmental tobacco smoke exposure), organochlorine pesticides, 
phenols, various phthalates, perfluorinated compounds (PFCs), polybrominated diphenyl ethers 
(PBDEs) and polyaromatic hydrocarbons (PAHs) have been measured in more than 25% of the 
investigated studies. 
Organophosphates, pyrethroids, and chlorinated phenols were analysed in 20% of the programmes, 
whereas acrylamide and carbamates were seldom measured. 
Mycotoxins, fungus-specific IgE, selected fungicides, perchlorate, nitrosamine and alkaloids have only 
been measured in single HBM programmes. At the European level, mycotoxins were only measured in 
France’s ESTEBAN and in the EU-based research project NewGeneris. Fungicides (e.g. chlorothalonil 
and trifloxystrobin) were measured only in France’s ESTEBAN and Germany’s GerES. Perchlorate 
and nitrosamine were not measured in any of the European HBM Programmes.  
Substance groups that were included in the literature search as substances of interest for EFSA but 
were not measured in any of the selected HBM programmes comprise the following: 
monochloropropane-ester (3-MCPD), mycotoxins other than aflatoxin and deoxynivalenol, alkaloids 
other than nicotine, mineral oil hydrocarbons (MOHs), pyrethroids, triazoles, neonicotinoids and other 
pesticides in current use, as well as smoke flavourings, BADGE, sweeteners and enzymes. 
Figure 9 and Table 14 provide an overview of the analysed substances among the reviewed HBM 
programmes and studies. Table 15 and Table 16 list the substances that have been analysed in only 1 
or 2 HBM programmes and have never been analysed, respectively. 
 
Figure 9 The overview of the substances analysed in the reviewed HBM programmes 
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Table 14 Overview of analysed substances (sorted by chemical groups) 
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Metals x x x x x x x x x x x   x x   x x x x x x x x x x  x x x 26 
PCBs x x x x x x x  x x    x  x  x x x     x x x x  x x 20 
Cotinine  x x  x x x  x        x  x x x x x x  x x  x   16 
Organochlorines x x x x  x x  x       x   x x     x  x  x  x x 15 
Phenols x x x  x x     x x       x x  x x x  x x  x   15 
Phthalates x  x  x x     x x     x  x x  x x x  x x  x   15 
PFCs x  x  x x       x   x x x x x      x x  x    13 
PBDEs   x  x x x   x x   x    x x x       x x    12 
Dioxins   x  x x    x    x      x     x x x x   x 11 
PAHs  x x   x x            x x  x  x   x x   x 11 
Furans   x  x x    x    x      x     x x x x    10 
Organophosphates  x x x x x           x  x x       x     9 
Pyrethroids  x x x x x             x x  x     x     9 
Chlorinated Phenols x x x x x x             x x            8 
Acrylamide                 x   x           x 3 
Carbamates     x              x x            3 
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Table 15 Substances that have only been or are to be analysed in 1 or 2 HBM programmes 
 Class of substances Substance of interest HBM Programme 
Analysed in 2 HBM programmes 
 
Mycotoxins Total aflatoxin France’s ESTEBAN 
EU’s NewGeneris 
Analysed in 1 HBM programme 
 Mycotoxins Aflatoxin B1 USA’s NHANES (a)  
  Deoxynivalenol EU’s NewGeneris 
 Perchlorate Perchlorate USA’s NHANES 
 Alkaloids Nicotine Germany’s GerES 
 Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol (NNAL) USA’s NHANES 
 Fungus-specific IgE 
Penicillium (notatum) chrysogenum, Aspergillus versicolor, 
Alternaria alternata, Wallemia sebi, Eurotium spp 
Germany’s GerES 
 Fungicide Chlorothalonil France’s ESTEBAN 
  Trifloxystrobin Germany’s GerES 
(a): The last NHANES measurement for aflatoxin B1-lysine (albumin adduct) occurred in 1999-2000. 
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Table 16 Substances that have not been analysed in any HBM programmes 
Class/type of substances Substances of interest 
3-Monochloropropane-1,2 Diol Ester (3-MCPD) 3-MCPD 
Mycotoxins Ochratoxin A, patulin, Zearalenone, Fumonisin B1 or B2, T-2 toxin, HT-2 toxin 
Mineral oil hydrocarbons Mineral oil saturated hydrocarbons, Mineral oil aromatic hydrocarbons, Naphthenes, Paraffins 
Alkaloids 
Piperine, cocaine, scopolamine, niacin, dopamine, mescaline, tubocuarine, capsicain, ephedrine, serotonin, 
ergotamine, caffeine, quinine, theobromine 
Regulated chemical substances Smoke flavourings, BADGE, sweeteners, enzymes 
Pyrethroids Acrinathrin, beta-cyfluthrin, bifenthrin, lambda-cyhalothrin, esfenvalerate, tefluthrin 
Triazoles 
Bromuconazole, Cyproconazole, Epoxiconazole, Fenbuconazole, Fluquinconazole, Flusilazole, Metconazole, 
Myclobutanil, Propiconazole 
Neonicotinoids Imidacloprid 
Pesticides 
8-Hydroxyquinoline incl. oxyquinoleine, Abamectin (aka avermectin), Aclonifen, Amitrole (aminotriazole), 
Azimsulfuron, Benfluralin, Bifenox, Bitertanol, Carbendazim, Carfentrazone-ethyl, Chloridazon (aka pyrazone), 
Chlorothalonil, Chlorotoluron (unstated stereochemistry), Copper compounds (Bordeaux mixture, Copper hydroxide, 
Copper oxide, Copper oxychloride), Cyprodinil, Diclofop, Difenacoum, Diflufenican, Dimethachlor, Dimethenamid-
P, Dimethoate, Dimoxystrobin, Diquat (dibromide), Diuron, Ethofumesate, Ethoprophos, Famoxadone, Fenamiphos 
(aka phenamiphos), Fenbutatin oxide, Fenpropimorph, Fipronil, Flufenacet (formerly fluthiamide), Flumioxazine, 
Fluometuron, Fluxapyroxad, Formetanate, Fuberidazole, Haloxyfop-P (Haloxyfop-R), Imazamox, Imazaquin, 
Imazosulfuron, Ioxynil, Linuron, Lufenuron, Metam (incl. -potassium and -sodium), Methiocarb (aka 
mercaptodimethur), Methomyl, Methoxyfenozide, Methyl nonyl ketone, Metribuzin, Metsulfuron-methyl, Molinate, 
Napropamide, Oxadiazon, Oxyfluorfen, Paclobutrazol, Pencycuron, Pendimethalin, Pirimicarb, Prochloraz, 
Prosulfocarb, Pyraclostrobin, Quinoclamine, Quinoxyfen, Quizalofop-P-tefuryl, Spirodiclofen, Sulcotrione, 
Tebufenpyrad, Terbuthylazine, Tralkoxydim, Triazoxide,  
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7. Biological matrices: Blood is the most commonly analysed matrix taken (67% of the studies), 
followed by urine (57% of the studies) and scalp hair (35% of the studies).  
9 studies (France’s ELFE, Korea’s MOCEH, Japan’s Tohoku Study, Hokkaido Study, and JECS, 
China’s POPs in Human Milk Study, Czech Republic’s CZ-HBM, Slovenia’s HBM Programme, and 
Sweden’s Mothers in Uppsala Study) analysed also breast milk samples.  
Other 9 studies (Germany’s ESBHum, Flanders’ FLEHS, Korea’s MOCEH, Japan’s Tohoku Study, 
Hokkaido Study, and JECS, and EU’s DEMOCOPHES, PHIME, and NewGeneris) analysed various 
samples of mother-child pairs (i.e., maternal blood, cord blood, maternal and child’s urines, child’s 
hair, placenta, amniotic fluid).  
Pubic hair, saliva, teeth and toe nails were less common biological materials in the investigated 
studies. Germany’s ESBHum had analysed pubic hair and saliva until 2004, and Finland’s Selenium 
Study analysed selenium in toenails. Norway’s MoBa began collecting teeth samples from the 
participating children while Czech Republic’s CZ-HBM analysed lead levels in teeth samples.  
Figure 10 provides an overview of the biological matrices that had been analysed in the reviewed 
HBM programmes. 
 
Figure 10 The overview of the biological matrices analysed in the reviewed HBM programmes 
 
8. Analytical methods: For most of the substances (in particular for all organic substances), different 
types of gas or liquid chromatography followed by mass spectometry (GC-MS or LC-MS, 
respectively) is the most commonly used analytical method. Among the reviewed HBM programmes, 
GC-MS (including GC-MSD) and LC-MS (including HPLC-MS and UPLC-MS) had been utilised 59 
and 53 times, respectively, to measure substances in different matrices. Other utilised methods include 
gas chromatography-electron capture detector (GC-ECD), enzyme-linked immunosorbent assay 
(ELISA), LC-UV detection, chemiluminesce and ion chromatography-mass spectrometry (IC-MS). 
Congeners within a substance class (e.g. PCBs, dioxins, furans, PBDEs) are always measured with the 
same analytical method among themselves in a HBM programme. For dioxins and furans, the CALUX 
assay has been used innovative approach for high throughput quantification in Flander’s FLEHS and 
Japan’s Tohoku Study for cost and time reasons. For metals except mercury, inductively-coupled 
plasma-mass spectrometry (ICP-MS) is the most commonly used method, followed by atomic 
absorption spectrometry (AAS). An overview of the frequency count of the analytical methods used 
among the reviewed HBM programmes (except methods used for measuring mercury) is provided in 
Figure 11. 
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Figure 11 The overview of the analytical methods used to measure the reviewed substances among 
the reviewed HBM programmes. Methods used for measurement of metals (except mercury) are 
marked in green while methods used for measurement of the other remaining compounds are marked 
in blue. (a): Count includes GC-MS and GC-MSD. (b): Count includes LC-MS, HPLC-MS and 
UPLC-MS. (c): Count includes GC-ECD and GC-ECD-MS. (d): Count includes ET- and GF-AAS. 
The detection for mercury is varied across the different HBM studies. France’s ENNS, Canada’s 
CHMS, the USA’s NHANES, Spain’s BIOAMBIENT.ES (for blood and urine), Italy’s PROBE, and 
Austria’s Pollutants in Humans Study measured mercury via ICP-MS. Germany’s ESBHum and 
GerES studies, Japan’s Tohoku Study, Korea’s MOCEH and Kor-EHS-C studies, Slovenia’s HBM 
Programme (for urine) on the other hand measured mercury via cold-vapour AAS. Spain’s 
BIOAMBIENT.ES (for hair), Korea’s KNHANES and KorSEP studies, Czech Republic’s CZ-HBM 
and Slovenia’s HBM programme (for hair and blood) measured mercury via a direct mercury analyser. 
Flanders’ FLEHS and AMAP measured mercury via atomic fluorescence spectroscopy (AFS) and 
HPLC, respectively. Figure 12 depicts the frequency count of various analytical methods used among 
the HBM programmes for the measurement of mercury in various matrices. 
 
Figure 12 The overview of the analytical methods used to measure mercury among the reviewed 
HBM programmes 
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A detailed overview of the analytical methods used for measuring different classes of substances in 
various biological matrices (i.e. blood, urine, hair, and milk) is provided in Table 38 in Appendix B. 
9. Biomarkers of exposure: Many of the investigated chemicals (i.e., metals, dioxins, furans, PCBs, 
PBDEs, etc.) were directly measured as the parent compounds in the matrices. On the other hand 
metabolites are measured as biomarkers of exposure for phthalates, polyaromatic hydrocarbons, 
organophosphate pesticides, organochlorine pesticides (mainly DDE for DDT), pyrethroid pesticides, 
and tobacco smoke (mainly cotinine) in all HBM studies.  
Glycidamide and NNAL were used as metabolic biomarkers of acrylamide and of nitrosamine 
exposure in the USA’s NHANES, whereas the Norwegian MoBa study analysed both urinary 
acrylamide/glycidamide metabolites and haemoglobin adducts of acrylamide/glycidamide in the 
blood.  
In the Flanders’ FLEHS and Japan’s JECS, 8-OHdG is envisaged to be analysed as a first biomarker 
of oxidative DNA damage. 
10. Dissemination of information: The most commonly used method to disseminate information 
regarding HBM studies is via peer-reviewed scientific articles. However, several HBM studies (e.g., 
Germany’s GerES, France’s ENNS, Italy’s PROBE, Canada’s CHMS, the USA’s NHANES, and 
Austria’s Pollutants in Humans Study) have released the findings as governmental reports, which are 
available for public to access online. Germany’s ESBHum published all the findings on their study 
programme’s website. Several programmes (e.g., Germany’s GerES, Flanders’ FLEHS, France’s 
ENNS, Spain’s BIOAMBIENT.ES, the USA’s NHANES, and Czech Republic’s CZ-HBM) have 
stated that the result findings would be communicated to the participants. 
11. Policy impacts: The HBM programs from Germany, Flanders, France, Italy, Canada, the USA, 
South Korea (particularly KNHANES and KorSEP), China, Czech Republic, and Slovenia have direct 
influences on policy-making of their respective governments. In addition, several European countries 
(e.g., Denmark, Austria, and Spain) have participated in the COPHES/DEMOCOPHES project. 
12. Biobanking:  
Biobanks may store wide array of biospecimens including blood, saliva, plasma and can play an 
important role in biomedical research and retrospective anaylsis of human tissues e.g. for the absence 
or presence of contaminants. Biobanks may catalog specimens using age, gender, blood type, and 
ethnicity or genetic traits. Some samples are also categorized according to environmental factors such 
as whether the donor had been exposed to substance that can affect human health.  
In biomedical research researchers access biobanks when they are in need of specimen with similar 
traits for their research studies. The ability to seek out very specific collections of biospecimens is how 
biobanks serve as an essential resource for scientists worldwide. 
However, there are important ethical and data protection issues which need to be taken into account. 
The protection of individual rights and the privacy of individuals is a primary concern in the 
management of any biobank. Therefore samples are normally codes with any biographical data of the 
donor being removed and the sample being identifiable only by a unique code.  
The Declaration of Helsinki states that all biobanks must take donated materials via a process of 
informed consent; research investigators must provide potential subjects with a clear appreciation and 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 126 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
understanding of the facts, implications, and future consequences of submitting biological samples to a 
biobank.  
An important aspect besides a thorough wording to the inform consent are thorough sample handling 
and transport condition, which prevent an external contamination of the sample from the storage 
device or the degradation of the biomarker during storage time, to enable for future use.  
As harmonised standards for data management and biobanking are a prerequisite for comparable 
European wide interpretation and potential reanalysis, it is considered crucial for future European 
HBM to establish guidance on these aspects and to establish one central data repository, which can 
virtually or physically be linked to national data bases. Based on current experiences and due to 
privacy issues a central European biobank does not seem to be feasible at this stage of time. But EU 
efforts could develop guidance for sample preparation for storage and biobank management in the 
light of retrospective analysis of chemical substances. 
Whereas there are quite a number of biobanks in the European Union, that store samples from clinical 
trials or public health surveys, there is not widespread use of biobanking in environmental HBM so 
far.  
Among the reviewed programmes, only ESBHum (Germany), DNBC (Denmark) and CHMS 
(Canada) store the collected biological samples to create biobanks. In addition, samples have been 
stored in national biobanks in the course of DEMOCOPHES based on the COPHES protocol.   
13. Accompanying activities to investigate exposure source: The investigated HBM programmes in 
general did not take environmental samples together with HBM except of house dust (Germany) and 
tap water measurements in Germany, Canada and France, as well as selective food monitoring in 
Czech Republic, Finland and Germany. For 60% of the investigated HBM programmes however, there 
was information about other measures (questionnaire or correlation with environmental and health 
registry data) taken to identify potential sources. Correlation of internal exposure to dietary intake has 
been mainly performed by data collection of food consumption. 
In this context it is important to note that in 2009, EFSA published a guidance on “General principles 
for the collection of national food consumption data in the view of a pan-European dietary survey” and 
launched a pan-European Food Consumption Survey, also known as “What’s on the Menu in Europe” 
("EU Menu") survey, for which two EU pilot studies developed and tested procedures and tools.  
The PILOT-PANEU project (Ambrus et al., 2013) developed, tested and evaluated the applicability of 
tools and procedures for conducting a dietary survey with adolescents, adults and elderly people, based 
on 2 x 24-hr recall.  
The Pilot Study for Assessment of Nutrient Intake and Food Consumption among Kids in Europe 
(PANCAKE) developed, tested, and evaluated tools and procedures for an EU Menu among infants, 
toddlers, children (up to ten years), and breastfeeding women. The tools included age-group specific 
food diaries, EPIC-Soft software for data entry, validated picture books for portion size estimation, a 
web repository for the picture series, a questionnaire on background characteristics, a food propensity 
questionnaire, a data entry tool, and evaluation questionnaires (Ocké et al., 2012). Based on these pilot 
studies and two methodological projects, EFSA has updated the former guidance document in 2014 to 
cover the EU Menu methodology to facilitate the collection of more harmonised food consumption 
data from all EU Member States by the year 2020. (EFSA, 2014) 
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The up-dated guidance recommends collection of information on food consumption by means of two 
non-consecutive 24-hour food diaries using computer assisted personal or telephone interview 
(CAPI/CATI). The reported foods should be described according to the EFSA FoodEx2 food 
classification system. A short food propensity questionnaire should be used to collect information on 
the consumption of some less frequently eaten foods and consumption frequencies of food 
supplements. Information on the weight and height of participants and physical activity levels should 
also be collected in the survey. 
In addition there exist other froms of questionnaires. Food-frequency questionnaire (FFQ) has been 
defined as a questionnaire in which the respondent is presented with a list of foods and is required to 
say how often each is eaten in broad terms such as x times per day/per week/per month, etc. Foods 
chosen are usually chosen for the specific purposes of a study and may not assess total diet (Margetts 
& Nelson, 1997). In addition, family and dietary habits questionnaires have been developed for 
specific age groups with a process of involving careful selection of items, pilot studies for setting 
scales, and testing reliability with many steps as thoroughly described in (Bjelland et al., 2014). 
Out of the 37 reviewed HBM programmes (60%) have mentioned the data collection in food 
consumption. The most common method has been using FFQs (9 out of 22 programmes), followed 
closely by general study questionnaires including questions about food consumption (8 out of 22 
programmes). In COPHES/DEMOCOPHES, a semi-qualitative approach was chosen in obtaining 
information about exposure-related food intake from the past 4 weeks from sources of drinking water, 
alcohol, and specified food items (meat, fish, bread, rice, etc.) (Becker et al., 2014). 
The only HBM programmes that use a customised 24-hr food recall method according to EFSA 
recommendations were France’s ENNS, Czech Republic’s CZ-HBM, and the USA’s NHANES. Only 
2 programmes use more than 1 method for food consumption: Norway’s MoBa using both FFQ & 
food diary and South Korea’s KNHANES using both FFQ and 24-hr recall.  
Figure 13 provides an overview of the individual methods used for collecting food consumption data.  
Table 17 in addition provides further details on the type of measurement and the food intake 
questioning. 
 
Figure 13 The distribution and count of the methods used for food consumption data collection
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Table 17 Food intake measurement and additional monitoring studies for further investigation of chemical exposure due to food intake or due to 
environment exposure 
Country HBM 
Food intake 
measurement 
Findings/activities related to food 
Measure in 
food 
Germany ESBHum 
Self-administered 
questionnaire 
including nutrition 
Collection and analysis of marine specimens (e.g. fish and mussels) for levels of 
metals, PCBs, pesticides, PAHs, HBCD, etc. Yes 
 GerES 
Food frequency 
questionnaire 
FFQ gathered consumption of 50 food groups about food selection of the children. 
The contribution of the domestic environment to chemical exposure was also 
assessed by analysing domestic drinking tap water mainly for metals among others. 
Yes 
(water) 
France ELFE 
Self-administered 
questionnaire 
The children's environment (e.g. water and ambient air) will be monitored. 
Yes 
(water) 
 ENNS 
Three 24-hr recall 
randomly distributed 
over 15 days 
Participants recalled food consumed the day before interview and gave details on 
amounts through a photography manual with typical portion sizes. 
No 
Spain BIOAMBIENT.ES 
Short food frequency 
questionnaire 
FFQ with HBM measurements showed a significant association between fish 
consumption and serum PCB concentrations. 
No 
Czech Republic CZ-HBM Two 24-hr recall 
Various food groups (fish, meats, rice, vegetables, etc.) as well as drinking water 
had been analysed for mercury levels to determine the sources of mercury body 
burden. Mercury burden in the Czech population appeared low. 
Yes 
Slovenia National HBM Short questionnaire 
The study participants answered a questionnaire with information regarding food 
consumption. 
No 
Austria Pollutants in Humans 
Food frequency 
questionnaire 
The study participants answered FFQs to gain information regarding food 
consumption. 
No 
Denmark DNBC 
Food frequency 
questionnaire 
Completed FFQs allowed further studies of determining chemical exposure to food 
consumption and occupational exposures (e.g. those of laboratory technicians, 
green house workers, and shift work). 
No 
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Country HBM 
Food intake 
measurement 
Findings/activities related to food 
Measure in 
food 
Sweden Mothers in Uppsala Short questionnaire 
The study participants answered a questionnaire with information regarding some 
dietary habits, e.g., fish intake. 
No 
Finland Selenium 
Self-administered 
questionnaire 
In addition to food intake data collection, sampling of foods for selenium levels has 
been done four times per year, and the measurements are complementary to the feed 
measurements of grains, meat, milk and soil. 
Yes 
Norway Tromsø cohort Not reported 
Estimates of average and high fish consumption in the Norwegian population were 
used to model the POPs concentrations as a result of fish consumption. 
No 
 MoBa 
Food frequency 
questionnaire & 4-
day weighed food 
diary 
FFQs, chemical measurements in blood/urine and previous chemical measurements 
in food revealed correlations of maternal chemical exposure to the estimated levels 
of Hg, dioxins, and PCBs, or acrylamide in food. 
No 
AMAP AMAP 
Semiquantitative 
food frequency 
questionnaire 
FFQ of 60 local (e.g. meats, fish, birds, berries) and imported (e.g. breads, fruits, 
vegetables) food items. Frequency categories range from once a year to several 
times a day. 
No 
Canada CHMS 
Semiquantitative 
food frequency 
questionnaire 
FFQ collecting data on dietary intake of meat and fish, grains, fruits and vegetables, 
dairy products, dietary fat, water and soft drinks. Frequency reported as number of 
times per day, week, month or year. 
Also, indoor air was measured for levels of VOCs in Cycle 2 of the CHMS. Future 
cycles to include tap water measurement of fluoride and VOCs. 
Yes 
(water) 
USA NHANES 
A customised 24-hr 
dietary recall 
A thorough dietary food collection using the Automated Multiple-Pass Method, a 5-
step dietary interview, see (Moshfegh et al., 2008) for more detail. 
No 
South Korea KNHANES 
Food frequency 
questionnaire & 24-hr 
recall 
Please refer to (Kweon et al., 2014) for more detail on the food intake data 
collection. 
Associations between blood mercury levels and the consumption of seafood, 
vegetables, fruits, and alcohol have been made. Also, urinary arsenic levels were 
shown to increase with the consumption of rice and seafood. 
No 
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Country HBM 
Food intake 
measurement 
Findings/activities related to food 
Measure in 
food 
 KorSEP 
Questionnaire-based 
interviews to include 
dietary information 
Dietary information and chemical measurements allowed comparison between the 
levels of heavy metals and several lifestyle factors such as fish consumption and 
smoking. 
No 
 MOCEH 
Food frequency 
questionnaire 
FFQ will be administered and blood samples will be collected when children are 3 
years or older. 
No 
Japan Tohoku 
Food frequency 
questionnaire 
Refer to (Suzuki et al., 2010) for more detail on the FFQ. 
Several studies have associated the exposure of methyl mercury and PCBs to fish 
consumption. 
No 
EU-wide (DEMO)COPHES 
Questionnaire 
including exposure-
related food intake 
(e.g. Hg) 
There was a highly significant correlation between national levels of fish 
consumption and mercury in hair. 
No 
 ECNIS None 
Environmental and occupational exposures as well as lifestyle including food intake 
have been recorded for the study subjects included in the ECNIS database. 
No 
 Environ-Genomarkers None 
Environmental and occupational exposures as well as lifestyle including food intake 
have been recorded for the study subjects included in the cohorts. 
No 
 PHIME Questionnaire Exposure sources were identified through questionnaires. No 
 NewGeneris 
Food frequency 
questionnaire 
Questionnaires gave estimates of exposure to acrylamide, dioxins, etc. No 
 EXPOsOMICS None 
DBPs in air and water and/or in biological samples such as exhaled breath (e.g. 
trihalomethanes) and urine (haloacetic acids) from study subjects have been 
examined. 
Yes 
(water) 
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Based on the data collection systems used in the selected HBM programmes, a number of chemicals 
have been identified to have associations with consumption of specific food (Table 18).  
Table 18 Identification of several analysed chemicals in HBM programmes and their associations 
with specific food consumption 
Chemical class Chemical Associated food HBM programme 
Metals Arsenic Seafood/Fish FLEHS (Flanders) 
ENNS (France) 
KorSEP (South Korea) 
  Rice NHANES (USA) 
  Alcohol ENNS (France) 
 Mercury Seafood/Fish GerES (Germany) 
FLEHS (Flanders) 
CHMS (Canada) 
NHANES (USA) 
KorSEP (South Korea) 
KorEHS-C (South Korea) 
DEMOCOPHES (EU) 
  Alcohol CHMS (Canada) 
KNHANES (South Korea) 
  Vegetables KNHANES (South Korea) 
 Lead Alcohol PROBE (Italy) 
 Cadmium Rice KorEHS-C (South Korea) 
 Manganese Alcohol PROBE (Italy) 
PCBs NDL-PCBs Food of animal origin/Seafood ENNS (France) 
 PCBs in general Seafood/Fish BIOAMBIENT.ES (Spain) 
Tohoku study (Japan) 
Organophosphates  Fresh fruits & Fruit juice GerES (Germany) 
Bisphenol A (BPA)  Canned food  DEMOCOPHES (EU) 
Beyond the reviewed HBM programmes, some additional studies have linked chemical exposure via 
dietary intake. In December 2013, very high levels of PFCs such as PFOA, PFOS and PFHxS 
(exceeding water quality guidelines with orders of magnitude) in groundwater coming from a 
municipal waterworks in Sweden were detected, possibly exposing the general population to PFAS via 
drinking water. The groundwater was contaminated with PFCs coming from fire-fighting foams used 
on a fire drill site situated near the waterworks. Consequently, a small biomonitoring study in children 
revealed markedly higher serum levels of several PFASs (15 to 50-fold) compared to a nearby control 
group. These findings are currently followed up in a research program 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 132 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
(http://www.skane.se/sv/Webbplatser/Labmedicin_Skane/Verksamhetsomraden/Arbets--och-
miljomedicin/Aktuellt-om-PFAS/ (only in Swedish)). 
The Swedish Mammography Cohort, which is excluded for review in this report as it started in 1987 
with a follow up in 1997, is a population-based prospective cohort of 30,210 postmenopausal women 
who were cancer-free at baseline (1987) and completed FFQ at baseline and at the follow-up (1997). 
Dietary Cd intake based on the questionnaire and Cd content in all foods were estimated. Results from 
this cohort study showed that average estimated dietary Cd intake was 15 µg/day, which 80% of this 
intake surprisingly came from cereals, bread, potatoes, roots, and vegetables. Furthermore, Cd intake 
was significantly associated with increased risk of endometrial cancer in all women (relative risk of 
1.39; Ptrend = 0.019) (Åkesson et al., 2008). Taking this association between dietary Cd intake and risk 
of endometrial cancer into consideration, it would be advantageous for future HBM programmes to 
measure chemical levels in food and to correlate these levels with the body burden levels within the 
general population.  
Table 19 provides an example of the contaminants and the known food-related sources where the 
contaminants could be found (WHO, 2002). 
Table 19 Food-related sources of chemicals and contaminants 
Contaminant Food-related sources 
aldrin, dieldrin, DDT (p,p'- and o,p'-), TDE (p, p'-), 
DDE (p,p'- and p,o'-) endosulfan (α, β and sulfate), 
endrin, HCH (α, β, γ), HCB, heptachlor, heptachlor 
epoxide, chlordane, PCBs ( 28, 52, 77, 101, 105, 114, 
118, 123, 126, 138, 153, 156, 167, 169, 180 and 189), 
and dioxins/furans (PCDDs and PCDFs) 
whole milk, dried milk, butter, eggs, animal fats and 
oils, fish, cereals, vegetable fats and oils, human milk 
Lead (Pb) milk, canned/fresh meat, kidney, fish, molluscs, 
crustaceans, cereals, pulses/beans, legumes, 
canned/fresh fruit, fruit juice, spices, infant food, 
drinking water 
Cadmium (Cd) kidney, molluscs, crustaceans, cereals, flour, 
vegetables 
Mercury (Hg) fish, fish products, mushrooms 
Arsenic (As), inorganic drinking water 
Aflatoxins milk, milk products, maize, cereals, 
groundnuts, other nuts, spices, dried figs 
Ochratoxin A wheat, cereals, wine 
Patulin apple juice 
Fumonisins maize, wheat 
Bisphenol A (BPA) protective internal epoxy resin coatings of canned 
foods, polycarbonate tableware, food storage 
containers, water bottles, and baby bottles 
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4.1.1. Strengths and limitations of the comparative analysis 
Strength of this comparative evaluation are the detailed assessment of analytical methodologies, study 
populations, study intervals, and analysed matrices. Information on stratification of results by region, 
gender and age has been taken into account, but is not conclusive in this report.  
The strongest weakness is the comparison of reference values, even though much effort has been made 
to increase comparability. Due to varying test methods and study design, as well as due to lack of 
information on analytical sensitivity and specifity the given reference values may only be considered 
as proxies for the dimensions of internal dose. 
Other weaknesses relate to public availability of information on communication, recruitment, detailed 
stratification of results, validation of biomarkers and development in substance coverage. Another 
limitation is the lack of results from the most recent programmes as well as the omission of a number 
of studies. Information on LOD/LOQ is generally not listed in this report.   
This report hence may not be used directly for risk assessment but may be understood as a detailed 
screening of the state of HBM in major population based survey in the European Union. 
Besides the fact, that detailed information on the type and detail of food frequency questionnaires and 
of results from environmental monitoring was often not easy to identify, the use of tailormade food 
intake questionnaires hampers considerably the reliability of the conclusions on food source taken 
from many of the existing HBM programmes, and increases the uncertainty regarding comparability of 
results obtained from food questionnaire within countries and between countries. In this context the 
successful comparability of data on maternal diet from the DNBC study and the MoBa Study through 
comparison of (i) the methodology used for dietary assessment and (ii) the estimated intake of selected 
food groups in the two cohorts could serve as a basis for future designs (Olsen et al., 2014), and the 
up-take of EFSA guidance recommendations needs to be improved. 
Regarding duration, frequency and number of substances covered (191), and collection of food intake 
data by means of 24h recall the American NHANES programme is the most extensive of the 
investigated HBM programmes. As seen in Table 15, NHANES has measured the exposure levels of a 
number of chemicals (e.g. perchlorate, nitrosamine, etc.) that no other HBM programme has included. 
In addition, it covers several classes of chemicals that are seldom or have never been analysed by other 
programmes but are of interest for EFSA. In the European Union in contrast although strong efforts 
have been made in recent years there are only few national programmes in Flanders, Germany, France 
and Sweden aim at least a a surveillance level which can be compared with the USA. 24h recall 
currently is only used in France’s ENNS, and Czech Republic’s CZ-HBM. 
EFSA has particularly raised concerns of 3-MCPD, mycotoxins, neonicotinoids, triazoles, and 
pyrethroids and MOHs. A broader inclusion of these chemicals into European HBM programmes 
would allow appropriate risk management and would facilitate the reduction of exposure of these 
chemicals.  
4.2. Review of HBM study results 
This chapter provides a review of results from HBM studies in line with study objective 3. This review 
focuses on emerging chemicals or chemical classes and possibly higher exposed sub-groups or 
specific vulnerable groups of a population from HBM investigations, with a particular focus on the 
exposure to foods and on an inventory of validated biomarkers of exposure to chemicals (e.g. metals, 
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polycyclic aromatic hydrocarbons (PAHs), phthalates, phenols, polychlorinated compounds, 
pesticides) that can be found in the diet identified through HBM.  
4.2.1. Emerging chemicals and chemical classes as identified in HBM programme 
As no definition of “emerging risk” is provided by EC Regulation 178/2002, an operational definition 
has been developed with reference to the food/feed chain, by the EFSA’s SC and adopted by EFSA in 
2007 (EFSA, 2007). 
According to this definition an emerging risk to human, animal and/or plant health is understood as a 
risk resulting from a newly identified hazard to which a significant exposure may occur or from an 
unexpected new or increased significant exposure and/or susceptibility to a known hazard. The term 
“new” is considered as new scientific evidence, or not regulated in the EU, or not yet addressed by 
EFSA. Exposure of human beings, animals and/or plants must be present or envisaged for the 
definition of emerging risk to be met.  
An assessment of emerging risk is characterized by the early detection of facts related to that risk 
derived either from research and/or from monitoring programs or episodic observations.  
The evidence supporting the identification of an emerging risk should preferably be in the form of an 
“indicator” (e.g. measurement and/or observation) and of a trend over time or space. Ideally, an 
“indicator”, should be reliable, sensitive, quantifiable, and should provide the information on the 
nature of the hazard (agent/process involved) and the source of the risk. For evaluation of an indicator, 
its relevance and value for predicting problems affecting human health, animal health, animal welfare 
and/or plant health should be confirmed. Moreover, tools and methods for the detection and 
measurement of an indicator and for effective monitoring should be in place. 
Based on this definition the TECHNICAL REPORT “Towards a methodological framework for 
emerging risk identification” (Supporting Publications 2012:EN-243) describes the main steps for a 
simplified framework for emerging risk identification (ERI). ERI systems, aim specifically at 
identifying risks pro-actively before they have any impact or at an early stage of development. Whilst 
not specifically designed for ERI, in certain cases early warning systems can be useful in the detection 
of emerging risks. Some past examples for emerging risks in this meaning are presented in chapter 
3.2.2. 
Within this chapter, “emerging chemicals” are understood as chemicals that have been taken up by 
HBM programmes in more recent year because they have been considered a new “emerging” threat.   
Within the reviewed HBM programmes, several emerging classes of chemicals have been added to 
their latest survey cycles. The Japanese JECS, Germany’s GerES (GerES V), Flanders’ FLEHS (Den 
Hond et al., 2013), Canada’s CHMS (CHMS 3) (http://www.eu-
hbm.info/cophes/HealthCanadasBiomonitoringApproachDHaines.pdf) , and the USA’s NHANES 
(survey cycles after 2009) (http://www.cdc.gov/exposurereport/pdf/NER_Chemical_List.pdf) have 
measured parabens (such as butyl/ethyl/methyl/n-propyl parabens), acrylamide/glycidamide, and 
perchlorate for the first time, suggesting a need to monitor the exposure of these emerging chemicals 
and to investigate their possible sources.  
Perfluorinated compounds (PFCs) have been reported as another group of “emerging” chemicals. In 
December 2013, high levels of multiple PFCs (particularly PFOA, PFOS and PFHxS) had been found 
in serum samples of Swedish children who might be exposed to such PFCs via contaminated drinking 
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water coming from a municipal waterwork situated near a fire drill site. The average levels found in 
the serum samples of 1 016 subjects living near this area were 290 ng/mL for PFOS, 256 ng/mL 
PFHxS and 16 ng/mL for PFOA. Research on the potential health risks from exposure to PFCs is 
currently ongoing (http://www.skane.se/sv/Webbplatser/Labmedicin_Skane/Verksamhetsomraden/ 
Arbets--och-miljomedicin/Aktuellt-om-PFAS/ (only in Swedish)). In addition, a study had shown all 
tested drinking water samples from the Rhine-Ruhr area in Germany to be contaminated with PFCs 
(particularly PFOA at concentrations to 0.5 µg/L), most likely due to waste materials contaminating 
the soils near the river area (Skutlarek et al., 2006). Subsequently, the Drinking Water Commission of 
the German Ministry of Health conducted a provisional toxicological assessment of PFOA and PFOS 
and established a “strictly health-based guidance value for safe lifelong exposure of all population 
groups” for combined PFOA and PFOS concentrations at 0.3 µg/L (TWK, 2006). The CONTAM 
Panel of EFSA established TDIs of 150 ng/kg body weight per day and 1.5 µg/kg body weight per day 
for PFOS and PFOA, respectively (http://www.efsa.europa.eu/en/press/news/contam080721.htm). 
Although it is currently not clear the health risks associated with exposure to PFCs, PFCs are known to 
be persistent in the body, therefore warranting further research on the potential health effects 
associated with the long-term exposure of PFCs. 
Parabens are anti-microbial preservatives commonly used in personal care products. Furthermore, 
two parabens [methylparaben (MeP) and ethylparaben (EtP)] are used for preservation of certain 
foods. The Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact 
with Food (AFC) published an opinion on the safety of using parabens (additives E 214-219) in foods 
in 2004. The Panel concluded that a group ADI (Acceptable Daily Intake) of 0-10 mg/kg body weight 
per day could be established for methyl and ethyl parabens and their sodium salts. However, the panel 
considered that propyl paraben could not be included in this group ADI due to effects on sperm 
production observed at a relatively low dose in male juvenile rats, for which no clear NOAEL (No 
Observed Adverse Effect Level) could be identified. In the meantime there are some of the national 
HBM programmes have reported human excretion of parabens. For example, excretion of parabens in 
school children and their mothers in Denmark were lower than reported values in US (Frederiksen et 
al., 2013).  
Acrylamide and its metabolite glycidamide are particular of high interest regarding food safety. The 
observation of normally-occurring background levels around 0.03 nmol/g globin in non-
occupationally exposed persons raised questions about sources of this background level, and formation 
of acrylamide during cooking (especially foods with high carbohydrate content) at elevated 
temperatures was identified. Coffee, fried potato products, bread, biscuits and breakfast cereals 
were further identified as major sources. A background level of 0.030 nmol/g Hb of the acrylamide 
adduct was calculated to correspond with an intake of 1.2 μg/kg bodyweight per day, which was 
higher than the 0.5 μg/kg bodyweight per day calculated from consumption statistics and measured 
levels of acrylamide in foods (Knudsen & Hansen, 2007). The BE value of 13-130 µg/L urine has 
been set as HBGV for acrylamide.Clinical symptoms of the peripheral nervous system, irritation of 
skin, eyes and the respiratory tract, and general discomfort of headache, dizziness and nausea. 
Acrylamide has been classified as a Group 2A carcinogen (probable carcinogenic to humans) by 
IARC, and a proxy NOAEL value of 0.51 nmol/g globin was estimated for symptoms of numbness or 
tingling in feet or legs (Knudsen & Hansen, 2007).  
Perchlorate is a man-made chemical that is used to produce rocket fuel, fireworks, flares and 
explosives and is a naturally occurring chemical. Perchlorate can also be present in bleach and in some 
fertilizers. Food areas of concern for Perchlorate contamination are mainly drinking water, but 
also fruits and vegetables (particularly leafy vegetables/herbs grown in glasshouse). In the USA, 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 136 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
an oral RfD of 7 x 10
-4
 mg/kg day has been set whilst the levels in the general population have been 
monitored in the last round of NHANES with a GM mean of 2.97 µg/L and a P95 of 12.8 µg/L. 
DINCH: The commonly used phthalate substitute, 1,2-cyclohexane dicarboxylic acid diisononyl ester 
(or better known by its trademark name ‘Hexamoll DINCH’) has not commonly been analysed in 
HBM programmes (with the USA’s NHANES as an exception). In a retrospective analysis of samples 
from the German Environment Specimen bank, it was observed that almost all the urinary samples of 
the participants (mainly children) had detectable levels of oxidized DINCH metabolites and that 
DINCH exposure in children appeared to be 5 times higher than that of adults. This was considered as 
a consequence of DINCH being introduced into the German market since 2002 and currently being 
used as a plasticiser substitute for phthalates such as DEHP and DINP besides other in food contact 
materials (Schutze et al., 2013). The AFC Panel of EFSA established a TDI of 1 mg/kg body weight 
per day for DINCH (EFSA AFC Panel, 2006), and in 2014, the German Commission established  
HBM-I values of 3.2 and 4.8 mg/L for children and adults, respectively. 
Imidacloprid (IMI) has been reported to be applied as an insecticide on crops like apples, tomatoes 
and sugar beets. It is currently one of the most used neonicotinoids as it is distributed in more than 
120 countries. Recent studies have reported cellular changes and cytotoxicity in mammalian neurons 
and human cell lines, respectively, after exposure to IMI (Kimura-Kuroda et al., 2012; Mesnage et al., 
2014). This raises the concern of the possible adverse effects in human health and warrants a need to 
monitor the IMI levels in humans. In 2013, EFSA’s Panel on Plant Protection Products and their 
Residues (PPR) reviewed the open scientific literature on IMI and concluded that IMI shows 
developmental neurotoxic potential and adverse effect on neuronal development (EFSA PPR Panel, 
2013). Although IMI has not been measured in the investigated HBM programmes, a pilot study was 
conducted in 2013 to measure IMI levels in hair specimens of urban and rural residents in Crete. His 
study showed that 65.6% of the rural but none in the urban population had positive levels of IMI with 
27 ng/mg as the highest detected level among the samples (Kavvalakis et al., 2013). According to 
European Commission’s Directive 08/116, an ADI of 0.06 mg/kg bw per day has been established for 
IMI (http://ec.europa.eu/food/plant/protection/evaluation/3010_rev_181208.xls). 
Pyrethroids: Pyrethroids are insecticides widely used in and around households, including on pets, in 
mosquito control, and in agriculture. The use of pyrethroids has increased during the past decade with 
the declining use of organophosphate pesticides. Several national HBM programmes have recently 
measured levels of pyrethroids via their metabolites. ENNS results show the highest geometric mean 
levels for all of the pyrethroid metabolites, followed by GerES (although the results are exclusively 
focused on children), CHMS, and NHANES.  In 363 serum samples obtained from non-occupationally 
exposed adults from Tenerife, Spain, 96.1% had detectable levels of pyrethroids with bifenthrin being 
the most prevalent type (Burillo-Putze et al., 2014). Another study reported detection of multiple 
pyrethroids (e.g. lambda-cyhalothrin, bifenthrin, and esfenvalerate) in human breast milk samples 
which increased along with the increased use of pyrethroids, yet the estimated daily intake values of 
nursing infants were always below the ADI levels (Corcellas et al., 2012). One study from Germany 
reported that the pyrethroid exposure of the general population (1 177 inhabitants in the Frankfurt 
area) is most likely attributable to dietary exposure of pyrethroid (Schettgen et al., 2002). 
Paracetamol (or N-acetyl-4-aminophenol, NAAP). Paracetamol is an over-the-counter drug used by 
many populations and excreted in the urine. Recent studies in Germany and Denmark showed that 
there is a ubiquitous body burden of NAAP in Danish mothers and children even when paracetamol 
analgesics had not been recently used. Hence, several unknown sources of NAAP/paracetamol 
exposure have to exist. An association in NAAP excretion between the mothers and their children 
could indicate common lifestyle-related exposure (e.g. via food or indoor air sources). However, 
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association between lifestyle data from questionnaires and levels of NAAP excretion has not been 
found yet. The knowledge about possible sources of exposure leading to this omnipresent paracetamol 
excretion is limited, and further investigation is needed (Nielsen et al., 2014). 
4.2.2. Exposed sub-groups and vulnerable population groups as identified in 
HBM programmes 
Possibly higher exposed sub-groups or specifically vulnerable groups of a population with higher 
susceptibility are of special interest in HBM programmes because they are at higher risk of adverse 
health effect upon exposure of chemicals. Many HBM programmes stratify the data according to 
various factors in order to determine the potential risk factors of higher body burden. In this chapter, 
we present the outcomes from HBM investigations, with a particular focus on the exposure to foods. 
HBM programmes, such as France’s ESTEBAN or the USA’s NHANES, collect participants of all 
ages; hence, age stratification analyses are often conducted to determine the chemical levels among 
different age groups. In addition, emerging HBM programmes are starting to focus only on specific 
populations. For example, the German GerES has performed the last 2 survey cycles focusing on 
children and adolescents, and the French ELFE cohort study intends to follow up on the children in 
France until adulthood. In Norway, South Korea, and Japan, there are also multiple HBM studies 
determining the exposure of chemicals in pregnant women and following up on the exposure in their 
newborns. On the European level, programmes such as NewGeneris and PHIME reported HBM data 
from birth cohorts, and such data has been included in the HELIX program, providing information 
about fetal exposures from measurements in cord blood. The first harmonised European cross-
sectional survey DEMOCOPHES included school children and their mothers and was able to 
demonstrate age differences in body burdens. 
4.2.2.1. Pregnant women and newborns 
Pregnant women and their newborns are particularly populations with high susceptibility risks as 
chemical exposure in pregnant women could result in prenatal exposure of chemical in newborns via 
the placenta. Numerous HBM studies have already shown that the prenatal exposure to chemicals in 
infants could result in some adverse health effects. For example, it was observed from the French 
ELFE study that pregnant women have a significant exposure to phthalates, reflecting a potential high 
exposure in the hospitals (Zeman et al., 2013), and findings from the South Korean MOCEH study 
suggested that prenatal exposure to phthalates may be inversely associated with the neurodevelopment 
of infants (Kim et al., 2011b). In the Flanders’ FLEHS study, a strong correlation for Pb, As, and Tl 
was found between levels in cord blood and maternal blood, suggesting that these metals are 
transported to the fetus from the mother (Baeyens et al., 2014), and it appears that prenatal exposure to 
metals have adverse effects on newborns. The MOCEH study indicated a negative relationship 
between maternal Pd and Cd levels during late pregnancy period and neurodevelopment (Kim et al., 
2013b). The EU-wide DEMOCOPHES project showed elevated levels of methyl mercury in fish 
eating subgroups of the investigated populations (i.e. mothers), and the Norwegian MoBa cohort study 
reported negative association between maternal exposure to mercury (via reported dietary intake 
during pregnancy) and birth weight(Vejrup et al., 2014). The Japanese Tohoku HBM study also 
reported a negative relationship between maternal hair mercury level and motor abilities of infants 
(Suzuki et al., 2010).  
Aside from phthalates and metals, the MoBa study also showed that maternal exposure to dioxins, 
PCBs, or benzo(a)pyrene resulted in decreased birth weight (Duarte-Salles et al., 2013a; 
Papadopoulou et al., 2013), and the Japanese Hokkaido HBM study observed lower birth weight, 
higher risk of infections in infants, and reduced motor development due to maternal exposure to 
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PFOS, 2,3,4,7,8-PeCDF, and PCDDs, respectively (Konishi et al., 2009; Miyashita et al., 2011; 
Nakajima et al., 2006; Washino et al., 2009). Collectively, these studies emphasised the importance to 
monitor the chemical levels in pregnant women in order to reduce chemical exposure and health risks 
in newborns. 
4.2.2.2. Children 
Children are regarded as a population of high risk for health impairment due to behavioural tendencies 
(e.g. hand-to-mouth contact, crawling, chewing toys), making them more susceptible to chemical 
exposure, and interest in children’s environmental health is increased by rapidly rising rates of chronic 
disease in children of asthma, cancer, autism, attention-deficit/hyperactivity disorder, birth defects, 
obesity, and diabetes (Landrigan & Etzel, 2014). Chemicals also have different effects on children 
than adults because of the ongoing body development in children. The impairment in 
neurodevelopment due to childhood lead exposure is a well-known example of this disparity (Becker 
et al., 2008). In 1993, a report of the US National Academy of Sciences (NAS) published a report on 
pesticides in the diets of infants and children identifying the following four differences between 
children and adults increasing the susceptibility to pesticides and other toxic chemicals(National 
Academy of Sciences, 1993): 
1. Children have proportionately greater exposures than adults to toxic chemicals on a body 
weight basis as children have a larger surface to volume ratio and more permeable skin. 
The respiratory rates are higher and the food intake per kg body weight higher. Further the 
age related behaviors further magnify their intake from the environment 
2. Children’s metabolic pathways are immature which may imply longer half-lives in the 
body of environmental chemicals. 
3. Children’s extremely rapid but exquisitely delicate developmental processes are easily 
disrupted which is associated with windows of vulnerability most frequently reported 
related to fetal development, however persisting throughout childhood. 
4. Children have more time than adults to develop chronic diseases that may be triggered by 
environmental exposures in early life related to diabetes and cardiovascular risk (Barker, 
2004). 
These observations have been summarized in Table 20. 
Table 20 Summary of children’s vulnerability to environmental health hazards (Bearer, 1995; 
WHO & EEA, 2002) 
Developmental 
stage 
Developmental 
characteristics 
Exposure Vulnerability 
Preconception Lack of awareness of 
gonadal exposure 
All environmental exposures Potential for genotoxicity 
Pregnancy High calory intake 
Permeable placenta 
All environmental exposures 
Ad-hoc diagnostic 
investigations 
Potential for teratogenicity 
due to embryonic 
development of various 
organs and apparatuses 
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Developmental 
stage 
Developmental 
characteristics 
Exposure Vulnerability 
First three years Oral exploration 
Beginning to walk 
Stereotyped diet 
Food (milk and baby foods) 
Air (indoor) 
Water 
Mattress/carpets/floor 
Potential for damage to 
brain (synapses) and lungs 
(developing alveoli) 
Allergic sensitization 
Injuries 
Preschool and 
school-age child 
Growing independence 
Playground activities 
Food (milk, fruit, vegetables) 
Air (indoor and outdoor) 
Potential for damage to 
brain (specific synapse 
formation, dendritic 
trimming) and lungs 
(volume expansion) 
Injuries 
Adolescence Puberty 
Growth spurt 
Risk-taking behavior 
Youth employment 
Food (any) 
Air (indoor and outdoor) 
Water 
Occupational exposure 
Potential for damage to 
brain (continued synapse 
formation), lungs (volume 
expansion) and pubertal 
development 
Injuries 
 
Among the existing HBM studies, phthalates have shown to be a major concern for children as HBM 
studies and programmes from Denmark, Germany (GerES), and the USA (NHANES) all showed that 
children had higher body burden of several phthalate metabolites than adults (Becker et al., 2009; 
Calafat et al., 2011; Frederiksen et al., 2014). In addition, the GerES found that levels of 
organochlorine pesticides (such as HCB, HCH, and DDE) in children decreases with increasing age 
(Kolossa-Gehring et al., 2008), and data analysis from the NHANES survey showed that children aged 
6-11 had the highest urinary level of the PAH metabolite 1-hydroxypyrene compared to adolescents 
and adults (Huang et al., 2006; Li et al., 2008). Other scientific HBM studies also indicated higher 
levels of PBDEs and fluorocarbons (PFOA/PFDA/PFNA) in children aged 1.5-9 than other subjects 
aged 9 or older (Lunder et al., 2010; Toms et al., 2009). These studies emphasises the need of HBM in 
children in order to generate the data appropriate for accurate risk assessment and management 
regarding children’s exposure to chemicals. 
4.2.2.3. Socioeconomic, regional and gender factors 
Aside from age, study designs of many HBM programmes often include data collection of multiple 
factors from participants such as gender, living environment (urban vs. rural), SES, lifestyle habits 
(e.g. smoking, vegetarians), medical history (e.g. diabetes), etc. These factors have been proven useful 
for determining additional risk factors of higher body burden of chemicals. Table 21 shows a brief 
overview of the HBM findings associating different factors with chemical exposure. 
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Table 21 Factors that affect body burden of chemicals observed in HBM programmes 
Factors HBM findings 
Gender GerES IV: Boys had higher levels of As, Hg, and PCBs (except for PCB 138) than girls. 
ENNS/NHANES: Women had higher Cd levels than men. 
BIOAMBIENT.ES/PROBE/CHMS/KorEHS-C: Males had higher blood Pb level than 
females. 
PROBE: Men had higher blood Hg, Pd, and W levels than women while women had 
higher blood Co, Rh, V levels than men. 
CZ-HBM: Women had higher blood and urinary Hg levels than men. 
CHMS: Men had higher levels of PFOS than women, whereas women had higher levels 
of DDE than men. 
NHANES: Women had higher urinary parabens levels than men. 
KorSEP: Women had higher levels of urinary phthalate metabolites than men. 
SES GerES IV: Children with high SES had higher levels of PCBs, DDE, HCB, and β-HCH 
than children with low SES. 
CHMS: People with low household income had higher blood lead levels than people with 
high household income. 
NHANES: People with high household income had higher triclosan levels than people 
with low household income. 
KorSEP: Subjects with lower income had higher levels of urinary phthalate metabolites. 
KorEHS-C: Children with less educated parents had higher blood Pb level than children 
with higher educated parents. 
Region GerES: Children from large communities had higher As and DDE levels than children 
from small communities. 
FLEHS: People living in rural areas or near industrial hot-spots (i.e. waste incinerators, 
smelt plant) had higher exposure to persistent chlorinated compounds or metals such as 
Cd and Cu, respectively, compared to their respective control groups. 
CZ-HBM: Levels of indicator PCB congeners in breast milk samples in PCB hot-spots 
area of Uherské Hradiště were reported. 
Slovenia HBM: Children from rural areas had higher blood Cd and Pb levels than children 
from urban areas. Blood and urine Hg levels were higher in children from urban areas. 
Adults from urban areas showed the highest As level. 
KorEHS-C: Children from urban areas had higher levels of Pb. 
Smoking GerES/ENNS/PROBE/CZ-HBM: Increase Cd levels 
PROBE/CHMS: Increase Pb level 
NHANES: Increase urinary PAH and haemoglobin acrylamide adduct levels 
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In summary, most HBM programmes take age, gender, regional and socioeconomic strata, and 
lifestyle habits into account. However, specific populations such as vegetarians, people with illnesses 
such as diabetics, and ethnic groups (except for Canada’s CHMS and USA’s NHANES) are often 
excluded from HBM studies for reasons of representativity and thereby generalisability. 
4.2.2.4. Older adults 
As a part of the aging process, the body gradually deteriorates and physiologic and metabolic 
limitations arise. Changes that occur in organ anatomy and function present challenges for dealing 
with environmental stressors of all kinds, ranging from temperature regulation to drug metabolism and 
excretion. The elderly are not just older adults, but rather are individuals with unique challenges and 
different medical needs than younger adults. The ability of the body to respond to physiological 
challenge presented by environmental chemicals is dependent upon the health of the organ systems 
that eliminate those substances from the body. Any compromise in the function of those organ systems 
may result in a decrease in the body's ability to protect itself from the adverse effects of xenobiotics. 
With increasing life expectancy, more and more people will confront the problems associated with 
advancing years. Moreover, although proper diet and exercise may lessen the immediate severity of 
some aspects of aging, the process will continue to gradually degrade the ability to cope with a variety 
of injuries and diseases. Thus, the adverse effects of long-term, low-level exposure to environmental 
substances will have a longer time to be manifested in a physiologically weakened elderly population. 
When such exposures are coupled with concurrent exposure to prescription medications, the effects 
could be devastating (Risher et al., 2010).  
Among the HBM programmes, it has been observed that several metals appear to accumulate in the 
elderly population. FLEHS findings showed that the highest levels of total Hg in blood were found in 
the elderly (aged 50-65) (Croes et al., 2014), and the PROBE study also showed that both blood lead 
and palladium concentrations increased with age (Alimonti et al., 2011). The Slovenian HBM study 
found that the blood cadmium, blood lead, and hair mercury levels were the highest among the older 
women (aged 50-60) compared to children or adults (Tratnik et al., 2013). Aside from metals, urinary 
levels of phthalates also appeared to be higher among subjects with older age in the South Korean 
KorSEP study (Lee et al., 2011), and a scientific HBM study from Australia observed the highest level 
of PFOS in the serum of subjects aged 60 or older (Toms et al., 2009). These findings suggest slower 
clearance of these chemicals out of the body. Therefore, it is likely that the elderly is at a higher risk of 
developing adverse effects from exposure to chemicals, making it important to monitor the chemical 
levels in the elderly within a HBM programme. 
4.2.3. Reference values and health-based guidance values 
4.2.3.1. Reference values  
Reference values permit to assess the exposure of individuals or population groups compared to the 
ubiquitous background exposure. They indicate the upper margin of a measured pollutant 
concentration level in the general population to a given environmental toxin at a given time. Since 
environmental conditions are changing reference values have to be checked and updated continuously. 
Reference values are strictly statistically derived values, and do not represent health-related criteria for 
the evaluation of human biological monitoring data. According to the calculation from the 
International Union of Pure and Applied Chemistry (IUPAC), a reference value is defined as the 95
th
 
population percentile (P95) along with the 95% confidence interval (CI) of a substance‘s concentration 
(Poulson et al., 1997).  
HBM programmes have been proven to be useful in establishing reference values, which can be used 
to determine individuals of possible high exposure to chemicals. Usually, stratification by age or by 
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gender has been performed among the programmes. Several HBM programmes such as FLEHS 
(Flanders) and ENNS (France) have released such values in their reports, and other programmes such 
as GerES (Germany) and PROBE (Italy) have specifically published RVs based on this definition 
(Bocca et al., 2013; Schulz et al., 2012b). Among the reviewed HBM programmes, there are a total of 
165 substances with a reported reference values (Table 40 in Appendix C. ). The overview of the 
reference values for most studied chemicals within these HBM studies are reported in Appendix Table 
43 
The purpose of using RVs is to identify and assess the potential high-risk exposure of individuals or 
population groups when compared to the background population exposure, but it should be 
emphasised that RVs do not represent toxicologically derived biological exposure limits and should 
not be used for health-related evaluation of HBM data (Bocca et al., 2013; Schulz et al., 2009). For 
consideration of potential health risks from chemical exposure, several health-based guidance values 
have been developed. 
4.2.3.2. Health-based guidance values 
In food risk assessment, a number of authorities at European and international level, particularly 
EFSA, the FAO/WHO, and US EPA, aim at setting an exposure level of chemicals that show no 
appreciable health risk. Such values in risk assessment are known as health-based guidance value 
(HBGV).  
The establishment of a HBGV, is commonly based on a reference point (RP) derived from 
mathematical modelling of the dose-response relationship. The EFSA Scientific Committee 
recommended the use of a benchmark dose lower confidence limit (BMDL) as the RP (EFSA, 2009). 
If modelling is not considered appropriate, another RP may be used such as the no-observed-adverse-
effect level (NOAEL). The HBGV is established by dividing the RP by uncertainty factors to account 
for extrapolation from animals to humans and for variability in human sensitivity (Alexander et al., 
2012). Depending on the RP, EFSA and FAO/WHO establish HBGVs such as acceptable or tolerable 
daily/weekly intakes (ADIs/TDIs/TWIs), whereas the US EPA determines reference doses (RfD). If 
human exposure to the substance from food and other sources is below the HBGV, competent 
authorities usually conclude that such exposure does not pose an appreciable risk to human health.  
The HBGV approach, however, is valid only for chemicals that have thresholds of toxicity (i.e. non-
genotoxic chemicals) whilst another approach needs to be developed for genotoxic 
chemicals/substances. 
For genotoxic substances, the EFSA Scientific Committee proposed the margin of exposure (MOE) 
approach as a harmonised approach for the risk assessment of substances that are both genotoxic and 
carcinogenic. The MOE is the ratio between a defined point on the dose-response curve for the adverse 
effect and the human intake, and therefore, it makes no implicit assumptions about a “safe” intake 
(EFSA, 2005). The MOE approach, similar to the setting of a HBGV, uses an RP on the dose-response 
relationship, corresponding to a dose that causes a low, but measurable cancer incidence in animals. 
This RP is then compared with various dietary exposure estimates in humans, taking into account 
differences in consumption patterns. The MOE approach is not confined to substances that are 
genotoxic and carcinogenic and it can also be applied to cases where the data are insufficient or 
otherwise considered inappropriate to establish a HBGV.  
Collectively, EFSA, FAO/ WHO and US EPA have derived HBGVs for 187 of the reviewed 
substances in this report.   
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 143 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Apart from to a number of heavy metals, dioxins (TCDD) and polychlorinated Biphenyls (PCBs), 
polybrominated diphenyl ethers (PBDE), pentachlorophenol (PCP), bisphenol A (BPA), phthalate 
metabolites, arcylamide, and triclosan, the authorities have established a large number of HBGVs for 
perfluorinated compounds (PFCs), perchlorate, monochlorpropane, and a wide range of pesticides. 
Furthermore, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) has derived and 
reported HBGVs for an extensive list of chemicals used in food additives, as flavouring agents, in food 
preservatives, veterinary drugs, etc.  
An overview on HBGVs developed by European and US authorities as well as FAO/WHO is provided 
in Table 41 of Appendix C. while a list of pesticides with EU limit values from the EU Pesticides 
Database is provided in Table 42 of Appendix C.  
4.2.3.3.  HBM and BE values 
From the point of view of human biomonitoring health based guidance values are considered as values 
that allow for interpretation of HBM survey data for risk management purposes. Such values called 
“Human Biomonitoring Values” (HBM-I and HBM-II) in Germany or Biomonitoring Equivalents 
(BE) in the USA translate established reference values (e.g. TDIs, RfDs) into a biomarker 
concentration (Angerer et al., 2011). 
The German Commission has defined and derived health-related human biomonitoring values (HBM-I 
and HBM-II), based on reported human toxicological and epidemiological studies. HBM-I serves as a 
control value and represents the concentration of a substance in human biological matrix below which 
there is no risk for adverse health effects and consequently no need for action. Concentrations higher 
than HBM-I but lower than HBM-II should be reanalysed. HBM-II serves as an action value and 
represents the concentration of a substance in a human biological matrix above which there is an 
increased risk for adverse health effects and consequently a need for exposure reduction measures and 
the provision of biomedical advice or care. 
BEs are defined as the concentrations of chemical (or metabolite) in a human biological matrix 
consistent with exposure guidance values such as TDI, RfD, or any risk specific (e.g. cancer) doses 
(Hays & Aylward, 2012). Similar to HBM values, BEs serve as a basis for risk assessment and 
management such that concentrations above BEs should prompt for follow-up analysis, evaluation of 
exposure sources, and a call for reduction in exposure. BE values are interpreted as follows: measured 
concentrations below the BEs derived from the RfD (BERfD) suggest a low priority for risk assessment 
follow-up; meanwhile, concentrations above the BEs derived from the point-of-departure (BEPOD) 
suggest high priority. Concentrations between BERfD and BEPOD would be considered as medium 
priority (Aylward & Hays, 2008).  
HBM values have been established for 10 chemicals thus far (Cd, Hg, Tl, PCBs, PCP, BPA,  glycol 
ether, phthalates DEHP and DPHP, and phthalate substitute DINCH) due to the lack of relevant 
human studies (UBA, 2014). However, the German Commission recently shifted towards an 
alternative approach using estimates such as ADIs and known uncertainties to derive HBM values for 
substances with no appropriate human studies. HBM values for the phthalate DEHP have already been 
established via this method (Schulz et al., 2012b), and HBM-I values for the another phthalate DPHP 
and phthalate substitute DINCH have recently been derived (Kolossa-Gehring et al., 2014).  
In addition, BEs for 56 chemicals have been derived as of 2014, which 20 of these established values 
have been reviewed in this report. Such BEs comprise heavy metals (As, Cd, Se), PBDE99, BPA, 
triclosan, pthtalate metabolites, acrylamide, the herbicide 2,4-D, and two pyrethroids (Cyfluthrin and 
Deltamethrin). An overview of all HBM and BE values has been summarised in Table 43 of Appendix 
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C. Overall, as depicted in Figure 14, a comparison among HBM reference values, HBM values, BEs 
values and the HBGVs from EFSA, FAO/WHO and the US EPA shows that there is a significant lack 
of overlaps between HBM-established reference values and HBGVs. A total of 118 out of 187 
reviewed substances with HBGVs that do not have an established HBM RV mostly due to the lack of 
HBM data for several classes of pesticides, mycotoxins, 3-MCPD, etc. (refer to Table 40-42 of 
Appendix C. ). On the other hand, there are 92 out of 165 substances with established HBM RVs that 
do not have HBGVs. This comparison however, is somehow biased, as it is mainly due to the number 
of RVs for individual dioxin and PCB congeners and differentPFCs. This constitutes a major deficit 
for efficient use of HBM in food risk assessment, which needs to be overcome. 
 
 
Figure 14 The number of overlaps and non-overlaps among the reviewed HBM-established 
reference values (RVs; green), health-based guidance values (HBGVs; orange), HBM values (blue) 
and biological equivalent values (BE; red) 
The fact that use of HBM in conjunction with HBGVs would provide high added value shall be 
illustrated at this point with a recent example. In 2014, the EFSA CONTAM stated in its scientific 
opinion on the risks for human and animal health related to the presence of modified forms of certain 
mycotoxins in food and feed that the upper bound of the 95
th
 percentile exposure to zearalenone was at 
least 2.2-fold the TDI and that the fumonisin exposure of toddlers and children exceeded the 
provisional maximum TDI (PMTDI), which could be of concern (EFSA CONTAM Panel, 2014). A 
verification of this estimate would be urgently needed to be able to take measures accordingly. 
4.2.4. Inventory of validated biomarkers of exposure to chemicals  
This chapter provides an overview on biomarkers of exposure to chemicals that have been identified in 
the investigated HBM surveys, and for which sufficient evidence for validity was considered 
available. 
BMs of exposure are an exogenous substance or its metabolite or the product of an interaction between 
a xenobiotic agent and some target molecule or cell that is measured in a compartment within an 
organism. Ideally the biomarker is associated with the overall individual exposure providing a measure 
of the internal dose. Biomarkers also ideally are sensitive, specific, biologically relevant, feasible, 
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practical and inexpensive. However, existing BMs do not commonly meet all of these criteria. Most 
biomarkers represent a compromise. Some BMs are stable over time while others reflect exposures 
with very short half-life. Some markers are easy to measure with standard laboratory techniques, 
whilst others require highly sophisticated techniques (see chapter 3.4).  
Most of the biomarkers used in population studies are covered by standard operating procedures 
(SOPs) as well as by internal and external quality assessment schemes. Therefore, HBM results from 
the leading laboratories worldwide are analytically reliable and comparable. A number of sensitive 
analytical methods have been developed to measure low concentrations including trace amounts of 
various chemicals in biological samples such as urine and blood. There are specialised laboratories 
that are able to elaborate the analytical prerequisites for chemicals that gain political or scientific 
interest in limited time. However, even these laboratories are challenged to keep up with the progress 
in instrumental analyses.  
The choice of matrix and biomarker depends on factors such as physio- and toxicokinetics, the validity 
(specificity and sensitivity) and toxicological significance of the biomarkers available, their stability 
and reproducibility, the purpose of the HBM program, the size and characteristics of the study 
population, etc. Further important aspects are an estimate of the cost-benefit and/or risk-benefit 
analysis, and an evaluation of the ethical procedures and constrains (Manno et al., 2010b).  
In general, urinary concentrations are not necessarily directly informative about concentrations at 
target tissues of interest in the body. However, as urine collection is a non-invasive procedure that is 
easily applicable for almost all population (sub-) groups, it remains an essential matrix in all 
population HBM surveys or for studies that require repeated sampling. Blood biomarker 
concentrations provide a measure of exposure that is more closely related to target tissue 
concentrations. However, relationship between the biomarker being measured and the toxicologically 
active compound has to be taken into account (Smolders et al., 2009; Aylward et al., 2014). 
Sometimes the ratio between the concentration of a metabolite product and that of the parent chemical 
in blood or urine is the biomarker and not the chemical or the metabolite per se. (Manno et al., 2010a). 
For further information, see chapter 3.4. The selection of the matrix and the biomarker is a matter of 
the pharmacokinetics of the substance in question, balanced with the invasiveness of sampling, 
analytical complexity and related costs. Finally comparisons with existing data from other programs 
and RVs may also guide your choices.One major limitation for use of HBM in risk assessment is the 
fact that the measurement of a BM alone cannot provide information how long a chemical has been in 
the body, and that many factors may affect the quality of the samples and the variability of 
measurement results in particular for substances with short half-lives and for low tissue levels. As 
biomarker concentrations vary both within and between individuals, the variation in biomarker 
concentrations observed in a population biomonitoring study is not always easy to interprete. For 
further details, please see chapter 3.4.1.  
Against this background validity of BMs must be ascertained in order to consider biomarker analyses 
as useful for risk assessment. In general, a need to refine and validate biomarkers of exposure follows 
the introduction of new chemicals (e.g. perfluorinated compounds and brominated flame retardants) to 
be monitored and increased interest in detecting lower exposure levels. Schulte and Mazzuckelli 
(1991) describe in detail the internal and external validities BMs need to have. Briefly, validation of a 
biomarker requires the measurement to be an appropriate reflection of the “phenomenon under study.” 
This means that a valid biomarker of exposure should reliably and accurately reflect the level of the 
internal dose (target tissue concentration and the temporal exposure pattern of the chemical of 
interest), and can be measured in a robust, consistent and reproducible way, without ethical, financial 
legal or regulatory issues that would prevent use. This requires a validation of the analytical test 
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methods (sample preparation, reagents, etc.) demonstrating besides other appropriate selectivity and 
specificity, accuracy, precision, reproducibility, and analyte stability. Furthermore, the validation 
process includes measurements among heterogeneous populations of appropriate sample sizes with 
reliable and reproducible findings that can be generalised to other populations. Validation is 
furthermore related to internal and external quality checks of the analytical methods with repeated 
analyses.  
Following these criteria for the validation of a biomarker (i.e. reproducible findings from 
heterogeneous populations of large sample sizes with internal and external quality checks), biomarkers 
from HBM programmes with a large sample size of more than 1000 participants, completed chemical 
analyses, and internal and external quality checks specified in the respective literature sources have 
been considered as validated biomarkers in this report. 
For metals, dioxins, furans, PCBs, PBDEs, parabens, and mycotoxins etc., direct measurement of the 
parent compounds in the matrices (blood, urine) are commonly used as validated BM of choice for 
exposure assessment.  
In contrast, one or several metabolites or haemoglobin adducts are used as validated BM of exposure 
for substances (groups) such as phthalates, polyaromatic hydrocarbons, organophosphate pesticides, 
organochlorine pesticides, acrylamide, nitrosamine, and pyrethroid pesticides, etc.).  
It is promising that 8-OHdG is envisaged to be analysed as first biomarker of oxidative DNA damage 
in two programmes that have recently been started to collect samples, so that results will be available 
in a few years. Unfortunately however, there are no validated BM in the investigated programmes for 
a large range of pesticides, veterinary pharmaceuticals, and food additives. 
A detailed compilation of the validated BMs identified in the investigated surveys is given in Table 39 
of Appendix B.  
This summary analysis however, shows that there is a lack of validated BM for a considerable number 
of substances for which health based guidance values (HBGVs) are set by EFSA or other risk 
assessment authorities (see chapter 4.2.3). This leads to major deficits in the current possibility to 
monitor substances of interest. 
4.2.4.1. Validated biomarkers and appropriate biological matrix  
Depending on the properties and the toxicokinetics of the chemical, blood and urine are the main 
biological matrices for measuring biomarkers of exposure in most HBM programmes. Nevertheless, 
there are also other non-invasive matrices such as hair and breast milk that are used to determine 
temporal exposure pattern and to measure chemical exposure in newborns, respectively.  
Blood is the predominant biological matrix for fluorocarbons, dioxins, furans, PCBs, BFRs, and 
organochlorine pesticides, as these chemicals are persistent in nature and can accumulate in the serum 
over a long period of time.  
Urine is the predominant biological matrix for phenols and chlorophenols, herbicides such as 2,4-D 
and 2,4,5-T, and metabolites of PAHs, phthalates, organophosphates, and pyrethroids, as these 
compounds are short-lived in the body and are quickly excreted. Also Cotinine is measured in urine in 
all the HBM programmes except for NHANES, which measures cotinine in serum for quantitative risk 
assessment purpose (CDC, 2013). 
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Breast milk is the preferred biological matrix for measurement of perinatal exposure to persistent 
contaminants. The biomarkers covered comprise mainly POPs (i.e. fluorocarbons, PCDDs/Fs, PCBs, 
BFRs, and organochlorine pesticides) and some metals (e.g. As, Cd, Hg, and Pb). The WHO released 
a guideline protocol in collaboration with UNEP for promoting reliability and comparability in 2007 
(WHO, 2007). Breast milk was used in ELFE (France), CZ-HBM (Czech Republic), national HBM 
programme in Slovenia, Uppsala Mothers programme in Sweden, the Hokkaido study (Japan), the 
Tohoku study (Japan), POPs in breast milk study (China). 
Keratinic matrices such as hair and nails are attractive biological samples for chemical exposure 
measurements because of the non-invasive collection and the stability of the measured substance due 
to its incorporation into the keratinic matrix.  
Hair has been analysed often for the exposure of heavy metals, especially methyl mercury (Esteban & 
Castano, 2009). Seafood consumption is known to be a major contributor of methyl mercury exposure, 
and several HBM programmes (Pirard et al., 2014; Puklova et al., 2010) and studies (Ip et al., 2004; 
Iwasaki et al., 2003) have found an association between total hair-Hg levels and fish consumption.  
Nails can also be employed to measure exposure of heavy metals such as As, Hg, Cd, and Pb (Hussein 
Were et al., 2008; Kim & Kim, 2011). The Finnish selenium HBM programme measured selenium 
levels in toenail as an indicator of long-term selenium exposure (Alfthan et al., 2014), and one study 
reported the relationship between the As concentrations in drinking water and As levels in toenails 
(Orloff et al., 2009).  
In contrary cadmium and lead levels measured in hair (Castano et al., 2012; Kim & Kim, 2011) may 
not reflect total body burden or may be highly variable (Esteban & Castano, 2009) and analysis of 
PFAS and nicotine/cotinine in nails (Liu et al., 2011; Stepanov et al., 2006) need further validation.  
The biggest drawback of using hair and nails is the possibility of external contamination as these 
matrices are exposed in the environment and chemicals could be easily deposited within these 
matrices. (Esteban & Castano, 2009). 
4.2.4.2. Emerging Biomarkers and biological matrices  
Novel biomarkers of exposure are being developed in saliva. Recently a portable and sensitive 
biosensor for the direct detection of trichloropyridinol (TCP), a specific biomarker of chlorpyrifos 
exposure, has been developed and the use of salivary carboxylesterase as biomarker for environmental 
organophosphate exposure have been reported (Bulgaroni et al., 2012; Zhang et al., 2013). Saliva is 
easy and simple to collect and inexpensive to analyse. However, there are drawbacks to using saliva 
due to small sample volume, low concentrations of analytes of interest, and the restriction to recent 
exposure (Caporossi et al., 2010). Further research is warranted to validate the use of saliva in HBM. 
Exposures are multifold and vary over time, which has raised the request of more integrated exposure 
assessment - exposome as described previously where biomarker data contribute as an element in the 
exposure characterisation. Similarly, adverse effects are multifold, and integrated biomarkers of 
effects predicting adverse health effects are requested by study persons, communities, medical doctors 
and others.  
Biomarkers of effect and the "exposome" are a current research priority. Much is expected from the 
new -omics technologies, where adverse effects may be traced at protein, RNA or DNA level at an 
early stage of disease development. An example is exhaled air analysis, which shows clear distinctions 
in proteins and metabolites between asthma and non-asthma patients.  
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The “exposome” concept was developed “to draw attention to the critical need for more complete 
environmental exposure data in epidemiological studies.” The exposome contains several overlapping 
domains of nongenetic factors contributing to disease risk, including a general external domain (social, 
societal, urban environment, climate factors), a specific external domain (specific contaminants, 
lifestyle factors, tobacco, occupation), gut microflora, inflammation, oxidative stress) (Wild, 2012).  
The exposome calls for improvement of often uncertain exposure data, for integration of data on 
biological mechanisms, and for a more holistic exposure approach in epidemiological studies. 
Furthermore, it has been proposed that the exposome may serve an important purpose in characterising 
not only the complex mixtures of already-identified exposures but also, through its untargeted 
approach and the use of high-throughput “omics” techniques, relevant exposures that have thus far 
remained unidentified (Rappaport 2011; Rappaport and Smith 2010).  
However, there are still large challenges in developing the exposome concept into a workable 
approach, including the consideration of multiple, longitudinal time periods of interest and of temporal 
variability, the acknowledgement of exposure uncertainty in an exposome study, the integration of 
omics data, and the development of powerful statistical techniques to analyse the associations between 
exposome data and adverse health end points (Vrijheid et al., 2014).  
Currently a number of ongoing EU-wide research projects have focused on developing the use of 
omics technology in HBM and in risk assessment. 
The EXPOsOMICS project (see chapter 3.7.19.8) is currently investigating the potential use of 
metabolomics, adductomics, transcriptomics, proteomics, and epigenomics in estimating the burden of 
environmental diseases (Vineis et al., 2013).  
The HELIX project (see chapter 3.7.19.9) has its general aim to implement tools and methods (e.g. 
biomarkers, omics-based approaches, remote sensing and GIS-based spatial methods, personal 
exposure devices, statistical tools for combined exposures, and burden of disease methodologies) to 
characterise early-life exposure to a wide range of chemical and physical environmental factors and to 
associate these with data on major child health outcomes (e.g. growth and obesity, neurodevelopment, 
respiratory health), thus developing an “early-life exposome” approach. (Vrijheid et al., 2014).  
The HEALS project (see chapter 3.7.19.10) introduces the integrated approach to health risk 
assessment. The external exposome will be derived by data and model fusion using algorithms for 
mining existing environmental monitoring datasets and ubiquitous sensing using geo-localised sensors 
and mobile phones and the coupling of these data with agent-based models. 
4.3. Political challenges and obstacles in the European Union 
In the light of the huge and constantly increasing number of chemicals on the European market, there 
is need for tools that may identify or verify exposure of human to substances of concern that can be 
used in risk assessment in several policy areas including risk assessment of food safety. In addition to 
regulatory processes, the development of processes and tools for the identification of “emerging” 
hazards (pollutants of concern) has been requested by European institutions and by EFSA in particular 
(see chapter 4.2.1). For this reason, there is a need for appropriate tools that can be used for 
identification of human exposure.  
HBM is becoming more acknowledged as a tool for human exposure assessment. As an example, the 
European Committee for Risk Assessment (RAC) in 2012 expressed a specific request for additional 
HBM data to follow up uncertainties regarding future exposure to four classified phthalates (DEHP, 
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DBP, BBP, and DIBP) in articles proposed for restriction under REACH (ECHA, 2012). This 
highlights the importance of this tool for decision making on chemicals and product regulation. But 
there are particular requirements and challenges that hamper use of HBM in the European Union. Due 
to the subsidiary principle with major responsibilities and institutional capacities in all Member States, 
the European Union is facing particular challenges, which are not an issue in individual countries.  
In countries like the USA and Canada one institution takes the overall responsibility for all the tasks 
related to HBM and its translation into policies. In the USA the Centers for Disease Control and 
Prevention (CDC) are the governmental body responsible for organisation of the national nutrition and 
health survey NHANES, and in this function, is also responsible to organise the selection of 
substances and nomination procedures including selection criteria to include or remove a certain 
substances from the list. In Canada, the federal public health authority is coordinating the surveys and 
performs science and research that support biomonitoring. This includes the development of new 
chemical measurements and analytical methodologies, the development of tools to better interpret 
biomonitoring results, and the investigation of possible adverse health effects that may result from 
exposure to environmental chemicals.   
In the European Union in contrast the situation is different. From the European policy perspective it is 
essential to be able to perform evaluation and interpretation of information on average and range, or 
proportion of population above a guidance or limit value, time and spatial trends, or interregional 
variability on a European scale. On the other hand data collection and surveillance measures lay in the 
responsibility of Members States that have divergent interests, legislation and data protection 
standards, capacities and financial means. In addition responsibilities for HBM related issues are 
widespread in the European Union both on Community level as well as on national level unlike the 
situation in countries like the United States of America.  
The major responsibilities for risk reduction policies and surveillance systems, is generally shared 
between the Ministries of Environment and Health and the related agencies. Accordingly existing 
surveillance structures and responsibilities depend on the allocation of responsibilities in national 
administration. In general, Member States rely on either health or environmental agencies or national 
institutes.  
Against this background particular challenges in the European Union are for example the prioritisation 
of substances, the development of biomarkers and analytical methods, survey design data 
interpretation and communication issues, as well as the chemical analysis. In order to ensure 
comparable monitoring data on a European scale, there is a need for guidance and advice on protocol 
development, quality standards and quality assurance systems. 
In addition sharing of research and development work, shared funding solutions, and effective use of 
existing resources and synergies are particular challenges and prerequisites for an efficient use of 
HBM. In this context it was considered important to coordinate to the extent possible the guidance and 
protocols developed by national, European and international monitoring programmes/initiatives. Read-
across of monitoring and research results from one country to another was suggested as another option 
to increase efficiency and reduce costs.   
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 150 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
5. Conclusion 
Based on 252 references (235 full text publications), which were selected by the project team in an 
extensive literature search on human biomonitoring (HBM) for the period 2002-2014 in major relevant 
databases such as Medline and SCOPUS, in recent conference proceedings, in grey literature, and in 
publicly available information from scientific research studies and supplemental searches from an 
initial set of almost 18,000 hits, this study could show that human biomonitoring (HBM) would be a 
suitable tool for human risk assessment in relation to food safety, when the necessary developments 
and adjustments have been made.  
HBM has a long tradition for human exposure assessment in occupational health care. HBM is 
requested by law in occupational health and is used in public health survey. Its use in environmental 
health policies started in the seventieths. Also within the European Union, significant resources have 
been spent on HBM in the filed of environment and health, however, the lack of a coherent approach 
and integration between countries and studies limits the use for European health impact assessments. 
To allow a better use of the data and to allow evaluations at European scale, harmonisation of 
activities was considered important and a process towards coherent HBM programmes in the 
European Union was started in 2003. 
Even if there is no official definition of HBM it is commonly understood as a method for assessing 
human exposure to exogenous substances by measuring the substances or their metabolites, or the 
product of an interaction between a xenobiotic agent and some target molecule or cell in human tissues 
or specimens. HBM relies on the use of biomarkers in human tissues or specimens.  
Some biomarkers are stable over time, others have very short half-life. Some markers are easy to 
measure with standard laboratory techniques whilst others require specialized techniques. Currently 
different types of liquid or gas chromatography in combination with different types of mass 
spectrometry are used as suitable and reliable analytical methods for analysis of biomarkers of 
exposure. The CALUX assay is tested for high throughput quantification of hormone activation from 
dioxins. As sensitivity and specificity of the analytical method, the reliability and replicability of the 
results and the inter-comparability with data from other surveys are important factors, chemical 
analysis of HBM samples should follow well-defined standard operation procedures and QS/QA 
systems to ensure validity of the result. 
HBM can be performed for many chemical substances which are in the focus of the worldwide 
discussion of environmental health, but this number is still small in comparison with the number of 
chemicals and contaminants in the environment. Depending on biomarkers (BM) used, HBM does not 
only allow to monitor exposure but also to detect early health effects. BM of biological effect are more 
closely related to adverse health effects but are more difficult to validate. Protein adducts specifically 
and sensitively measure exposure as well as biochemical effect. High throughput technologies (Omics 
technologies) have recently revolutionised the monitoring of BM of effect. 
HBM implies the development of a study protocol, recruitment of study persons, informed consent, 
sampling, and sample processing, sample analysis and interpretation, data reporting and 
communication. HBM programmes can be cross-sectional or vertical in design. Given the wide range 
of BMs, biological matrices, analytical methods and other influencing factors, the study design is a 
critical aspect in efficient use of HBM in risk assessment. This comprises the planning of which 
BM(s) should be measured, in which biological fluid or tissue, when and how many samples should be 
collected and from which study populations. 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 151 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Recruitment of participants can be done via hospitals, census registries, local newspapers or 
organisations, or at workplaces. It shall ensure a study population which is representative with age 
groups, gender, exposure risks (habitation, occupation, and socio-economic status) being equally 
distributed. HBM can be done with cross-sectional or cohort design, the study design includes the 
power of the study and the number of samples to request from each study person. However, 
recruitment is costly. In addition it is often a challenging issue and participant rates tend to be low. 
Therefore it is recommended to use surveillance synergies where possible. 
Sampling, and sample handling are decisive factors for the study results and need to be carefully 
designed. The samples must be handled in a uniform manner (e.g. cooling procedure) securing 
reproducible results. HBM can be accompanied by questionnaires, environmental monitoring and 
clinical investigations to collect additional information about exposure risks and vulnerability, or can 
be linked with registry data. Harmonisation of Data Treatment and Evaluation is necessary when 
comparing measurements and for publication purposes. 
Interpretation and communication of study results are other crucial but difficult aspects of HBM. At 
this stage there remain many challenges for a valid interpretation in terms of risk assessment. HBM 
based guidance values, translate the measured dose to intake estimates, but the number of such values 
is limited. Good communication at all stages of a HBM can increase participation rate, supports the 
collection of reliable data and fosters dissemination of results, but is a challenge. Communication 
needs to be considered right from the start of the study and should be multidisciplinary, as it requires a 
thorough translation of scientific results a proper appraisal of uncertainties with a balanced 
consideration of benefit and risks. Ethical issues are a challenge in particular in the absence of clear 
health guidance. Existing survey compare with existing health based guidance values, reference values 
and information from other countries, and aim at monitoring time trends. 
Based on the analysis of the investigated references HBM can be considered applicable to the 
different steps of human risk assessment ( hazard identification, hazard characterisation, exposure 
assessment and risk characterisation) (as relevant for EFSA) where HBM can make a significant or 
unique contribution (e.g. assessment of human exposure to chemical contaminants, or regulated 
chemical substances such as food contact materials, pesticides, etc.).  
The application of HBM in risk assessment of chemical contaminants in food is closely linked to its 
potential to provide knowledge about the human exposure to these substances via food and other 
routes, and their potential to cause adverse health effects. The core role of HBM in risk assessment is 
human exposure assessment whether for environmental contamination, contamination from air, water 
or consumer products or in food safety areas. Hazard identification and hazard characterisation is 
conventionally performed in toxicology studies in vivo or in vitro. But in certain cases HBM could 
contribute to the elucidation of the dose-response relationship or to hazard identification in highly 
exposed subgroups. In risk characterisation HBM can be used to validate exposure assessment.  
A particular strength of HBM in exposure assessment of chemical substances from food source 
(chemical contaminants and regulated chemical substances) is the fact that HBM is the only available 
tool that integrates exposures from all sources and provides data to epidemiology enabling studies of 
strengths of associations, dose response relationships. Biomonitoring data reflect the internal dose at a 
point in time. HBM can provide results that are stratified by regions and subgroups, hence allowing to 
identify populations at particular risks as well as population of increased vulnerability due to age, 
gender, region, SES, lifestyle and dietary habits, and thus can reduce the number of assumptions that 
have to be made regarding consumption rates. 
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One major limitation for use of HBM in risk assessment is the fact that HBM alone cannot provide 
information how long a chemical has been in the body, and that many factors may affect the quality of 
the samples and the variability of measurement results in particular for substances with short half-lives 
and for low tissue levels.  
The other major limitation is the fact that HBM alone cannot provide information about the source of 
exposure or the health risk. For interpretation in risk assessment HBM data need to be combined with 
other data and tools such as environmental and health registry data, modelling data from PBPK models 
or HBM based guidance values like Human Biomonitoring Values (HBM I and HBM II) and 
Biomonitoring Equivalents (BE) that translate established guidance values (HBGV) from risk 
assessment (e.g. ADI/TDI, RfD) into a biomarker concentration. 
Finally HBM raises ethical and privacy issues because it involves human samples. But those 
challenges can be overcome. 
HBM can absolutely be considered useful for the implementation of a systematic Post Market 
Monitoring (PMM) approach for regulated chemical substances, because it can verify risk assessment 
results. It could be used to monitor real exposure if estimated daily intake (EDI) is close to the 
acceptable daily intake (ADI) in different exposure groups, and can detect exposure in case of 
unexpected complaints. Strength and limitations apply like for exposure assessment. 
The inventory of the different HBM surveillance programmes/initiatives at national, EU and 
international level and the relevant HBM studies published in the literature provides an excellent 
overview on the substances covered, analytical methods applied and existing reference and health 
based guidance values, and provides a good information source on major challenges. Overall the 
comparative analysis of the results from the investigated HBM studies shows that HBM can bring 
added value for chemical risk assessment in food safety areas, but that further work needs to be done 
to improve usability. Although a number of HBM programmes have extensive data and well-
structured study design, there are some major deficits and challenges regarding its use in chemical risk 
assessment for food safety in the European Union, which need to be reduced. 
As national HBM Programmes are generally funded, coordinated and managed by the respective 
governmental bodies important infrastructural prerequisites for a systematic longterm use are already 
established also in the European Union today. On the other hand HBM programmes except of 
NHANES do not occur yearly but in intervals and only in very few European Member States 
(Flanders, Slovenia, Germany, Sweden, Czech Republic) a long-term regular surveillance system has 
been established.  
Whereas globally the majority of the national HBM programmes are cross-sectional surveys with 
repeated monitoring over time to assess reference values and trends, some countries, also choose 
longitudinal mother-child cohorts to better be able to determine particular risks for vulnerable groups 
(newborn) and potential health effects. Retrospective analysis of time trends based on bio-banked 
samples currently is only done in Germany. Whereas study populations still range from less than 1000 
to more than 100,000 participants, it is good to see a tendency towards larger cohorts in recent years. 
From a risk assessment point of view it is a positive signal, that elderly, adolescents, children and new-
borns are increasingly included, even if the majority of investigated HBM programmes is still focusing 
on adults.  
The inventory shows clearly that blood and urine are by far the most approved biological matrices. In 
addition human milk has frequently been used for persistent organic pollutants, and hair and saliva 
have become important specimens in more recent years. This choice is determined by the analytical 
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needs to reliably determine the internal dose combined with the attempt to use easily available low 
invasive samples. Combinations of maternal blood, cord blood, placenta, and amniotic fluid are used 
in birth cohorts. The fact that most programmes are using similar analytical methods reflects the fact 
that established validated standards are used for the substances covered by the selected HBM studies. 
The analysis of the national/regional HBM programmes reveals that they allow to establish HBM 
reference values (RV) for the general population as well as to identify highly exposed subgroups. RV 
tend to be stratified by region, age and gender or life-style and RVs s are compared with HBGV, if 
such values exist. On the other hand it is disappointing that population reference values (RV) exist 
only for roughly 70 chemical groups (165 isomers but 92 without HBGV) such as PFCs, 
dioxins/furans/PCBs, metals, PBDEs, PAHs, phthalates, phenols, cotinine as well as 
carbamate/organophosphate/organochlorine/pyrethroid pesticides., and that in addition, the calculation 
of reference values varies in the European Union with the geometric mean with P95 not being 
consistently used.  
It is promising, that in the majority of the longer running programmes the number of analysed 
substance groups was increased considerable over time. The broadest range of chemicals is covered in 
NHANES, CHMS, FLEHS, ESTEBAN and JECS. But the range of analysed substances (substance 
groups) remains highly variable, and in the European Union the availability of data is still limited. 
Heavy metals (particularly cadmium, lead, and mercury), PCBs and cotinine are the most investigated 
classes of chemicals and have been analysed in more than 65% of the investigated HBM programmes. 
Organophosphates, pyrethroids, and chlorinated phenols were analysed in 20% of the programmes 
each, whereas acrylamide and carbamates were rarely measured. Mycotoxins, Fungus-specific IgE, 
selected fungicides, perchlorate, nitrosamine and alkaloids have only been measured in single 
programmes. 
Hence the major deficit of the large scale HBM programmes and studies identified up to 2014, is a 
lack of data on a considerable number of key food contaminants, food additives or food contact 
materials, for which HBGVs have been developed by EFSA or FAO/WHO. To date 118 out of the 187 
reviewed substances with HBGVs do not have an established RV. Deficits are particularly strong for 
several classes of pesticides (e.g. neonicotinoids or triazoles), mycotoxins, veterinary pharmaceuticals, 
food contact materials and food additives, flavouring agents, food preservatives. But there are also 
deficits for nitrosamine, perchlorate, 3-MCPD, mineral oil hydrocarbons, In addition there are deficits 
in knowledge about the exposure sources or environmental levels and about associations between 
measured body burdens and health effects. 
It is disappointing that accompanying environmental monitoring or measurements in food are rare. 
Food-related questions have been used in roughly 60% of the investigated studies, but unfortunately, 
this is not very convincing from the point of view of risk assessment in food. In addition there is an 
important lack of standardisation and validation of food questionnaires and customised 24-hr food 
recall method according to EFSA recommendations was only used in France’s ENNS, Czech 
Republic’s CZ-HBM, and the USA’s NHANES.  
The review of the results from the investigated HBM studies shows that there are examples where 
HBM contributed to the identification of a new hazard in the sense of the EFSA definition of emerging 
risks with the term “new” being considered as new scientific evidence, or not regulated in the EU, or 
not yet addressed by EFSA. HBM programmes can inform policy about emerging threats and trigger 
exposure prevention and restriction strategies, e.g. by means of screening substances for which science 
has generated some evidence of potential risks. However, there are not too many striking results with a 
particular focus on the exposure to foods. When screening the analysed HBM programmes for changes 
over time, the project team detected that some pesticides (pyrethroids, herbicides), parabens, 
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acrylamide/glycidamide, nitrosamine and nitrate as smoke flavouring (NHANES), and perchlorate as 
well as perfluorinated compounds (PFCs) have been recently added to the monitoring because they 
have been considered as new risks with a potential correlation to food source. In the past other 
substances groups such as heavy metals, dioxins and PCBs, brominated flame retardants, carbamates, 
and mycotoxins have been investigated as “emerging” chemicals.  
With respect to identification of vulnerable groups it can be stated that existing HBM programmes 
commonly stratify results by age and gender, and life-style or race with some aspects including dietary 
habits. In this context pregnant women and foetuses, children, and in some cases elderly have been 
identified in varying contexts as possibly higher exposed sub-groups or specific vulnerable groups for 
specific groups of chemicals, including some with food as major exposure source. Higher socio-
economic class can either be a protective or a risk factor to contamination from food source. However, 
so far there is no systematic investigation for fundamental dietary life-style decisions such as 
conventional versus organic or vegetarian food. 
National, regional and international HBM programmes that have been selected for this report use 
validated biomarkers with standard operating procedures (SOPs) as well as by internal and external 
quality assessment schemes. Validated BM of exposure to chemicals that can be found in the diet from 
the investigated HBM programmes are either the chemical itself (i.e., metals, dioxins, furans, PCBs, 
PBDEs, parabens, mycotoxins, etc.) directly measured as the parent compounds in the matrices, or a 
metabolite or haemoglobin adducts (e.g. phthalates, polyaromatic hydrocarbons, organophosphate 
pesticides, organochlorine pesticides, acrylamide, nitrosamine, and pyrethroid pesticides, etc.). The 
selection of the biomarker is a matter of the pharmacokinetic properties of the substance in question 
balanced with the invasiveness of sampling, analytical complexity and related costs. It is promising 
that 8-OHdG is envisaged to be analysed as first biomarker of oxidative DNA damage in two 
programmes that have recently been started to collect samples, so that results will be available in a few 
years. Unfortunately however, there are no validated BM in the investigated programmes for a large 
range of pesticides, veterinary pharmaceuticals, and food additives. Also the use of biobanks for HBM 
is currently still very limited in the European Union and across the world.  
In addition to the above mentioned results, it can be concluded that there are three major other aspects 
that are relevant for use of HBM in risk assessment in food safety.  
The first one relates to biomarkers of effect and the "exposome" as attempts to establish high 
throughput tools and to close the causality gaps. Both are current research priority, but there is a lot of 
further research needed to allow for application in surveillance for food risk assessment.  
The second one relates to the possibility to link HBM data with external monitoring and food intake 
estimates. In this context it can be emphasised that the EU wide HBM pilot projects 
(COPHES/DEMOCOPHES) could show that it was possible to use good quality data to support 
interpretation of HBM data related to food source. The study however, showed at the same time, that 
quality of data about food quality and quantity still needs to be improved and needs to become more 
readily available across Member States.   
Finally there are particular political challenges and obstacles in the European Union, which hamper 
the use of HBM, even if it is more and more acknowledged as a tool for human exposure assessment.  
National HBM programmes are designed to support, lead and assess policy and preventive actions in 
the field of environmental health. However, there is no EU legal framework that mandatorily requests 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 155 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
the use of HBM in risk assessment, unlike the legal embedding that is established for HBM in 
occupational health since several decades. 
In addition, due to the subsidiary principle, major responsibilities, legislation and institutional 
capacities related to HBM is with Member States, which have divergent interest and possibilities, 
whilst European Institutions would need comparable data at European scale in order to be able to 
perform evaluation and interpretation of information on a European scale.  
Particular challenges in the European Union are for example the prioritisation of substances, the 
shared or joined development of biomarkers and analytical methods, chemical analysis, survey design, 
data interpretation and communication issues, as well as the data management and transfer.  
Even if the EU wide HBM pilot projects (COPHES/DEMOCOPHES) could show the added value of 
comparable HBM results for policy recommendations including food source, there remains a lack of a 
coherent approach and integration between European Member States, which hampers the cross-border 
comparison and the applicability of study results for risk assessments. To foster a better use of the data 
obtained and to allow evaluations at European and international scale, further efforts are needed 
towards a coherent approachsuch as the ongoing European Human Biomonitoring Initiative (EHBMI). 
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6. Recommendations 
In order to improve the added value of HBM to food safety risk assessment, the following 
recommendations could be made: 
 Foster the development of HBM specific health based guidance values as core tools to translate 
HBM data to intake limits set, and by further improving availability of suitable monitoring data for 
environmental and food contamination and reverse modelling tools to enhance interpretation of 
HBM data in risk assessment; 
 Fasten development of appropriate BM and analytical methods to promote monitoring of 
substances of interest for EFSA and food related emerging risks (namely several classes of 
pesticides and fungicides, mycotoxins, veterinary pharmaceuticals, food contact materials and 
food additives, flavouring agents, food preservatives) in order to increase the number of HBM 
reference values in the EU; 
 Expand substance coverage and ensure long-term establishment of HBM programmes throughout 
European Member States in order to improve data availability and trend analysis;  
 Expand monitoring in different age groups, and for different dietary regimes (eg. vegetarian etc) to 
get better information on vulnerable and particularly exposed subgroups, and combine longitudinal 
and cross-sectional approaches for an improved knowledge on potential health risks; 
 Promote coherent use of customised 24-hr food recall method according to EFSA 
recommendations and reporting on food quality and quantity in order to improve knowledge on 
exposure source; 
 Establish coherent documentation for HBM data including a uniform measure for the central 
tendency as well as information on high exposures, in ordert to ensure better comparability of 
reported RF; 
 Promote wider use of biobanking and biobanked samples in order to be able to trace back time 
trends of contamination with newly identified threats;  
 Promote use of surveillance synergies (dietary intake surveys, health examination surveys and 
HBM) where possible to limit field work costs and increase participation rates; 
 Continue research in BM of effect and OMICs technologies and evaluate its added value for 
application in surveillance for food risk assessment; 
 Continue efforts towards reducing the particular political challenges and obstacles in the European 
Union, which hamper the use of HBM namely regarding prioritisation of substances, shared or 
joined method developments, chemical analysis, survey design, data interpretation and 
communication issues, as well as data management and transfer, by supporting the development of 
a European wide decision structure and exchange platform (such as EHBMI); 
 Promote the use of HBM in exposure assessment and PMM in risk assessment in the food safety 
area as relevant for EFSA. 
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APPENDICES 
 
A.  SEARCH STRATEGY FOR HBM REVIEW 
Table 22 Search terms for the HBM literature review 
 Related review questions  Search terms (combination AND) 
1.1.a How is HBM defined?  Human Biomonitoring Definition 
1.1.b Which biological matrices are used for 
HBM? 
Human Biomonitoring human tissues 
Human Biomonitoring, Sample Matrix 
1.1.c Which kinds of studies are conducted?  Human Biomonitoring, cross sectional 
Human Biomonitoring, longitudinal 
Human Biomonitoring, mother child cohort 
1.1.d Which recruitment strategies are available 
and used? 
Human Biomonitoring recruitment  
Human Biomonitoring participation 
1.1.e Which sampling strategies are available 
and used? 
Human Biomonitoring sampling (Abstract) 
Human Biomonitoring sample collection 
1.1.f Which parameters can be analysed in 
which matrix? 
Human Biomonitoring in **= answers of 1.1.b 
(e.g. blood, serum, urine, saliva, hair, ...) 
1.1.g Which analytical methods are suitable and 
used (for parameters and matrices 
individually)? 
Human biomonitoring, and **= individual  
substance groups as indicated in Table 23 
(Appendix A) 
Biomonitoring, and **= individual substance 
groups as indicated in Table 23 (Appendix A) 
1.1.h How are analysis data reported?  Human Biomonitoring reporting (Abstract) 
1.1.i How are analysis data are communicated 
(consider different target audiences)?  
Human Biomonitoring communication 
(Abstract) 
1.2 How is HBM generally applied to food 
risk assessment 
Human Biomonitoring, food,  
Human Biomonitoring, food safety 
Human Biomonitoring, risk assessment 
1.2.a 
 
 
 
1.3.a 
How is HBM applied to the risk 
assessment step “exposure assessment” in 
food safety areas 
 
How useful (including strengths and 
limitations) is HBM for exposure 
assessment of chemical substances from 
food source (chemical contaminants and 
regulated chemical substances)? 
Human Biomonitoring, exposure assessment, 
food 
1.2.b How is HBM generally applied to the risk 
assessment step “hazard identification” in 
food safety areas 
Human Biomonitoring, hazard identification 
food 
1.2.c How is HBM generally applied to the risk 
assessment step “hazard characterisation” 
in food safety areas 
Human Biomonitoring, hazard characterisation 
food 
1.2.d How is HBM generally applied to the risk Human Biomonitoring, risk characterisation, 
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 Related review questions  Search terms (combination AND) 
assessment step “risk characterisation” in 
food safety areas 
food 
1.3.b How useful (including strengths and 
limitations) is HBM for the 
implementation of a systematic Post 
Market Monitoring (PMM) approach for 
regulated chemical substances.  
Human Biomonitoring, Post Market 
Monitoring  
2.1 Which HBM programmes/ initiatives are 
conducted 
Human Biomonitoring, Programme 
Human Biomonitoring, survey, chemicals,  
Human Biomonitoring, nutrition survey,  
Human Biomonitoring, chemicals, food 
Human Biomonitoring, chemicals, nutrition 
survey 
Human Biomonitoring food contaminants 
Human Biomonitoring, pollutants, food 
(Abstracts only) 
Human Biomonitoring, environmental 
chemicals, food 
2.1.a Which HBM programmes/ initiatives are 
conducted on EU level? (general 
information) 
Human Biomonitoring European Union  
Human Biomonitoring Europe (Abstract) 
Human Biomonitoring EU 
2.2.a Which HBM programmes/ initiatives are 
conducted on national levels? (general 
information) 
Human Biomonitoring, [country name] * 
 
2.3.a Which HBM programmes/ initiatives are 
conducted on international level? (general 
information) 
Human Biomonitoring ** 
**= countries individually  
3.1.a Which emerging chemicals, chemical 
classes can be identified with a focus on 
food?  
 
Human Biomonitoring, emerging chemicals, 
food 
Human Biomonitoring, emerging substances, 
food 
Human Biomonitoring, new substances, food 
Human Biomonitoring, new chemicals, food 
3.1.b Which high exposed sub groups or 
specific vulnerable groups can be 
identified from HBM investigation with a 
focus on food? 
Human Biomonitoring, vulnerable groups, 
food 
3.2.a Which biomarkers of exposure that can be 
found in the diet are validated? 
Biomarkers of exposure, food, validated 
Biomarkers of exposure, diet, validated 
 
* European countries/regions include the following: Germany, France, Flanders, Spain, Italy, Austria, 
Czech Republic, Slovenia, Denmark, Sweden, Norway 
** International countries/regions include the following: Canada, the USA, Arctic regions (for the 
AMAP programme), South Korea, Japan, China 
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Table 23 Substance groups (any individual substances) covered by the HBM literature search 
Chemical substance group List of individual substances  
Brominated flame retardants (BFRs)  
 
2,4,4’-Tribromodiphenyl ether (BDE 28) 
2,2’,4,4’-Tetrabromodiphenyl ether (BDE 47) 
2,2’,4,4’,5-Pentabromodiphenyl ether (BDE 99) 
2,2’,4,4’,6-Pentabromodiphenyl ether (BDE 100) 
2,2',4,4',5,5'-Hexabromodiphenylether (BDE 153) 
2,2’,4,4’,5,6’-Hexabromodiphenyl ether (BDE 154) 
2,2’,3,4,4’,5’,6-Heptabromodiphenyl ether (BDE 183) 
2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE 209) 
Hexabromocyclododecanes (HBCDDs)  
Tetrabromobisphenol A (TBBPA) 
2,4,6-tribromophenol (2,4,6-TBP)  
emerging BFRs:  
tris(2,3-dibromopropyl) phosphate (TDBPP) and the  
novel BFR 2,2-Bis(bromomethyl)-1,3-propanediol (DBNPG)  
1,2-bis(2,4,6-tribromophenoxy)ethane (BTBPE) and hexabromobenzene (HBB) 
Fluorocarbons (PFCs) Perfluorobutane sulfonic acid (PFBuS)  
Perfluorodecanoic acid (PFDeA)  
Perfluorododecanoic acid (PFDoA)  
Perfluoroheptanoic acid (PFHpA)  
Perfluorohexane sulfonic acid (PFHxS)  
Perfluorononanoic acid (PFNA)  
Perfluorooctanoic acid (PFOA) 
Perfluorooctane sulfonic acid (PFOS)  
Perfluorooctane sulfonamide (PFOSA)  
Perfluoroundecanoic acid (PFUA)  
Perfluorohexanoic acid (PFHxA) 
Perfluoropentadecanoic acid (PFTeDA) 
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Chemical substance group List of individual substances  
N-ethyl perfluoroalkane sulphonamide (N-EtFOSA) 
Phthalates metabolites Mono-benzyl phthalate (MBzP) 
Mono-isobutyl phthalate (MiBP) 
Mono-n-butyl phthalate (MnBP) 
Mono-cyclohexyl phthalate (MCHP) 
Mono-ethyl phthalate (MEP) 
Mono-2-ethylhexyl phthalate (MEHP) 
Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) 
Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) 
Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) 
Mono-(carboxynonyl) phthalate (MCNP) 
Mono-isononyl phthalate (MiNP) 
Mono-(carboxyoctyl) phthalate (MCOP) 
Mono-methyl phthalate (MMP) 
Mono-(3-carboxypropyl) phthalate (MCPP) 
Mono-n-octyl phthalate (MOP) 
Phenols Bisphenol A  
4-tert-Octylphenol  
Triclosan  
8-Hydroxyquinoline 
Metals Antimony 
Arsenic  
Barium  
Beryllium 
Cadmium 
Chromium VI 
Cesium 
Cobalt 
Fluoride 
Iridium 
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Chemical substance group List of individual substances  
Lead 
Manganese 
Mercury, Organic 
Mercury, Inorganic 
Molybdenum 
Nickel 
Palladium 
Platinum 
Rhodium 
Selenium 
Silver 
Thallium 
Tin 
Tungsten 
Zinc 
PAHs metabolites 2-Hydroxyfluorene 
3-Hydroxyfluorene 
9-Hydroxyfluorene 
1-Hydroxyphenanthrene  
2-Hydroxyphenanthrene 
3-Hydroxyphenanthrene 
4-Hydroxyphenanthrene 
9-Hydroxyphenanthrene 
1-Hydroxypyrene 
1-Hydroxynaphthalene (1-Naphthol) 
2-Hydroxynaphthalene (2-Naphthol) 
3-hydroxy- and 9-hydroxybenzo[a]pyrene  
hydroxypyrene glucuronide (1-OHPG) 
3-hydroxybenz[a]anthracene 
1-OH- Benzo[c]phenanthrene 
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Chemical substance group List of individual substances  
2-OH- Benzo[c]phenanthrene 
3-OH- Benzo[c]phenanthrene 
1-OH- Benz[a]anthracene 
3-OH- Benz[a]anthracene 
9-OH- Benz[a]anthracene 
1-OH- Chrysene 
2-OH- Chrysene 
3-OH- Chrysene 
4-OH- Chrysene 
6-OH- Chrysene 
benzo[a]pyrene-trans-4,5-dihydrodiol (±)  
benzo[a]pyrene-trans-7,8-dihydrodiol (±) 
benzo[a]pyrene-trans-9,10-dihydrodiol (±)  
benzo[a]pyrene-3,6-dione 
polychlorinated biphenols 
polybrominated biphenols 
Dioxin-like PCBs (DL-PCBs): 
3,3',4,4'-Tetrachlorobiphenyl (PCB 77) 
3,4,4',5-Tetrachlorobiphenyl (PCB 81)  
3,3',4,4',5-Pentachlorobiphenyl (PCB 126)  
3,3',4,4',5,5'-Hexachlorobiphenyl (PCB 169)  
2,3,3',4,4'-Pentachlorobiphenyl (PCB 105)  
2,3,3',4,4'-Pentachlorobiphenyl (PCB 114) 
2,3',4,4',5-Pentachlorobiphenyl (PCB 118)  
2',3,4,4',5-Pentachlorobiphenyl (PCB 123) 
2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156)  
2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157)  
2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167)  
2,3,3’,4,4’,5,5’-Heptachlorobiphenyl (PCB 189) 
Non-dioxin-like PCBs (NDL-PCBs): 
2,4,4'-Trichlorobiphenyl (PCB 28) 
2,2'3,5'-Tetrachloro biphenyl (PCB 44) 
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Chemical substance group List of individual substances  
2,2',4,5'-Tetrachloro biphenyl (PCB 49) 
2,2',5,5'-Tetrachlorobiphenyl (PCB 52) 
2,3',4,4'-Tetrachlorobiphenyl (PCB 66) 
2,4,4',5-Tetrachlorobiphenyl (PCB 74) 
2,2',3,4,5'-Pentachlorobiphenyl (PCB 87) 
2,2',4,4',5-Pentachlorobiphenyl (PCB 99) 
2,2',4,5,5'-Pentachlorobiphenyl (PCB 101) 
2,3,3’,4’,6-Pentachlorobiphenyl (PCB 110) 
2,2',3,3',4,4'-Hexachlorobiphenyl (PCB 128) 
2,2',3,4,4',5' and 2,3,3’,4,4’,6-Hexachlorobiphenyl (PCB 138 & 158) 
2,2',3,4',5,5'-Hexachlorobiphenyl (PCB 146) 
2,2’,3,4’,5’,6-Hexachlorobiphenyl (PCB 149) 
2,2’,3,5,5’,6-Hexachlorobiphenyl (PCB 151) 
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153) 
2,2',3,3',4,4',5-Heptachlorobiphenyl (PCB 170) 
2,2',3,3',4,5,5'-Heptachlorobiphenyl (PCB 172) 
2,2',3,3',4,5',6'-Heptachlorobiphenyl (PCB 177) 
2,2',3,3',5,5',6-Heptachlorobiphenyl (PCB 178) 
2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB 180) 
2,2',3,4,4',5',6-Heptachlorobiphenyl (PCB 183) 
2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB 187) 
2,2’,3,3’,4,4’,5,5’-Octachlorobiphenyl (PCB 194) 
2,2’,3,3’,4,4’,5,6-Octachlorobiphenyl (PCB 195) 
2,2’,3,3’,4,4’,5,6’ and 2,2’,3,4,4’,5,5’,6-Octachlorobiphenyl (PCB 196 & 203) 
2,2’,3,3’,4,5,5’,6-Octachlorobiphenyl (PCB 199)  
2,2’,3,3’,4,4’,5,5’,6-Nonachlorobiphenyl (PCB 206) 
2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl (PCB 209) 
Dioxins 1,2,3,4,6,7,8-Heptabromodibenzo-p-dioxin (HpBDD) 
1,2,3,4,7,8 and 1,2,3,6,7,8-Hexabromodibenzo-p-dioxin (HxBDD) 
1,2,3,7,8,9-Hexabromodibenzo-p-dioxin (HxBDD) 
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Chemical substance group List of individual substances  
1,2,3,7,8-Pentabromodibenzo-p-dioxin (PeBDD) 
2,3,7,8-Tetrabromorodienzo-p-dioxin (TBDD) 
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin (HpCDD)  
1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin (HxCDD) 
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin (HxCDD)  
1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (HxCDD)  
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin (OCDD)  
1,2,3,7,8-Pentachlorodibenzo-p-dioxin (PeCDD)  
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) 
Furans 1,2,3,4,6,7,8-Heptabromodibenzofuran (HpBDF) 
1,2,3,4,7,8-Hexabromodibenzofuran (HxBDF) 
1,2,3,7,8-Pentabromodibenzofuran (PeBDF) 
2,3,4,7,8-Pentabromodibenzofuran (PeBDF) 
2,3,7,8-Tetrabromodibenzofuran (TBDF) 
1,2,3,4,6,7,8-Heptachlorodibenzofuran (HpCDF)  
1,2,3,4,7,8,9-Heptachlorodibenzofuran (HpCDF) 
1,2,3,4,7,8-Hexachlorodibenzofuran (HxCDF)  
1,2,3,6,7,8-Hexachlorodibenzofuran (HxCDF)  
1,2,3,7,8,9-Hexachlorodibenzofuran (HxCDF)  
2,3,4,6,7,8-Hexachlorodibenzofuran (HxCDF)  
1,2,3,4,6,7,8,9-Octachlorodibenzofuran (OCDF)  
1,2,3,7,8-Pentachlorodibenzofuran (PeCDF)  
2,3,4,7,8-Pentachlorodibenzofuran (PeCDF)  
2,3,7,8-Tetrachlorodibenzofuran (TCDF) 
Perchlorate   
Acrylamide and glycidamide  
3-Monochloropropane-1,2 Diol Ester (3-MCPD)  
Mycotoxin  Aflatoxins 
aflatoxin B1 
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Chemical substance group List of individual substances  
aflatoxin M1   
ochratoxin A 
Deoxynivalenol 
Nivalenol 
citrinin 
Zearalenone 
Fumonisin B1 or B2 
T-2 toxin 
HT-2 toxin 
Alternaria toxins 
Beauvericin and enniatins 
Sterigmatocystin 
Moniliformin 
Diacetoxyscirpenol 
Alkaloids 
(Piperidine, Pyrrolidine, Pyridine, Catecholamine, 
Phenylalanine, Indole, Quinoline, Purine) 
Piperine, 
Niacine,  
Dopamine, 
Capsicain 
Ephedrine 
Serotonine,  
Quinine, Caffein, theobromine 
Mineral oil hydrocarbons (MOH) paraffins (comprising linear and branched alkanes), naphthenes (comprising alkyl-
substituted cyclo-alkanes), and aromatics (including polyaromatic hydrocarbons (PAHs). 
Components divided into two main types, mineral oil saturated hydrocarbons (MOSH) and 
mineral oil aromatic hydrocarbons (MOAH). 
regulated chemical substances such as food contact 
materials  
Smoke flavourings: 
Plastic contact materials:see BPA 
Sweeteners: 
Enzymes: 
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Chemical substance group List of individual substances  
Pesticides - Neonicotinoid Acetamiprid 
Imidaclorpid 
Thiacloprid 
Thiamethoxam 
Clothianidin 
Thiacloprid 
Thiamethoxam 
 
Pesticides -Pyrethroids 
 
Acrinathrin 
Beta-Cyfluthrin 
Esfenvalerate 
Bifenthrin 
Cyfluthrin 
Cypermethrin 
Deltamethrin 
Etofenprox 
Fenpropathrin 
Fenvalerate 
Lambda-cyhalothrin 
Permethrin 
Pyrethrins 
Resmethrin 
Taufluvalinate 
Tefluthrin 
 
Pesticides -Triazoles Amitrole 
Bitertanol 
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Chemical substance group List of individual substances  
Bromuconazole 
Cyproconazole 
Difenoconazole 
Epoxiconazole 
Fenbuconazole 
Flusilazole 
Flutriafol 
Metconazole 
Myclobutanil 
Paclobutrazole 
Prothioconazole 
Tetraconazole 
Triticonazole 
Fuberidazole 
Propiconazole 
Triadimenol 
Hexaconazole 
Penconazole 
Tebuconazole 
Fluquinconazole 
Thiabendazole 
Terbuthylazine 
 
Pesticides  -Organochlorines 
 
Aldrin 
Heptachlor epoxide 
Oxychlordane 
trans-Nonachlor 
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Chemical substance group List of individual substances  
Mirex 
Chlordan 
Chlorobenzilate 
Chlorothalonil 
DDT 
Dicofol 
Dieldrin 
Endosulfan 
Endrin 
Heptachlor 
Hexachlorbenzene 
Hexachlorocyclohexane (HCH) 
Lindane 
Linuron 
Mepiquat 
Methoxychlor 
Quinoxyfen 
Quintozene 
Tetradifon 
Tolylfluanid 
Haloxyfop 
Carbofuranphenol 
2-Isopropoxyphenol 
2,4-Dichlorophenol 
2,5-Dichlorophenol 
 
Pesticides -Organophosphates Acephate  
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Chemical substance group List of individual substances  
Azinphos-methyl 
Cadusafos 
Chlorfenvinphos 
Chlorpyrifos 
Chlorpyrifos methyl 
Diazinon 
Dichlorvos 
Dimethoate 
Ethephon 
Ethion 
Ethoprophos 
Fenamiphos 
Fenitrothion 
Fenthion 
Fosthiazate 
Malathion 
Methamidophos 
Methidathion 
Monocrotophos 
Oxydemeton-methyl 
Parathion & parathion methyl 
Phentoate 
Phosalone 
Phosmet 
Phoxim 
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Chemical substance group List of individual substances  
Pirimiphos-methyl 
Profenofos 
Pyrazophos 
Tolcolflos-methyl 
Triazophos 
Trichlorfon 
Diethylphosphate (DEP) 
Dimethylphosphate (DMP) 
Diethylthiophosphate (DETP) 
Dimethylthiophosphate (DMTP) 
Diethyldithiophosphate (DEDTP) 
Dimethyldithiophosphate (DMDTP) 
Methamidophos 
Omethoate 
 
Pesticides -Carbamates Aldicarb 
Benfuracarb 
Carbaryl 
Carbendazim 
Carbofuran 
Carbosulfan 
Chlorpropham 
Dinocap 
Dithiocarbamates 
Fenoxycarb 
Formetanate  
Iprovalicarb 
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Chemical substance group List of individual substances  
Methiocarb 
Methomyl 
Oxamyl 
Pirimicarb 
Propamocarb  
Thiophanate methyl 
Metam potassium, Metam sodium 
Molinate 
Prosulfocarb 
 
Pesticides - Amides/Anilides Flumioxazin 
Amitraz 
Diphenylamine 
Hexythiazox 
Methoxyfenozide 
Boscalid 
Propyzamide 
Tebufenozide 
Fenhexamid 
oxadixyl 
Diflufenican 
Dimethachlor 
Dimethenamid-P 
Flufenacet 
Napropamide 
Dichlofluanid 
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Chemical substance group List of individual substances  
Zoxamide 
 
Pesticides - Aniline Pendimethalin 
Trifluralin 
Benfluralin 
Pesticides - Pyrazoles chlorfenapyr 
Fipronil 
Tebufenpyrad 
Fluxapyroxad 
 
Pesticides  -Imidazoles Imazalil 
Prochloraz (2,4,5-Trichlorophenol, 2,4,6-Trichlorophenol as metabolites) 
Imazamox 
Imazaquin 
Thiabendazole 
 
Pesticdes - Dicarboximide Iprodione 
Procymidone 
Vinclozolin 
Pesticides -Diphenylether 
 
Aclonifen 
Bifenox 
 
Pesticides -Pyrimidine 
 
Bupirimate 
Cyprodinil 
Fenarimol 
Mepanipyrim 
Pyrimethanil 
 
Pesticides -Pyrrole Fludioxonil 
 
Pesticides -Strobilurins Azoxystrobin 
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Chemical substance group List of individual substances  
 Kresoxim-methyl 
Pyraclostrobin 
Trifloxystrobin 
Dimoxystrobin 
 
Pesticides -Thiadiazines Buprofezin 
Indoxacarb (Oxadiazine) 
 
Pesticides - Triazine & Triazonine  Metribuzine 
Triazoxide 
Carfentrazone-ethy 
Terbuthylazine (chlorotriazine) 
Pesticides – Xylylalanine Metalaxyl 
Metalaxyl-M 
Pesticides- Pyridazione Chloridazon 
Pyridaben 
Pesticides -Phtalimides Flumioxazin 
Captan 
Folpet 
 
Pesticides  -Morpholines Dimethomorph 
Fenpropimorph 
 
Pesticides - Urea derivates Azimsulfron 
Chlortoluron 
Diuron 
Fluometuron 
Lufenuron 
Imazosulfuron 
Pencycuron 
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Chemical substance group List of individual substances  
Metsulfuron-methyl 
Teflubenzuron 
Triflumuron 
 
Pesticides -Others  Diclofop (Chlorophenoxy acid or ester) 
Famoxadone (Oxazolidinedione) 
Quizalofop-P-tefuryl (Aryloxyphenoxy propionic acid) 
Sulcotrione (Benzoylcyclohexanedione) 
Clofentezine (Tetrazine) 
Spirodiclofen (Keto-enol) 
Chlormequat (quaternary ammonium compound) 
Pyriproxyfen (Juvenile hormone mimic) 
Diquat (dibromid) (Bipyridylium) 
Propargite (Sulfite ester) 
Spinosad (Macrocyclic Lactone) 
Oxadiazon (Oxadiazole) 
2,4-D (2,4-Dichlorophenoxyacetic acid) 
Fenbutatin Oxide 
Dicloran (Chloronitrobenzene) 
Fenazaquin (Quinazoline) 
Methyl nonyl ketone (Ketone) 
Glyphosate (Phosphonoglycine) 
Difenacoum (Coumarin) 
Tralkoxydim (Cyclohexenone derivate) 
Bromopropylate (Organobromine) 
Fluazifop (Aryloxypheoxy propionic acid) 
Abamectin (Botanical, Macrocyclic Lactone) 
Ethofumesate (Benzofuran) 
Bromide Ion 
Pesticides (candidates for substitution) 8-Hydroxyquinoline incl. oxyquinoleine (Phenole) 
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Chemical substance group List of individual substances  
Benfluralin 
Beta-Cyfluthrin 
Bifenox 
Copper compounds, Bordeaux mixture, Copper hydroxide, Copper oxide, Copper 
oxychloride 
Dimethoate 
Ioxynil 
Oxyfluorfen 
Quinoclamine 
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B.  RESULTS FROM INVESTIGATED HBM STUDIES 
Table 24 Chemical levels of student volunteers from ESBHum (Germany) 
 
  
Chemical group Substance Matrix Geometric mean 
Metals 
Arsenic urine 5.66 µg/L 
Cadmium blood 0.29 µg/L 
Copper plasma 1.07 mg/L 
 urine 5.80 µg/L 
Lead blood 12.86 µg/L 
Mercury blood 0.68 µg/L 
 urine 0.13 µg/L 
Selenium plasma 78.27 µg/L 
Strontium urine 98.24 µg/L 
Thallium blood 29.68 ng/L 
 urine 0.19 µg/L 
Zinc plasma 0.69 mg/L 
 urine 210.57 µg/L 
Organochlorines 
HCB plasma 0.10 µg/L 
PCP plasma 0.77 µg/L 
 urine 0.09 µg/L 
PCB 138 plasma 0.39 µg/L 
PCB 153 plasma 0.25 µg/L 
PCB 180 plasma 0.13 µg/L 
Fluorocarbons 
PFOA plasma 4.03 µg/L 
PFOS plasma 6.05 µg/L 
Phthalate 
metabolites 
5OH-MEHP urine 9.49 µg/L 
5oxo-MEHP urine 6.27 µg/L 
5cx-MEPP urine 9.31 µg/L 
MEHP urine 3.02 µg/L 
MnBP urine 18.75 µg/L 
MiBP urine 26.76 µg/L 
MBzP urine 3.57 µg/L 
Phenol Bisphenol A urine 1.33 µg/L 
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Table 25 Chemical levels of participants (children) in GerES IV (Germany) 
Chemical Group Substance Matrix Geometric mean 
Metals 
Arsenic urine 4.4 µg/L 
Lead blood 16.3 µg/L 
   
Cadmium blood <0.12 µg/L (a) 
 urine 0.068 µg/L 
Nickel urine 1.26 µg/L 
Mercury blood 0.23 µg/L 
 urine <0.1 µg/L (a) 
Organochlorines 
PCB 28 blood <0.001 µg/L (a) 
PCB 52 blood <0.001 µg/L (a) 
PCB 101 blood <0.001 µg/L (a) 
PCB 138 blood 0.089 µg/L 
PCB 153 blood 0.129 µg/L 
PCB 180 blood 0.065 µg/L 
Total PCB (138, 153, 180) blood 0.286 µg/L 
α-HCH blood <LOQ 
β-HCH blood 0.011 µg/L 
γ-HCH blood <LOQ 
DDE blood 0.206 µg/L 
HCB blood 0.098 µg/L 
Tobacco smoke 
Nicotine urine 1.3 µg/L 
Cotinine urine 2.5 µg/L 
Organophosphates 
DMP urine 15.8 µg/L 
DMTP urine 16.8 µg/L 
DMDTP urine 0.56 µg/L 
DEP urine 5.92 µg/L 
DETP urine 1.09 µg/L 
DEDTP urine 0.023 µg/L 
Chlorophenols 
2-MCP urine 1.72 µg/L 
3-MCP urine 4.49 µg/L 
2,4-DCP urine 0.332 µg/L 
2,5-DCP urine 0.853 µg/L 
2,6-DCP urine <0.10 µg/L (a) 
2,3,4-TCP urine <0.10 µg/L (a) 
2,4,5-TCP urine 0.141 µg/L 
2,4,6-TCP urine 0.208 µg/L 
2,3,4,6-TeCP urine <0.30 µg/L (a) 
PCP urine <0.60 µg/L (a) 
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Chemical Group Substance Matrix Geometric mean 
PAHs metabolites 
1-hydroxypyrene urine 0.129 µg/L 
1-Hydroxyphenanthrene urine 0.185 µg/L 
2/9-Hydroxyphenanthrene urine 0.119 µg/L 
3-Hydroxyphenanthrene urine 0.162 µg/L 
4-Hydroxyphenanthrene urine 0.024 µg/L 
Total OH-phenanthrene (1, 2/9, 3, 4) urine 0.524 µg/L 
Pyrethroid 
metabolites 
cis-Cl2CA urine 0.136 µg/L 
trans-Cl2CA urine 0.280 µg/L 
Br2CA urine 0.110 µg/L 
3-PBA urine 0.486 µg/L 
F-PBA urine <0.10 µg/L (a) 
(a): The geometric mean is lower than the limit of quantification stated here. 
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Table 26 Overview of analysed chemicals in the three age groups of FLEHS II (2007-2011; 
Flanders) 
Newborns/mothers Adolescents (14–15 yrs) Adults (20–40 yrs) 
Cord blood: 
Metals (Pb, Cd, Mn, Cu, Tl, 
As) 
Persistent chlorinated 
compounds (PCBs, p,p’-
DDE, HCB, Calux) 
Persistent brominated 
pollutants (BDE28, 47, 99, 
100, 153, 154, 183, 209, 
HBCD, TBBPA) 
Perfluorocompounds (PFOS, 
PFOA) 
Personal hygiene products 
(triclosan, parabens, UV-
screens) 
 
Blood: 
Metals (Pb, Cd, Mn, Cu, Tl, 
As) 
Persistent chlorinated 
compounds (PCBs, p,p’-DDE, 
HCB, Calux) 
Persistent brominated 
pollutants (BDE28, 47, 99, 
100, 153, 154, 183, 209, 
HBCD, TBBPA) 
Personal hygiene products 
(musks, galaxolide, tonalide) 
UV-screens (BP-3, DHB, 
DHMB, THB, HMS, DABI, 4-
MBC) 
 
Blood: 
Perfluorocompounds (PFOS, 
PFOA) 
UV-screens (BP-3, DHB, 
DHMB, THB, HMS, DABI, 4-
MBC) 
 
Maternal blood: 
Metals (Pb, Cd, Mn, Cu, Tl, As) 
 
Urine: 
Metals (As, TRA) 
PAHs (1-hydroxypyrene, BaP-tetrol, 
1- and 2-naphtol) 
Benzene (t,t’-muconic acid) 
Phthalates (MEHP, MEHHP,MEOHP,  
MNBP, MBzP) 
Bisphenol A 
Organophosphate pesticides (DMP,  
DMTP, DMDTP, DEP, DETP,  
DEDTP) 
Para dichlorobenzene (2,5-DCP) 
Triclosan 
Cotinine 
Paraben metabolite (HBA) 
Herbicide (2,4–D) 
Carbamate pest (ETU) 
Fungicides (3,5-DCA, 3,4-DCA, 
DCPU, DCPMU) 
Pyrethroids (3-BPA, FPBA) 
 
Urine: 
Metals (Cd, As, TRA) 
PAHs (1-hydroxypyrene, BaP-tetrol, 
1- and 2-naphtol) 
Benzene (t,t’-muconic acid) 
Phthalates (MEHP, MEHHP,MEOHP,  
MNBP, MBzP) 
Organophosphate pesticides (DMP,  
DMTP, DMDTP, DEP, DETP, DEDTP) 
Para dichlorobenzene (2,5-DCP) 
Cotinine 
Paraben metabolite (HBA) 
Herbicide (2,4–D) 
Carbamate pest (ETU) 
Fungicides (3,5-DCA, 3,4-DCA, 
DCPU, DCPMU) 
Pyrethroids (3-BPA, FPBA) 
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Newborns/mothers Adolescents (14–15 yrs) Adults (20–40 yrs) 
Maternal hair: 
Metals (Hg, MeHg) 
 
Hair: 
Metals (Hg, MeHg) 
 
 
Pb: lead; Cd: cadmium; Mn: manganese; Cu: copper; Tl: thallium; PCBs: polychlorinated biphenyls; p,p’-DDE: p,p’-
dichlorodiphenyldichloroethylene; HCB: hexachlorobenzene; BDEs: brominated diphenylethers; HBCD: hexabromocyclododecane; 
TBBPA: tetrabromo bisphenol A; PFOS: perfluoroctanesulphonic acid; PFOA: perfluoroctanoic acid; Hg: mercury; MeHg: methylmercury; 
As: arsenic; TRA: toxic relevant arsene; PAHs: polycyclic aromatic hydrocarbons; 2,5-DCP: 2,5-dichlorophenol; ETU: ethylenethiourea 2,4-
D: 2,4-dichlorophenoxy-acetic acid; BaP-tetrol: benzo[a]pyrene tetrol; MEHP = mono-2-ethylhexyl phthalate (primary metabolite of di-2-
ethylhexyl phthalate [DEHP]); MEHHP = mono-2-ethyl-5-hydroxyhexyl phthalate (secundary metabolite of DEHP); MEOHP = mono-2-
ethyl-5-oxohexyl phthalate (secundary metabolite of DEHP); MnBP = mono-n-butyl phthalate (metabolite of di-n-butyl phthalate [DBP]); 
MBzP = mono-benzyl phthalate (metabolite of benzylbutyl phthalate [BzBP]); DMP = dimethylphosphate; DMTP = dimethylthiophosphate; 
DMDTP = dimethyldithiophosphate; DEP = diethylphosphate; DETP = diethylthiophosphate; DEDTP = diethyldithiophosphate; HBA = 
para-hydroxybenzoic acid; 3,5-DCA = 3,5-dichloroaniline; 3,4-DCA = 3,4-dichloroaniline; DCPU = 3,4-dichlorophenyl urea; DCPMU = 
3,4-dichlorophenyl-3-methylurea; 3-PBA = 3-phenoxybenzoic acid; FPBA = 4-fluoro-3-phenoxybenzoic acid; BP-3 = benzophenone-3; 
DHB = 2,4-dihydroxybenzophenone; DHMB = 2,2’-dihydroxy-4-methoxybenzophenone; THB = 2,3,4-trihydroxybenzophenone; HMS = 
homosalate; DABI = octyl dimethyl PABA; 4-MBC = 4-methylbenzylidenecamphor. 
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Table 27 Results from FLEHS I (Flanders) 
 
Chemical Unit Age group 
Geometric 
mean 
95% CI 
Dioxin-like compounds 
(CALUX) 
pg/g Lipid 
Newborn 23 21 - 24 
Adults 19.2 18.2 - 20.2 
PCBs ng/g Lipid 
Newborns 64.4 61.1 - 67.9 
Adolescents 68 66 -70 
Adults 333 325 - 341 
DDE ng/g Lipid 
Newborns 110 104 - 116 
Adolescents 94 89 - 99 
Adults 423 398 - 449 
HCB ng/g Lipid 
Newborns 18.9 17.9 - 20 
Adolescents 20.9 20.4 - 21.3 
Adults 56.9 55.2 - 58.6 
Blood Pb µg/L 
Newborns 14.7 14 - 15.5 
Adolescents 21.7 20.8 - 22.6 
Adults 39.6 38.4 - 40.9 
Blood Cd µg/L 
Newborns 0.21 0.19 - 0.23 
Adolescents 0.36 0.33 - 0.38 
Adults 0.42 0.4 - 0.44 
Urinary Cd µg/ g Creatinine Adults 0.62 0.6 - 0.64 
1 HO-pyrene µg/ g Creatinine 
Adolescents 88 81 - 95 
Adults 147 138 - 157 
Tt'-muconic acid µg/ g Creatinine 
Adolescents 72 66 -79 
Adults 85 79 -92 
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Table 28 Results from ENNS study (France) 
Chemical Group Substance Matrix Geometric mean 
 Antimony urine 0.083 µg/L 
Metals 
Arsenic urine 13.42 µg/L 
Cadmium urine 0.32 µg/L 
Chromium urine 0.19 µg/L 
Cobalt urine 0.24 µg/L 
Lead blood 25.7 µg/L 
Mercury hair 0.59 µg/g hair (adults) 
  0.37 µg/g hair (children) 
Nickel urine 1.36 µg/L 
Tin urine 0.50 µg/L 
Uranium urine 4.9 ng/L 
 Vanadium urine 0.95 µg/L 
Organochlorines 
PCB 28 serum 2.2 ng/g lipid 
PCB 52 serum 0.27 ng/g lipid 
PCB 101 serum 1.08 ng/g lipid 
PCB 138 serum 70.8 ng/g lipid 
PCB 153 serum 113.3 ng/g lipid 
PCB 180 serum 93.7 ng/g lipid 
α-HCH serum 0.66 ng/g lipid 
β-HCH serum 30 ng/g lipid 
γ-HCH serum <LOD 
DDE serum 118 ng/g lipid 
DDT serum 33.2 ng/g lipid 
HCB serum 24 ng/g lipid 
Organophosphates 
DMP urine 7.19 µg/L 
DMTP urine 6.65 µg/L 
DMDTP urine 0.76 µg/L 
DEP urine 3.94 µg/L 
DETP urine 1.07 µg/L 
DEDTP urine 0.02 µg/L 
Chlorophenols 
4-MCP urine 5.56 µg/L 
2,4-DCP urine 1.10 µg/L 
2,5-DCP urine 10.56 µg/L 
2,6-DCP urine <LOD 
2,3,4-TCP urine <LOD 
2,4,5-TCP urine 0.15 µg/L 
2,4,6-TCP urine 0.37 µg/L 
PCP urine 0.90 µg/L 
Pyrethroid 
metabolites 
cis-Cl2CA urine 0.17 µg/L 
trans-Cl2CA urine 0.39 µg/L 
Br2CA urine 0.37 µg/L 
3-PBA urine 0.74 µg/L 
F-PBA urine <LOD 
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Table 29 Findings of Pb, Hg, and PCBs in BIOAMBIENT.ES (Spain) 
a. 
 
 
 
 
b. 
 
 
 
c. 
 
 
 
PCBs 28 and 52 were only detected in 1% of the total samples, and PCB 101 was detected in 6% of 
the total samples.  
  
Sample 
Geometric mean 
(blood lead levels) 
95% CI 
Total (n=1880) 24.03 µg/L 22.98-25.12 
Males (n=962) 28.33 µg/L 26.76-29.99 
Females (n=918) 19.47 µg/L 18.55-20.45 
Sample 
Geometric mean 
(hair Hg levels) 
95% CI 
Total (n=604) 1.86 ng/mg 1.76-1.97 
Sample 
Geometric mean 
(Σ PCB 138,153,180) 
95% CI 
Total (n=1880) 135.4 ng/g lipid 121.3-151.4 
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Table 30 The levels of metal [µg/L unless specified otherwise] found in the Italian population from 
the PROBE study 
Metal Fluid Geometric Mean P95 
As Blood 1.14 5.32 
Be Blood 0.08 0.18 
Cd Blood 0.53 1.42 
Co Blood 0.15 0.44 
Cr Blood 0.24 1.09 
Hg Blood 1.19 5.16 
Ir Serum 2.46 ng/L 7.05 
Mn Blood 8.19 14.5 
Mo Blood 1.21 2.05 
Ni Serum 0.35 0.94 
Pb Blood 19.9 51.7 
Pd Serum 10.6 ng/L 29.4 
Pt Serum 5.23 ng/L 13.3 
Rh Serum 9.28 ng/L 23.1 
Sb Blood 0.31 0.72 
Sn Blood 0.54 2.25 
Tl Blood 0.037 0.098 
U Blood 0.006 0.014 
V Serum 0.044 0.11 
W Blood 0.028 0.075 
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Table 31 Results of phthalate metabolites of Austrian children and adults (from the Schadstoffe im 
Menschen HBM study) 
Substance Matrix Arithmetic mean P95 
MBzP urine 2.7 µg/L 6.2 µg/L 
MiBP urine 13 µg/L 25 µg/L 
MnBP urine 9.6 µg/L 22 µg/L 
MCHP urine <LOQ <LOQ 
MEP urine 59 µg/L 214 µg/L 
MEHP urine 1.9 µg/L 5.2 µg/L 
MEHHP 
(5OH-MEHP) 
urine 6.2 µg/L 14 µg/L 
MEOHP 
(5oxo-MEHP) 
urine 3.6 µg/L 8.7 µg/L 
MECPP 
(5cx-MEPP) 
urine 43 µg/L 121 µg/L 
MiNP urine <LOQ <LOQ 
MOP/MnOP urine <LOQ <LOQ 
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Table 32 Results of the levels found in the tested substances of CHMS (Canada) 
Chemical Group Substance Matrix Geometric mean 
Metals 
Antimony urine 0.048 µg/L 
Arsenic blood 0.89 µg/L 
 urine 9.1 µg/L 
Cadmium blood 0.29 µg/L 
 urine 0.39 µg/L 
Cesium urine 4.9 µg/L 
Cobalt urine 0.23 µg/L 
Copper blood 900 µg/L 
 urine 11 µg/L 
Fluoride urine 500 µg/L 
Lead blood 1.2 µg/dL 
 urine 0.52 µg/L 
Manganese blood 9.8 µg/L 
 urine <LOD 
Mercury hair 0.70 µg/L 
Molybdenum blood 0.66 µg/L 
 urine 45 µg/L 
Nickel blood 0.48 µg/L 
 urine 1.3 µg/L 
Selenium blood 190 µg/L 
 urine 51 µg/L 
Silver blood <LOD 
Thallium blood 0.23 µg/L 
Tungsten urine <LOD 
Uranium blood <LOD 
Vanadium urine <LOD 
Zinc blood 5.9 µg/L 
 urine 320 µg/L 
PCBs 
PCB 105 plasma <LOD 
PCB 118 plasma 0.03 µg/L 
PCB 156 plasma 0.02 µg/L 
PCB 167 plasma <LOD 
PCB 28 plasma <LOD 
PCB 52 plasma <LOD 
PCB 66 plasma <LOD 
PCB 74 plasma <LOD 
PCB 99 plasma <LOD 
PCB 101 plasma <LOD 
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Chemical Group Substance Matrix Geometric mean 
PCB 128 plasma <LOD 
PCB 138 plasma 0.06 µg/L 
PCB 146 plasma 0.01 µg/L 
PCB 153 plasma 0.11 µg/L 
PCB 170 plasma 0.03 µg/L 
PCB 178 plasma <LOD 
PCB 180 plasma 0.09 µg/L 
PCB 183 plasma <LOD 
PCB 187 plasma 0.02 µg/L 
PCB 194 plasma 0.02 µg/L 
PCB 196 plasma 0.01 µg/L 
PCB 206 plasma <LOD 
Fluorocarbons 
PFBuS plasma <LOD 
PFDeA plasma 0.20 µg/L 
PFHxS plasma 1.8 µg/L 
PFNA plasma 0.82 µg/L 
PFOA plasma 2.3 µg/L 
PFOS plasma 6.5 µg/L 
PFUA plasma 0.12 µg/L 
PBDEs 
PBDE 17 plasma <LOD 
PBDE 28 plasma <LOD 
PBDE 47 plasma 0.06 µg/L 
PBDE 99 plasma <LOD 
PBDE 100 plasma <LOD 
PBDE 153 plasma <LOD 
PBB 153 plasma <LOD 
Phthalates 
MBzP urine 7.5 µg/L 
MiBP urine 14 µg/L 
MnBP urine 20 µg/L 
MCHP urine <LOD 
MEP urine 45 µg/L 
 MEHP urine 1.9 µg/L 
MEHHP urine 13 µg/L 
MEOHP urine 7.4 µg/L 
MiNP urine <LOD 
MMP urine <LOD 
MCPP urine 1.9 µg/L 
MOP urine <LOD 
Phenols Bisphenol A urine 1.2 µg/L 
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Chemical Group Substance Matrix Geometric mean 
Triclosan urine 16 µg/L 
Carbamate 
pesticides 
Carbofuranphenol urine <LOD 
2-isopropoxyphenol urine <LOD 
Herbicide 2,4-D urine <LOD 
Organophosphates 
DMP urine 3.3 µg/L 
DMTP urine 2.7 µg/L 
DMDTP urine <LOD 
DEP urine 2.8 µg/L 
DETP urine 0.66 µg/L 
DEDTP urine <LOD 
Pesticides 
Aldrin plasma <LOD 
p,p'-DDE plasma 0.91 µg/L 
p,p'-DDT plasma <LOD 
β-HCH plasma 0.04 µg/L 
γ-HCH plasma <LOD 
HCB plasma 0.05 µg/L 
Mirex plasma <LOD 
Oxychlordane plasma 0.03 µg/L 
trans-Nonachlor plasma 0.04 µg/L 
Chlorophenols 
2,4-DCP urine 1.2 µg/L 
2,5-DCP urine 5.5 µg/L 
2,4,5-TCP urine <LOD 
2,4,6-TCP urine <LOD 
PCP urine <LOD 
PAHs metabolites 
3-hydroxybenzo[a]pyrene urine <LOD 
2-hydroxyfluorene urine 0.27 µg/L 
3-hydroxyfluorene urine 0.096 µg/L 
9-hydroxyfluorene urine 0.16 µg/L 
1-hydroxypyrene urine 0.11 µg/L 
1-hydroxyphenanthrene urine 0.15 µg/L 
2-hydroxyphenanthrene urine 0.067 µg/L 
3-hydroxyphenanthrene urine 0.087 µg/L 
4-hydroxyphenanthrene urine 0.025 µg/L 
9-hydroxyphenanthrene urine 0.039 µg/L 
1-hydroxynaphthalene urine 1.5 µg/L 
2-hydroxynaphthalene urine 3.8 µg/L 
Pyrethroid 
metabolites 
cis-Cl2CA urine 0.12 µg/L 
trans-Cl2CA urine 0.29 µg/L 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 206 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Chemical Group Substance Matrix Geometric mean 
Br2CA urine 0.012 µg/L 
3-PBA urine 0.43 µg/L 
F-PBA urine <LOD 
Tobacco smoke Cotinine urine 
<LOD (non-smokers) 
2600 µg/L (smokers) 
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Table 33 Results of the levels found in the tested substances of NHANES (USA) 
Chemical Group Substance Matrix Geometric mean 
Metals 
Antimony urine <LOD 
Arsenic urine 6.84 µg/L 
Barium urine 1.20 µg/L 
Beryllium urine <LOD 
Cadmium blood 0.279 µg/L 
 urine 0.154 µg/L 
Caesium urine 3.82 µg/L 
Cobalt urine 0.327 µg/L 
Copper serum 114 µg/dL 
Lead blood 0.973 µg/dL 
 urine 0.358 µg/L 
Manganese blood 9.35 µg/L 
 urine 0.124 µg/L 
Mercury blood 0.703 µg/L 
 urine 0.323 µg/L 
Molybdenum urine 36.9 µg/L 
Platinum urine <LOD 
Selenium blood 190 µg/L 
 serum 127 µg/L 
Strontium urine 85.4 µg/L 
Thallium urine 0.150 µg/L 
Tin urine 0.617 µg/L 
Tungsten urine 0.073 µg/L 
Uranium urine 0.006 µg/L 
Zinc serum 81.8 µg/dL 
PCBs 
PCB 77 serum 36.7 ng/g lipid (a) 
PCB 81 serum <LOD 
PCB 126 serum 16.3 pg/g lipid 
PCB 169 serum <LOD 
PCB 105 serum 1.20 pg/g lipid 
PCB 114 serum 2.83 ng/g lipid (a) 
PCB 118 serum 6.00 ng/g lipid 
PCB 123 serum <LOD 
PCB 156 serum 2.54 pg/g lipid 
PCB 157 serum 0.605 pg/g lipid 
PCB 167 serum 0.494 pg/g lipid 
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Chemical Group Substance Matrix Geometric mean 
PCB 189 serum <LOD 
PCB 28 serum 4.90 ng/g lipid 
PCB 44 serum 2.06 ng/g lipid 
PCB 49 serum 1.29 ng/g lipid 
PCB 52 serum 2.66 ng/g lipid 
PCB 66 serum 1.39 ng/g lipid 
PCB 74 serum 4.81 ng/g lipid 
PCB 87 serum 0.656 ng/g lipid 
PCB 99 serum 4.16 ng/g lipid 
PCB 101 serum 1.65 ng/g lipid 
PCB 110 serum 1.22 ng/g lipid 
PCB 128 serum <LOD 
PCB 138 serum 15.1 ng/g lipid 
PCB 146 serum 2.17 ng/g lipid 
PCB 149 serum 0.598 ng/g lipid 
PCB 151 serum <LOD 
PCB 153 serum 19.8 ng/g lipid 
PCB 170 serum 5.46 ng/g lipid 
PCB 172 serum 0.647 ng/g lipid 
PCB 177 serum 1.13 ng/g lipid 
PCB 178 serum 0.933 ng/g lipid 
PCB 180 serum 15.1 ng/g lipid 
PCB 183 serum 1.45 ng/g lipid 
PCB 187 serum 4.23 ng/g lipid 
PCB 194 serum 2.69 ng/g lipid 
PCB 195 serum <LOD 
PCB 196 serum 2.61 ng/g lipid 
PCB 199 serum 2.81 ng/g lipid 
PCB 206 serum 2.13 ng/g lipid 
PCB 209 serum 1.40 ng/g lipid 
Perchlorate Perchlorate urine 2.97 µg/L 
Fluorocarbons 
PFBuS serum <LOD 
PFDeA serum 0.279 µg/L 
PFDoA serum <LOD 
PFHpA serum <LOD 
PFHxS serum 1.66 µg/L 
PFNA serum 1.26 µg/L 
PFOA serum 3.07 µg/L 
PFOS serum 9.32 µg/L 
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Chemical Group Substance Matrix Geometric mean 
PFOSA serum <LOD 
Et-PFOSA-AcOH serum <LOD 
Me-PFOSA-AcOH serum <LOD 
PFUA serum <LOD 
Dioxins 
1,2,3,4,6,7,8-HpBDD serum 29.1 ng/g lipid (a) 
1,2,3,4,7,8-HxBDD and 
1,2,3,6,7,8-HxBDD 
serum <LOD 
1,2,3,7,8,9-HxBDD serum <LOD 
1,2,3,7,8-PeBDD serum <LOD 
2,3,7,8-TBDD serum <LOD 
1,2,3,4,6,7,8-HpCDD serum 25.3 pg/g lipid 
1,2,3,4,7,8-HxCDD serum <LOD 
1,2,3,6,7,8-HxCDD serum 17.2 pg/g lipid 
1,2,3,7,8,9-HxCDD serum <LOD 
1,2,3,4,6,7,8,9-OCDD serum <LOD 
1,2,3,7,8-PeCDD serum <LOD 
2,3,7,8-TCDD serum <LOD 
Furans 
1,2,3,4,6,7,8-HpBDF serum 19.6 ng/g lipid 
(a) 
1,2,3,4,7,8-HxBDF serum <LOD 
1,2,3,7,8-PeBDF serum <LOD 
2,3,4,7,8-PeBDF serum <LOD 
2,3,7,8-TBDF serum <LOD 
1,2,3,4,6,7,8-HpCDF serum <LOD 
1,2,3,4,7,8,9-HpCDF serum <LOD 
1,2,3,4,7,8-HxCDF serum <LOD 
1,2,3,6,7,8-HxCDF serum <LOD 
1,2,3,7,8,9-HxCDF serum <LOD 
2,3,4,6,7,8-HxCDF serum <LOD 
1,2,3,4,6,7,8,9-OCDF serum <LOD 
1,2,3,7,8-PeCDF serum <LOD 
2,3,4,7,8-PeCDF serum <LOD 
2,3,7,8-TCDF serum <LOD 
PBDEs 
PBDE 17 serum <LOD 
PBDE 28 serum 1.19 ng/g lipid 
PBDE 47 serum 20.5 ng/g lipid 
PBDE 66 serum <LOD 
PBDE 85 serum <LOD 
PBDE 99 serum <LOD 
PBDE 100 serum 3.93 ng/g lipid 
PBDE 153 serum 5.69 ng/g lipid 
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Chemical Group Substance Matrix Geometric mean 
PBDE 154 serum <LOD 
PBDE 183 serum <LOD 
BDE 209 serum <LOD 
PBB 153 serum 2.29 ng/g lipid 
Phthalates 
MBzP urine 4.48 µg/L 
MiBP urine 5.99 µg/L 
MnBP urine 7.60 µg/L 
MCHP urine <LOD 
MEP urine 37.6 µg/L 
MEHP urine 1.37 µg/L 
MEHHP urine 7.90 µg/L 
MEOHP urine 5.08 µg/L 
MECPP urine 12.9 µg/L 
MCNP urine 2.48 µg/L 
MiNP urine <LOD 
MMP urine <LOD 
MCOP urine 19.7 µg/L 
MCPP urine 3.01 µg/L 
MOP urine <LOD 
MHNCH urine <LOD 
Phenols 
Benzophenone-3 urine 23.3 µg/L 
Bisphenol A urine 1.51 µg/L 
Butyl paraben urine <LOD 
Ethyl paraben urine <LOD 
Methyl paraben urine 40.6 µg/L 
Propyl paraben urine 5.44 µg/L 
4-tert-octylphenol urine <LOD 
Triclosan urine 12.0 µg/L 
Nitrosamine NNAL urine <LOD 
Smoke flavouring Nitrate urine 42.0 mg/L 
Carbamate 
pesticides 
Carbofuranphenol urine <LOD 
2-isopropoxyphenol urine <LOD 
Herbicides 
2,4-D urine 0.245 µg/L 
2,4,5-T urine <LOD 
Organophosphates 
Acephate urine <LOD 
Dimethoate urine <LOD 
Methamidophos urine <LOD 
Omethoate urine <LOD 
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Chemical Group Substance Matrix Geometric mean 
Malathion diacid urine <LOD 
Paranitrophenol urine 0.673 µg/L 
3,5,6-trichloropyridinol urine 1.29 µg/L 
DMP urine <LOD 
DMTP urine 2.28 µg/L 
DMDTP urine <LOD 
DEP urine <LOD 
DETP urine <LOD 
DEDTP urine <LOD 
Pesticides 
Aldrin serum <LOD 
Dieldrin serum <LOD 
Endrin serum <LOD 
Heptachlor epoxide serum <LOD 
p,p'-DDE serum 238 ng/g lipid 
o,p'-DDT serum <LOD 
p,p'-DDT serum <LOD 
β-HCH serum <LOD 
γ-HCH serum <LOD 
HCB serum 15.2 ng/g lipid 
Mirex serum <LOD 
Oxychlordane serum 9.37 ng/g lipid 
trans-Nonachlor serum 14.7 ng/g lipid 
Chlorophenols 
2,4-DCP urine 0.696 µg/L 
2,5-DCP urine 4.15 µg/L 
2,4,5-TCP urine <LOD 
2,4,6-TCP urine <LOD 
PCP urine <LOD 
PAHs metabolites 
2-hydroxyfluorene urine 237 ng/L 
3-hydroxyfluorene urine 92.4 ng/L 
9-hydroxyfluorene urine 241 ng/L 
1-hydroxypyrene urine 110 ng/L 
1-hydroxyphenanthrene urine 125 ng/L 
2-hydroxyphenanthrene urine 60.3 ng/L 
3-hydroxyphenanthrene urine 61.3 ng/L 
4-hydroxyphenanthrene urine 20.3 ng/L 
1-hydroxynaphthalene urine 2.58 µg/L 
2-hydroxynaphthalene urine 3.83 µg/L 
Pyrethroid 
metabolites 
Br2CA urine <LOD 
3-PBA urine 0.401 µg/L 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 212 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Chemical Group Substance Matrix Geometric mean 
F-PBA urine <LOD 
Tobacco smoke Cotinine serum 0.041 ng/mL 
           (a): The arithmetic mean is reported here. 
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Table 34 Levels of metals and cotinine found in KNHANES (South Korea) 
 
Table 35 Levels of metals found in KorSEP III  
Substances Geometric mean 95% CI 
Lead (blood) 19.1 µg/L 18.2-20.1 
Mercury (blood) 3.23 µg/L 3.06-3.39 
Manganese (blood) 10.8 µg/L 10.4-11.1 
Arsenic (urine) 43.5 µg/L 41.6-45.4 
Cadmium (urine) 0.65 µg/L 0.56-0.74 
 
Table 36 Levels of PAH metabolites found in KorSEP III  
Substances Geometric mean 95% CI 
1-hydroxypyrene (urine) 0.15 µg/L 0.13-0.17 
2-naphthol (urine) 3.84 µg/L 3.57-4.11 
Cotinine (urine) 47.42 µg/L 40.52-54.32 
  
  
Chemical Group Substance Matrix Geometric mean 
Metals 
Arsenic urine 
101.0 µg/g creatinine  
(low shellfish intake) 
Cadmium blood 1.07 µg/L 
Lead blood 2.49 µg/dL 
Manganese blood 1.35 µg/dL 
Mercury blood 5.19 µg/L 
Tobacco smoke Cotinine urine 
5.31 ng/mL (male non-smokers) 
4.49 ng/mL (female non-smokers) 
1221.93 ng/mL (male smokers) 
822.93 ng/mL (female smokers) 
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Table 37 Levels of phthalate metabolites found in KorSEP III  
Substances Geometric mean 
Geometric 
standard error 
MnBP 41.7 µg/L 1.9 
MeHHP 38.1 µg/L 1.9 
MeOHP 17.5 µg/L 1.9 
MiBP 17.0 µg/L 2.2 
MBzP 15.8 µg/L 2.8 
MCHP <LOD N/A 
MnOP <LOD N/A 
MINP <LOD N/A 
MiDP Too low for quantification N/A 
MEHP not reported N/A 
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Table 38 A summary overview of the analytical methods used in the reviewed HBM programmes 
 
Class of 
substances 
HBM Programme Method Matrix 
Acrylamide MoBa (Norway), NHANES (USA) LC-MS 
(a)
 Blood 
(d)
 
 MoBa (Norway) LC-MS Urine 
BFRs FLEHS (Flanders), BIOAMBIENT.ES (Spain), Pollutants in humans (Austria), NHANES (USA) GC-MS
 (b)
 Blood 
 CHMS (Canada) GC-ECD
 (c)
  
 AMAP LC-MS  
 Mothers in Uppsala (Sweden), POPs in milk (China) GC-MS Breast milk 
Bisphenol A ESBHum (Germany), Pollutants in humans (Austria), Danish HBM (Denmark), NHANES 
(USA), MOCEH (South Korea), KorEHS-C (South Korea) 
LC-MS Urine 
 ELFE (France), FLEHS (Flanders), MoBa (Norway), CHMS (Canada) GC-MS  
Carbamate CHMS (Canada), NHANES (USA) GC-MS Urine 
Chlorophenols ESBHum (Germany), GerES (Germany), ENNS (France), FLEHS (Flanders), CHMS (Canada) GC-MS Urine 
 NHANES (USA) LC-MS  
Cotinine NHANES (USA) LC-MS Blood 
 Hokkaido (Japan) ELISA  
 GerES (Germany) LC-UV detection Urine 
 FLEHS (Flanders) Chemiluminescence  
 MoBa (Norway), CHMS (Canada) LC-MS  
 KHNANES (South Korea), KorSEP (South Korea) GC-MS  
 MOCEH (South Korea), KorEHS-C (South Korea) ELISA  
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Class of 
substances 
HBM Programme Method Matrix 
Fluorocarbons ESBHum (Germany), FLEHS (Flanders), Tromsø cohort (Norway), MoBa (Norway), AMAP, 
CHMS (Canada), NHANES (USA), Hokkaido (Japan) 
LC-MS Blood 
 ELFE (France), Hokkaido (Japan), POPs in milk (China) LC-MS Breast milk 
Dioxins & furans FLEHS (Flanders), Tohoku (Japan) CALUX 
(e)
 Blood 
 NHANES (USA), Hokkaido (Japan) GC-MS  
 ELFE (France), Mothers in Uppsala (Sweden), POPs in milk (China) GC-MS Breast milk 
Herbicides (i.e. 
2,4-D & 2,4,5-T) 
FLEHS (Flanders), NHANES (USA) 
CHMS (Canada) 
LC-MS 
GC-MS 
Urine 
Mercury ESBHum (Germany), GerES (Germany), Tohoku (Japan), MOCEH (South Korea), KorEHS-C 
(South Korea) 
CV-AAS Blood 
 BIOAMBIENT.ES (Spain), PROBE (Italy), CHMS (Canada),  NHANES (USA) ICP-MS  
 CZ-HBM (Czech Republic), Slovenia HBM, KNHANES (South Korea), KorSEP (South Korea) DMA  
 AMAP HPLC-MS  
 ESBHum (Germany), Slovenia HBM,  CV-AAS Urine 
 BIOAMBIENT.ES (Spain), NHANES (USA) ICP-MS  
 ENNS (France), Pollutants in humans (Austria) 
FLEHS (Flanders) 
ICP-MS 
AFS 
Hair (for 
MeHg) 
 BIOAMBIENT.ES (Spain), CZ-HBM (Czech Republic), Slovenia HBM DMA  
 Hokkaido (Japan) Atomic absorption 
detection 
 
 Tohoku (Japan) CV-AAS  
 Slovenia HBM CV-AAS Milk 
Metals (excluding ESBHum (Germany), FLEHS (Flanders), BIOAMBIENT.ES (Spain), PROBE (Italy), Slovenia ICP-MS Blood 
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Class of 
substances 
HBM Programme Method Matrix 
mercury) HBM, CHMS (Canada), NHANES (USA), Tohoku (Japan) 
 ESBHum (Germany), GerES (Germany), ENNS (France), CZ-HBM (Czech Republic), Selenium 
supplement (Finland) 
ET-AAS  
 Tohoku (Japan), KorSEP (South Korea) GF-AAS  
 ESBHum (Germany), ENNS (France), FLEHS (Flanders), BIOAMBIENT.ES (Spain), Slovenia 
HBM, CHMS (Canada), NHANES (USA) 
ICP-MS Urine 
 GerES (Germany), CZ-HBM (Czech Republic) ET-AAS  
 Slovenia HBM, Mothers in Uppsala (Sweden) ICP-MS Milk 
Mycotoxin NHANES (USA) LC-MS Blood 
Nicotine GerES (Germany) LC-UV detection Urine 
Nitrosamine NHANES (USA) LC-MS Urine 
Organochlorines ESBHum (Germany), FLEHS (Flanders), CZ-HBM (Czech Republic), Tromsø cohort (Norway), 
NHANES (USA), Tohoku (Japan) 
GC-MS Blood 
 GerES (Germany), ENNS (France), CHMS (Canada) GC-ECD  
 Tohoku (Japan), POPs in milk (China) GC-MS Breast milk 
Organophosphate 
pesticides 
NHANES (USA) LC-MS Urine 
Organophosphate 
metabolites 
GerES (Germany), ENNS (France), FLEHS (Flanders), MoBa (Norway), CHMS (Canada), 
NHANES (USA) 
GC-MS Urine 
PAH metabolites GerES (Germany), FLEHS (Flanders), BIOAMBIENT.ES (Spain), KorSEP (South Korea), 
MOCEH (South Korea), KorEHS-C (South Korea) 
LC-MS Urine 
 CHMS (Canada), NHANES (USA) GC-MS  
PCBs ESBHum (Germany), BIOAMBIENT.ES (Spain), CZ-HBM (Czech Republic), Tromsø cohort 
(Norway), NHANES (USA), Hokkaido (Japan), Tohoku (Japan) 
GC-MS Blood 
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Class of 
substances 
HBM Programme Method Matrix 
 GerES (Germany), ENNS (France), CHMS (Canada) GC-ECD  
 AMAP LC-MS  
 ELFE (France), CZ-HBM (Czech Republic), Mothers in Uppsala (Sweden), Tohoku (Japan), 
POPs in milk (China) 
GC-MS Breast milk 
Perchlorate NHANES (USA) IC-MS Urine 
Phenols FLEHS (Flanders), Pollutants in humans (Austria), Danish HBM (Denmark), NHANES (USA) LC-MS Urine 
Phthalates ESBHum (Germany), ELFE (France), FLEHS (Flanders), Pollutants in humans (Austria), Danish 
HBM (Denmark), MoBa (Norway), CHMS (Canada), NHANES (USA), KorSEP (South Korea), 
MOCEH (South Korea), KorEHS-C (South Korea) 
LC-MS Urine 
Pyrethroid 
metabolites 
GerES (Germany), FLEHS (Flanders), ENNS (France), CHMS (Canada) GC-MS Urine 
 NHANES (USA) LC-MS  
Triclosan FLEHS (Flanders), CHMS (Canada) GC-MS Urine 
(a): Including LC-MS, HPLC-MS and UPLC-MS. 
(b): Including GC-MSD. 
(c): Including GC-ECD-MS. 
(d): Including whole blood, serum, plasma samples. 
(e): Total dioxins or furans were measured with this assay. 
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Table 39  Inventory of the validated biomarkers of exposure in various biological matrices measured in the national/European HBM programmes 
Biological 
matrix 
Validated biomarkers of exposure HBM programme (region; age range) 
Blood 
(a)
 Acrylamide/Glycidamide NHANES (USA; age ≥6) 
 
Aflatoxin B1 NHANES (USA; age ≥6) 
BFRs (PBDE 17, 28, 47, 66, 85, 99, 100, 153, 154, 183, BDE 209,  
HBCDDs, TBBPA, PBB 153) 
BIOAMBIENT.ES (Spain; age ≥16); CHMS I (Canada; age 6-79); NHANES 
(USA; age ≥6) 
 Cotinine NHANES (USA; age ≥6) 
 Dioxins (1,2,3,4,6,7,8-HpBDD, 1,2,3,4,7,8-HxBDD, 1,2,3,6,7,8-HxBDD, 
1,2,3,7,8,9-HxBDD, 1,2,3,7,8-PeBDD, 2,3,7,8-TBDD, 1,2,3,4,6,7,8-HpCDD, 
1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, 
1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD) 
NHANES (USA; age ≥6) 
 Fluorocarbons (PFBuS, PFDeA/PFDA, PFDoA, PFHpA, PFHxS, PFNA, 
PFOA, PFOS, PFOSA, Et-PFOSA-AcOH, Me-PFOSA-AcOH, 
PFUA/PFUdA) 
CHMS I-II (Canada; age 3-79) 
 Furans (1,2,3,4,6,7,8-HpBDF, 1,2,3,4,7,8-HxBDF,  1,2,3,7,8-PeBDF, 
2,3,4,7,8-PeBDF, 2,3,7,8-TBDF, 1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 
1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-
HxCDF, 1,2,3,4,6,7,8,9-OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-
TCDF) 
NHANES (USA; age ≥6) 
 Metals (Sb, As, Be, Cd, Cr, Co, Cu, Ir, Pb, Mn, Hg, Mo, Ni, Pd, Pt, Rh, Se, 
Ag, Tl, Sn, W, U, V, Zn) 
GerES IV (Germany; age 3-14); FLEHS I (Flanders; age 0-65); ENNS 
(France; age 3-74); BIOAMBIENT.ES (Spain; age ≥16); PROBE (Italy; age 
18-65); CHMS I-II (Canada; age 3-79); NHANES (USA; age ≥6); 
KNHANES (South Korea; age ≥1) 
 Organochlorine pesticides (Aldrin, Dieldrin, Endrin, Heptachlor, 
Heptachlor epoxide, DDT, DDE, Oxychlordane, trans-Nonachlor, HCB, α-
HCH, β-HCH, γ-HCH, Mirex) 
GerES IV (Germany; age 3-14); FLEHS I (Flanders; age 0-65); CHMS I 
(Canada; age 6-79); NHANES (USA; age ≥6) 
  PCBs (PCB 28, 44, 49, 52, 66, 74, 77, 81, 87, 99, 101, 105, 110, 114, 118, 
123, 126, 128, 138, 146, 149, 151, 153, 156, 157, 158, 167, 169, 170, 172, 
177, 178, 180, 183, 187, 189, 194, 195, 196, 199, 203, 206, 209) 
GerES IV (Germany; age 3-14); FLEHS I (Flanders; age 0-65); 
BIOAMBIENT.ES (Spain; age ≥16); CHMS I (Canada; age 6-79); NHANES 
(USA; age ≥6) 
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Biological 
matrix 
Validated biomarkers of exposure HBM programme (region; age range) 
Urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol (NNAL) NHANES (USA; age ≥6) 
Bisphenol A CHMS I-II (Canada; age 3-79); NHANES (USA; age ≥6); 
COPHES/DEMOCOPHES (Europe; age 6-45) 
Carbamate pesticides (Carbofuranphenol, 2-isopropoxyphenol) CHMS II (Canada; age 3-79); NHANES (USA; age ≥6) 
Chlorophenols (2-MCP, 4-MCP, 2,4-DCP, 2,5-DCP, 2,6-DCP, 2,3,4-TCP, 
2,4,5-TCP, 2,4,6-TCP, 2,3,4,6-TeCP, PCP) 
GerES IV (Germany; age 3-14); CHMS I-II (Canada; age 3-79); NHANES 
(USA; age ≥6) 
Cotinine GerES IV-V (Germany; age 3-17); CHMS I-II (Canada; age 3-79); 
KNHANES (South Korea; age ≥1); COPHES/DEMOCOPHES (Europe; age 
6-45) 
Herbicides (2,4-D, 2,4,5-T) CHMS I-II (Canada; age 3-79); NHANES (USA; age ≥6) 
Metals (Sb, As, Ba, Be, Cd, Cs, Cr, Co, Cu, Fl, Pb, Mn, Hg, Mo, Ni, Pt, Se, 
Ag, Sr, Tl, Sn, W, U, V, Zn) 
GerES IV-V (Germany; age 3-17); ENNS (France; age 3-74); 
BIOAMBIENT.ES (Spain; age ≥16); CHMS I-II (Canada; age 3-79); 
NHANES (USA; age ≥6); KNHANES (South Korea; age ≥1); 
COPHES/DEMOCOPHES (Europe; age 6-45) 
Organophosphate pesticides & metabolites [3,5,6-trichloropyridinol, 
Acephate, Dimethoate, Malathion diacid, Methamidophos, Omethoate, 
Oxypyrimidine, Paranitrophenol, DEP, DMP, DETP, DMTP, DEDTP, 
DMDTP] 
GerES IV-V (Germany; age 3-17); CHMS I-II (Canada; age 3-79); NHANES 
(USA; age ≥6) 
PAH metabolites (3-Hydroxybenzo(a)pyrene, 2-Hydroxyfluorene, 3-
Hydroxyfluorene, 9-Hydroxyfluorene, 1-Hydroxyphenanthrene, 2-
Hydroxyphenanthrene, 3-Hydroxyphenanthrene, 4-Hydroxyphenanthrene, 9-
Hydroxyphenanthrene, 1-Hydroxypyrene, 1-Hydroxynaphthalene, 2-
Hydroxynaphthalene) 
GerES IV-V (Germany; age 3-17);  FLEHS I (Flanders; age 0-65); 
BIOAMBIENT.ES (Spain; age ≥16); CHMS II (Canada; age 3-79); 
NHANES (USA; age ≥6) 
Perchlorate NHANES (USA; age ≥6) 
Phenols (Benzophenone-3, Butyl paraben, Ethyl paraben, Methyl paraben, 
Propyl paraben, 4-tert-octylphenol, Triclosan) 
GerES V (Germany; age 3-17); CHMS II (Canada; age 3-79); NHANES 
(USA; age ≥6) 
Phthalate metabolites (MBzP, MiBP, MnBP, MEP, MiNP, MCOP, MEHP, 
MEHHP/5OH-MEHP, MEOHP/5oxo-MEHP, MECPP/5cx-MEPP, MMP, 
MOP/MnOP, MCPP, MCHP, MCNP) 
GerES V (Germany; age 3-17); CHMS II (Canada; age 3-79); NHANES 
(USA; age ≥6); COPHES/DEMOCOPHES (Europe; age 6-45) 
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Biological 
matrix 
Validated biomarkers of exposure HBM programme (region; age range) 
Pyrethroid pesticides & metabolites (cypermethrin, permethrin, cis-Cl2CA, 
trans-Cl2CA, F-PBA, Br2CA, 3-PBA) 
GerES IV-V (Germany; age 3-17); CHMS I-II (Canada; age 3-79); NHANES 
(USA; age ≥6) 
Hair Metals (total/methyl Hg) ENNS (France; age 3-74); BIOAMBIENT.ES (Spain; age ≥16); 
COPHES/DEMOCOPHES (Europe; age 6-45) 
Breast milk BFRs (PBDE 47, 99, 100, 153, 154, 183, HBCDDs, TBBPA) POPs in breast milk (China; mothers aged 18-35) 
Dioxins (1,2,3,4,6,7,8-HpCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD, 
1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8,9-OCDD, 1,2,3,7,8-PeCDD, 2,3,7,8-
TCDD) 
POPs in breast milk (China; mothers aged 18-35) 
Fluorocarbons (PFDeA/PFDA, PFHxS, PFNA, PFOS, PFOA, 
PFUA/PFUdA) 
POPs in breast milk (China; mothers aged 18-35) 
Furans (1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,7,8-HxCDF, 
1,2,3,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8,9-
OCDF, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF) 
POPs in breast milk (China; mothers aged 18-35) 
 
Organochlorine pesticides [Aldrin, Dieldrin, Endrin, Heptachlor, 
Heptachlor epoxide, DDT, DDE, Oxychlordane, trans-Nonachlor, HCB, α-
HCH, β-HCH, γ-HCH, Mirex] 
POPs in breast milk (China; mothers aged 18-35) 
PCBs (PCB 77, 81, 126, 169, 105, 114, 118, 123, 156, 157, 167, 189) POPs in breast milk (China; mothers aged 18-35) 
(a): including serum, plasma, and whole blood 
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C.  SUBSTANCES WITH HEALTH-BASED GUIDANCE VALUES  (HBGV) AND COVERAGE BY HBM GUIDANCE AND REFERENCE VALUES 
Table 40 Substances with reference values (RVs) established by HBM programmes 
Substance / family Substance/ Biomarker HBM Programmes with reference values 
PFCs 
PFDA NHANES, CHMS, Tromsø 
PFDoA NHANES 
PFHpA NHANES, Tromsø 
PFHxS NHANES, CHMS, Uppsala, Tromsø 
PFNA NHANES, CHMS, Uppsala, Tromsø 
PFOA GerES, FLEHS, NHANES, CHMS, Uppsala, Tromsø 
PFOS GerES, FLEHS, NHANES, CHMS, Uppsala, Tromsø 
PFOSA Uppsala, Tromsø 
Et-PFOSA-AcOH NHANES 
Me-PFOSA-AcOH NHANES 
PFUA NHANES, CHMS, Uppsala, Tromsø 
Dioxins 
2,3,7,8-TCDD NHANES, Uppsala 
1,2,3,7,8-PeCDD NHANES, Uppsala 
1,2,3,6,7,8-HxCDD NHANES, Uppsala 
1,2,3,4,6,7,8-HpCDD NHANES 
1,2,3,4,6,7,8,9-OCDD NHANES 
Furans 
2,3,4,7,8-PeCDF NHANES, Uppsala 
1,2,3,4,7,8-HxCDF NHANES 
1,2,3,6,7,8-HxCDF NHANES 
1,2,3,4,6,7,8-HpCDF NHANES 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
PCBs 
PCB28 ENNS, NHANES, CZ-HBM, Uppsala, Tromsø 
PCB44 NHANES 
PCB49 NHANES, Tromsø 
PCB52 ENNS, NHANES, CZ-HBM 
PCB66 NHANES 
PCB74 NHANES, CHMS 
PCB77 FLEHS 
PCB81 NHANES 
PCB87 NHANES 
PCB99 NHANES, CHMS, Tromsø 
PCB101 ENNS, NHANES, CZ-HBM, Tromsø 
PCB105 NHANES, CHMS, Uppsala, Tromsø 
PCB110 NHANES 
PCB118 NHANES, CHMS, CZ-HBM, Uppsala, Tromsø 
PCB123 Tromsø 
PCB126 NHANES, Uppsala 
PCB128 NHANES 
PCB138 & 158 
GerES, FLEHS, ENNS, NHANES, CHMS, BIOAMBIENT.ES, CZ-HBM, Uppsala, 
Tromsø 
PCB146 NHANES, CHMS 
PCB149 NHANES 
PCB151 NHANES 
PCB153 GerES, FLEHS, ENNS, NHANES, CHMS, CZ-HBM, Uppsala, Tromsø 
PCB156 NHANES, CHMS, Uppsala, Tromsø 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
PCB157 NHANES, Tromsø 
PCB167 NHANES, CHMS, Uppsala, Tromsø 
PCB169 NHANES, Uppsala 
PCB170 NHANES, CHMS, CZ-HBM, Tromsø 
PCB172 NHANES 
PCB177 NHANES 
PCB178 NHANES, CHMS 
PCB180 
GerES, FLEHS, ENNS, NHANES, CHMS, BIOAMBIENT.ES, CZ-HBM, Uppsala, 
Tromsø 
PCB183 NHANES, CHMS, Tromsø 
PCB187 NHANES, CHMS, Tromsø 
PCB189 NHANES, Tromsø 
PCB194 NHANES, CHMS, Tromsø 
PCB195 NHANES 
PCB196 & 203 NHANES, CHMS 
PCB199 NHANES 
PCB206 NHANES, CHMS 
PCB209 NHANES 
Perchlorate Perchlorate NHANES 
Metals and trace elements 
Antimony (Sb) GerES, ENNS, NHANES, CHMS, PROBE, Uppsala 
Arsenic (As) GerES, ENNS, NHANES, CHMS, PROBE, Uppsala, KorSEP 
Barium (Ba) NHANES, Uppsala 
Beryllium (Be) NHANES, PROBE, Uppsala 
Cadmium (Cd) GerES, FLEHS, ENNS, NHANES, CHMS, PROBE, CZ-HBM, Uppsala, KHNANES, 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
KorSEP 
Cesium (Cs) NHANES, CHMS, Uppsala 
Chromium VI (Cr) GerES, ENNS, PROBE, Uppsala 
Cobalt (Co) ENNS, NHANES, CHMS, PROBE, Uppsala 
Copper (Cu) FLEHS, NHANES, CHMS, Uppsala 
Fluoride (Fl) CHMS 
Iridium (Ir) PROBE 
Lead (Pb) 
GerES, FLEHS, ENNS, NHANES, CHMS, PROBE, BIOAMBIENT.ES, CZ-HBM, 
Uppsala, KNHANES, KorSEP 
Manganese (Mn) FLEHS,  NHANES, CHMS, PROBE, Uppsala, KorSEP 
Mercury (Hg) 
GerES, FLEHS, ENNS, NHANES, CHMS, PROBE, BIOAMBIENT.ES, CZ-HBM, 
Uppsala, KNHANES, KorSEP 
Molybdenum (Mo) NHANES, CHMS, PROBE, Uppsala 
Nickel (Ni) GerES, ENNS, CHMS, PROBE, Uppsala 
Palladium (Pd) PROBE 
Platinum (Pt) GerES, NHANES, PROBE 
Rhodium (Rh) PROBE 
Selenium (Se) GerES, NHANES, CHMS, Uppsala, Selenium (Finland) 
Silver (Ag) CHMS, Uppsala 
Strontium (Sr) NHANES, Uppsala 
Thallium (Tl) GerES, FLEHS, NHANES, CHMS, PROBE 
Tin (Sn) ENNS, NHANES, PROBE 
Tungsten (W) NHANES, CHMS, PROBE 
Uranium (U) GerES, ENNS, NHANES, CHMS, PROBE, Uppsala 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
Vanadium (V) ENNS, CHMS, PROBE, Uppsala 
Zinc (Zn) NHANES, CHMS, Uppsala 
PAH metabolites 
3-Hydroxyphenanthrene GerES, NHANES, CHMS 
4-Hydroxyphenanthrene GerES, NHANES, CHMS 
9-Hydroxyphenanthrene GerES, CHMS 
1-Hydroxypyrene GerES, FLEHS, NHANES, CHMS, KorSEP 
1-Hydroxynaphthalene FLEHS, NHANES, CHMS 
2-Hydroxynaphthalene FLEHS, NHANES, CHMS, KorSEP 
 PBDEs 
PBDE 28 NHANES,  
PBDE 47 FLEHS, NHANES, CHMS, Uppsala 
PBDE 66 NHANES,  
PBDE 85 NHANES 
PBDE 99 NHANES, CHMS, Uppsala 
PBDE 100 NHANES, CHMS, Uppsala 
PBDE 153 FLEHS, NHANES, CHMS, Uppsala 
PBDE 154 NHANES  
BDE 209 NHANES 
PBB 153 NHANES 
Phthalates metabolites 
MBzP GerES, FLEHS, NHANES, CHMS, KorSEP 
MiBP GerES, NHANES, CHMS, KorSEP 
MnBP GerES, FLEHS, NHANES, CHMS, KorSEP 
MCHP CHMS 
MEP NHANES, CHMS,  
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
MEHP FLEHS, NHANES, CHMS 
MEHHP; 5OH-MEHP GerES, FLEHS, NHANES, CHMS, KorSEP 
MEOHP; 5oxo-MEHP GerES, FLEHS, NHANES, CHMS, KorSEP 
MECPP; 5cx-MEPP GerES, NHANES 
MCNP NHANES 
MNP/MiNP NHANES 
MCOP NHANES 
MMP NHANES, CHMS 
MCPP NHANES, CHMS 
MHNCH NHANES 
Phenols  
Benzophenone-3 NHANES 
Bisphenol A  FLEHS, NHANES, CHMS, Uppsala 
Butyl paraben FLEHS, NHANES 
Ethyl paraben FLEHS, NHANES 
Methyl paraben FLEHS, NHANES 
Propyl paraben FLEHS, NHANES 
4-tert-octylphenol NHANES 
Triclosan  FLEHS, NHANES, CHMS 
Herbicides 
2,4-D NHANES, CHMS 
2,4,5-T NHANES 
Organophosphate pesticides 
Malathion diacid NHANES 
Paranitrophenol NHANES 
3,5,6-trichloropyridinol NHANES 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
DEP GerES, FLEHS, ENNS, NHANES, CHMS 
DMP GerES, FLEHS, ENNS, NHANES, CHMS 
DETP GerES, ENNS, NHANES, CHMS 
DMTP GerES, FLEHS, ENNS, CHMS 
DEDTP GerES, ENNS 
DMDTP GerES, ENNS, NHANES, CHMS 
Organochlorine pesticides 
Dieldrin NHANES 
Heptachlor epoxide NHANES 
p,p'-DDT (4,4'-DDT) ENNS, NHANES, CHMS, CZ-HBM, Tromsø 
o,p'-DDT (2,4′-DDT) CZ-HBM 
p,p'-DDE (4,4'-DDE) GerES, FLEHS, ENNS, NHANES, CHMS, CZ-HBM, Tromsø  
Oxychlordane NHANES, CHMS, Tromsø  
trans-Nonachlor NHANES, CHMS, Tromsø 
HCB GerES, FLEHS, ENNS, NHANES, CHMS, CZ-HBM, Tromsø 
α-HCH GerES, ENNS, CZ-HBM 
β-HCH GerES, ENNS, NHANES, CHMS, CZ-HBM, Tromsø 
γ-HCH CZ-HBM 
Mirex NHANES, CHMS, Tromsø 
 Chlorophenols 
2-MCP GerES 
4-MCP GerES, ENNS 
2,4-DCP GerES, ENNS, NHANES, CHMS 
2,5-DCP GerES, FLEHS, CHMS 
2,6-DCP GerES, ENNS 
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Substance / family Substance/ Biomarker HBM Programmes with reference values 
2,3,4-TCP GerES 
2,4,5-TCP GerES, ENNS, NHANES 
2,4,6-TCP GerES, ENNS 
2,3,4,6-TeCP GerES 
PCP GerES, ENNS, NHANES, CHMS 
Pyrethroids 
F-PBA FLEHS, ENNS, NHANES, CHMS 
Br2CA ENNS, NHANES, CHMS 
cis-Cl2CA GerES, ENNS, CHMS 
trans-Cl2CA GerES, ENNS, CHMS 
3-PBA GerES, FLEHS, ENNS, NHANES, CHMS 
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Table 41 Reported HBGVs (e.g. TDIs, RfDs) by EFSA, the WHO, and US EPA for the substances covered in this report 
Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
3-Monochloropropane-1,2 
Diol Ester (3-MCPD) 
3-MCPD 2 µg/kg bw TDI 2 µg/kg bw per day PMTDI 
  
Acrylamide  
+ metabolite 
Acrylamide         0.002 mg/kg bw per day 
Glycidamide         4x10
-4
 mg/kg bw per day 
Alkaloids Ergot 1. 0.6 µg/kg 
bw per day 
2. 1 µg/kg 
bw 
1. Group TDI 
 
2. Acute RfD 
      
Chlorophenols 2,3,4,6-TeCP         0.03 mg/kg bw per day 
PCP         0.005 mg/kg bw per day 
2,4,5-TCP         0.1 mg/kg bw per day 
2,4-DCP         0.003 mg/kg bw per day 
Dioxins 1,2,3,4,6,7,8-HpCDD     
70 pg/kg bw per month 
PTMI 
(applied to 
intake of 
PCDDs, 
PCDFs and 
coplanar 
PCBs) 
  
1,2,3,4,7,8-HxCDD       
1,2,3,6,7,8-HxCDD       
1,2,3,7,8,9-HxCDD       
1,2,3,4,6,7,8,9-OCDD       
1,2,3,7,8-PeCDD       
2,3,7,8-TCDD     7x10
-10
 mg/kg bw per day 
Fluorocarbons  
(PFCs) 
PFOA 1.5 µg/kg bw TDI       
PFOS 150 ng/kg 
bw 
TDI       
Furans 1,2,3,4,6,7,8-HpCDF     
70 pg/kg bw per month 
PTMI 
(applied to 
intake of 
PCDDs, 
  
1,2,3,4,7,8,9-HpCDF       
1,2,3,4,7,8-HxCDF       
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Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
1,2,3,6,7,8-HxCDF     PCDFs and 
coplanar 
PCBs) 
  
1,2,3,7,8,9-HxCDF       
2,3,4,6,7,8-HxCDF       
1,2,3,4,6,7,8,9-OCDF       
1,2,3,7,8-PeCDF       
2,3,4,7,8-PeCDF       
2,3,7,8-TCDF       
Herbicides 2,4-D         0.01 mg/kg bw per day 
2,4,5-T         0.01 mg/kg bw per day 
Metals Antimony (Sb)         4x10
-4
 mg/kg bw per day 
Arsenic (As) 0.3-8 µg/kg 
bw-day 
BMDL01 for inorganic 
As 
    3x10
-4
  mg/kg bw per day
 
(inorganic As) 
Barium (Ba)         0.2 mg/kg bw per day 
Beryllium (Be)         0.002 mg/kg bw per day 
Cadmium (Cd) 
2.5 µg/kg bw TWI 25 µg/kg bw per month PTMI 
5x10
-4
 mg/kg bw per day (water) 
 
0.001 mg/kg bw per day (food) 
Chromium VI (Cr)         3x10
-3
 mg/kg bw per day 
Copper (Cu) 
    0.5 mg/kg bw per day PMTDI 
 
Fluoride (Fl)         0.06 mg/kg bw per day 
Manganese (Mn)         0.14 mg/kg bw per day 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724        232 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food 
Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the 
rights of the authors. 
 
Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
Mercury (Hg) 1.3 µg/kg bw TWI for MeHg 1. 4 µg/kg bw 
 
2. 1.6 µg/kg bw 
1. PTWI for 
total Hg 
2. PTWI for 
MeHg 
1x10
-4
 mg/kg bw per day (for 
MeHg) 
Mercury, Inorganic 4 µg/kg bw TWI       
Molybdenum (Mo)         0.005 mg/kg bw per day 
Nickel (Ni)         0.02 mg/kg bw per day 
Selenium (Se)         0.005 mg/kg bw per day 
Strontium (Sr)         0.6 mg/kg bw per day 
Tin (Sn) 
    14 mg/kg bw per day PTWI   
Uranium (U)     0.6 µg/kg bw TDI   
Zinc (Zn) 
    0.3-1 mg/kg bw per day PMTDI 0.3 mg/kg bw per day 
Mineral oil hydrocarbons 
(MOH) 
MOHs 
1. 12 mg/kg 
bw 
2. 10 mg/kg 
bw 
3. 0.01 
mg/kg bw 
1. ADI for MOHs (high 
viscosity) 
2. ADI for MOHs (med-
low viscosity - Class I) 
3. ADI for MOHs (med-
low viscosity - Class 
II+III) 
0-20 mg/kg bw 
ADI for 
MOHs (high 
viscosity) 
  
Mycotoxins ochratoxin A 120 ng/kg 
bw 
TWI 112 ng/kg bw per week PTWI   
patulin     0.4 µg/kg bw PMTDI   
Deoxynivalenol 
    
1. 1 µg/kg bw-day 
2. 8 µg/kg bw 
1. PMTDI 
2. ARfD 
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Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
Zearalenone 0.25 µg/kg 
bw-day 
TDI 0.5 µg/kg bw per day PMTDI   
Fumonisin B1 or B2     2 µg/kg bw-day PMTDI   
T-2 toxin 
100 ng/kg 
bw 
TDI for the sum of T-2 
and HT-2 
60 ng/kg bw per day 
PMTDI for 
the sum of 
T-2 and HT-
2 
  HT-2 toxin 
Organophosphate 
pesticides 
Acephate         0.004 mg/kg bw per day 
Malathion diacid         0.02 mg/kg bw per day 
Organochlorine 
pesticides 
Aldrin         3x10
-5
 mg/kg bw per day 
Dieldrin         5x10
-5
 mg/kg bw per day 
Endrin         3x10
-4
 mg/kg bw per day 
Heptachlor         5x10
-4
 mg/kg bw per day 
Heptachlor epoxide         1.3x10
-5
 mg/kg bw per day 
DDT 
    0.01 mg/kg bw per day  
PTDI for 
DDT  
5x10
-4
 mg/kg bw per day 
 HCB         8x10
-4
 mg/kg bw per day 
 Mirex         2x10
-4
 mg/kg bw per day 
PBDEs PBDE 47         1x10
-4
 mg/kg bw per day 
PBDE 85         0.002 mg/kg bw per day 
PBDE 99         1x10
-4
 mg/kg bw per day 
PBDE 100         0.002 mg/kg bw per day 
PBDE 119         0.002 mg/kg bw per day 
PBDE 126         0.002 mg/kg bw per day 
PBDE 153         2x10
-4
 mg/kg bw per day 
BDE 209         7x10
-3
 mg/kg bw per day 
HBB         0.002 mg/kg bw per day 
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Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
PCBs PCB 77 14 pg WHO-
TEQ/kg bw 
TWI 
70 pg/kg bw per month 
PTMI 
(applied to 
intake of 
PCDDs, 
PCDFs and 
coplanar 
PCBs) 
  
PCB 81       
PCB 126       
PCB 169       
PCB 105       
PCB 114       
PCB 118       
PCB 123       
PCB 156       
PCB 157       
PCB 167       
PCB 189       
Perchlorate Perchlorate 0.3 µg/kg bw TDI 0.01 mg/kg bw PMTDI 7x10
-4
 mg/kg bw per day 
Phenols Bisphenol A  5 µg/kg 
bw/day 
TDI   0.05 mg/kg bw per day 
Phthalates  
metabolites 
Mono-benzyl phthalate 
(MBzP) 0.5 mg/kg 
bw 
TDI for benzylbutyl 
phthalate (BBzP) 
    0.2 mg/kg bw per day 
Mono-isobutyl phthalate 
(MiBP) 0.01 mg/kg 
bw 
TDI for dibutyl 
phthalate (DBP) 
    0.1 mg/kg bw per day 
Mono-n-butyl phthalate 
(MnBP) 
Mono-ethyl phthalate 
(MEP) 
        0.8 mg/kg bw per day 
Mono-2-ethylhexyl 
phthalate (MEHP) 
0.05 mg/kg 
bw 
TDI for bis(2-
ethylhexyl)phthalate 
    0.02 mg/kg bw per day 
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Substance class Substance/ Biomarker 
EFSA 
          Value                         Unit 
WHO 
          Value                        Unit 
US EPA 
RfD 
Mono-(2-ethyl-5-
hydroxyhexyl) phthalate 
(MEHHP; 5OH-MEHP) 
(DEHP) 
Mono-(2-ethyl-5-
oxohexyl) phthalate 
(MEOHP; 5oxo-MEHP) 
Mono-(2-ethyl-5-
carboxypentyl) phthalate 
(MECPP; 5cx-MEPP) 
Mono-(carboxynonyl) 
phthalate (MCNP) 
0.15 mg/kg 
bw 
TDI for di-isodecyl 
phthalate (DIDP) 
      
Mono-isononyl phthalate 
(MNP/MiNP) 
0.15 mg/kg 
bw 
TDI for di-isononyl 
phthalate (DiNP) 
      
Pyrethroids Bifenthrin         0.015 mg/kg bw per day 
Cyfluthrin 
  0-0.02 mg/kg bw 
ADI for 
cyfluthrin 
 
Cyhalothrin 
    0-0.005 mg/kg bw 
ADI for 
cyhalothrin 
0.005 mg/kg bw per day 
Cypermethrin 
    0-0.02 mg/kg bw 
ADI for 
cypermethrin 
0.01 mg/kg bw per day 
Deltamethrin     0-0.01 mg/kg bw ADI   
Permethrin         0.05 mg/kg bw per day 
regulated chemical 
substances such as food 
contact materials  
Smoke flavourings 0.5 mg/kg 
bw 
TDI for phenol 
      
BADGE  0.15 mg/kg 
bw 
TDI 
      
Sweeteners     Covered
(a)
     
Enzymes     Covered
(a)
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Table 42 Pesticides with EU limit values (Pesticides Database) not covered by HBM reference 
values 
Substance/ Biomarker 
ADI [mg/kg 
bw] 
Substance/Biomarker 
ADI [mg/kg bw] 
(Hydr)oxyquinoline 0.05  Fluxapyroxad 0.02  
Abamectin (aka avermectin) 0-0.002 Formetanate 0.004  
Aclonifen 0.07 Fuberidazole 0.0072  
Amitrole (aminotriazole) 
0.001 Haloxyfop-P 
(Haloxyfop-R) 
0.00065  
Azimsulfuron 0.1 Imazamox 9  
Benfluralin 0.005 Imazaquin 0.25  
Bifenox 0.3 Imazosulfuron 0.75  
Bitertanol 0.003 Ioxynil 0.005  
Carbendazim 0.02 Linuron 0.003  
Carfentrazone-ethyl 0.03 Lufenuron 0.015  
Chloridazon (aka pyrazone) 0.1  Metam  0.001  
Chlorothalonil 
0.015  Methiocarb (aka 
mercaptodimethur) 
0.013  
Chlorotoluron  0.04  Methomyl 0.0025  
Cyprodinil 0.03  Methoxyfenozide 0.1  
Diclofop 0,001 Metribuzin 0.013  
Difenacoum N/A Metsulfuron-methyl 0.22  
Diflufenican 0.2  Molinate 0.008  
Dimethachlor 0.1  Napropamide 0.3  
Dimethenamid-P 0.02  Oxadiazon 0.0036  
Dimethoate 0.001  Oxyfluorfen 0.003  
Dimoxystrobin 0.004  Paclobutrazol 0.022  
Diquat (dibromide) 0.002  Pencycuron 0.2  
Diuron 0.007  Pendimethalin 0.125  
Ethofumesate 0.07  Pirimicarb 0.035  
Ethoprophos 0.0004  Prochloraz 0.01  
Famoxadone 0.012  Prosulfocarb 0.005  
Fenamiphos (aka phenamiphos) 0.0008  Pyraclostrobin 0.03  
Fenbutatin oxide 0.05  Quinoclamine 0.002  
Fenpropimorph 0.003  Quinoxyfen 0.2  
Fipronil 0.0002  Quizalofop-P-tefuryl 0.013  
Flufenacet  0.005  Spirodiclofen 0.015  
Flumioxazine 0.009  Sulcotrione 0.0004  
Fluometuron 0.0005  Tebufenpyrad 0.01  
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Substance/ Biomarker 
ADI [mg/kg 
bw] 
Terbuthylazine 0.004  
Tralkoxydim 0.005  
Triazoxide 0.0002  
Trifloxystrobin 0.1  
Bromuconazole 0,01 
Cyproconazole 0.02  
Epoxiconazole 0.008  
Fenbuconazole 0.006  
Fluquinconazole 0.002  
Flusilazole 0.002  
Metconazole 0.01  
Myclobutanil 0.025  
Propiconazole 0.04  
Acrinathrin 0,01 
Bifenthrin 0,015 
Cyfluthrin 0.003 
Cyhalothrin 0-0.02 
Cypermethrin 0.05  
Esfenvalerate 0.02  
Permethrin 0-0.05 
Tefluthrin 0.005  
Imidacloprid 0.06  
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Table 43 Summary of the published human biomonitoring (HBM) and biological equivalent (BE) values 
 HBM values Biological equivalents 
Chemical name Reference population HBM-I HBM-II BERfD BEPOD Basis for BEs 
2,3,7,8- TCDD  
  15 ng TEQ/kg lipid  
(serum) 
45 ng/kg lipid MRL (ATSDR) 
PCBs 138+153+180 
Infants and women of 
childbearing age 
3.5 µg/L 
(serum) 
7 µg/L   
 
Acrylamide    
8 fmol/mg globin 
(blood; AAVal) 
13 µg/L 
(urine; AAMA) 
25.3 fmol/mg 
globin (blood) 
130 µg/L (urine) 
 
Glycidamide    
13 fmol/mg globin 
(blood; GAVal) 
39.8 fmol/mg 
globin 
 
Arsenic (total)    
6.4 µg/L 
(urine) 
19.3 µg/L 
RfD (US EPA) 
& 
chronic MRL 
(ATSDR) 
Cadmium 
1. Children and adolescents 
2. Adults 
1. 0.5 µg/L 
2. 1 µg/L 
(urine) 
1. 2 µg/L 
2. 4 µg/L 
1.5 µg/L (urine) 
1.7 µg/L (blood) 
4.6 µg/L (urine) 
5.3 µg/L (blood) 
RfD (US EPA) 
Mercury Children and adults 
7 µg/L (urine) 
5 µg/L (blood) 
25 µg/L (urine) 
15 µg/L (blood) 
  
 
Selenium   
 400 µg/L (blood) 
180 µg/L (plasma) 
90 µg/L (urine) 
1200 µg/L 
(blood) 
540 µg/L 
RfD (US EPA) 
& 
chronic MRL 
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 HBM values Biological equivalents 
Chemical name Reference population HBM-I HBM-II BERfD BEPOD Basis for BEs 
(plasma) 
280 µg/L (urine) 
(ATSDR) 
Thallium General population 
5 µg/L 
(urine) 
N/A 
   
PBDE 99   
 520 ng/g lipid 
(blood) 
51.6 mg/kg lipid RfD (US EPA) 
Mono-benzyl 
phthalate (MBzP) 
  
 
3.8 mg/L (urine) 38 mg/L RfD (US EPA) 
Mono-n-butyl 
phthalate (MnBP) 
  
 
2.7 mg/L (urine) 27 mg/L RfD (US EPA) 
Mono-ethyl phthalate 
(MEP) 
  
 
18 mg/L (urine) 180 mg/L RfD (US EPA) 
Mono-(2-ethyl-5-
carboxypentyl) 
phthalate (MECPP; 
5cx-MEPP) 
  
 400 µg/L 
(urine; sum of 
MEHP + MEHHP + 
MEOHP + 5cx-
MEPP) 
4000 µg/L RfD (US EPA) 
Mono-isononyl 
phthalate 
(MNP/MiNP) 
  
 
72 µg/L (urine) 720 µg/L 
ADI (US 
CPSC) 
Metabolites of di(2-
ethylhexyl)phthalate 
(DEHP) 
1. Children (age 6-13) 
2. Women of childbearing age 
3. Men (age >14) and rest of 
the general population 
1. 500 µg/L 
2. 300 µg/L 
3. 750 µg/L 
(urine) 
N/A 
260 µg/L 
(urine; sum of 
MEHP + MEHHP + 
MEOHP) 
2600 µg/L RfD (US EPA) 
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 HBM values Biological equivalents 
Chemical name Reference population HBM-I HBM-II BERfD BEPOD Basis for BEs 
(sum of MEHHP + MEOHP) 
Metabolites of di(2-
propylheptyl)phthalate 
(DPHP) 
1. Children 
2. Adults 
1. 1163 µg/L 
2. 1744 µg/L 
(urine) 
    
Diisononylcyclohex-
anoate (DINCH) 
1. Children 
2. Adults 
1. 3200 µg/L 
2. 4800 µg/L 
(urine) 
    
Bisphenol A 
1. Children 
2. Adults 
1. 1.5 mg/L 
2. 2.5 mg/L 
(urine) 
N/A 2 mg/L (urine) 20 mg/L RfD (US EPA) 
Triclosan    6.4 mg/L (urine) 64 mg/L RfD (US EPA) 
2,4-
dichlorophenoxyacetic 
acid (2,4-D) 
 
 
 
5 µg/L (plasma) 
200 µg/L (urine) 
170 µg/L 
(plasma) 
20,000 µg/L 
(urine) 
 
DDT  
 
 
4 mg/kg lipid  
(total DDT) 
14 mg/kg lipid RfD (US EPA) 
DDT+DDE+DDD    5 mg/kg lipid 16 mg/kg lipid RfD (US EPA) 
Hexachlorobenzene 
(HCB) 
 
 
 340 ng/g lipid 3384 ng/g lipid RfD (US EPA) 
Pentachlorophenol 
(PCP) 
General population 
40 µg/L 
(serum) 
25 µg/L (urine) 
70 µg/L (serum) 
40 µg/L (urine) 
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 HBM values Biological equivalents 
Chemical name Reference population HBM-I HBM-II BERfD BEPOD Basis for BEs 
4-Fluoro-3-
phenoxybenzoic acid 
(F-PBA) 
   
240 µg/L (urine) 2400 µg/L 
chronic RfD 
(US EPA) 
cis-3-(2,2-dibromo-
vinyl)-2,2-
dimethylcyclo-
propane carboxylic 
acid (Br2CA) 
   
50 µg/L (adults) 
7 µg/L (infants & 
children) 
(urine) 
540 µg/L 
(adults) 
720 µg/L 
(infants & 
children) 
RfD (US EPA) 
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D.  REFERENCE VALUES 
This appendix provides an overview of the substances with 3 or more reported reference values (RV). RV in this report is defined as the 95th percentile (P95; 
unless stated otherwise).   
Table 44 Perfluorooctanoic acid (PFOA) 
Country Reference values (matrix) 95% CI Study population Study period Reference 
Germany 10 µg/L (plasma) N/A 
Women, men, and  
children aged <10 years 
2003-2007 
(Schulz et al., 
2012b) 
Flanders 
1.2.56 µg/L (plasma) 
2. 5.70 µg/L (serum) 
1. 2.35-2.76 
2. 5.10-6.20 
1. Newborns 
2. Adults 
2007-2009 FLEHS II 
(a)
 
USA 7.50 µg/L (serum) 6.20-9.70 
Males and females 
(age 12 or older) 
2009-2010 
NHANES  
(Fourth report) 
(b)
 
Canada 5.30 µg/L (plasma) 3.90-6.70 
Canadian population 
(age 12-79) 
2009-2011 
CHMS II 
(Second Report) 
(c)
 
Sweden 3.8 ng/mL (serum) 
(d)
 2.4-5.3 
(e)
 Primiparous Swedish women 2004 
(Karrman et al., 
2007) 
Norway 3.2 ng/mL (serum) 
(d)
 1.3-6.8 
(e)
 Norwegian adult males 2007 (Nøst et al., 2014) 
(a): All FLEHS II results were retrieved from http://www.milieu-en-gezondheid.be/resultaten/referentiebiomonitoring/Eindrapport_referentiewaarden_finaal_met_voorblad.pdf 
(b): All NHANES results were retrieved from http://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Jul2014.pdf 
(c): All CHMS II results were retrieved from http://www.occupationalcancer.ca/wp-content/uploads/2013/05/2ndHumanBiomonitoringReport.pdf  
(d): The mean value is reported here as the P95 value is not reported in this study. 
(e): The range value (min-max) is reported here.  
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Table 45 Perfluorooctane sulfonic acid (PFOS) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 20 µg/L (plasma) 
2. 25 µg/L (plasma) 
3. 10 µg/L (plasma) 
N/A 
1. Women 
2. Men 
3. Children <10 years 
2003-2007 
(Schulz et al., 
2012b) 
Flanders 
1. 5.10 µg/L (plasma) 
2. 24.80 µg/L (serum) 
1. 4.59-5.61 
2. 20.70-28.90 
1. Newborns 
2. Adults 
2007-2009 FLEHS II 
USA 32.0 µg/L (serum) 22.6-48.5 
Males and females  
(age 12 or older) 
2009-2010 
NHANES  
(Fourth report) 
Canada 18 µg/L (plasma) 13-23 
Canadian population 
(age 12-79) 
2009-2011 
CHMS II  
(Second Report) 
Sweden 
20.7 ng/mL (serum) 
(a) 
0.201 ng/mL (milk) 
(a) 
8.2-48 (serum) 
(b) 
0.060-0.47 (milk) 
(b)
 
Primiparous Swedish women 2004 
(Karrman et al., 
2007) 
Norway 33 ng/mL (serum) 
(a)
 11-65 
(b)
 Norwegian adult males 2007 (Nøst et al., 2014) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here.  
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Table 46 PCB 28 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany <0.1 µg/L (whole blood) N/A 
Children 
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 5.70 ng/g lipid (serum) 5.10-7.40 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
(a)
 
Spain Could not be calculated (serum) N/A 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 11.30 ng/g lipid (serum) 10.7-11.8 
Males and females  
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada Could not be calculated (plasma) <LOD 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
(b)
 
Czech Rep 35 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Sweden 2.8 ng/g lipid (serum) 
(c)
  <0.50-31 
(d)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
Norway 2.7 ng/g lipid (serum) 
(c)
 1.3-6.1 
(d)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): All results from ENNS analyses of pollutants were retrieved from http://www.invs.sante.fr/content/download/63890/250887/version/2/file/rapport_enns_tome_2.pdf  
(b): All CHMS I results were retrieved from http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/pubs/contaminants/chms-ecms/report-rapport-eng.pdf  
(c): The mean value is reported here as the P95 value is not reported in this study. 
(d): The range value (min-max) is reported here.  
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Table 47 PCB 52 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany <0.1 µg/L (whole blood) N/A 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 1.76 ng/g lipid (serum) 1.40-1.88 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Spain Could not be calculated (serum) N/A 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 7.60 ng/g lipid (serum) 7.01-8.00 
Males and females  
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada Could not be calculated (plasma) <LOD 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Rep 138.7 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway Could not be calculated (serum) N/A Norwegian adult males 2007 (Nøst et al., 2013) 
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Table 48 PCB 101 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany <0.1 µg/L (whole blood) N/A 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 3.66 ng/g lipid (serum) 3.23-4.16 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Spain Could not be calculated (serum) N/A 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 5.83 ng/g lipid (serum) 5.29-6.66 
Males and females  
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada Could not be calculated (plasma) <LOD 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Rep 15 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway 2.7 ng/g lipid (serum) 
(a)
 1.2-7.7 
(b)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 49 PCB 138 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.3 µg/L (whole blood) 0.28-0.32 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 0.4-2.2 µg/L (whole blood) N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 112 ng/g fat (plasma) 
(a)
 
2. 98 ng/g fat (plasma) 
(a)
 
1. 98-126 
2. 83-115 
1. Newborns 
2. Adolescents (age 14-15) 
2002-2006 FLEHS I 
(b)
 
France 139.9 ng/g lipid (serum) 163.0-225.0 
French adults  
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Spain 135.4 ng/g lipid (serum) 
(a, c)
 121.3-151.4 
(d)
 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 75.3 ng/g lipid (serum) 69.0-81.8 
Males and females 
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada 0.28 µg/L (plasma) 0.23-32 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Rep 347 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Sweden 29 ng/g lipid (serum) 
(e)
  7.8-94 
(f)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
Norway 140 ng/g lipid (serum) 
(e)
 45-310 
(f)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): This value is the sum of the marker PCBs (PCB 138, 153, and 180). 
(b): All FLEHS I results were retrieved from http://www.milieu-en-gezondheid.be/English/results.html 
(c): The geometric mean is reported here as the P95 value is not reported in this study. 
(d): The 95% CI for the geometric mean is reported here. 
(e): The mean value is reported here as the P95 value is not reported in this study. 
(f): The range value (min-max) is reported here. 
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Table 50 PCB 153 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.40 µg/L (whole blood) 0.40-0.45 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 0.60-3.30 µg/L (whole blood) N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 112 ng/g fat (plasma) 
(a)
 
2. 98 ng/g fat (plasma) 
(a)
 
1. 98-126 
2. 83-115 
1. Newborns 
2. Adolescents (age 14-15) 
2002-2006 FLEHS I 
France 286.9 ng/g lipid (serum) 263.9-369.3 
French adults  
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Spain 135.4 ng/g lipid (serum) 
(a, b)
 121.3-151.4 
(c)
 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 97.1 ng/g lipid (serum) 88.8-111 
Males and females  
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada 0.54 µg/L (plasma) 0.42-0.66 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Rep 498 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Sweden 58 ng/g lipid (serum) 
(d)
  12-186 
(e)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
Norway 200 ng/g lipid (serum) 
(d)
 67-470 
(e)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): This value is the sum of the marker PCBs (PCB 138, 153, and 180). 
(b): The geometric mean is reported here as the P95 value is not reported in this study. 
(c): The 95% CI for the geometric mean is reported here. 
(d): The mean value is reported here as the P95 value is not reported in this study. 
(e): The range value (min-max) is reported here. 
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Table 51 PCB 180 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.3 µg/L (whole blood) 0.27-0.32 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 0.3-2.4 µg/L (whole blood) N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 112 ng/g fat (plasma) 
(a)
 
2. 98 ng/g fat (plasma) 
(a)
 
1. 98-126 
2. 83-115 
1. Newborns 
2. Adolescents (age 14-15) 
2002-2006 FLEHS I 
France 274.4 ng/g lipid (serum) 225.0-296.4 
French adults  
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Spain 135.4 ng/g lipid (serum) 
(a, b)
 121.3-151.4 
(c)
 
Adults  
(age 16 or older) 
March 2009 –  
July 2010 
(Huetos Hidalgo et 
al., 2013) 
USA 81.5 ng/g lipid (serum) 75.8-89.9 
Males and females 
(age 12 or older) 
2003-2004 
NHANES  
(Fourth report) 
Canada 0.49 µg/L (plasma) 0.38-0.60 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Rep 388.5 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Sweden 28 ng/g lipid (serum) 
(d)
  5.0-84 
(e)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
Norway 150 ng/g lipid (serum) 
(d)
 66-370 
(e)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): This value is the sum of the marker PCBs (PCB 138, 153, and 180). 
(b): The geometric mean is reported here as the P95 value is not reported in this study. 
(c): The 95% CI for the geometric mean is reported here. 
(d): The mean value is reported here as the P95 value is not reported in this study. 
(e): The range value (min-max) is reported here. 
  
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724        250 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively by the author(s) in the context of a contract between the European Food 
Safety Authority and the author(s), awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the 
rights of the authors. 
 
Table 52 Antimony (Sb) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.300 µg/L (urine) 0.305-0.335 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 0.320 µg/L (urine) 0.290-0.340 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
(a)
 
Italy 
0.720 µg/L (blood) 
0.265 µg/L (serum) 
N/A 
Adults  
(age 18-65) 
2008-2010 PROBE report 
(b)
 
USA 0.184 µg/L (urine) 0.169-0.222 
Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.19 µg/L (urine) 0.16-0.22 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
Sweden 0.042 µg/L (breast milk) 
(c)
 0.018-0.15 
(d)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): All results from ENNS analyses of metals were retrieved from http://www.invs.sante.fr/publications/2011/exposition_polluants_enns/rapport_exposition_polluants_enns.pdf 
(b): All PROBE results were retrieved from http://www.iss.it/binary/publ/cont/11_9_web.pdf 
(c): The mean value is reported here as the P95 value is not reported in this study. 
(d): The range value (min-max) is reported here. 
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Table 53 Arsenic (As) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 15 µg/L (urine) 12.8-14.3 
Children without fish 
consumption 48h prior to sample 
collection (age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 15 µg/L (urine) 14.9-16.3 
Adults without fish consumption 
48h prior to sample collection 
(age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 
2004) 
Flanders 
1. 2.18 µg/L (cord blood) 
2. 2.04 µg/L (maternal blood) 
3. 2.12 µg/L (whole blood) 
90.0 µg/L (urine) 
4. 85.3 ng/L (urine) 
1. 1.53-2.83 
2. 1.38-2.69 
3. 1.52-2.71 (blood) 
60.7-119.4 (urine) 
4. 61.7-108.8 
1. Newborns 
2. Mothers of newborns 
3. Adolescents (age 14-15) 
4. Adults 
2007-2009 FLEHS II 
France 72.75 µg/L (urine) 63.74-76.49 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
5.32 µg/L (blood) 
3.12 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 52.4 µg/L (urine) 42.5-66.3 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
1. 4.08 µg/L (blood) 
2. 76 µg/L (urine) 
1. 2.94-5.23 (blood) 
2. 58-94 (urine) 
1. Canadian population 
(age 6-79) 
2. Canadian population 
(age 3-79) 
1. 2007-2009 
2. 2009-2011 
1. CHMS I  
(First Report) 
2. CHMS II  
(Second Report) 
South Korea 119.7 µg/L (urine) 112.7-126.8 
Adults  
(age 20 or older) 
2008 (Lee et al., 2012) 
Sweden 0.55 µg/L (breast milk) 
(a)
 0.041-4.6 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here.  
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Table 54 Cadmium (Cd) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
0.2 µg/L (urine) 
<0.3 µg/L (blood) 
0.20-0.22 (urine) 
0.25-0.29 (blood) 
Non-smoking children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 
0.8 µg/L (urine)  
1 µg/L (blood) 
0.74-0.80 (urine) 
0.83-0.90 (blood) 
Non-smoking adults 
(age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 2004) 
Flanders 
1. 0.160 µg/L (cord blood) 
2. 0.728 µg/L (maternal blood) 
3. 0.471 µg/L (whole blood) 
    4. 444 ng/L (urine) 
1. 0.095-0.226 
2. 0.592-0.864 
3. 0.333-0.609 
    4. 363-525 
1. Newborns 
2. Mothers of newborns 
3. Adolescents (age 14-15) 
4. Adults 
2007-2009 FLEHS II 
France 0.95 µg/L (urine) 0.91-0.99 French adults  (age 18-74) 2006-2007 ENNS report (metals) 
Italy 
1.42 µg/L (blood) 
0.269 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 
1. 1.50 µg/L (blood) 
2. 0.873 µg/L (urine) 
1. 1.30-1.70 
2. 0.807-1.02 
1. Males and females  
(age 1 or older) 
2. Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
2.6 µg/L (blood) 
1.8 µg/L (urine) 
2.1-3.0 (blood) 
1.6-2.0 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 2.62 µg/L (blood) N/A 
Adults  
(age 18 or older) 
August 2007 - 
April 2008 
(Son et al., 2009) 
 3.11 µg/L (urine) 2.58-3.43 Adults  (age 20 or older) 2008 (Lee et al., 2012) 
Czech Republic 
1.0 µg/L (blood) 
(a)
 
1.3 µg/L (urine)
 (a)
 
N/A Non-smoking adults 2005-2009 (Cerna et al., 2012) 
Sweden 0.086 µg/L (breast milk) 
(b)
 0.028-0.27 
(c)
 Swedish mothers 2002-2009 (Bjorklund et al., 2012) 
(a): The reference value (which is not defined as the P95) is directly provided in the literature source. 
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here. 
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Table 55 Chromium (Cr) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.62 µg/L (urine) N/A 
Adults 
(age 25-69) 
1990-1992 (Seifert et al., 2000) 
France 0.65 µg/L (urine) 0.61-0.68 
French adults 
 (age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
1.09 µg/L (blood) 
0.294 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
Sweden 0.30 µg/L (breast milk) 
(a)
 0.026-1.6 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 56 Cobalt (Co) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
France 1.40 µg/L (urine) 1.25-1.66 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
0.443 µg/L (blood) 
0.607 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 1.30 µg/L (urine) 1.10-1.49 
Males and females  
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 0.40 µg/L (urine) 0.36-0.43 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
Sweden 0.059 µg/L (breast milk) 
(a)
 0.022-0.38 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 57 Copper (Cu) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 754 µg/L (cord blood) 
2. 1715 µg/L (maternal blood) 
3. 938 µg/L (whole blood) 
1. 711-797 
2. 1631-1799 
3. 908-967 
1. Newborns 
2. Mother of newborns 
3. Adolescents (age 14-15) 
2007-2009 FLEHS II 
USA 169 µg/dL (serum) 162-180 
Males and females  
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 
1200 µg/L (blood) 
28 µg/L (urine) 
1200-1300 (blood) 
27-29 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
Sweden 471 µg/L (breast milk) 
(a)
 327-670 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 58 Lead (Pb) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 35 µg/L (whole blood) 35.0-37.7 
Children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 
70 µg/L (blood; female) 
90 µg/L (blood; male) 
63-67 (female) 
78-83 (male) 
Adults 
(age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 
2004) 
Flanders 
1. 15.9 µg/L (cord blood) 
2. 18.9 µg/L (maternal blood) 
3. 27.6 µg/L (whole blood) 
1: 13.9-17.9 
2. 17.1-20.7 
3. 23.1-32.1 
1. Newborns 
2. Mothers of newborns 
3. Adolescents (age 14-15) 
2007-2009 FLEHS II 
France 73 µg/L (blood) 68-77 
French adults  
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Spain 56.80 µg/L (blood) N/A 
Adults 
 (age 16 or older) 
March 2009 –  
 July 2010 
(Cañas et al., 2014) 
Italy 
51.7 µg/L (blood) 
0.60 µg/L (serum) 
N/A 
Adults  
(age 18-65) 
2008-2010 PROBE report 
USA 
1. 3.16 µg/dL (blood) 
2. 1.45 µg/L (urine) 
1. 2.77-3.68 
2. 1.24-1.75 
1. Males and females  
(age 1 or older) 
2. Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
3.2 µg/dL (blood) 
1.9 µg/L (urine) 
2.9-3.4 (blood) 
1.7-2.0 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
South Korea 4.01 µg/dL (blood) N/A 
Adults  
(age 18 or older) 
August 2007 - 
April 2008 
(Son et al., 2009) 
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Country Reference values (matrix) 95% CI Reference population Study period Reference 
 42.3 µg/L (blood) 40.4-44.7 
Adults  
(age 20 or older) 
2008 (Lee et al., 2012) 
Czech Republic 
1. 80 µg/L (blood) 
(a)
 
2. 50 µg/L (blood) 
(a)
 
3. 45 µg/L (blood) 
(a)
 
N/A 
1. Men 
2. Women 
3. Children 
2005-2009 (Cerna et al., 2012) 
Sweden 1.5 µg/L (breast milk) 
(b)
 0.74-6.4 
(c)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The reference value (which is not defined as the P95) is directly provided in the literature source. 
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here. 
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Table 59 Manganese (Mn) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 52.2 µg/L (cord blood) 
2. 18.6 µg/L (maternal blood) 
3. 13.6 µg/L (whole blood) 
1. 47.6-56.8 
2. 16.8-20.5 
3. 12.8-14.4 
1. Newborns 
2. Mothers of newborns 
3. Adolescents (age 14-15) 
2007-2009 FLEHS II 
Italy 
14.5 µg/L (blood) 
1.41 µg/L (serum) 
N/A 
Adults  
(age 18-65) 
2008-2010 PROBE report 
USA 
1. 16.7 µg/L (blood) 
2. 0.38 µg/L (urine) 
1. 16.2-17.3 
2. 0.32-0.45 
1. Males and females  
(age 1 or older) 
2. Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
15 µg/L (blood) 
0.36 µg/L (urine) 
14-16 (blood) 
0.32-0.40 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 19.8 µg/L (blood) 18.7-21.7 
Adults 
(age 20 or older) 
2008 (Lee et al., 2012) 
Sweden 3.0 µg/L (breast milk) 
(a)
 0.79-8.4 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here.  
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Table 60 Mercury (Hg) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
0.8 µg/L (whole blood) 
0.4 µg/L (urine) 
0.67-0.82 (blood) 
0.39-0.48 (urine) 
Whole blood: children with fish 
consumption ≤3 times/month 
Urine: children without amalgam 
fillings for teeth (age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 
2.0 µg/L (blood) 
1.0 µg/L (urine) 
2.01-2.25 (blood) 
0.86-0.99 (urine) 
Blood: adults with fish 
consumption ≤3 times/month 
Urine: adults without amalgam 
fillings for teeth (age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 
2004) 
Flanders 
1. 0.821 µg/g hair (hair) 
2. 0.468 µg/g hair (hair) 
1. 0.676-0.965 
2. 0.363-0.573 
1. Mothers of newborns 
2. Adolescents (age 14-15) 
2007-2009 FLEHS II 
France 
1. 1.20 µg/g hair (hair) 
2. 1.80 µg/g hair (hair) 
1. 1.00-1.40 
2. 1.72-1.90 
1. Children (age 3-17) 
2. Adults (age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
5.16 µg/L (blood) 
1.89 µg/L (serum) 
N/A 
Adults  
(age 18-65) 
2008-2010 PROBE report 
Spain 6.4 ng/mg hair (hair) 5.5-8.4 
Adults  
(average age 43±11) 
2008 Esteban M. (2010) 
(a)
 
USA 
1. 4.40 µg/L (blood) 
2. 1.83 µg/L (urine) 
1. 3.50-5.71 
2. 1.61-2.14 
1. Males and females  
(age 1 or older) 
2. Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
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Country Reference values (matrix) 95% CI Reference population Study period Reference 
Canada 5.5 µg/L (blood) 3.3-7.6 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
South Korea 14.94 µg/L (blood) N/A 
Adults 
(age 18 or older) 
August 2007 –  
April 2008 
(Son et al., 2009) 
 11.00 µg/L (blood) 10.22-11.89 
Adults 
(age 20 or older) 
2008 (Lee et al., 2012) 
Czech Republic 
1. 2.6 µg/L (blood)
 (b)
 
2. 9 µg/L (urine)
 (b)
 
N/A 
1. Adults with little to no fish 
consumption 
2. Adults 
2005-2009 (Cerna et al., 2012) 
Sweden 0.94 µg/L (blood) 
(c)
 0.19-2.5 
(d)
 Swedish mothers 1994-1995 (Vahter et al., 2000)  
(a): Esteban, M. (2010, December). Non-invasive biomonitoring of metals using hair. Workshop presentation on non-invasive human biomonitoring, Brussels, Belgium. Retrieved from 
http://www.eu-hbm.info/cophes/project-work-packages/hbm-research/documents/EstebanHairDec2010.pdf 
(b): The reference value (which is not defined as the P95) is directly provided in the literature source. 
(c): The median value is reported here as the P95 value is not reported in this study. 
(d): The range value (min-max) is reported here. 
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Table 61 Molybdenum (Mo) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Italy 
2.05 µg/L (blood) 
1.83 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 145 µg/L (urine) 140-158 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
1.5 µg/L (blood) 
170 µg/L (urine) 
1.4-1.5 (blood) 
150-190 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
Sweden 3.5 µg/L (breast milk) 
(a)
 0.80-12 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 62 Nickel (Ni) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 4.5 µg/L (urine) 4.20-4.72 
Children 
(ages 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 4.54 µg/L (urine) 4.30-4.97 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
2.62 µg/L (blood) 
0.94 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
Canada 
1.1 µg/L (blood) 
4.8 µg/L (urine) 
1.1-1.2 (blood) 
4.2-5.3 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
Sweden 0.96 µg/L (breast milk) 
(a)
 <LOD-47 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 63 Platinum (Pt) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.01 µg/L (urine) 0.008-0.011 
Adults without any dental inlays, 
crowns, bridge elements  
(age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 
2004) 
Italy 
31.6 ng/L (blood) 
13.3 ng/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 0.016 µg/L (urine) 0.009-0.049 
Males and females  
(age 6 or older) 
2009-2010 
NHANES  
(Fourth Report) 
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Table 64 Selenium (Se) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 50-120 µg/L (serum) 
(a)
 
2. 33-84 µg/L (serum)
 (a)
 
N/A 
1. Females & males 
2. Children (age 0-16) 
2002 
(Wilhelm et al., 
2004) 
USA 
1. 236 µg/L (blood) 
2. 161 µg/L (serum) 
1. 231-241 
2. 155-164 
1. Males and females  
(age 1 or older) 
2. Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 
240 µg/L (blood) 
130 µg/L (urine) 
230-250 (blood) 
130-140 (urine) 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
Sweden 13 µg/L (breast milk) 
(b)
 8.8-18 
(c)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
Finland 1.4 µmol/L (serum) 
(d)
 N/A Healthy Finnish population 2010 (Alfthan et al., 2014) 
(a): The range of reference values from lowest to highest is reported here. 
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here. 
(d): The reference value (which is not defined as the P95) is directly provided in the literature source.  
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Table 65 Thallium (Tl) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.6 µg/L (urine) 0.56-0.61 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
Flanders 
1. 0.025 µg/L (cord blood) 
2. 0.038 µg/L (maternal blood) 
3. 0.036 µg/L (whole blood) 
1. 0.023-0.028 
2. 0.036-0.040 
3. 0.034-0.038 
1. Newborns 
2. Mothers of newborns 
3. Adolescents (age 14-15) 
2007-2009 FLEHS II 
Italy 
0.098 µg/L (blood) 
0.071 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 0.438 µg/L (urine) 0.385-0.522 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.62 µg/L (blood) 0.55-0.70 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
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Table 66 Tungsten (W) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Italy 
0.075 µg/L (blood) 
0.235 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
USA 0.434 µg/L (urine) 0.341-0.522 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.63 µg/L (urine) 0.50-0.76 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
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Table 67 Uranium (U) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 40 ng/L (urine) 36.7-41.4 
Children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France 21.2 ng/L (urine) 18.4-26.4 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 0.0140 µg/L (blood) N/A 
Adults  
(age 18-65) 
2008-2010 PROBE report 
USA 0.029 µg/L (urine) 0.022-0.041 
Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.0051 µg/L (urine) <LOD-0.0070 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
Sweden 0.42 µg/L (breast milk) 
(a)
 0.0097-2.0 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 68 Vanadium (V) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
France 2.79 µg/L (urine) 2.63-2.99 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(metals) 
Italy 
0.146 µg/L (blood) 
0.115 µg/L (serum) 
N/A 
Adults 
(age 18-65) 
2008-2010 PROBE report 
Canada <LOD (urine) <LOD-0.12 µg/L 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
Sweden 0.050 µg/L (breast milk) 
(a)
 0.015-0.56 
(b)
 Swedish mothers 2002-2009 
(Bjorklund et al., 
2012) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 69 PBDE 28 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders Could not be calculated (serum) N/A 
Newborns & adolescents  
(age 14-15) 
2007-2011 FLEHS II 
USA 8.00 ng/g lipid (serum) 5.40-11.3 
Males and females  
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada Could not be calculated (plasma) <LOD 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
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Table 70 PBDE 47 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 1.70 ng/g fat (serum) 1.92-2.12 
Adolescents  
(age 14-15) 
2007-2009 FLEHS II 
USA 163 ng/g lipid (serum) 108-240 
Males and females 
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 0.41 µg/L (plasma) 0.33-0.49 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Sweden 1.9 ng/g lipid (breast milk) 
(a)
 <0.40-16 
(b)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 71 PBDE 99 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders Could not be calculated (serum) N/A 
Adolescents  
(age 14-15) 
2007-2009 FLEHS II 
USA 42.2 ng/g lipid (serum) 33.3-54.8 
Males and females 
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 0.08 µg/L (plasma) 0.07-0.09 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Sweden 0.45 ng/g lipid (breast milk) 
(a)
 <0.12-5.2 
(b)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 72 PBDE 100 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders Could not be calculated (serum) N/A 
Adolescents  
(age 14-15) 
2007-2009 FLEHS II 
USA 36.5 ng/g lipid (serum) 24.6-54.0 
Males and females  
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 0.09 µg/L (plasma) 0.06-0.12 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Sweden 0.36 ng/g lipid (breast milk) 
(a)
 <0.1-5.1 
(b)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 73 PBDE 153 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 1.43 ng/g fat (serum) 1.20-1.65 
Adolescents  
(age 14-15) 
2007-2009 FLEHS II 
USA 65.7 ng/g lipid (serum) 54.9-88.4 
Males and females  
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 0.22 µg/L (plasma) 0.14-0.29 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Sweden 0.64 ng/g lipid (breast milk) 
(a)
 <0.20-4.6 
(b)
 Swedish mothers 1996-2006 (Lignell et al., 2009) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 74 1-Hydroxyphenanthrene (PAH metabolite for phenanthrene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.6 µg/L (urine) 0.54-0.64 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
USA 565 ng/L (urine) 476-699 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.69 µg/L (urine) 0.53-0.84 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 75 2-Hydroxyphenanthrene (PAH metabolite for phenanthrene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.4 µg/L (urine) 0.32-0.37 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
USA 285 ng/L (urine) 259-317 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.23 µg/L (urine) 0.18-0.29 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 76 3-Hydroxyphenanthrene (PAH metabolite for phenanthrene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.5 µg/L (urine) 0.44-0.52 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
USA 371 ng/L (urine) 270-491 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.39 µg/L (urine) 0.31-0.46 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 77 4-Hydroxyphenanthrene (PAH metabolite for phenanthrene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.2 µg/L (urine) 0.16-0.23 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
USA 98.0 ng/L (urine) 88.0-113 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.13 µg/L (urine) 0.11-0.15 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 78 1-Hydroxypyrene (PAH metabolite for pyrene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.5 µg/L (urine) 0.42-0.57 
Adults  
(age 18-69) 
GerES III 
(1997-1999) 
(Wilhelm et al., 
2008) 
 0.5 µg/L (urine) 0.40-0.48 
Non-smoking children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
Flanders 
1. 281 ng/L (urine)  
2. 281 ng/L (urine) 
1. 216-347 
2. 223-338 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 629 ng/L (urine) 513-833 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 0.57 µg/L (urine) 0.47-0.68 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II  
(Second Report) 
South Korea 0.15 µg/L (urine) 
(a)
 0.13-0.17 
(b)
 
Adults  
(age 20 or older) 
2008-2009 (Sul et al., 2012) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The 95% CI for the geometric mean is reported here.  
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Table 79 1-Hydroxynaphthalene (1-Naphthol; PAH metabolite for naphthalene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 3.26 µg/L (urine) 
(a)
 
2. 9.58 µg/L (urine) 
(a)
 
N/A 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
USA 29.2 µg/L (urine) 22.2-41.1 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 15 µg/L (urine) 12-19 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
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Table 80 2-Hydroxynaphthalene (2-Naphthol; PAH metabolite for naphthalene) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 7.49 µg/L (urine) 
(a)
 
2. 12.27 µg/L (urine) 
(a)
 
N/A 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
USA 26.7 µg/L (urine) 23.1-30.8 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 24 µg/L (urine) 18-30 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 3.84 µg/L (urine) 
(a)
 3.57-4.11 
(b)
 
Adults  
(age 20 or older) 
2008-2009 (Sul et al., 2012) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The 95% CI for the geometric mean is reported here. 
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Table 81 Mono-benzyl phthalate [MBzP; phthalate metabolite for benzylbutyl phthalate (BzbP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 75 µg/L (urine) 
2. 15 µg/L (urine) 
N/A 
1. Children (age 3-14) 
2. Adults (age 20-29) 
1. 2003-2006 
2. 2006 & 2008 
(Schulz et al., 
2012b) 
Flanders 
1. 109.4 µg/L (urine) 
2. 71.6 µg/L (urine) 
1. 83.4-135.5 
2. 52.6-90.5 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 33.6 µg/L (urine) 28.6-39.4 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 57 µg/L (urine) 48-65 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 15.8 µg/L (urine) 
(a)
 2.8 
(b)
 
Adults  
(age 18-70) 
2009 (Lee et al., 2011) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The standard error of the geometric mean is reported here.  
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Table 82 Mono-isobutyl phthalate [MiBP; phthalate metabolite for dibutyl phthalates (DBP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 300 µg/L (urine) 
2. 140 µg/L (urine) 
N/A 
1. Children (age 3-14) 
2. Adults (age 20-29) 
1. 2003-2006 
2. 2006 & 2008 
(Schulz et al., 
2012b) 
USA 36.0 µg/L (urine) 32.4-41.0 
Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 64 µg/L (urine) 50-79 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 17.0 µg/L (urine) 
(a)
 2.2 
(b)
 
Adults  
(age 18-70) 
2009 (Lee et al., 2011) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The standard error of the geometric mean is reported here.  
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Table 83 Mono-n-butyl phthalate [MnBP; phthalate metabolite for dibutyl phthalates (DBP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 300 µg/L (urine) 
2. 70 µg/L (urine) 
N/A 
1. Children (age 3-14) 
2. Adults (age 20-29) 
1. 2003-2006 
2. 2006 & 2008 
(Schulz et al., 
2012b) 
Flanders 
1. 87.6 µg/L (urine) 
2. 84.5 µg/L (urine) 
1. 72.7-102.4 
2. 61.9-107.0 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 53.1 µg/L (urine) 43.3-70.4 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 87 µg/L (urine) 74-100 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II (Second 
Report) 
South Korea 41.7 µg/L (urine) 
(a)
 1.9 
(b)
 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The standard error of the geometric mean is reported here.  
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Table 84 Mono-cyclohexyl phthalate [MCHP; phthalate metabolite for dicyclohexyl phthalate (DCHP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
USA Could not be calculated (urine) N/A 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 0.47 µg/L (urine) 0.28-0.67 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea Could not be calculated (urine) N/A 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
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Table 85 Mono-2-ethylhexyl phthalate [MEHP; phthalate metabolite for di-2-ethylhexyl phthalate (DEHP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 12.4 µg/L (urine) 
2. 9.9 µg/L (urine) 
1. 8.7-16.2 
2. 7.5-12.4 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 8.8 µg/L (urine) 7.6-10 
Males and females  
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 9.0 µg/L (urine) 7.8-10 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 86 Mono-(2-ethyl-5-hydroxyhexyl) phthalate [MEHHP/5OH-MEHP; phthalate metabolite for di-2-ethylhexyl phthalate (DEHP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 160 µg/L (urine) 
2. 30 µg/L (urine) 
N/A 
1. Children (age 3-14) 
2. Adults (age 20-29) 
1. 2003-2006 
2. 2006 & 2008 
(Schulz et al., 
2012b) 
Flanders 
1. 75.1 µg/L (urine) 
2. 35.7 µg/L (urine) 
1. 57.8-92.3 
2. 24.3-47.0 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 43.8 µg/L (urine) 40.3-47.2 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 59 µg/L (urine) 48-70 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 38.1 µg/L (urine) 
(a)
 1.9 
(b)
 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The standard error of the geometric mean is reported here.  
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Table 87 Mono-(2-ethyl-5-oxohexyl) phthalate [MEOHP/5oxo-MEHP; phthalate metabolite for di-2-ethylhexyl phthalate (DEHP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1. 120 µg/L (urine) 
2. 20 µg/L (urine) 
N/A 
1. Children (age 3-14) 
2. Adults (age 20-29) 
1. 2003-2006 
2. 2006 & 2008 
(Schulz et al., 
2012b) 
Flanders 
1. 116.5 µg/L (urine) 
2. 71.9 µg/L (urine) 
1. 85.7-147.2 
2. 45.0-98.9 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
USA 26.6 µg/L (urine) 23.5-30.5 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 34 µg/L (urine) 30-39 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea 17.5 µg/L (urine) 
(a)
 1.9 
(b)
 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The standard error of the geometric mean is reported here.  
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Table 88 Mono-isononyl phthalate [MNP/MiNP; phthalate metabolite for di-isononyl phthalate (DiNP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
USA 19.5 µg/L (urine) 13.7-28.3 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada Could not be calculated (urine) <LOD 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea Could not be calculated (urine) N/A 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
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Table 89 Mono-n-octyl phthalate [MOP/MnOP; phthalate metabolite for di-n-octyl phthalate (DOP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
USA Could not be calculated (urine) N/A 
Males and females 
(age 6 or older) 
2009-2010 
NHANES 
(Fourth Report) 
Canada Could not be calculated (urine) N/A 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
South Korea Could not be calculated (urine) N/A 
Adults 
(age 18-70) 
2009 (Lee et al., 2011) 
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Table 90 Bisphenol A 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 6.60 µg/L (urine) 4.61-8.59 
Adolescents 
(age 14-15) 
2007-2009 FLEHS II 
USA 8.9 µg/L (urine) 7.6-11 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 6.7 µg/L (urine) 4.8-8.6 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 91 Triclosan 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 91.5 µg/L (urine) 41.5-141.4 
Adolescents  
(age 14-15) 
2007-2009 FLEHS II 
USA 565 µg/L (urine) 427-747 
Males and females 
(age 6 or older) 
2011-2012 
NHANES 
(Fourth Report) 
Canada 710 µg/L (urine) 540-880 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 92 p,p’-DDT (4,4’-DDT)  
Country Reference values (matrix) 95% CI Reference population Study period Reference 
France 33.2 ng/g lipid (serum) 10.7-47.8 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 19.5 ng/g lipid (serum) 15.1-27.5 
Males and females 
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 0.09 µg/L (plasma) <LOD-0.15 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Republic 98 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway 5.3 ng/g lipid (serum) 
(a)
 0.20-25 
(b)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): The mean value is reported here as the P95 value is not reported in this study. 
(b): The range value (min-max) is reported here. 
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Table 93 2,4,5-trichlorophenol (2,4,5-TCP) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1: 0.5 µg/L (urine) 
2: 1 µg/L (urine) 
N/A 
1: Children (age 3-14) 
2: Adults (age 18-69) 
1: 2003-2006 
2: 1997-1999 
(Schulz et al., 
2012b) 
France 0.67 µg/L (urine) 0.43-0.76 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 0.30 µg/L (urine) 0.20-0.30 
Males and females 
(age 6 or older) 
2009-2010 
NHANES  
(Fourth Report) 
Canada Could not be calculated (urine) <LOD 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 94 2,4,6-trichlorophenol (2,4,6-TCP) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1: 0.7 µg/L (urine) 
2: 1.5 µg/L (urine) 
N/A 
1: Children (age 3-14) 
2: Adults (age 18-69) 
1: 2003-2006 
2: 1997-1999 
(Schulz et al., 
2012b) 
France 1.00 µg/L (urine) 0.80-1.06 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 1.10 µg/L (urine) 1.00-1.40 
Males and females 
(age 6 or older) 
2009-2010 
NHANES  
(Fourth Report) 
Canada Could not be calculated (urine) <LOD 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 95 2,4-dichlorophenol (2,4-DCP) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1: 2 µg/L (urine) 
2: 3 µg/L (urine) 
N/A 
1: Children (age 3-14) 
2: Adults (age 18-69) 
1: 2003-2006 
2: 1997-1999 
(Schulz et al., 
2012b) 
France 7.62 µg/L (urine) 4.92-17.45 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 9.10 µg/L (urine) 5.70-12.6 
Males and females 
(age 6 or older) 
2011-2012 
NHANES  
(Fourth Report) 
Canada 12 µg/L (urine) 7.1-18 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 96 2,5-dichlorophenol (2,5-DCP) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
1: 6 µg/L (urine) 
2: 20 µg/L (urine) 
N/A 
1: Children (age 3-14) 
2: Adults (age 18-69) 
1: 2003-2006 
2: 1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 8.88 µg/L (urine) 
2. 14.2 µg/L (urine) 
1. 4.90-12.86 
2. 8.2-20.2 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
France 216.23 µg/L (urine) 107.41-933.79 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 227 µg/L (urine) 126-404 
Males and females 
(age 6 or older) 
2009-2010 
NHANES  
(Fourth Report) 
Canada 77 µg/L (urine) 35-120 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 97 Diethylphosphate [DEP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 30 µg/L (urine) 27.6-35.4 
Children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 16 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
Flanders 
1. 11.8 µg/L (urine) 
2. 8.2 µg/L (urine) 
1. 7.7-15.8 
2. 5.8-10.6 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
France 22.44 µg/L (urine) 17.88-46.72 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 15.3 µg/L (urine) 13.1-17.8 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 19 µg/L (urine) 16-21 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 98 Dimethylphosphate [DMP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 75 µg/L (urine) 69.3-88.0 
Children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 135 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
Flanders 
1. 20.6 µg/L (urine) 
2. 14.7 µg/L (urine) 
1. 15.4-25.9 
2. 10.6-18.9 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
France 64.95 µg/L (urine) 43.98-108.18 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 35.6 µg/L (urine) 30.3-39.4 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 26 µg/L (urine) 22-29 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 99 Diethylthiophosphate [DETP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 10 µg/L (urine) 7.79-10.7 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
Flanders Could not be calculated (urine) N/A 
Newborns & adolescents  
(age 14-15) 
2007-2011 FLEHS II 
France 8.18 µg/L (urine) 5.28-9.91 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 4.35 µg/L (urine) 2.95-6.01 
Males and females 
(age 12 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 5.3 µg/L (urine) 3.2-7.4 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 100 Dimethylthiophosphate [DMTP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 100 µg/L (urine) 93.1-123 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 160 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
Flanders 
1. 16.6 µg/L (urine) 
2. 19.0 µg/L (urine) 
1. 11.3-21.4 
2. 13.2-24.8 
1. Adolescents (age 14-15) 
2. Adults 
2007-2009 FLEHS II 
France 62.95 µg/L (urine) 49.24-75.80 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 36.8 µg/L (urine) 27.8-45.7 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 37 µg/L (urine) 27-47 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 101 Diethyldithiophosphate [DEDTP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany <0.3 µg/L (urine) 0.20-0.36 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
Flanders Could not be calculated (urine) N/A 
Newborns & adolescents  
(age 14-15) 
2007-2011 FLEHS II 
France 0.358 µg/L (urine) 0.134-0.762 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA Could not be calculated (urine) <LOD 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada Could not be calculated (urine) <LOD 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 102 Dimethyldithiophosphate [DMDTP; organophosphate metabolite for dialkyl phosphate (DAP)] 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 10 µg/L (urine) 6.10-12.9 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
Flanders Could not be calculated (urine) N/A 
Newborns & adolescents  
(age 14-15) 
2007-2011 FLEHS II 
France 6.94 µg/L (urine) 4.88-9.43 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 5.60 µg/L (urine) 4.62-6.79 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 6.5 µg/L (urine) 5.2-7.8 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 103 p,p'-DDE (4,4'-DDE) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 1.4 µg/L (whole blood) 1.31-2.00 
Children living in eastern Germany 
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 1.5-31 µg/L (whole blood) 
(a)
 N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 192 ng/g fat (serum) 
2. 207 ng/g fat (serum) 
1. 162-221 
2. 151-263 
1. Newborns 
2. Adolescents (age 14-15) 
2007-2011 FLEHS II 
France 729 ng/g lipid (serum) 604-934 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 1860 ng/g lipid (serum) 1400-2380 
Males and females 
(age 12 or older) 
2003-2004 
NHANES 
(Fourth Report) 
Canada 6.51 µg/L (plasma) 4.37-8.66 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I 
(First Report) 
Czech Republic 880 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway 210 ng/g lipid (serum) 
(b)
 29-770 
(c)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): The range of reference values from lowest to highest is reported here. 
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here. 
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Table 104 Hexachlorobenzene (HCB) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.2 µg/L (whole blood) 0.21-0.23 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 0.4-5.8 µg/L (whole blood) 
(a)
 N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
Flanders 
1. 22.5 ng/g fat (serum) 
2. 14.0 ng/g fat (serum) 
1. 19.9-25.1 
2. 12.4-15.7 
1. Newborns 
2. Adolescents (age 14-15) 
2007-2011 FLEHS II 
France 73 ng/g lipid (serum) 60-117 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 28.9 ng/g lipid (serum) 25.6-32.8 
Males and females 
(age 12 or older) 
2003-2004 
NHANES  
(Fourth Report) 
Canada 0.17 µg/L (plasma) 0.14-0.20 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Republic 642.3 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway 43 ng/g lipid (serum) 
(b)
 15-85 
(c)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): The range of reference values from lowest to highest is reported here.  
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here.  
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Table 105 beta-Hexachlorocyclohexane (β-HCH) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 0.1 µg/L (whole blood) 0.077-0.097 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 0.1-0.9 µg/L (whole blood) 
(a)
 N/A 
Adults 
(age 18-69) 
1997-1999 
(Schulz et al., 
2012b) 
France 190 ng/g lipid (serum) 160-260 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 56.5 ng/g lipid (serum) 43.7-69.4 
Males and females 
(age 12 or older) 
1999-2000 
NHANES  
(Fourth Report) 
Canada 0.54 µg/L (plasma) 0.07-1.01 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Republic 75.2 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway 8.8 ng/g lipid (serum) 
(b)
 1.4-25 
(c)
 Norwegian adult males 2007 (Nøst et al., 2013) 
(a): The range of reference values from lowest to highest is reported here. 
(b): The mean value is reported here as the P95 value is not reported in this study. 
(c): The range value (min-max) is reported here.  
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Table 106 gamma-Hexachlorocyclohexane (γ-HCH) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 
Could not be calculated (whole 
blood) 
<LOD 
Children  
(age 7-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
France Could not be calculated (serum) <LOD 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA Could not be calculated (serum) <LOD 
Males and females 
(age 12 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada Could not be calculated (plasma) <LOD 
Canadian adults 
(age 20-79) 
2007-2009 
CHMS I  
(First Report) 
Czech Republic 19.8 ng/g lipid (breast milk) N/A 
Mothers 
(Median age: 26) 
1993-2003 (Mikeš et al., 2012) 
Norway Could not be calculated (serum) <LOD Norwegian adult males 2007 (Nøst et al., 2013) 
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Table 107 cis-2,2-dichlorovinyl-2,2-dimethylcyclopropane-1-carboxylic acid (cis-Cl2CA; pyrethroid metabolite) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 1 µg/L (urine) 0.64-1.65 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 1 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
France 1.42 µg/L (urine) 0.67-2.17 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Canada 2.2 µg/L (urine) 0.78-3.6 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 108 trans-2,2-dichlorovinyl-2,2-dimethylcyclopropane-1-carboxylic acid (trans-Cl2CA; pyrethroid metabolite) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 2 µg/L (urine) 1.66-2.22 
Children  
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 2 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
France 3.85 µg/L (urine) 2.44-5.27 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
Canada 6.8 µg/L (urine) 2.1-11 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
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Table 109 3-phenoxybenzoic acid (3-PBA) 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Germany 2 µg/L (urine) 2.24-2.87 
Children 
(age 3-14) 
GerES IV 
(2003-2006) 
(Schulz et al., 2009) 
 2 µg/L (urine) N/A General population 1998 
(Schulz et al., 
2012b) 
Flanders 
1. 0.41 µg/L (urine) 
(a)
 
2. 0.58 µg/L (urine) 
(a)
 
N/A 
1. Adolescents (age 14-15) 
2. Adults 
2007-2011 FLEHS II 
France 4.36 µg/L (urine) 3.41-6.15 
French adults 
(age 18-74) 
2006-2007 
ENNS report 
(pollutants) 
USA 6.63 µg/L (urine) 4.99-8.24 
Males and females 
(age 6 or older) 
2007-2008 
NHANES  
(Fourth Report) 
Canada 5.9 µg/L (urine) 2.2-9.5 
Canadian population 
(age 3-79) 
2009-2011 
CHMS II 
(Second Report) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
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Table 110 Cotinine 
Country Reference values (matrix) 95% CI Reference population Study period Reference 
Flanders 
1. 2329 µg/g creatinine (urine) 
(a)
 
2. 4572 µg/g creatinine (urine) 
(a)
 
N/A 
1. Adolescent smokers (age 14-15) 
2. Adult smokers 
2007-2011 FLEHS II 
USA 1.29 ng/mL (serum) 1.04-1.61 
Non-smokers 
(age 3 or older) 
2009-2010 
NHANES 
(Fourth Report) 
Canada 
1. Could not be calculated (urine) 
2. 2600 µg/L (urine) 
1. N/A 
2. 2100-3100 
1. Non-smokers (age 3-79) 
2. Smokers (age 12-79) 
2009-2011 
CHMS II  
(Second Report) 
South Korea 
1. 769.88 µg/L (urine) 
(a) 
2. 21.52 µg/L (urine) 
(a)
 
1. 610.55-929.21 
(b)
 
2. 19.11-23.93 
(b)
 
1. Non-smokers (age 20 or older) 
2. Smokers (age 20 or older) 
2008-2009 (Sul et al., 2012) 
(a): The geometric mean is reported here as the P95 value is not reported in this study. 
(b): The 95% CI for the geometric mean is reported here. 
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ABBREVIATIONS 
2,4-D   2,4-dichlorophenoxyacetic acid 
2,4,5-T   2,4,5-trichlorophenoxyacetic acid 
3-MCPD  3-monochloropropane-1,2 diol ester 
3-PBA   3-phenoxybenzoic acid 
5cx-MEPP/MECPP Mono(2-ethyl-5-carboxypentyl) phthalate 
5OH-MEHP/MEHHP Mono(2-ethyl-5-hydroxyhexyl) phthalate 
5oxo-MEHP/MEOHP Mono(2-ethyl-5-oxohexyl) phthalate 
6-CINA  6-chloronicotinic acid 
8-OHdG  8-hydroxydeoxyguanosine 
AAS   Atomic absorption spectrometry 
ADI   Acceptable Daily Intake 
AFC The Panel on Food Additives, Flavourings, Processing Aids and Materials in 
Contact with Food (EFSA) 
AFS Atomic Fluorescence Spectroscopy 
Ag   Silver 
Al   Aluminium 
ALARA  As Low As Reasonably Achievable 
AMAP   Arctic Monitoring and Assessment Programme 
AMI   Danish National Institute of Occupational Health 
ANMI Associazione Nazionale Per La Lotta Contro Le Microcitemie [National 
Italian Association against Microcythemia (Italy)] 
ANS The Panel on Food Additives and Nutrient Sources Added to Food (EFSA) 
APCI Atmospheric Pressure Chemical Ionisation 
As   Arsenic 
Au   Gold 
AVIS   Associazione Volontari Italiani Sungue (Italian Blood Volunteer Association) 
B   Boron 
Ba   Barium 
BAL   Biomonitoring Action Level 
BBzP   Butyl-benzyl phthalate 
Be   Beryllium 
BE   Biological Equivalent 
BEPOD   Biological Equivalent derived from the Point-of-Departure 
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BERfD   Biological Equivalent derived from the Reference Dose 
BEI   Biological Exposure Indices 
BFR   Brominated Flame Retardant 
BM   Biomarker 
BMBF Bundesministerium für Bildung und Forschung [Federal Ministry of 
Education and Research (Germany)] 
BMDL Benchmark Dose Lower Confidence Limit 
BMI   Body Mass Index 
BMUB  Bundesministerium für Umwelt, Naturschutz, Bau und Reaktorsicherheit 
[Federal Ministry of the Environment, Nature Conservation and Nuclear 
Safety (Germany)] 
BPA   Bisphenol A 
Br2CA   cis-3-(2,2-dibromo-vinyl)-2,2-dimethylcyclo-propanecarboxylic acid 
BTBPE   1,2-bis(2,4,6-tribromophenoxy)ethane 
Ca   Calcium 
CALUX  Chemically activated luciferase gene expression assay 
CATI   Computer-assisted interviews 
Cd   Cadmium 
CDC   Centers for Disease Control and Prevention (USA) 
CEF The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (EFSA) 
CF Consultative Forum 
CHMS   Canadian Health Measures Survey 
CI   Confidence Interval 
cis-Cl2CA  cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid 
CNAF Caisse nationale des allocations familiales [National Family Allowance Office 
(France)] 
CNAMTS Caisse nationale d'assurance maladie des travailleurs salaries [National Health 
Insurance Fund for Salaried Workers (France)] 
Co   Cobalt 
CONTAM  The Panel on Contaminants in the Food Chain (EFSA)  
COPHES  Consortium to Perform Human biomonitoring on a European Scale 
CORDIS Community Research and Development Information Service (European 
Commission) 
Cr   Chromium 
Cs   Cesium 
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Cu   Copper 
CV-AAS  Cold Vapour Atomic Absorption Spectrometry 
DAP   Dialkylphosphate 
DBNC   Danish National Birth Cohort 
DBNPG  2,2-bis(bromomethyl)-1,3-propanediol 
DBP   Disinfection by-products 
DCHP   Di-cyclohexyl phthalate 
DCP   Dichlorophenol 
DDD   Dichlorodiphenyldichloroethane 
DDE   Dichlorodiphenyldichloroethylene 
DDT   Dichlorodiphenyltrichloroethanes 
DEDTP   Diethyl dithiophosphate 
DEHP   Di(2-ethylhexyl) phthalate 
DEMOCOPHES Demonstration of a Study to Coordinate and Perform Human Biomonitoring 
on an European Scale 
DEP   Diethylphosphate (organophosphate) or Diethyl phthalate (phthalate) 
DETP   Diethylthiophosphate 
DiBP   Di-iso-butyl phthalate 
DiDP   Di-iso-decyl phthalate 
DINCH   Di(isononyl) cyclohexane-1,2-dicarboxylate or Diisononylcyclohexanoate 
DiNP   Di-iso-nonyl phthalate 
DL   Dioxin-like 
DMA   Direct mercury analyser 
DMDTP  Dimethyl dithiophosphate 
DMEL   Derived Minimal Effect Level 
DMP   Dimethylphosphate (organophosphate) or Dimethyl phthalate (phthalate) 
DMTP   Dimethyl thiophosphate 
DNA   Deoxyribonucleic acid 
DNBC   Danish National Birth Cohort Study 
DnBP   Di-n-butyl phthalate 
DNEL   Derived No Effect Level 
DnOP/DOP  Di-n-(Octyl) phthalate 
DnPeP   Di-n-pentyl phthalate 
DPHP   Di-propy-heptyl phthalate 
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ECD   Electron Capture Detector 
ECHA   European Chemicals Agency 
ECNI   Electron Capture Negative Ion 
ECNIS   Environmental Cancer Risk, Nutrition and Individual Susceptibility (Europe) 
EDEN French cohort study on early live determinants for neurodevelopment and 
children’s health (Etude de cohorte généraliste, menée en France sur les 
Déterminants pré et post natals précoces du développement psychomoteur et 
de la santé de l’Enfant) 
EDI   Estimated Dietary Intakes 
EFSA   European Food Safety Authority 
EHA   Environmental Health Act (Korea) 
EHAP   Environment and Health Action Plan (EU) 
EHBMI  European HBM Initiative  
EHMS   Environmental Health Monitoring System (Czech Republic) 
ELFE   Étude longitudinal française depuis l’enfance (France) 
ELISA   Enzyme-linked immunosorbent assay 
ENNS Étude nationale nutrition santé [National Nutrition and Health Survey 
(France)] 
EPA   Environmental Protection Agency (USA) 
EQUAS  External Quality Assessment Schemes 
ERI   Emerging Risk Identification 
ESB   Environmental Specimen Bank (Germany) 
ESBHum   Environmental Specimen Bank for Human Tissues (Germany)  
ESBIO   Expert Team to Support Biomonitoring in Europe 
ESTEBAN Étude de santé sur l’environment, la biosurveillance, l’activité physique 
(France) 
ET-AAS  Electrothermal Atomic Absorption Spectroscopy 
EtP   Ethylparaben 
Et-PFOSA-AcOH 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid 
EU   European Union 
EU MS   European Union Member State 
EWAS   Exposome-Wide Association Study 
FAO   Food and Agriculture Organization of the United Nations 
F-AAS   Flame Atomic Absorption Spectroscopy 
Fe   Iron 
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FEEDAP The Panel on Additives and Products or Substances used in Animal Feed 
(EFSA) 
FFQ   Food Frequency Questionnaire 
FIP   Food Ingredients and Packaging Unit (EFSA) 
Fl   Fluoride 
FLEHS   Flemish Environment and Health Study 
FP   Framework Programme (European Commission) 
F-PBA   4-fluoro-3-phenoxybenzoic acid 
FUGE   Functional Genomics Programme(Norway) 
GC   Gas Chromatography 
GC-MSD  Gas Chromatography-Mass Spectrometer Detector 
GerES   German Environmental Survey 
GF-AAS  Graphite Furnace Atomic Absorption Spectroscopy 
GIS   Geographic Information Systems 
GM   Geometric Mean 
GMO   Genetically Modified Organisms 
GP   General Practitioner 
GWAS   Genome-Wide Association Study 
Hb   Haemoglobin 
HBB   Hexabromobenzene  
HBCD/HBCDD Hexabromocyclododecane 
HBGV   Health-Based Guidance Value 
HBM   Human Biomonitoring 
HCB   Hexachlorobenzene 
HCH   Hexachlorocyclohexane 
HEALS Health and Environment-wide Associations based on Large Population 
Surveys (Europe) 
HELIX The Human Early Life Exposome (Europe) 
Hg   Mercury 
HG-AAS  Hydride Generation Atomic Absorption Spectroscopy 
HpBDD  Heptabromodibenzo-p-dioxin 
HpBDF   Heptabromodibenzo-p-furan 
HpCDD  Heptachlorodibenzo-p-dioxin 
HpCDF   Heptachlorodibenzo-p-furan 
HPLC   High Performance Liquid Chromatography 
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HRGC   High Resolution Gas Chromatography 
HRMS   High Resolution Mass Spectrometry 
HxBDD  Hexabromodibenzo-p-dioxin 
HxBDF   Hexabromodibenzo-p-furan 
HxCDD  Hexachlorodibenzo-p-dioxin 
HxCDF   Hexachlorodibenzo-p-furan 
IARC   International Agency for Research on Cancer 
IC   Ion Chromatography 
ICI   Interlaboratory Comparison Investigations 
ICP   Inductively Coupled Plasma 
ID-ICP-MS  Isotope Dilution Inductively Coupled Plasma Mass Spectrometry 
IEHIAS  Integrated Environment Health Impact Assessment System 
IgE   Immunoglobulin E 
IMI   Imidacloprid 
INED Institut national d’études démographiques [National Institute for 
Demographic Studies (France)] 
INMA Infancia y Medio Ambiente (Spain) 
INSEE Institut national de la statistique et des études économiques [National Institute 
for Statistics and Economic Studies (France)] 
INSERM Institut national de la santé et de la recherche médicale [National Institute for 
Health and Medical Research (France)] 
INTARESE Integrated Assessment of Health Risks from Environmental Stressors in 
Europe 
InVS   Institut de Veille Sanitaire [Institute for Public Health Surveillance (France)] 
Ir   Iridium 
ISCIII   Instituto de Salud Carlos III [National Institute of Health Carlos III (Spain)] 
ISS   Istituto Superiore di Sanità [National Institute of Health (Italy)] 
JECFA   The Joint FAO/WHO Expert Committee on Food Additives 
JECS   Japan Environmental and Children’s Study 
K   Potassium 
KCDC   Korea Centers for Disease Control and Prevention 
KiGGS Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland 
(German Health Interview and Examination Survey for Children and 
Adolescents) 
KNHANES  Korea National Health and Nutrition Examination Survey  
KorEHS-C  Korean Environmental Health Survey in Children and Adolescents  
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KorSEP  Korea National Survey for Environmental Pollutants in the Human Body 
LC   Liquid Chromatography 
LC/LC   Multidimensional Liquid Chromatography 
Li   Lithium 
LOAEL  Lowest-Observed-Adverse-Effect Level 
LOD   Limit of Detection 
LOQ   Limit of Quantitation 
MBRN   Medical Birth Registry of Norway 
MBzP   Mono-benzyl phthalate 
MCHP   Mono-cyclohexyl phthalate 
MCNP   Mono-carboxy-isononyl phthalate 
MCOP   Mono-carboxy-octyl phthalate 
MCP   Monochlorophenol 
MCPP   Mono-3-carboxypropyl phthalate 
MDA   Malondialdehyde 
MDI   Mental Developmental Indices 
MeHg   Methyl mercury 
MEHP   Mono(2-ethylhexyl) phthalate 
MeP   Methylparaben 
MEP   Mono-ethyl phthalate 
Me-PFOSA-AcOH 2-(N-methyl-perfluorooctane sulfonamido) acetic acid 
Mg   Magnesium 
MHNCH  Mono hydroxyisononyl ester 
MiBP   Mono-iso-butyl phthalate 
MiNP   Mono-iso-nonyl phthalate 
MIREC   Maternal-Infant Research on Environmental Chemicals (Canada) 
MMP   Mono-methyl phthalate 
Mn   Manganese 
MnBP   Mono-n-butyl phthalate 
MnOP/MOP  Mono-n-(octyl) phthalate 
Mo   Molybdenum 
MoBa   The Norwegian Mother and Children Cohort Study 
MOCEH  The Mother’s and Children’s Environmental Health Study (Korea) 
MOE   Margin of Exposure (risk assessment) or Ministry of the Environment (Japan) 
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MS   Mass Spectrometry 
MS/MS   Tandem Mass Spectrometry 
Na   Sodium 
NAAP   N-acetyl-4-aminophenol 
NAS   National Academy of Sciences (USA) 
NBAS   Neonatal Behavioral Assessment Scale 
NCHS   National Center for Health Statistics (USA) 
NCI   Negative Chemical Ionisation 
NDA   The Panel on Dietetic Products, Nutrition and Allergies (EFSA) 
NDL   Non-dioxin like 
NEHAP  National Environmental Health Action Plan (Korea) 
NHANES  National Health and Nutrition Examination Survey (USA)  
Ni   Nickel 
NIEHS   National Institute of Environmental Health Sciences (USA) 
NIER   National Institute of Environmental Research (Korea) 
NIH   National Institute of Health (USA) 
NINDS   National Institute of Neurological Disorders and Stroke (USA) 
NIPH   Norwegian Institute of Public Health 
NNAL   4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol 
NOAEL  No-Observed-Adverse-Effect Level 
OCDD   Octachlorodibenzo-p-dioxin 
OCDF   Octachlorodibenzo-p-furan 
OCP   Organochlorine pesticide 
OECD   Organisation for Economic Co-operation and Development 
OELV   Occupational Exposure Limit Values 
OP   Organophosphate 
OR   Odds Ratio 
P   Phosphorus 
P90   90
th
 Percentile 
P95   95
th
 Percentile 
PAH   Polyaromatic hydrocarbon 
PANCAKE Pilot Study for Assessment of Nutrient Intake and Food Consumption among 
Kids in Europe (EFSA) 
Pb   Lead 
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PBDE   Polybrominated diphenyl ethers 
PBPK   Physiologically based pharmacokinetic 
PBT   Persistent bioaccumulative and toxic chemicals 
PCB   Polychlorinated biphenyls 
PCDD   Polychlorinated dibenzodioxins 
PCDF   Polychlorinated dibenzofurans 
PCP   Pentachlorophenol 
Pd   Palladium 
PDI   Psychomotor Developmental Indices 
PeBDD   Pentabromodibenzo-p-dioxin 
PeBDF   Pentabromodibenzo-p-furan 
PeCDD   Pentachlorodibenzo-p-dioxin 
PeCDF   Pentachlorodibenzo-p-furan 
PEM   Personal Exposure Monitoring 
PFAS   Perfluoroalkylated substance 
PFBuS   Perfluorobutane sulfonate 
PFC   Perfluorinated compound 
PFDA/PFDeA  Perfluorodecanoic acid 
PFDoA   Perfluorododecanoic acid 
PFHpA   Perfluoroheptanoic acid 
PFHxS   Perfluorohexane sulfonate 
PFNA   Perfluorononanoic acid 
PFOA   Perfluorooctanoic acid 
PFOS   Perfluorooctane sulfonate 
PFOSA   Perfluorooctanesulfonamide 
PFUA/PFUDA  Perfluoroundecanoic acid 
PHIME Public Health Impact of Long-Term, Low-Level Mixed Element Exposure in 
Susceptible Population Strata (Europe) 
PLM Post-Launch Monitoring 
PM(E)M Post-Market (Environmental) Monitoring 
PMS Post-Market Surveillance 
PMTDI Provisional Maximum Tolerable Daily Intake 
PNNS Programme national nutrition santé [National Programme on Health and 
Nutrition (France)] 
POP   Persistent Organic Pollutant 
  
Review of HBM and its application  
to exposure assessment for food safety 
 
EFSA supporting publication 2015:EN-724 320 
   
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
PPR   The Panel on Plant Protection Products and their Residues (EFSA) 
PROBE Programma per il biomonitoraggio dell’esposizione della popolazione 
generale [Programme for Biomonitoring of the Exposure (Italy)] 
PSA Prostate-Specific Antigen 
PSU   Primary Sampling Unit 
Pt   Platinum 
PVC   Polyvinyl chloride 
QA/QC   Quality Assurance/Control 
Rb   Rubidium 
RDA   Recommended Dietary Allowance 
REACH  Registration, Evaluation, Authorisation, and Restriction of Chemicals 
Rh   Rhodium 
RKI   Robert Koch Institute (Germany) 
(m/mi/r/t) RNA  (messenger/micro/ribosomal/transfer) Ribonucleic acid 
ROC   Receiver Operating Characteristic 
RP   Reference Point 
RSD   Relative Standard Deviation 
RV   Reference Value 
S   Sulfur 
Sb   Antimony 
SCALE   Science, Children, Awareness, Legal instrument, Evaluation (EU) 
SCOEL   Scientific Committee on Occupational Exposure Limit Values 
Se   Selenium 
SEBIOREC Epidemiological biomonitoring study on persistent organic pollutants in 
mothers milk in the Campania region (Studio epidemiologico sullo stato di 
salute e sui livelli d’accumulo di contaminanti organici persistenti nel sangue 
e nel latte materno in gruppi di popolazione a differente rischio d’esposizione 
nella Regione Campania) 
SES   Socioeconomic status 
SF-ICP-MS  Sector Field Inductively Coupled Plasma Mass Spectrometry  
SHS   Secondhand Smoke 
Sn   Tin 
S/N   Signal-to-noise ratio 
SNP   Single Nucleotide Polymorphism 
SOP   Standard Operating Procedure 
SPE   Solid Phase Extraction 
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Sr   Strontium 
SVHC                          Substances of Very High Concern 
TBBPA  Tetrabromobisphenol A 
TBDD   Tetrabromodibenzo-p-dioxin 
TBDF   Tetrabromodibenzo-p-furan 
TCDD   Tetrachlorodibenzo-p-dioxin 
TCDF   Tetrachlorodibenzo-p-furan 
TCP   Trichloropyridinol 
TDI   Tolerable Daily Intake 
TEF   Toxic Equivalent Factor 
TEQ   Toxic Equivalent Quantity 
TIS   Turbo Ion Spray ionisation 
Tl   Thallium 
trans-Cl2CA  trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid 
TWI   Tolerable Weekly Intake 
U   Uranium 
UBA   Umweltbundesamt [Federal Environment Agency (Germany)] 
UNEP   United Nations Environment Programme 
UPLC   Ultra Performance Liquid Chromatography 
USA   United States of America 
UV   Ultraviolet 
V   Vanadium 
VCI Verband der Chemischen Industrie [Chemical Industry Association 
(Germany)] 
VOC   Volatile Organic Compound 
W   Tungsten 
WHO   World Health Organisation 
WWF   World Wildlife Fund 
Zn   Zinc 
 
